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Interstrand cross-links (ICLs) are covalent linkages formed by reaction of 
nucleobases with a variety of bifunctional agents of exogenous (e.g. nitrogen mustard 
reagents) and endogenous (e.g. malondialdehyde) origin. Recently, electrophilic DNA 
lesions such as an AP site (apurinic/apyrimidinic site), C4'-oxidized abasic site (C4-AP), 
and dioxobutane (DOB) have also been implicated in ICL formation. A covalent linkage 
between the DNA strands prevents their separation, acting as a block for necessary 
cellular processes such as transcription and replication. Given the deleterious 
consequences of ICL formation on cellular pathways, eukaryotes and prokaryotes use 
nucleotide excision repair (NER) to remove interstrand cross-links. On one hand, cross-
link-causing external agents, a number of which are active anti-cancer drugs, try to 
exploit the toxicity of ICLs to kill the cell. On the other hand, diseases that hamper 
activities of proteins involved in NER (e.g. Fanconi anemia) increase vulnerability to 
ICL-causing agents. Therefore, understanding the mechanism of cross-link formation and 
tracing their biochemical fate remains extremely important.  
 C4-AP and DOB lesions are formed by anti-cancer chemotherapeutics and -
irradiation. The lesions reversibly react with the N6 amine of an adenosine (A) to form an 
unstable ICL. While the ICL between C4-AP and A has 3 h half-life, the one between 
DOB and A is modestly more stable (t1/2 = 10.1 h). Although unstable, both ICLs last 
long enough to potentially disrupt replication and transcription in cells. Intriguingly, both 
C4-AP and DOB ICLs are formed in a site selective manner, with an A opposite their 3'-
adjacent thymidine (T). The distances computed between N6 amine of A at the preferred 
site and the C1'-aldehyde of the electrophilic lesions is not radically different from that 
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involving an opposing A, making the site selectivity ambiguous. The C4-AP ICL 
eventually reverts to the lesion, undergoes a strand scission and forms a thermodynamic 
cross-link. The short lifetime of DOB and C4-AP ICLs make the investigation of their 
biochemical fate and site selective formation difficult.  
 Herein, we report the development of synthetic methodologies to prepare stable 
analogues of DOB and C4-AP ICLs. The procedures involve orthogonal removal of 
protecting groups from oligonucleotides on solid support without affecting any native 
DNA nucleobase or cyanoethyl protection and subsequent solid phase synthesis. In 
addition to being able to prepare any cross-link irrespective of sequence, the strategies 
can be applied to the synthesis of branched DNA and RNA.  
 The stable analogues of C4-AP and DOB ICLs were treated with UvrABC, the 
bacterial nucleotide excision repair proteins to understand their repair. The incision on 
C4-AP lesion was slow, with maximum 27 – 30% cleavage reported after 8 h, implying 
potentially deleterious consequence for processes like transcription and replication. No 
double strand break caused by repetitive incision on opposing strand was detected. In 
contrast, the DOB ICL analogue exclusively produced double strand breaks upon 
UvrABC treatment.  
 In addition to distance, relative stability in resulting ICL secondary structure was 
hypothesized as a driving force behind site selective cross-link formation. Stable 
oligonucleotides analogues of DOB and C4-AP ICLs with “observed” (ICL with A 
opposite 3'-adjacent T) and “unobserved” (ICL with opposing A) connectivities were 
synthesized. Upon treatment with chemical agents that detect distorted (solvent exposed) 
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nucleotides, the oligonucleotides with “unobserved” ICLs were found to have greater 
distortion. This was further verified using thermodynamic UV melting, where the 
“observed” ICLs had higher Tms.  
 In conclusion, our work describes novel strategies for synthesizing stable 
analogues of DOB and C4-AP ICLs irrespective of their sequence. The work is 
compatible with other ICL preparations, but is also extendable to branched DNA and 
RNA synthesis. The stable analogues were employed to address the biochemical fate of 
the respective ICLs in the context of bacterial nucleotide excision repair proteins, 
UvrABC endonuclease. Finally, the structures of the analogues were probed using 
chemical agents. The result was correlated with thermodynamic UV melting to draw light 
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1. Introduction 
DNA interstrand cross-link (ICL) is the formation of a covalent linkage between 
the strands. The covalent linkages can occur because of reaction between bifunctional 
agents and nucleobases from opposing strands (Figure 1A). The bifunctional agents have 











) origin (Figure 1B). Alternatively, reactions between 
electrophilic lesions such as an AP site,
6,7
 C4′-oxidized abasic site (C4-AP),
8
 dioxobutane  
 
Figure 1. Formation of interstrand cross-link (ICL) by reaction of DNA with a reagent (E) and structure of 
the AP site, C4-AP and DOB lesions. (A) ICL formation by reaction of DNA with a reagent (E). (B) 
Chemical structure of the AP site, C4-AP, DOB, nitrogen mustard, nitrosoureas, mitomycin C, psoralen, 
and malondialdehyde.  
(DOB)
9
 and nucleobases can also contribute to ICL formation (Figure 1B). Unless 

































































 and recombigenic effects.
14
 Exploiting their damaging potential, nitrogen 





 and skin diseases
17
 respectively. However, low 
selectivity of these chemotherapeutic agents against cancer cells along with metabolic 
biogenesis of bis-electrophiles such as malondialdehyde can lead to ICL formation in 
non-cancerous cells as well, endangering their survival. For these reasons, investigation 
of the formation and biochemical fate of ICLs is a vibrant area of research.  
Due to their potential genotoxicity, ICLs are removed by the nucleotide excision 
repair (NER) pathway in bacterial and mammalian cells. In bacterial cells UvrA, UvrB, 
and UvrC endonuclease proteins are responsible for the removal of cross-links. UvrA and 
UvrB recognize the damage while UvrC carries out the incision.
18
 The incision removes a 
12 – 13 nucleotide long segment that contains one of the cross-linked nucleotides. 
Following “gap filling” by a DNA polymerase in that strand, the remnants of the ICL are 
then removed by incision of the other strand.
18
 The incision efficiency is influenced by 
the size of the cross-link and the deformities it induces in the surrounding nucleotides.
19
 
However, UvrABC does not always remove ICLs in a flawless manner. Generation of 
double strand breaks (DSBs) by UvrABC treatment has been reported by simultaneous 
incision on both strands in more than one instance.
20,21
 In another study, DSBs are 
generated as a consequence of indiscriminate incisions on an ICL accompanied by a 
strand break.
22
 In-order-to capture the complete picture of ICL incision by UvrABC, the 
structural characterization of the ICL and an understanding of the structural influence on 
incision are necessary. 
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The C4′-oxidized abasic site (C4-AP) and dioxobutane (DOB) lesions are derived 
from hydrogen atom abstraction at the C4′ and C5′-position, respectively. Such hydrogen 
atom abstractions occur as a result of –radiolysis.23,24 In addition, the antitumor 
antibiotic bleomycin produces C4-AP, while the enediyne class of chemotherapeutic 
drugs produces C4-AP and DOB lesions.
25
 Both lesions form ICLs with deoxyadenosine 
(A) (Scheme 1).
8,9
  The cross-link by C4-AP is a kinetic ICL (1) generated reversibly 
with a half life of 3.5 h. The DOB ICL (2) is formed reversibly as well, albeit with a 
greater half life (10 h). Another intriguing fact about both the ICLs is their site-selective 
formation. The cross-links are generated predominantly with an A opposite the 3′-
adjacent nucleotide.
8,9
 Although lifetimes of both the ICLs are long enough to cause 
disruptions in cellular activities, their unstable nature renders their biochemical fates 
difficult to investigate. Likewise, the rationale behind the site-selective formation also 
remains unknown.  






















































In order to probe the biochemical fate and site-selective formation of the DOB 
and C4-AP kinetic ICLs, I synthesized stable mimics. Among the commonly used cross-
link synthesis strategies, one involves direct treatment of the duplex with a cross-linking 
agent. This method often results in mixtures of monoadducts and unstable ICLs.
26
 
Another drawback of this method are the low yields of isolated ICLs.
27
 An alternative 
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strategy is the use of post-oligomerization modification where a masked ICL precursor is 
incorporated into one of the strands by solid phase synthesis.
28
 The precursor is 
unmasked after duplex formation leading to cross-link formation with a nucleotide from 
the opposing strand. A similar approach involves incorporation of masked ICL precursors 
in both strands and  their conversion into an ICL following duplex formation.
29
 However, 
this method is conceptually identical with the formation of C4-AP and DOB ICLs which 
were originally generated by reaction of an electrophile in one strand with a nucleobase 
from the other.
30,31


























Figure 2. Structures of the synthetic mimics of DOB (3) and C4-AP kinetic ICL (4).  
An additional drawback of this method is sequence restriction. Due to the employment of 
highly reactive monoadducts, the adjoining sequence is deliberately deprived of 
nucleophilic nucleobases to prevent unwanted cross-linking. The third approach is the 
direct synthesis of the cross-linked dinucleotide. The dinucleotides are then converted 
into phosphoramidites where one or more hydroxyls are masked with protecting groups. 
After the phosphoramidite is incorporated into DNA by solid phase synthesis, sequential 
removal of protecting groups and oligonucleotide synthesis using the free hydroxyl group 
are employed for the cross-link mimic synthesis.
32,33
 Applicability of this method has 
been limited by either sequence symmetry or the lengths of the ICLs produced. We 
decided to upgrade the third method for the syntheses of mimics of 1 and 2. The 
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hemiaminal linkages were identified as the source of instability in the actual ICLs (1 and 
2) and were removed to stabilize the mimics.  Therefore, the proposed mimics (3 and 4, 
Figure 2) were in lower oxidation states than those of the actual ICLs. We deduced that 
such minor changes in chemical structure would not significantly affect their structural 
aspects or interaction with repair proteins.  
We report the synthesis of C4-AP and DOB ICL mimics using novel orthogonal 
deprotection strategies without any sequence restrictions. The strategies enabled synthesis 
of both mimics with oligonucleotide lengths appropriate for repair investigation. In an 
attempt to understand the biochemical fates of the ICLs, treatment of these mimics with 
UvrABC endonuclease is described. Finally, we hypothesized that site-selectivity of 
DOB and C4-AP ICL formation can originate as a result of attaining minimal 
deformation in the final ICL structure. We thus contemplated that chemical reagents, 
which react preferentially at the site of deformities would help us detect the stated 
structural distortion. Using the same line of reasoning we anticipated that we could 
employ thermal denaturation to probe the stability of the mimics. Therefore, we also 
outline the treatment of the mimics with chemical agents and thermal denaturation studies 
to uncover the reason behind site selective ICL formation.  
2. Background 
2.1. In vitro syntheses of interstrand cross-links (ICLs) 
According to the central dogma of genetics, genetic information vital to the life 
processes flows from DNA to RNA via transcription. Another process responsible for 
existential maintenance of organisms is replication, which is carried out by DNA 
polymerases. These key processes involve strand separation of duplex DNA. Due to the 
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core role of DNA in two pathways for sustaining the life cycle of any cell including 
cancerous ones, DNA remains one of the favorite targets of drug molecules. One class of 
DNA lesions generated is the interstrand cross-link (ICL). ICLs are covalent linkages 
formed by reaction between nucleobases from opposing strands with a bis-electrophile.
15
 
Alternatively, they can also be formed upon reaction between nucleobases and DNA 






). Typically, the bis-electrophiles are administered 
as a drug candidate for diseases like cancer. Many such bis-electrophiles like nitrogen 
mustards, cyanoethylnitrosourea (CENU), and mitomycin effectively fight diseases. 
Better understanding of the DNA biochemistry lead to discovery of bifunctional cross-
linking agents that are not bis-electrophiles, such as psoralens. Ironically, bis-
electrophiles such as malondialdehyde which are capable of cross-linking were 
discovered to be side products of the cell’s own metabolism. Similarly, cross-links are 
reported to be produced from damaged nucleotides themselves.  
In order to comprehend the biochemical nature of damage caused by ICLs, it is 
necessary to synthesize ICLs in a pure and sequence specific manner. These synthesized 
ICLs can be studied in vitro using repair proteins or can be transfected into the cell by a 
plasmid. The structures of the synthesized ICLs are also studied in depth due to direct 
implication with repair. In this report we discuss the existing methods of ICL synthesis, 
their advantages, drawbacks, the effect of ICL formation on DNA structure and DNA 
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2.1.1. ICL generation by treatment of chemical agents with DNA  
2.1.1.1. ICLs generated from nitrogen mustard reagents 
Nitrogen mustards (NM) are bifunctional agents widely used against leukemia, 
lymphoma, multiple myeloma, and ovarian carcinoma.
15
 Although quite effective as anti-
cancer agents, classical NM drugs are non-selective in nature and lead to undesired 
cytotoxicity in non-cancerous cells.
34
  One such agent, N,N-bis(2-
chloroethyl)methylamine (mechlorethamine) predominantly reacted with N7s of 
deoxyguanosine (G) to generate N-(2-[N7-guanyl]ethyl)-N-(2-[N7-guanyl]ethyl) 









































































EMA = ethylmethylamine  
methylamine (N7G-N7G-EMA, 5). Additionally, mechlorethamine ICLs were generated 
between N3 of deoxyadenosine (dA) and N7 of G (N3A-N7G-EMA), N1 of A and N7 of 
G (N1A-N7G-EMA), N6 of A and N7 of G (N6A-N7G-EMA), and between N3s of A 
(N3A-N3A-EMA).
35
 N7G-N7G-EMA ICL was predominantly formed in 5'-GNC 




 N1A-N7G-EMA, and N6A-N7G-EMA ICLs were formed in 5'-GGT 
sequence, while N3A-N7G-EMA ICLs are formed in 5'-GT sequences.
35
 No sequence 
selectivity was found for N3A-N3A-EMA in the literature. The alkylation of bases makes 
them labile to depurination with half lives ranging from hours to days.
26,36
 The ICL yield 
is typically low and varies from 1-6%.
36
 Generation of a mixture of products combined 
with low yield and instability render any repair analysis for these ICLs difficult. 
2.1.1.2. ICL generated from Chloroethylnitrosoureas (CENU) 
Chloroethylnitrosoureas (CENU) are commonly used to treat brain tumors due to 
their robust potential in traversing the blood brain barrier.
37
 CENU ICL (6) did not show 
any sequence selectivity and formed the ICL between N3 of C and N1 of the opposing G 
(Scheme 3).
27
 In contrast to NM ICLs, which were formed through either the major or 
minor groove, CENU ICL was formed at the hydrogen bonding face. However, the ICL 
yield upon direct treatment of DNA with CENU reagent was low (0.4  3.7%), making 
their structural characterization and repair investigation difficult.
27
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2.1.1.3. ICL generated from mitomycin C 








































Originally isolated as an antibiotic metabolite from Streptomyces caespitosus, 
mitomycin C has been effectively used in chemotherapeutic treatment of various forms of 
gastrointestinal tumors.
16
 Upon reduction, mitomycin C is converted to a bis-electrophile 
capable of cross-linking with N2 of Gs on opposing strands (Scheme 4). The minor 
groove ICL (7) was formed in a 5'-(GC) sequence.
38
 In addition to forming of 
monoadducts and intrastrand cross-links,
38,39
 the ICL yield varies from 5  50% when a 
single 5'-(GC) was present in a duplex
40,41
  The cross-link was generally stable, but 
decomposed upon treatment with hot piperidine or treatment with reducing agents like 
Na2S2O4 and dithiothreitol (DTT).
41
  
2.1.1.4. ICL generated by psoralen 
Psoralens belong to the family of fucomycin natural products and are planar 
compounds isolated from a number of diverse sources ranging from plant seeds to 
bacterial broth.
42,43
 They intercalate into DNA and upon UV irradiation form ICL 8 in a 
5'-(AT) sequence with C5-C6 double bond of T (Scheme 5).
44
 This major groove ICL 
forms in a modest yield (5%).
45
 Due to their ability to form ICLs in a light controlled 
manner, they are used against skin diseases such as psoriasis.
17
 The side products of 
 10  
 
psoralen compounds reacting with DNA are the pyrone-side and furan-side monoadducts 
while no intrastrand cross-links have been reported.
44
 














































2.1.1.5. ICL generated by aldehydes 
Aldehydes like acrolein and malondialdehyde (MDA) contributes towards minor 
groove ICL generation in DNA. Acrolein has endogenous (lipid peroxidation
46
) as well 
as exogenous origins (cigarette combustion
47
), while MDA is generated as an unstable 
side product of lipid peroxidation.
48
 Both acrolein and MDA are mutagenic in 
mammalian and bacterial cell assays.
49–52
 The bis-electrophiles generate ICLs by reacting 
with N2 of G in a 5'-(CG) sequence (Scheme 6  




































and Scheme 7). Due to inherent instability of the hemiaminal bond formed, 20% of 
acrolein ICL 9 reverts to un-cross-linked duplex in 16 h at 25 C and pH 7.0.
53
 Under 
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conditions that disfavor duplex formation (absence of buffer), the reversal was faster and 
complete within 1 h.
53
 When DNA was directly treated with acrolein the ICL yield 
remained low
54
 and was accompanied by -hydroxy-1,N2-propanodeoxyguanosine (-
OH-PdG) as the major monoadducts.
55
 The monoadduct was also reported to generate 
intrastrand cross-link with 5'-adjacent A, T and Gs.
56
 In contrast, no intrastrand cross-link 

























2.1.1.6. ICLs generated by various abasic sites 
2.1.1.6.1. ICLs generated by an AP site 



















































AP sites are DNA lesions resulting from enzymatic or non-enzymatic hydrolysis 
of a glycosidic bond with approximately 10000 sites generated per cell every day.
58,59
 AP 
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exists in equilibrium between a ring opened carbonyl and a ring closed hemiacetal 
structure. Recently, Gates and coworkers reported that AP cross-links with G and A.
6,7
  
Generation of AP-G ICL 11 occurred in 18% yield and involved reaction with guanosine 
opposite the 5'-adjacent nucleotide of AP. The N2 amine of G participated in ICL 
formation (Scheme 8). This minor groove ICL formation was unaffected by pH alteration 
(3  10). Although methoxyamine presence in the beginning of the assay severely 
inhibited cross-link formation, post-formation treatment of the ICL with methoxyamine  

























































or hydrazine (aldehyde trapping reagents) did not decrease the yield.
6
 In contrast to G, the 
participating A was exclusively the one opposite the 3'-adjacent nucleotide of the AP 
with the N6 amine acting as a nucleophile (Scheme 9). The AP-A ICL 12 was formed in 
13-71% yield depending on the sequence and was stable within the pH range 3 – 10 or 
mild piperidine workup. In contrast to the G-AP ICL, this major groove ICL decomposed 
when heated at 90 C or upon treatment with aldehyde trapping methoxyamine, 
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2.1.1.6.2. ICL generated by C4'-oxidized abasic site (C4-AP) 
C4-AP is generated from C4 oxidation of the deoxyribose sugar by exposure to 





). Bleomycin coordinates with Fe (II) 
and oxygen in blood plasma to form an activated ternary complex that has the properties 
of iron-superoxide complexes. The activated species binds in the minor groove of DNA. 
The O-O bond then undergoes heterolytic cleavage and forms a (O)Fe(III) species  
Scheme 10. Kinetic and thermodynamic ICL formation by C4-AP 
 
responsible for C4 hydrogen abstraction. The damage is sequence selective, and occurs 
primarily on the pyrimidine residues 3-to a guanosine: 5-(GC) and 5-(GT).
25
 
Abstraction of the C4-hydrogen is postulated to lead to two pathways. In the oxygen 
dependent pathway, it produces 3-phosphoglycolate and base propenal. In an oxygen 
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Neocarzinostatin (NCS) also binds in the minor groove of DNA. Nucleophilic addition of 
a thiol to NCS leads to spontaneous rearrangement of its enediyne core to a reactive 




Regulus et al. reported that C4-AP generated from ionizing radiation or 
bleomycin treatment of calf thymus DNA forms an adduct with C, although the exact 
mechanism of its formation was unclear.
61
 Recently, it was demonstrated that C4-AP 
generates a high (2) and a low (13) molecular weight ICL. Reversible adduct formation 
with A opposite the 3'-adjacent nucleotide of C4-AP provided the high molecular weight 
ICL (2) in yields ranging from 16  37%. Similar to AP-A ICL, the N6 amino group of A 
was involved in ICL formation. The ICL was unstable with a half life of 3.1 h and 
reverted back to C4-AP. β-Elimination resulting in a strand scission and generation of an 
α,β-unsaturated aldehyde effected further reaction with dA and led to irreversible 









), establishing 2 as the kinetic product. 
Importantly, the site selective formation of the 2 with dA opposite the 3'-adjacent 
nucleotide could not be justified.
31
 
2.1.1.6.3. ICL generated by dioxobutane (DOB) 
C5-oxidation of the deoxyribose sugar originates from the assault of a variety of 





 and radiolysis.66 In the case of enediynes, the same carbon 
centered diradical generated acts as the hydrogen atom scavenger. One of the major 
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products formed from such oxidation was the 5-(2-phosphoryl-1,4-dioxobutane), DOB.
62
 
Generation of the dioxobutane species was observed during treatment of a short 
oligonucleotide with neocarzinostatin.
67
 The DOB lesion was detected in aerobic 
radiolysis of thymidine as well.66 The DOB lesion eventually eliminates  to form trans-
1,4-dioxo-2-butene (Scheme 11).
63
 The latter pathway is biologically important because 
cis-1,4-dioxo-2-butene, a furan metabolite, is a carcinogen in rodents.
68
 
Scheme 11. ICL generation by DOB lesion 
 
Participation of dioxobutane in interstrand cross-link formation preferentially with 
a A opposite a 3-adjacent T of the damaged nucleotide was first reported by Guan.
9
 
When the cross-link (1) was characterized by ESI-MS, the adduct formation was found to 
involve the N6 amino group of A. The cross-link yield varied between 23-32%. 
Generation of the cross-link was reversible with a 10.1 h half life, while both the 








) of ICL were first order 
processes. 
The equilibrium constant (Keq = 1.4) of the ICL formation between A and DOB 
indicated that adduct formation was not significantly stabilized.
9
 Intriguingly, there was 
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reaction with 1,4-butanedial, a DOB analogue.
9
 In fact, the rate of the forward reaction of 




) was almost 10 times higher than that with A 




). The distances between the C1'-aldehyde of DOB and the exocyclic 
amines of A and C from the opposing strand were compared by Guan using a Spartan 
model. When bases were positioned opposite the 3'-adjacent nucleotide of DOB, the 
exocyclic amine of the former was closer by almost 1 Å (7.03 Å for A vs 8.04 Å for dC). 
However, whether the larger distance predicted by the model was the determining factor 
behind ICL formation remains debatable. There was modest ICL formation (yield 3.2%) 
with a dA placed opposite the lesion even though its exocyclic amine was within 7.39 Å 
of the DOB aldehydic carbon.  
2.1.2. Synthesis of Interstrand cross-links using post-oligomerization modification.  
The origin of ICLs can be traced to a vast spectrum of DNA assaults ranging from 
therapeutic treatment with exogenous chemical agents and radiolysis, to endogenous 
metabolites, to deoxyribose sugar oxidation products. Due to the threat posed by ICLs to 
cellular pathways, organisms evolved to develop specific repair capabilities to deal with 
them. In the absence of such repair pathways, individuals can suffer from disorders such 
as Fanconi anemia.
69
  In this cancer prone genetic disease, cellular pathways responsible 
for surveillance and removal of interstrand cross-linked DNA are crippled, making the 
patients vulnerable to cross-linking agents.
69
 However, multiple aspects of such repair 
pathways still remain unexplored, making the associated research highly coveted in terms 
of drug designing and DNA damage diagnosis. A major limitation of such investigations 
is the dearth of pure cross-linked DNA due to extremely low isolation yields, generation 
of mixtures of products, and instability of the cross-links. Bioorganic chemists have 
 17  
 
responded with two strategies to generate pure ICLs in high yields. The first one is based 
on post-oligomerization modification, where a nucleotide containing the masked 
monoadduct of a bifunctional agent is introduced into one or both strands of DNA using 
solid phase synthesis. After the two strands are annealed, the protecting groups are 
removed and the cross-link generated. In the second approach involving orthogonal 
deprotection strategy, a dinucleotide containing the stabilized cross-link is synthesized. 
The hydroxyls of the dinucleotide are masked using various protecting groups. Upon 
incorporation into the DNA using solid phase synthesis, the hydroxyls are unmasked 
sequentially and orthogonally. Finally, complete DNA strands are synthesized using the 
free hydroxyls. Both methods have their advantages and limitations as illustrated below.  


















N7G-N7G-EMA adduct,  5EMA = N,N-bis(2-chloroethyl)methylamine, 
a nitrogen mustard reagent  
Attempts to synthesize nitrogen mustard (NM) ICLs have been limited to dG-NM 
ICL adducts. To bypass the susceptibility of the N7G-N7G-NM adduct (e.g. 5) to 
glycosidic bond hydrolysis, Schärer and coworkers employed isosteric 7-deaza analogues 
of G (Scheme 12).
29,70,71
 The phosphoramidite containing the TBDMS-protected 
dialcohol (14) was incorporated into DNA using solid phase oligonucleotide synthesis. 
After the nucleobase and alcohol protections were removed, the single strand with the 
unprotected diol containing dG analogue was annealed with a complementary strand 
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having the same modification. The G-NM-G ICL analogue (15) was then synthesized in 
25-75% yield after oxidation of the duplex, followed by reductive amination.
70
  
Scheme 12. Synthesis of nitrogen mustard ICL analogue by post-oligomerization modification 
 
Key: (a) Solid phase oligonucleotide synthesis; (b) NH3, 50 C, 16 h; (c) TEA.3HF, 40 C, overnight; (d) 
annealing; (e) NaIO4, pH 5.4; (f) NH4OAc, NaCNBH3.    
2.1.2.2. ICL made by chloroethylnitrosourea 































































Key: a) Solid phase synthesis; b) h 365 nm, 3 min, room temperature; c) 17 h incubation, 37 C. 
A mimic of chloroethylnitrosourea (CENU) ICL between the N3 of C and the N1 
of G was synthesized using a photocaged nucleobase analogue (Scheme 13).
72
 In this 
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approach, O6-(2-chloroethyl) and N2-ortho-nitrobenzyloxycarbonyl (NBOC) protected G 
phosphoramidite (16) was incorporated into DNA using solid phase synthesis. The 
electron withdrawing nature of NBOC reduced the nucleophilicity of the N1 positon 
preventing its nucleophilic attack on the chloroethyl group. After annealing with the 
complementary strand, the NBOC group was deprotected by irradiation at 365 nm, and 
N1 displaced the chloride. Attack by N3 of the opposing C freed the O6 of G generating 
the ICL (17). The ICL was synthesized in 37% yield. Interestingly, the presence of A, T 
or G opposite NBOC modified G resulted in ICL generation as well.  
2.1.2.3. Synthesis of interstrand cross-links of bifunctional pyrroles 























































Key: (a) 20 C, 4 days; (b) 20 C, 8 days. 
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Synthesis of a mimic of an ICL between G and 2,3-dihydro-pyrrolizine 
bis(isopropylcarbamate) (IPP) was accomplished in a reaction in which the traditional 
roles of the nucleobase and the cross-linking reagent were inverted (Scheme 14).
73
 The 
nucleobase was a fluoropurine that served as the electrophile, while the cross-linking 
bifunctional pyrrole functioned as the nucleophile. In this synthesis, O6-protected 
fluorodeoxyinosine incorporated in ssDNA (18) was treated with diamine 19, an IPP 
analogue. This reaction resulted in formation of monoadducts in 40% yield that were then 
treated with 18 to obtain cross-link 20.  
2.1.2.4. Synthesis of interstrand cross-links from aldehydes 
Stable cross-link adducts between DNA and bis-electrophilic aldehydes were 
synthesized by two different post-oligomerization modifications. In the first, the saturated 
N2-N2-propano analogue (22) of malondialdehyde ICL was synthesized in a 5'-(CG) 
motif by Harris and co-workers using nucleophilic attack of the alkyl amine on 
fluoronucleoside 21 (Scheme 15).
74
 In the second method (Scheme 16), 1,N
2
--
hydroxypropano-dG (-OH-PDG), the monoadduct between acrolein and G was 
synthesized from the O6-protected fluoronucleoside 21 in a stepwise manner. After 
reaction of 21 with 4-amino-1,2-butanediol, subsequent removal of the O6-protection and 
oxidation of the vicinal diol produced -OH-PDG. After annealing with its complement, 
its reaction with an opposing strand dG in a 5'-CpG sequence for 7 days at 25 C 
produced ICL 23 with 50% yield.
29
 The cross-link 23 showed the same stability as 
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Key: (a) DMSO, iPrEt2N, 65C; (b) 0.2 M HCl; (c) NaIO4; (d) Annealing; (e) 25C, 7 days. 
2.1.2.5. Synthesis of oligonucleotides containing disulfide interstrand cross-links  
Utilizing a nucleophilic attack of 3,3'-dithio bis(propylamine) on convertible 
nucleoside O6-phenyl-2'-deoxyinosine (24) the alkane disulfide tethers were attached to 
the N6-amino group of dA (Scheme 17).
75
 In a duplex containing two N6-alkane-
disulfide-tethered dAs in a 5'-(AT) sequence, incubation with dithiothreitol (DTT) 
converted it to a N6-alkane. Upon removal of DTT from the solution, the sulfides from 
opposing strands were spontaneously linked to generate a site-specific alkane-tethered 
disulfide ICL (25) in quantitative yield. Introduction of DTT led to reversal of the cross-
linked duplex to un-cross-linked N6-alkane sulfide. 
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Key: (a) Annealing with complementary strand; (b) DTT. 
2.1.2.6. Cytidine selective cross-link generation from 2'-O-furan modified dU and 2-
amino-6-vinylpurine 
Scheme 18. dC selective cross-linking by 2'-O-furan modified U 
 
Key: (a) Annealing with complementary strand; (b) N-bromosuccinimide; (c) incubation, 15 min, 25 C; 
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In this strategy exploiting the natural cytotoxicity of furan, the 2'-O position of 
uridine was modified with a masked furan as a -keto enal (26, Scheme 18).
30
 When a 
duplex containing masked 2'-O-furan-U in one strand was oxidized, cross-linking 
occurred with an opposing dC producing ICL 27 (Scheme 18) with an average 20% yield. 
The unstable product containing a hemiacetal linkage was converted into stable 28 by 
aromatization upon heating at 50C.
30
  
In another instance of site selective cross-link generation with C, a 
phenylsulfoxide precursor of 2-amino-6-vinylpurine (AVP, 29) was incorporated into 
DNA via solid phase synthesis (Scheme 19).
76
 After the strand containing the precursor 
was annealed with a complement, in situ elimination of phenylsulfoxide generated 2-
amino-6-vinylpurine that cross-linked with the opposing dC, producing 30 in 82% yield 
after 24 h.  








































29 2-amino vinyl purine 30  
Key: (a) Incubation in 50 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 5.0, 100 mM NaCl. 
2.1.2.7. Photoinduced cross-linking reactions 
Irradiation of 3-cyanovinylcarbazole nucleoside (
CNV
K, 31) led to efficient ICL formation 
with T (32) or C (33) opposite the 5'-adjacent nucleotide (Scheme 20).
77,78
 Quantitative 
ICL generation with C and T occurred within 5 s and 60 s of 366 nm light exposure, 
respectively. Irradiation at 312 nm reverted the ICL to non-cross-linked duplex.  
 24  
 




In an example by Chuan He, a highly reactive carbene intermediate generated 
from a diazirine-based nucleotide analogue (34) formed an interstrand cross-link with the 
opposite nucleotide irrespective of its identity (Scheme 21).
35
 The cross-linking reaction 
was complete after 10 min of 350-360 nm irradiation, but the chemical structures of the 
cross-links were not characterized.  
Scheme 21. ICL generation from diazirine-based nucleotide analogue 
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Site-selective generation of a psoralen ICL was achieved by Koberts and co-
workers using a furan-side monoadduct of the bi-functional photocross-linking agent  

























































































incorporated in one of the strands (Scheme 22). When annealed with a complement with 
the monoadduct residing in a 5'-TA local sequence, irradiation with 366 nm UV light 
yielded the cross-link (35) in 84% yield.
79
 
Photolysis and subsequent reactions of 36 have served as a model for the 
reactivity of 5-(2′-deoxyuridinyl)methyl radical 37 that was generated upon -radiolysis 
of DNA (Scheme 23).
80
 Recently, the Greenberg laboratory demonstrated the cross-
linking ability of a phenylselenyl modified thymidine 36 with A upon photolysis.
81
 Single 
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electron oxidation of 37 and/or heterolysis of the C-Se bond in 36 upon photolysis 
generated carbocation 38, which reacted with the N1 of A to generate ICL 69 in 25% 
yield.
82
 Utilizing an associative (Dimroth-like) rearrangement, 39 isomerized to 40.
83
  
2.1.3. Use of orthogonal deprotection strategy for synthesizing ICL 
2.1.3.1. Synthesis of nitrous acid ICL 
The first example of this approach was demonstrated by the application of cross-
linked bis-phosphoramidite (41) for the synthesis of a nitrous acid cross-link (Scheme 
24). More heavily loaded solid support was employed where 41 simultaneously coupled 
with two growing oligomers yielding 42. Continued oligomeric synthesis generated 
support bound 43 that was subjected to ammonia deprotection and PAGE purification.
84
 
Finally, the O6-benzyl groups were removed by transfer hydrogenolysis on isolated DNA 
to yield palindromic ICL 44 in 10% overall yield. A similar strategy has been used to 








C cross-linked DNA 
Synthesis of a N4C-ethyl-N4C cross-link, a proposed structural mimic of the 
mechloroethamine adduct with a C-C mismatch was achieved using phosphoramidite 45 
(Scheme 25).87 The phosphoramidite was coupled with an oligomer on a solid support to 
yield 46, that upon continued synthesis and end-capping, generated 47. After removal 
of the TBDMS group, the synthesis of the full length support-bound cross-link (48) was 
completed by coupling 3'-cyanoethyl “reverse” phosphoramidites. Ammonolysis yielded 
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5'-d(GCA  TCC  GGA   TGC)

























Key: (a) Coupling of 41 during Solid phase oligonucleotide synthesis; (b) oligomer synthesis; (c) 
ammonolysis and purification; (d) hydrogenolysis. 
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5'-d(AAA  CTT  TGG  G)
























Key: (a) Coupling of 45 during solid phase oligonucleotide synthesis; (b) oligomer synthesis; (c) capping; 
(d) desilylation; (e) oligomer synthesis using 3'-cyanoethyl “reverse” phosphoramidites; (f) ammonolysis. 
2.1.3.3. Synthesis of N3-thymidine-butylene-N3-thymidine ICL 
In addition to a TBDMS protection on the 3'-hydroxyl, ICL dinucleotide phosphoramidite 
50 was protected with an allyloxycarbonyl (Alloc) group on one of its 5'-termini (Scheme 
26).
33
 After incorporating the phosphoramidite using solid phase synthesis, 51 was 
converted to 52 upon continued synthesis and acyl end-capping. Once the Alloc was 
removed, solid phase synthesis using regular phosphoramidites and end capping yielded 
53. Finally, removal of TBDMS and synthesis using 3'-cyanoethyl “reverse” 
phosphoramidites led to 54, that upon ammonolysis produced full length ICL product 
55.
33
 Synthesis of N3-thymidine-butylene-N3-thymidine ICL (55) demonstrated that 
 29  
 
using a greater number of orthogonal hydroxyl group protections provides more complete 
control over the DNA sequence. 
































5'-d(GCG  TAT  ACG C)



























































































Key: a) Coupling of 50 during solid phase synthesis; b) DMT removal; c) solid phase synthesis with 5'-
DMT 3'-cyanoethyl “regular” phosphoramidites and capping; d) ALLOC removal; e) solid phase synthesis 
with 5'-DMT 3'-cyanoethyl “regular” phosphoramidites and capping; f) TBDMS removal; g) solid phase 
synthesis with 3'-cyanoethyl “reverse” phosphoramidites; h) ammonolysis. 
2.2. Structural effects of interstrand cross-link formation 
ICL induced structural change has been investigated using various methods 
including interatomic distance calculated by NOESY,
88
 proton exchange measured by 
HSQC,
89







sometimes with the combination
91
 of more than one of these methods. In other instances, 
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cross-linked DNA was treated with Maxam-Gilbert sequencing reagents to probe for 
backbone deformity.
40
 Differences in UV thermal melting temperature between cross-
linked and un-cross-linked duplexes serve as a measure of stability offered by cross-
linking as well.
32
 As shown below, a combination of these techniques has often been used 
to elucidate ICL structure.  
















EMA = ethylmethylamine  
The structural effect of N7G-N7G-EMA (5) was first investigated by Hopkins 
employing molecular mechanics energy minimization computations, coupled with gel 
retardation to measure DNA bending.
1
  The difference in cross-linking bridge length (7.5 
Å) and the distance between the N7 of Gs in a 5'-(GNC) sequence (8.9 Å) forced the 
cross-linked DNA to depart from its canonical B form. Computation showed that the 
cross-link induced local structural distortions including buckling and propeller twist of 
trinucleotides encompassing the ICL. Especially, the cross-linking guanosines were 
reorganized. Additionally, reduced electrophoretic mobility of DNA containing multiple 
mechlorethamine ICLs within one or two turns (10.5 bp per turn) indicated 12 bending 
per lesion.
1
 A consequence of this distortion was noticed when nitrogen mustard ICL 
mimics were synthesized by reductive amination of aldehydes (Scheme 12). Greater 
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2.2.2. Structural effect of CENU ICL formation 
 
Figure 3. Structural probing N4C-ethyl-N4C ICL (49). (A) Oligonucleotide used to determine the 
structural effect of 49. (B) C4'-exo sugar pucker detected for cross-linked residues. (C) C2'-endo sugar 
pucker of B-form DNA. 
N4C-ethyl-N4C ICL 49 in a 5'-(CG) sequence was used as a CENU mimic by the 




H NMR and restrained molecular 
dynamics showed that the ICL was accommodated within the major grove without 
affecting any base pairing interaction (Figure 3).
91
 Enhanced propeller twisting was 
detected in cross-linked nucleotides, along with buckling between the bases within and 
around the ICL that gradually attenuated within three nucleotides from 5'-(CG) sequence 
(Figure 3).
91
 Most notably, the conformation of the sugar bases of cross-linked nucleotide 
switched to C4'-exo pucker compared to the C2'-endo observed in B-form DNA (Figure 
3B and C).
91
 Formation of 5'-(CG) ICL stabilized the duplex. For 5'-(GAA C*GT TC) in 
PBS buffer (C* was the position of cross-linking), the Tm increased from 14.5C to 81C.  
Attempted structural decryption of 49 in the “unobserved” 5'-(GC) sequence context (by 
NMR) was unsuccessful due to considerable exchange around the cross-linking site, 
indicating instability.
91
 This was further corroborated by thermal UV denaturation of 
duplexe with ICL 49 in 5'-(CG) sequence that showed significantly higher Tm compared 






















5'-d(CGA18 AXG15 TTC12 G)
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Figure 4. Sequence of Oligonucleotide (56) used to determine the structural effect of N2G-N2G-MC ICL 
(7).
 
2.2.2. Structural effect of mitomycin ICL formation 
The solution structure of a mitomycin ICL (7, Figure 4) was divulged by 
computational studies aided with inputs from NMR interproton distance parameters 
obtained for oligonucleotide 56 (Figure 4).
88
 Accommodating the mitomycin C (MC) ICL 
affected the two strands in a different manner but overall the cross-linked DNA did not 
deviate from B-form structure. Distance correlation identified the position of the adduct 
in a widened minor groove (9-10 Å compared to 3-7 Å for B-form DNA) and established 
the connectivity of N2G-MC(C10") and N2G-MC(C1") linkages.
90
 The base pairing and 
stacking were unaffected (including the cross-linked C3-G4 step). Both G10-T11 and G4-T5 
sugar rings were in closer proximity than their counterparts in the noncross-linked 
duplex, with the former pair having a relatively smaller distance. In addition, differences 
in 
31
P chemical shifts between duplex and cross-link revealed that the C3-G4-T5 and C9-
G10-T11 steps were perturbed differently. The aromatic ring of the mitomycin cross-link 
was aligned towards G10-T11 instead of positioning at the center of minor groove. 
Furthermore, sugar puckers in G10 and T11 deviated from C2'-endo. The different 
perturbation of the two strands could possibly be attributed to an asymmetric chemical 























5'-d(T1    A2    C3   J  T5  A6)
3'-d(A12  T11  K  C9  A9  T7)
K
MC = Mitomycin C
J
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DNA across the minor groove.  The Tm of an un-cross-linked 10 bp duplex increased 
from 18C to 50C upon introduction of MC ICL in the middle of the sequence.
41
 
Furthermore, structural probing using chemical agents was carried out on cross-linked 
and un-cross-linked duplex using nucleotide specific sequencing reagents.
40
 
Hyperreactivity towards footprinting agents was highest at the cross-linked dGs and 
gradually diminished after three to four nucleotides.  
2.2.3. Solution structure of ICL generated from an aldehyde 
 
Figure 5. Determination of solution structure for ICLs generated by aldehydes. (A) Duplex 57 used for the 
structure determination of acrolein ICL (23). (B) Duplex 58 and 59 containing ICL 22 in 5'-(CG) and 5'-
(GC) sequence, respectively. 
Asymmetric deformities in the strands were observed when cross-linked duplex 
57 was probed for distortion induced by acrolein ICL (23) in 5'-(CG) sequence using 
NMR (Figure 5A).
92
 The chemical shift change of deoxyribose C1' and imino protons of 
nucleobases were compared between 57 and un-cross-linked duplex. The exchangeability 
of the base imino protons (probed by change in peak broadness with temperature) was 
investigated for the two substrates to study the stability of base pairs. In addition, the 
distances between aromatic nucleobase protons and C1' protons for the two substrates 
(detected by NOESY) was compared to detect cross-link induced changes in the 
5'-d(A1   G2   G3   C4   X5   C6   C7   T8)
3'-d(T16  C15 C14  Y13 C12 G11 G10  A9)
5'-d(A1   G2   G3   X4   C5   C6   C7   T8)








































5'-d(G1   C2   T3   A4   G5   C6     N7    A8   G9   T10  C11  C12)
3'-d(C24  G23  A22  T21 C20  M19  C18   T7   C16  A15 G14 G13)
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backbone. The minor groove ICL only minimally affected the H-bonding for the cross-
linked nucleotides, with no observed effect on base pairing beyond the C6-Y19 and X7-C18 
pairs. In the top strand, backbone deformities were highest for C6 and X7, dissipated 
towards G5 and G9 and then completely disappeared. Distortion was detected in 
nucleotides T17, C18, Y19 and C20 in the bottom strand, with the latter three being most 
deformed.  
Trimethylene ICL 22, the reduced analogue of the acrolein ICL (23), was inserted 
in the native 5'-(CG) (58) and 5'-(GC) (59) sequences to probe the selective formation of 
the ICL in the former (Figure 5B).
93
 In the former sequence, the cross-linked X5 N2 was 
in gauche conformation with C, while in the latter they were in an unfavorable half 
gauche conformation. In addition, the X4-C13 and C5-Y12 pairs completely lost  stacking 
interactions with neighboring bases by roll and twist in ICL 59, destabilizing the 
structure. This was supported by UV thermal melting of a trimethylene ICL in a 5'-(GC) 




2.2.4. Structural effect of psoralen ICL formation 
Solution phase NMR was employed to explore the structure of 4'-
(hydroxymethyl)-4,5',8-trimethylpsoralen (HMT) induced cross-linked duplex 60 (Figure 
6).
89
 The T4 in the top strand was involved in formation of the furan-side adduct while 
T12 in the bottom strand was part of the pyrone-side cross-linking. Like aldehyde and 
mitomycin ICLs, HMT adduct formation affected the two strands differently, with the 
distortion being more on the pyrone-side.  The H-bonding in the base pairs encompassing 
the cross-link were minimally affected. The NH imino protons in T12 and G11 were more 
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prone to temperature induced broadness than T4 and G3 bases. The distance between the 
cross-linked Ts with the purine moieties in their 5'-adjacent dGs was reduced after cross-
linking, enhancing -stacking. No bending in the backbone was observed as a result of 
ICL formation. In both strands the base pairing returned to normal within three 
nucleotides from the site of adduct formation. Overall, the cross-linked structure was 
significantly more stabilized than the un-cross-linked duplex due to enhanced base 
stacking and intercalation of the psoralen moiety. As a result, introduction of a psoralen 
cross-link in the middle of the strand increased of Tm of a 16-mer duplex from 51 C to 




Figure 6. Structures of HMT molecule and cross-linked duplex used for investigating psoralen cross-link 
structure. (A) Chemical structure of HMT molecule. (B) Sequence of HMT cross-linked duplex, with the 
cross-link formed between T4 and T12. 
2.3. Repair of interstrand cross-links using UvrABC 
The SOS response is actuated when a bacteria is exposed to stress. In this state, 
many defense and repair proteins are produced from genes, which otherwise remain in a 
dormant state.
96
 SOS induced protein expression and related nucleotide excision repair 
was first observed in 1964, when excision of damaged DNA strands containing a thymine 
dimer
97
 was detected in UV irradiated cells.
98
 The excision was mediated by three genes 
controlled through the SOS response, uvrA, uvrB and uvrC.
98
 Articles published during 
the mid-seventies reported repair of bulky lesions by extracted gene products from the 
above mentioned genes in E. coli.
99,100
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coined the term UvrA, UvrB, and UvrC for these repair proteins in E. coli.
101
 The 
UvrABC repair system recognizes and repairs a diverse collection of lesions, indicating 
that chemical structure of the damage probably plays minimal role in recognition. Rather, 
backbone deformity induced by a lesion has been revealed to play a significant role in 
damage recognition, and incision efficiency.
102
 Presence of ICLs affects both strands and 
requires the repair proteins to make even more complex choices than for lesions on a 
single strand, making cross-link forming agents of the most potent genotoxins according 
to some researchers.
103
 Herein we discuss the effect of damage induced distortion on 
recognition and incision in the context of all three proteins. 
2.3.1. Role of UvrA 
UvrA, the 105 kDa ATPase enzyme acts as a dimer (UvrA2) during primary 
damage recognition.
104,105
 A recently published crystal structure shed light on the binding 
and damage recognition of a modified DNA [two fluoresceinylated Ts (F) present in 
palindromic 5'-FCCGGA sequence] by UvrA (Figure 7A).
106
 The dual modifications 
resulted in a 15 bend and 20 unwinding in the sequence encompassing the 
fluoresceinylated T (Fl-T) bases along with greater shear (movement of H-bonded bases 
in the plane) and stretch (span between the bases along helical axis).
106
 A previously 
identified concave semicylindrical lane on the surface of the UvrA dimer (UvrA2) 
accommodated the DNA in a non-specific manner (Figure 7B and 7C).
107
 Two zinc 
finger motifs (one from each UvrA monomer) were seen approaching the DNA backbone 
(Figure 7D). The unwound and bent region placed in the middle of the lane and probably 
serves as the primary damage reporter to UvrA.
106
 It was speculated that the clash of the 
DNA binding region with the bulged region of a damaged DNA acted as the signal for 
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damage, whereas this steric conflict would be absent for undamaged DNA. Deleting the 
zinc fingers affected the differentiation capability of UvrA and they were thus speculated 
 
Figure 7. DNA damage recognition by UvrA as visualized in crystal structure.
106,107
 (A) Structure of 
fluoresceinylated T (Fl-T). (B) Surface representation of the UvrA dimer (UvrA2) with surface potential in 
red (negative) and blue (positive) (PDB 2R6F). Region containing charged amino acids (circled) and UvrB 
binding domain are indicated.
107
 (C) UvrA2 in complex with DNA (yellow) (PDB 3PIH).
106
 (D) Non-
specific  interaction of zinc finger motifs with damaged DNA (blue) (PDB 3PIH). Zinc atoms are shown in 
grey.
106





to play some role in damage recognition.
106
 Based on the mutation studies both 
hydrophobic and charged residues present at the end of the lane were deemed responsible 
for damage recognition (Figure 8A). The length (100 Å) of the lane was in accordance 
with UvrA footprinting (33 bp).
108
 The binding of UvrA to DNA was accompanied by 
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2.3.2.  Role of UvrB, damage recognition and dynamics of preincision complex 
formation 
After the initial scanning, the complex between UvrA dimer and DNA (UvrA2-
DNA) further associates with UvrB dimer (UvrB2) and forms the UvrA2UvrB2-DNA 
heterotetramer protein-DNA complex for further damage localization. A set of recently 
published crystal structures elucidated how the complex distinguished between damaged 
and undamaged DNA (Figure 8).
110
 In the UvrA2-DNA complex, the protein remained in 
an “open tray” like conformation. In this conformation, the damaged DNA does not 
closely interact with the surface of shallow and wide (43 Å) semicylindrical lane of UvrA 
(Figure 7C and 8A). As a result of the weak interaction, UvrA alone has a low specificity 
for damaged DNA (2-5 fold over native DNA)
111
 and comparable affinity for a wide 
range of lesions (Kd = 1-14 nM).
112,113
 However, the lane becomes narrow (30 Å) and 
deeper in the “closed groove” heterotetramer structure (width 30Å, Figure 8B).
110
 This 
conformation change (“open tray” to “closed groove”) can be attained uninhibitedly for a 
native DNA (Figure 10C).
110
 The UvrA2B2 complex then reversibly disassembles from 
the native DNA and UvrA2 returns to the “open tray” structure (Figure 8C). The UvrA2 
then resumes its search for damaged DNA. However, the backbone deformation of a 
DNA lesion impedes this conformational change (“open tray” to “closed groove”), 
generating a steric clash, and indicating the presence of damage (Figure 8D).
110
 The 
subsequent events leading to UvrC binding are still debated. It was proposed that the 
UvrB molecules translocate from the 5' to 3' direction, displacing the A2 dimer and 
converge on the damage site to form the preincision complex (Figure 8E).
115
 However, it 
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Figure 8. Damage detection by A2B2 heterotetramer and formation of preincision complex. (A) Location 
and width of DNA binding surface in UvrA2 “open tray” conformation.
110
 (B) Location and width of DNA 
binding surface in UvrA2B2 closed groove conformation.
110
 (C) Model of uninhibited transition from A2 
“open tray” to A2B2 “closed groove” conformation for a native DNA. DNA binding surface and native 
DNA are shown in green and cyan, respectively.
110
 (D) Model of transition from A2 “open tray” to A2B2 
“closed groove” conformation for a damaged DNA. DNA binding surface and native DNA are shown in 
green and cyan, respectively.
110
 (E) Proposed model for UvrB localization on damage and preincision 
complex formation.
114
 Lesion containing strand, undamaged strand, and β hairpin are shown in green, red, 
and cyan. (G) Proposed path of damaged DNA on A2B2 complex.
110
 Images are reproduced without 
permission from the work of Pakotipraha.
110
  
is unclear whether the preincision complex was comprised of one or two molecules of 
UvrB, and evidences for both models have been reported.
116,117
 In the complex, the 
nucleic acid is wrapped around the UvrB surface, further aiding local DNA unwinding.
118
 
In a model of the preincision complex based on a crystal structure of a hairpin DNA and 
a lone UvrB molecule, insertion of a β hairpin from the latter into the helix caused local 
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unwinding and base flipping (Figure 8F).
114
 The damaged base remained on the outer 
DNA strand while extrahelical bases on the inner strand were flipped and inserted into a 
hydrophobic pocket behind the β hairpin in UvrB.
114,119
 Transfer of DNA from the “open 
tray” UvrA2-DNA to “closed groove” UvrB-UvrA-UvrA-UvrB heterotetramer (groove 
length length 145 Å, Figure 10G) to UvrB (68 kDa, Figure 10F) is consistent with 
changes in footprinting from 30 bp to 45 bp to 19 bp.
108,111
  
2.3.3. Role of UvrC and strand selection for ICLs 
After the presence of damage is confirmed by UvrA and UvrB, repair advances by 
recruitment of UvrC, which incises the lesion containing strand 5' and 3' to the damage. 
The incisions take place at the fourth or fifth phosphodiester bond 3' to the damage (third 
phosphodiester bond for ICL
120
), and eighth phosphodiester bond 5' to the damage (ninth 
phosphodiester bond for ICL
120
) both generating 3'-OH and 5'-phosphate (Figure 9).
121
 
While a single strand nick is recognized as a substrate by UvrABC, its incision is not 
properly characterized.
122,123
 In a substrate containing a single strand nick, UvrABC 
incision occurs at sixth phosphodiester bond 5' to the nick.
123
 However, no study 
addressed the UvrABC incision 3' to a nick. The N-terminal and C-terminal sides of 
UvrC carry out the 3'- and 5'-incisions respectively.
121
 For monoadducts, the incision is 
followed by removal of the incised oligonucleotide patch by UvrD helicase activity 
(“unhooking”), subsequent repair synthesis and ligation (by DNA polymerase and 
ligase).
121
 For interstrand cross-links, the first strand repaired is followed by another 
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Figure 9. UvrC incision locations on cross-linked and un-cross-linked substrates. (A) UvrC cleavage sites 
for the incision of oligonucleotide containing a damaged  nucleotide (P).
121
 (B) UvrC cleavage sites for the 
incision of oligonucleotide containing an interstrand cross-link (X – Y).
121
  
2.3.4. Effect of distortion and adjacent sequence on preincision complex dynamics 
and incision yield 
Gel retardation assays have been extensively used to analyze protein-DNA 
interactions in the UvrABC pathway. DNA binding affinities of UvrA, UvrAB and UvrB 
have been juxtaposed against the size of the lesion, helical distortion, and incision 
efficiency to investigate their interrelation.  Due to its weak interaction with damaged 
DNA, UvrA affinity for assorted lesions that induce a range of distortion often does not 
parallel incision yields. For instance, o-benzylhydroxylamine-modified apyrimidinic 
(BA) sites were incised more efficiently than abasic sites due to the larger size of the 
former despite UvrA binding being similar (Kd = 14 nM and 6 nM, respectively) (Figure 
10A and B).
124
 In contrast, recognition of DNA by UvrAB or UvrB in the form of a 
preincision complex can be translated more reliably into incision yield. The higher 
affinity of UvrAB for BA lesion (Kd = 80 – 120 nM and 4 nM for AP and BA lesions, 
respectively) paralleled the greater incision yield for BA over AP lesions. Therefore, the 
preincision complex formation was proposed as the rate determining step of bacterial 
NER.
124
 Similar correlation between UvrAB affinity, incision efficiency, and lesion size 
A
B
P = damaged nucleotide
X – Y = Interstrand cross-link
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was established for bulky spiroiminodihydantoin adducts and the smaller 
guanidinohydantoin lesion as well (Figure 10C and D).
125
 However, as shown for similar- 
 
Figure 10. Chemical structures of various electrophiles and their nucleobase adducts. (A) 
Benzylhydroxylamine-modified apyrimidine (BA). (B) AP site. (C) Guanidinohydantoin. (D) 
Spiroiminodihydantoin. (E) (+)-Anti-benzo[a]pyrene diol epoxide (BPDE). (F) ()-Anti-BPDE. (G) N2-
dG-(+)-trans-BPDE. (H) N2-dG-(+)-cis-BPDE. (I) N2-dG-()-trans-BPDE. (J) N2-dG-()-cis-BPDE. (K)  
N-(2'-deoxyguanosine-8-yl)-7-fluoro-2-acetylamino-fluorene. 
sized anti-benzopyrene diol epoxide (BPDE) adducts of G, interrelation of preincision 
complex, incision yield, and inherent backbone deformity (unrelated to size) could be less 
straightforward (Figure 10E  J). BPDE compounds reacted with G to generate four 
different adducts, N2-G-(+)trans-, ()trans-, (+)cis-, ()cis-BPDE.
126
 The cis adducts 
induced greater backbone distortion by intercalation of the aromatic core.
127
 In contrast, 
due to placement of the adduct in the minor groove, the trans adducts were less deformed 
with all the base pairing remaining intact.
127
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incised, no clear distinction was visible in terms of preincision complex formation.
126
 
Larger lesion size and higher backbone deformity may be linked to greater 
thermodynamic destabilization, since the latter would ease local unwinding seen in the 
preincision complex. The effect of thermodynamic destabilization was emphasized 
during repair of N-(2'-deoxyguanosine-8-yl)-7-fluoro-2-acetylaminofluorene adducts at 
G1, G2, or G3 in 5'-d(CCG1G2CG3CC) (Figure 10K).
102
 Among the three, greater 
destabilization (characterized by thermal melting) for the G1 and G3 adducts were 
consistent with their more efficient incision compared to G2. 
 
Figure 11. Influence of G-C content of an oligonucleotide containing a psoralen ICL (35) on the strand 
specificity of UvrABC incision. (A) Incision profile when 5'-side and 3'-side of the furan adducted strand 
(F) has 70-80% and 50% G-C content, respectively. (B) Incision profile when 5'-side and 3'-side of the 
pyrone adducted strand (P) has 70-80% and 50% G-C content, respectively. (C) Incision profile when 5'-
side and 3'-side of either strand has less than 50% G-C content.  
A related unresolved issue is the strand preference during incision of asymmetric 
ICLs (different chemical structures at the termini). Although the strand preference for 
psoralen ICL has been linked with distortion and adjacent sequence, no clear trend has 
been found. The initial findings of exclusive furan side bimodal incision could be 
correlated with greater distortion seen at the furan side of ICL.
89,120
 Further research 
70 – 80% G-C content 50% G-C content
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demonstrated that the presence of more than 70-85% G-C content on 5' side and 50% G-
C content on 3' side of the furan adducted strand led to predominant or exclusive incision 
 
Figure 12. Generation of double strand break by UvrABC incision on C4-AP thermodynamic ICL (13), A-
T ICL (40) and mitomycin C ICL (7). (A) Cartoon showing UvrABC incision of a substrate containing 
13.
22
 (B) Cartoon showing UvrABC incision of a substrate containing 40.
21
 (C) Cartoon showing UvrABC 
incision of a substrate containing 7.
20
 
on that side (Figure 11).
128
 However, similar base composition on the pyrone adducted 
strand, or less than 50% G-C content on either side caused incisions on both strands 
without any clear preference.
128 Unfortunately, neither of the two independent studies on 
the repair of the mitomycin C cross-link (another asymmetric ICL) have addressed the 
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Importantly, analysis of UvrABC treatment of C4-AP thermodynamic ICL (13), 
A-T ICL (36) and mitomycin C ICL (7) detected double strand break (DSB) generation. 
C4-AP thermodynamic ICL 13 is accompanied by an adjacent strand break and is 
therefore classified as a clustered lesion (more than one damage site within 1 – 1.5 helical 
turns).
31
 The DSB detected during UvrABC treatment of 13 occurred as a result of 
incision on the  strand containing the cross-linked A (Figure 12A).
22
 In contrast, the 
DSBs formed during UvrABC incision of 36 and 7 results from repetitive cleavages on 
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3. Results and discussion 
3.1. Synthesis of ICL mimics 
3.1.1. Synthesis of cross-linked oligonucleotides containing DOB ICL mimic (3)  
 
In order to stabilize the DOB and C4-AP kinetic cross-links (1 and 2), analogues 
of the reduced versions of the native ICLs were synthesized, where the unstable 
hemiaminal functionalities were removed (3 and 4). An orthogonal protecting group 
strategy, in combination with solid phase oligonucleotide synthesis approach was utilized 
to synthesize the ICL mimics. The strategy necessitated one protecting group for the 
DOB and two for the C4-AP analogue, that would allow further extension from their 
respective pyrrolidinyl hydroxyls during solid phase synthesis. The protecting groups 
needed to be robust enough to survive the standard solid phase DNA synthesis conditions 
but cleavable without any loss of various protecting groups on commercial 
phosphoramidites. We experimented with a number of commercial DNA 
phosphoramidite protectors and hydroxyl masking groups, as well as various demasking 
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3.1.1.1. Synthesis of Lev-DOB and NVOC-DOB ICL analogue phosphoramidites 
Synthesis of the oligonucleotide containing 3 involved making the “template” 
strand carrying the cross-linked A portion of 3 using commercially available 5'-
dimethoxytrityl-protected 3'-cyanoethyl (CE) “regular” phosphoramidites. The requisite 
phosphoramidites (66a,b) were synthesized from an activated form of 2'-deoxyinosine 
(61, Scheme 27). The hydroxypyrrolidine (HP) substitution was carried out by employing 
the SNAr chemistry developed by Lakshman.
129
 The substitution product was utilized to 
install the levulinyl and nitroveratryloxycarbonyl protecting groups to afford 63a and 63b 
respectively. After removing the silyl groups, the nucleoside analogues (64a,b) were 
dimethoxytritylated (65a,b) and phosphitylated via standard procedures to produce the 
phosphoramidites.  










































aKey: a) HP, Cs2CO3, THF  b) Levulinic acid, EDCI, DMAP, DMF or o-nitroveratryl chloroformate, DMAP, CH2Cl2  
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3.1.1.2. Incorporation of Lev-DOB phosphoramidite 
3.1.1.2.1. Stability of acetyl and pivaloyl capping and standard phosphoramidite 
amine protecting groups under delevulinylation condition 



















































=  Solid-phase synthesis support
X  = OLev or ONV
 
The compatibility of various standard protecting groups used in phosphoramidite 
based solid phase DNA synthesis needed to be verified for the synthesis of the DOB ICL 
mimic 3 using an orthogonal deprotection strategy. During the incorporation of 66a into 
support bound oligonucleotide (67), the best coupling yields (50-98%) were obtained 
when 66a was double-coupled (concentration 0.15 M) for 15 min (Scheme 28). 
Following removal of the levulinyl group to free the pyrrolidinyl hydroxyl (68), 5'-
cyanoethyl “reverse” phosphoramidites were employed to prepare the opposing strand or 
“arm” (69). Cleavage of 69 from the support by ammonolysis produced DOB ICL 
analogue 3. To avoid unwanted branching during the synthesis of the opposing or “non-
template” strand, complete 5'-OH protection (capping) and its stability under 
delevulinylation conditions was essential. Following detritylation, the 5'-OH of the 
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template strand was manually acetyl capped using a solution containing 5% each of 
acetic anhydride (vol/vol), N-methylimidazole (weight/vol), and pyridine (vol/vol) in 
THF following detritylation. The resin was subjected to typical capping steps including 
mixing of reagents (5 s), passing the capping solution through the support (10 s), and 
waiting (10 s). These steps were repeated for 10 consecutive cycles to ensure complete 
capping.  
We first attempted to synthesize cross-linked poly T oligonucleotide (72) 
containing 3 from resin bound 70 (Figure 13). Three different delevulinylation 
procedures, 0.5 M hydrazine in 4:1 pyridine/acetic acid (room temperature, 10 min), 0.25 
M hydrazine in 3:2 pyridine acetic acid for 10 and 20 min (room temperature) were 
tested. Following delevulinylation, six nucleotides added via solid phase synthesis 
comprised the opposing strand (“arm”). The 5'-cyanoethyl “reverse” phosphoramidites 
were coupled for 15 min each to ensure complete conversion of 68 to 69 (Scheme 28). 
The synthesis was monitored by deprotecting the oligonucleotide after each step, loading 






































Figure 13. Sequence of the resin bound oligonucleotide 70, template strand 71, desired DOB ICL 72 and 
proposed sequence of the oligonucleotide with 12 T extension (73).  
and fluorescent TLC plate (Figure 14). In addition to the desired 72, a 12 nucleotide 
extension product was detected using any of the three delevulinylation conditions (Figure 
14). The starting material 71 (from unmodified 70) was not observed. Formation of 73 
 50  
 
was highest for the delevulinylation treatment using 0.5 M hydrazine in 4:1 
pyridine/acetic acid (10 min, room temperature) and lowest for 0.25 M hydrazine in 3:2 
pyridine/acetic acid (10 min, room temperature) (Figures 14B and C). We suspect that 
inefficient capping could be responsible for the generation of undesired extension, which 
was aggravated further during the treatment with higher hydrazine concentration (0.5 M). 
Characterization of the gel purified template strand (71), 
 
Figure 14. Stability of acetyl capping under hydrazine treatment. (A) Resin bound O-acetyl capped 
oligonucleotide 70 with levulinyl protection on pyrrolidine hydroxyl. (B) Preparative PAGE gel visualized 
with UV lamp and fluorescent TLC plate showing treatment of 70 with various hydrazine treatment 
conditions followed by 6T extensions. Positions of 71 (from unmodified 70), 72 and 73 are annotated. Lane 
1, treatment of 70 with 0.5 M hydrazine in 4:1 pyridine/acetic acid for 10 min.  Lane 2, treatment of 70 
with 0.25 M hydrazine in 3:2 pyridine/acetic acid for 10 min. Lane 3, treatment of 70 with 0.25 M 
hydrazine  in 3:2 pyridine/acetic acid for 20 min. (C) Percentage of 72 isolated with respect to total 
extension product (72 and 73) formation. 
cross-link (72) and unwanted extension product (73) were done by MALDI-TOF mass 
spectrometry (App. Figure 97 – 99). Position of 3 in 72 at the fifth nucleotide from 3'-
terminus was confirmed by T sequencing of 3'-
32
P-72 (Figure 15). 
To improve the 5'-hydroxyl protection, acetyl and pivaloyl protections were 
applied in modified manual capping methodology where the resin was incubated 10 times 
with the capping reagents for 4 min (as opposed to 10 s during the previous capping 
method) each cycle. The capped resin was treated with 0.25 M hydrazine in 3:2 
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Oligonucleotides were subsequently deprotected and cleaved from the support by 
ammonolysis. An aliquot from the crude mixture was 5'-
32
P-labeled, and analyzed by  
 
Figure 15. ICL location determination by T sequencing using KMnO4. Lane 1, T sequencing of  3'-
32
P-71. 
Lane 2 and 3, T sequencing of 3'-
32
P-72 for 8 and 15 min, respectively. Positions of the nucleotides are 
annotated.  
20% denaturing PAGE. (App. Figure 1). The pivaloyl protection was partially removed 
after delevulinylation while the acetyl was unaffected. The efficiency of acetyl capping 
and delevulinylation using 0.25 M hydrazine in 3:2 pyridine/acetic acid (10 min, room 
temperature) was reaffirmed by resynthesizing 72. After delevulinylation and synthesis of 
the arm using 5'-dimethoxytrityl 3'-cyanoethyl “regular” phosphoramidites, the 
oligonucleotides were deprotected and cleaved from support by ammonolysis. Analysis 
of a 
32
P-labeled aliquot from the crude by 20% denaturing PAGE showed complete 
absence of 73 or 71 (App. Figure 2) and 94.3% conversion into the 72 (yield calculated 
based on the band intensity of 71 and 72).  
After the 5'-OH protection (capping) and delevulinylation steps were optimized, 
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under hydrazinolysis conditions. Commercially available “regular” 5'-dimethoxytrityl 
(DMT) 3'-β-cyanoethyl (CE) phosphoramidites containing standard amine protections 
(benzoyl-A, isobutyryl-G, and benzoyl-C) and 66a were employed to prepare the 
template strand (the strand carrying the cross-linked A) of 3. N-benzoyl-dC was used 
instead of N-acetyl-C to avert deprotection during hydrazine treatment (Jonathan T. 





















5'-d(TAC GAZ AAC TCA)
3'-d(TTT TTY ) 
5'-d(TAC GAX AAC TCA)
74
75













Figure 16. Sequences of resin bound capped oligonucleotide 73, template strand 74 and corresponding 
DOB ICL mimic 75.  
Synthesis of ICL 75 was attempted to establish the feasibility of this approach (Figure 
16).  Following template strand synthesis and capping of the resin-bound oligonucleotide 
(74), three different delevulinylation procedures (0.25 M hydrazine in 3:2 pyridine/acetic 
acid for 1, 5, and 10 min, room temperature, respectively) were tested. As described 
before, the oligonucleotides were analyzed following extension using 5'-CE “reverse” 
phosphoramidites, deprotection, and cleavage from the resin. After loading on 
preparative denaturing 20% PAGE, the extension products were visualized using a UV 
lamp and fluorescent TLC plate (App. Figure 3). While none of these treatments caused 
any unwanted extension (branching), complete consumption of starting material was 
obtained only for the 10 min treatment. We therefore decided to adopt 0.25 M hydrazine 
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in 3:2 pyridine/acetic acid (10 min, room temperature) as the standard delevulinylation 
treatment. Gel purified template strand (74) and the cross-link (75) were characterized by 
MALDI-TOF MS (App. Figure 100 and 101). 
3.1.1.2.2. Modification of capping, delevulinylation and coupling durations for 
template strand length  25 nucleotides 
After establishing a standard capping and delevulinylation strategy, we attempted 
the synthesis of longer cross-linked oligonucleotides 77 and 79 containing DOB ICL 
analogue 3 (Figure 17). Due to greater length of the final products, the syntheses were 
done on 1000 Å resin. To maximize the yield, native phosphoramidites were double-
coupled during the automated solid phase synthesis of the template strand of 79.  The 






















3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GXA AAG CGT -
-TAG CCA TTA)
5'-d(AGA CTG CAT TAC GZA -
-AAG CGT TAG CCA TTA)
76
77
5'-d(TAC ATA CTC GTA GTC TGC ATT ACG YAA AGC GTT - 
-AGC GAT TAA CATCGA GTC)-3'
3'-d(TAA TGC TX)
5'-d(TAC ATA CTC GTA GTC TGC ATT ACG ZAA AGC GTT - 
-AGC GAT TAA CATCGA GTC)-3'
78
79  
Figure 17. Sequences of template strands 76 and 78 and corresponding DOB ICL mimics 77 and 79. 
oligonucleotide on 20% denaturing PAGE and visualizing the product using a UV lamp 
and fluorescent TLC plate. In addition to the desired cross-linked oligonucleotide 77, a 
significant amount of the corresponding template strand 76 was observed (App. Figure 
4). On the other hand, we investigated reverse phase HPLC purification following 
 54  
 
synthesis of 79. Therefore, the DMT protection of the last nucleotide during the synthesis 
of the opposing strand or “arm” of 79 was left intact. The chromatogram of the synthesis 
of 79 contained several peaks, all of which were collected (App. Figure 5A). Denaturing 
PAGE (15%) analysis of the radiolabeled fractions indicated the material in fraction 3 as  
 
Figure 18. Assessment of delevulinylation efficiency and subsequent extension capability for resin bound 
and 5'-O-acetyl capped oligonucleotide 80. Following solid phase synthesis, oligonucleotides were 
deprotected, cleaved from the support (ammonolysis), 
32
P-labeled, and analyzed on 20% denaturing PAGE.  
Positions of template strand 81 and corresponding cross-link product 82 on the gel are annotated. Lane 1, 
80 deprotected and 
32
P-labeled. Lane 2, 80 delevulinylated (0.25 M hydrazine in 3:2 pyridine/acetic acid for 




the possible product (79), which was later confirmed by MALDI-TOF MS (App. Figure 
104).  Migration of fraction 2 near the 50 bp DNA from the ladder suggested that it was 
the template strand (78). The large peak area of fraction 2 suggested the presence of a 
significant amount of the unmodified template strand. In principle, the presence of a 
unmodified template strand could occur from incomplete delevulinylation or inefficient 
extension. Both could occur as a consequence of greater load on the solid support due to 
the longer length of 77 and 79. In addition, slower moving and (possibly) higher 

























5'-d(ATG AAC ATA CTC GTA CTC TGC ATT TCG XAG GCC - 
-CGC CAA CCT CCG CTC CAC GCC G)
3'-d(G TAA AGC TY)
5'-d(ATG AAC ATA CTC GTA CTC TGC ATT TCG ZAG GCC - 
-CGC CAA CCT CCG CTC CAC GCC G)
81
82
5'-AcO-d[(ATG AAC ATA CTC GTA CTC TGC ATT TCG) dR (AG GCC -
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Figure 4 and fraction 4 in App. Figure 5A-B). We speculated that the slower moving 
bands were branched products originating from inefficient capping due to greater load on 
the resin. Oligonucleotides 76 and 77 were characterized by MALDI TOF MS and ESI-
MS (App. Figure 102 and 103). 
After speculating about the reason behind incomplete delevulinylation, extension 
and the origin of branching, we attempted to improve the syntheses by increasing the 
capping and delevulinylation times. To ensure a more efficient capping, the resin was 
incubated 25 times (as opposed to 10 times for oligonucleotides  25 nucleotides) with 












3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GAX AAG CGT TAG CCA TTA)
3'-d(CGT AAT GCT Y ) 
5'-d(GCA TTA CGX AAA GCG TTA)
3'-d(CGT AAT GCT Y ) 
5'-d(GCA TTA CGA XAA GCG TTA)
83
                                  3'-d(GTA ATG CTY ) 





Figure 19. Chemically synthesized cross-linked oligonucleotides containing DOB ICL mimic (3).  
nucleotides), the delevulinylation time was extended to 25 min. To ensure complete 
reaction of delevulinylated support bound oligonucleotide (68), the first phosphoramidite 
was double coupled (15 min coupling time) while the rest were single coupled for the 
same duration. The modified procedures were applied for the the synthesis of 82 from 
resin bound 80, where the oligonucleotide was subsequently deprotected and cleaved 
from the support by ammonolysis. Denaturing PAGE (15%) analysis of the crude 
material following 5'-
32
P-labeling indicated efficient conversion (87%) of the template 
strand 81 into 82 without formation of any branched product (Figure 18). Cross-link 82 
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was characterized using ESI-MS (App. Figure 105). Using the same procedures, other 
cross-linked oligonucleotides (83  86) containing 3 were synthesized (Figure 19), 
purified by denaturing PAGE, and characterized by either MALDI-TOF MS or ESI-MS 
(App. Figure 106 – 109). 
3.1.1.3. Synthesis of DOB ICL from NVOC phosphoramidite 
3.1.1.3.1. Incorporation of photolabile phosphoramidite 66b and 
photodecomposition of N4-benzoyl-dC 
After establishing a strategy for DOB cross-link mimic (3) synthesis using the 
levulinyl group, we looked into the employability of photolabile 66b in ICL synthesis  
 
(Scheme 28). We envisioned that development of o-nitroveratryloxycarbonyl (ONV) 
chemistry along with levulinyl could potentially be helpful in the synthesis of 4, which 
requires two orthogonal protections of the 5'- and 3'- hydroxyl group on the cross-linked 
pyrrolidinyl moiety. Toluene as the photolysis solvent and 2 h irradiation time were 
adopted based on earlier reports.
130,131
 The photolysis tube containing the resin in toluene 
was equipped with a pipe cleaner as a stirrer to prevent crushing the resin. The synthesis 
of cross-link 89 was therefore attempted by irradiating (Rayonet photoreactor (model 



































) at 350 nm) 5'-capped support bound 87 (Figure 20) for 2 h, followed by 
extension of the opposing strand (“arm”) using  regular T phosphoramidites, deprotection  
 
Figure 20. Assessment of photolysis and subsequent extension capability for resin bound and 5'-O-acetyl 
capped oligonucleotide 87.  (A) Resin bound 5'-O-acetyl capped oligonucleotide 87, template strand 88 and 
corresponding DOB ICL mimic 89. (B) Photolysis and extension of 87 Following solid phase synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and analyzed on 
20% denaturing PAGE gel. Positions of template strand 88 (from unmodified 87) and corresponding cross-
link product 89 on the gel are annotated. Lane 1, 87 deprotected, and 5'-
32
P-labeled. Lane 2, 87 photolyzed 
in toluene for 2 h, extended using regular T phosphoramidites, deprotected, and 5'-
32
P-labeled. (C) 
MALDI-TOF-MS of recovered  photodecomposed “template strand” from lane 2 of panel (B). Calc’d 
mass, 2462.233, observed mass 2486.355 [M + Na]
+
, 2506.845 [M + 2Na]
+
, 2548.773 [M + 2Na + K]
+
, 
2564.459 [M + 2K]
+
, 2599.342 [M + 3K]
+
.  
and cleavage from the resin by ammonolysis. However, analysis of the 5'-
32
P-labeled 
crude material on 20% denaturing PAGE and MALDI-TOF MS indicated a modest yield 
(18%) of 89 (App. Figure 110) along with decomposition of template strand 88 (Figure 
20). The cause of the decomposition was traced to the previously reported susceptibility 


















   5'-d(TTT TTY)
89
5'-d(CAT ZAT AT)
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3.1.1.3.2. Replacement of N6-benzoyl-A and N4-benzoyl-C by isobutyryl-C and 
isobutyryl A for template strand synthesis 
To assess the vulnerability of N-benzoyl protecting groups to UV radiation, we measured 
the absorbances of N6-benzoyl-A and N4-benzoyl-C phosphoramidites (54 μM) between 
350 and 400 nm and compared them with that of 63b (Figure 21 and App. Figure 6). The 
spectral distribution graph of RPR-3500 lamp used in Rayonet photreactor 
(http://www.rayonet.org/graphscharts.htm) suggests the wavelengths of the light emitted 
 
Figure 21. Absorbance of nitroveratryloxycarbonyl protected 63b, and benzoyl protected A and C 
phosphoramidites between 350 and 400 nm. Concentrations of all solutions were 54 μM.  
from the lamp spans over the range 300 – 400 nm, with the maximum emission occurring 
at 350 nm. While the max of 63b was at 350 nm (Figure 21), the same for N4-benzoyl-C 
and N6-benzoyl-A phosphoramidites were at 315 and 330 nm, making them susceptible 
to photodamage (App. Figure 6). Instead of changing the light source from 350 nm, we 
explored the possibility of using alternative protecting groups that do not absorb light at 
350 nm. Attractive possibilities were commercially available N6-isobutyryl-A and N4-
isobutyryl-C phosphoramidites. As we intended to use both ONV and levulinyl protecting 
groups during the C4-AP ICL analogue (4) synthesis, isobutyryl (iBu) had to be 
compatible with delevulinylation too. This was addressed by making oligonucleotides 
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treatment, and subjecting them to solid phase synthesis (Figure 22). After ammonolysis 
of the synthesized oligonucleotides, an aliquot from the crude was 5'-
32
P-labeled, and 
analyzed on 20% denaturing PAGE gel (App. Figure 7A and B). If the iBu protections 





























































Figure 22. Sequences of support bound 5'-capped template strands 90, 93, 96, and 99, deprotected template 
strands 91, 94, 97 and 100, branching products 92 and 95, and DOB ICL mimics 98 and 101.  
gel. However, if the groups do not survive, branched oligonucleotides (92 and 95) will be 
formed. To distinguish between the extension products resulting from inefficient capping 
and those from branching (92 and 95), we subjected the capped 90 and 93 to the same 
solid phase extension without delevulinylation (Lane 2, App. Figure 7A and B, Table 2). 
Although 90, containing a single iBu-A survived the delevulinylation (extension yield 
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2.84 0.08% and 2.76% with and without delevulinylation, respectively, Figure 23A and 
App. Figure 7A), the presence of a single iBu-dC led to 3.32  1.01% extension for 
delevulinylated 93 (compared to 0.1% extension without delevulinylation, Figure 23B 
and App. Figure 7B).  
 
Figure 23. Extension of oligonucleotides 90, 93, 96 and 99 after delevulinylation.  (A) Comparison of 
extension of 90 with or without delevulinylation. (B) Comparison of extension of 93 with or without 
delevulinylation. (C) Comparison of extension of 96 and 99 after delevulinylation. Extension yields were 
calculated based on the band intensity of template strand and final product.  
This was further validated during the synthesis of the DOB ICLs from resin 
bound oligonucleotides 96 and 99 (Figure 22) with two iBu-dAs and iBu-Cs, 
respectively, and a levulinyl protected DOB ICL mimic. We probed their 
delevulinylation and subsequent solid phase extension to produce 98 and 101 by 
deprotection, 
32
P-labeling and gel analysis as described before (App. Figure 7). 
Reaffirming our effective capping and delevulinylation strategies, no unwanted extension 
without delevulinylation (branching products) or leftover template strand (97 and 100, 
from unmodified 96 and 99) was detected (Lane 2, 3, 4 and 5, App Figure 7C).  In 
accordance with the previous finding on iBu-A and iBu-C, the latter caused greater yield 
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Figure 23C, App. Figure 7C). Therefore, the strategy to replace the photolabile N6-
benzoyl-A and N4-benzoyl-C with their isobutyryl protected analogues was abandoned.  
3.1.1.3.3. Synthesis of DOB ICL from nitroveratryloxycarbonyl phosphoramidite 
using a long-pass optical filter 
A reexamination of absorbance of 66b and benzoyl protected A and C 
phosphoramidites (Figure 21) revealed that the absorption of the benzoyl group is 
negligible above 375 nm. In contrast, the o-nitroveratryl group still has significant 
absorption at this wavelength. Consequently, we used a 375 nm long pass filter (Newport 
no. CGA-375, App. Figure 8) that had zero transmittance at 370 nm and 50% at 375 nm 
(App. Figure 8). The filter was fitted into a Schoeffel 1000 W short-arc lamp (model 
LH151N/2, intensity 9 mW/cm
2
 at 350 nm). When the ONV protected support bound 
oligonucleotide 87 was deprotected via the filter-aided-photolysis (2 h in toluene, room 
temperature) and subjected to solid phase extension, cross-link 89 was formed in a 
modest 30% yield (App. Figure 9). In contrast to the previous photolysis without filter, 
template strand 88 (produced from unmodified 87) did not divulge any sign of 
decomposition of the benzoyl groups. Having overcome the vulnerability of N4-benzoyl-
C and N6-benzoyl-A from photolysis, we focused on improving the extension yield.  
When support bound o-nitroveratryloxycarbonyl (NV) protected 87 was 
converted to 89 by photolysis in toluene for 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h (room 
temperature), followed by extension, the highest yields were obtained at 1 h (35.8%) and 
2.5 h (32.5%) (App. Figure 10). The yield dropped after 1 h, surged at 2.5 h, and then 
continued to drop, reaching 16% at 4 h. While the gradual drop after 2.5 or 3 h could be 
attributable to photodecomposition of 87 due to prolonged photo-exposure, we could not 
readily explain the low yields at 1.5 or 2.0 h. When the same support bound 5'-capped 
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oligonucleotide (87) was photolyzed in 9:1 acetonitrile/water (2 h, room temperature) 
prior to solid phase synthesis, it produced 50% extension (App. Figure 11). We expected 
that the hydrolysis of the photoreduced NV group will be easier in an acidic medium. In 
accordance with our hypothesis, 90% extension yield was obtained when the solid 
support was washed with 4:1 pyridine/acetic acid (pH 5.5) for 10 min at room 
temperature following photolysis in 9:1 acetonitrile/water (App. Figure 11). The absence  
 
Figure 24. Assessment of filter-aided-photolysis (375 nm long pass) and subsequent extension capability 
for resin bound and 5'-O-acetyl capped oligonucleotide 87.  Oligonucleotide was subsequently deprotected 
and cleaved from the support by ammonolysis. An aliquot from the crude was 5'-
32
P-radiolabeled, and 
loaded on 20% denaturing PAGE gel. Positions of the template strand 88 (from unmodified 87) and 
corresponding cross-link product 89 on the gel are annotated. Lane 1, 87 deprotected without any 
modification. Lane 2, 87 subjected to extension using regular T phosphoramidite. Lane 3 and 4, 87 
subjected to 2.0 and 2.5 h of photolysis followed by extension using regular T phosphoramidites, 
respectively. 
of any extension for support bound 87 after washing it under the same conditions 
confirmed that the removal of NV group was not due to the treatment with the 4:1 
pyridine/acetic acid mixture (App. Figure 11). However, attempts to replicate this 
astonishing extension yield by washing with 4:1 pyridine/acetic acid was unsuccessful 
irrespective of the solvent used in photolysis (toluene or 9:1 acetonitrile/water, App. 
Figure 12). Instead, we noticed an unexplained decomposition of 88 when photolysis was 
followed by 4:1 pyridine/acetic acid wash (10 min, room temperature). Despite the 














   5'-d(TTT TTY)
89
5'-d(CAT ZAT AT)
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setback in the pyridine/acetic washing procedure, we were finally able to efficiently 
convert 87 into 89 by a simple mechanical readjustment of the light source that enabled 
the beam to cover the whole solution for more efficient irradiation (Figure 24). Solid 
phase extension following photolysis for 2.0 and 2.5 h provided nearly quantitative 
conversion of 87 to 89. We adopted these photolysis durations (2.0 and 2.5 h for template 
strand length shorter or longer than 25 nucleotides, respectively) in toluene for use in the 
C4-AP cross-link mimic (4) synthesis. 
3.1.2. Synthesis of C4-AP ICL mimic 
3.1.2.1. Synthesis of C4-AP ICL mimic from 5'-ONV-3'-Lev-C4-AP 
phosphoramidite 
3.1.2.1.1. Removal of o-nitroveratryloxycarbonyl and levulinyl protecting groups 
from 5'- and 3'- hydroxyls of pyrrolidine 
 
After establishing the compatibility of the levulinyl (Lev) and o-
nitroveratryloxycarbonyl (NV) groups with solid phase synthesis conditions, we sought 
to synthesize C4-AP ICL mimic 4 using them. We decided to implement the solid phase 
synthesis and capping conditions developed for the DOB analogue for this purpose. In 
addition, we explored combining allyloxycarbonyl (ALLOC) and levulinyl for 
synthesizing 4. We envisioned that the two hydroxyls in the pyrrolidinol ring in 4 would 
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them would protect the 5'- and 3'- hydroxyls of pyrrolidinol and more importantly, which 
would be removed first during the course of the solid phase synthesis. To determine 
whether NV or levulinyl could be removed first, we subjected support bound 5'-capped 
levulinyl protected oligonucleotide 102 to photolysis in toluene (2 h, room temperature), 
followed by delevulinylation (0.25 M hydrazine, 3:2 pyridine/acetic acid, 10 min, room 
temperature) and solid phase extension (Figure 25 and App. Figure 13). Based on the 
strategy established for DOB ICL analogue 3, all photoirradiation experiments were 
carried out using a Schoeffel 1000 W short-arc lamp (model LH151N/2, intensity 9 
mW/cm
2
 at 350 nm) fitted with a 375 nm long pass filter. The product or extension 
efficiency did not differ from that done without photolysis (Lane 3 and 4, App. Figure 
13).  Having established that photolysis followed by hydrazine treatment did not affect 
extension, we sought to explore the consequences when the order of steps were reversed. 
The support bound NV protected 5'-capped-87 was subjected to delevulinylation (0.25 M 


























Figure 25. Support bound oligonucleotides 87 and 102. 
temperature) prior to subsequent photolysis (toluene, 2 h, room temperature) and solid 
phase extension. While only photolysis followed by extension successfully yielded cross-
link 89 (Lane 5, App. Figure 14), delevulinylation preceding the photoirradiation led to 
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decomposition (Lane 4, App. Figure 14). This was consistent with the previously 
observed decomposition of oligonucleotide for photolysis followed by pyridine/acetic 
acid washing. Although unexplainable, the observation led us to abandon the second 
route, delevulinylation and 3'-arm synthesis followed by photolysis and 5'-arm synthesis. 
Next, we sought to resolve the preferential location of NV and levulinyl group on 5' and 
3' hydroxyls of the pyrrolidine ring of C4-AP ICL analogue. Similar to DOB ICL mimic 
analogue 3, the solid phase synthesis of the 3'-arm involves less efficient 3' to 5' coupling 
using 5'-cyanoethyl (CE) reverse phosphoramidites. Therefore, we decided to employ the 
levulinyl group to protect the 3'-hydroxyl of the pyrrolidinol, anticipating its efficient 
removal compared to the NV (as seen during synthesis of DOB ICL analogue 3) would 
compensate for the relatively inefficient 3' to 5' extension. Hence,  





















































































the 5'-hydroxyl was protected with the NV group, so that its inefficient removal could be 
balanced by the more efficient 5' to 3' synthesis using 5'-dimethoxytrityl (DMT) 3'-CE 
“regular” phosphoramidites (Scheme 29). We used the same argument for making a C4-
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AP ICL analogue using ALLOC and levulinyl groups, putting the ALLOC group on the 
5'-OH of the pyrrolidinol moiety of 4. 
According to the strategy of synthesizing 4 (Scheme 29), requisite 
phosphoramidite (113a) would be employed to make the template strand (103). 
Following acetyl capping of the template strand, the NV group would be removed from 
103 (Scheme 29). After extending the primary alcohol of 104 using “regular” 
phosphoramidites, the nascent 5'-arm would be acetyl capped (105). Following 
hydrazinolysis (0.25 M hydrazine in 3:2 pyridine/acetic acid, 10 or 25 min, room 
temperature) of 105, the free 3'-hydroxyl of 106 would be extended using 5'-CE “reverse” 
phosphoramidites (107). Finally, ammonolysis and cleavage of 107 containing both 5' 
and 3' arms from the solid phase support, purification by denaturing PAGE would yield 
4. We anticipated that deprotection of levulinyl and NV groups and subsequent 
extensions would follow methodologies developed earlier during the synthesis of 3. 
The synthetic strategy (Scheme 30) for making the requisite C4-AP ICL mimic 
phosphoramidite (113a) was derived from methodology developed for the synthesis of 
DOB ICL mimic phosphoramidites. The same strategy was implemented to make the C4-
AP ICL mimic phosphoramidite containing the ALLOC protecting group (113b). Similar 
SNAr chemistry between 108 and 61 led to production of cross-link analogue 109. We 
could not selectively protect the 5'-pyrrolidinyl hydroxyl with a nitroveratryloxycarbonyl 
(NV) or allyloxycarbonyl (ALLOC) moiety by treating 109 with the corresponding 
chloroformates.  Therefore, we protected it with DMT followed by functionalization of 
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Key: a) Cs2CO3, THF  b) DMTCl, pyridine c) Levulinic acid, EDCI, DMAP, DMF 
d) AcOH, H2O, THF (3:1:1)  e) o-nitroveratryl or allyloxycarbonyl chloroformate, DMAP, CH2Cl2  







































































































the 3'-pyrrolidinyl hydroxyl with the levulinyl group (110). Afterwards, DMT protecting 
group on 5'-pyrrolidinyl OH was removed to have it protected with NV (111a) or 
ALLOC (111b). Following desilylation, 112a and 112b were converted to the 
corresponding phosphoramidites (113a,b) using standard procedures.  
The first attempt at synthesizing of (R,S)-3-hydroxy-2-hydroxymethylpyrrolidine 
(108) was done using the strategy reported in Scheme 31.
133
 Starting from methyl ester of 
D-serine, this method involves synthesis of an oxazoline ring which later rearranges to 
the desired pyrrolidine framework. The stereochemistry at C4-position of the final 
pyrrolidine ring was derived from the chirality of serine itself. The stereochemistry of the  
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Key: a) DIPEA, DCM, reflux; b) DIBAL-H, MeOH quench; c) (+)-IPc2B(CH2CH=CH2), -78 
oC  d) Ac2O, 
triethylamine; e)OsO4, THF, NaIO4; f) NaBH4, MeOH; g) NaH, p-toluenesulfonyl chloride; h) 1 M HCl in MeOH; 



















hydroxyl substitution of the R,S-homoallylic alcohol was the result of a diastereoselective 
nucleophilic attack by (+)-IPc2B(CH2CH=CH2) on the carbonyl (Scheme 31). Scheme 
32, on the other hand is an almost identical synthetic sequence described in the same 
report
133
 to make (R,R)-3-hydroxy-2-hydroxymethylpyrrolidine. It differs from Scheme 
31 only in the direction of diastereoselective nucleophilic attack at the second step using 
()-IPc2B(CH2CH=CH2) instead of (+)-IPc2B(CH2CH=CH2). The changed directionality 
of the nucleophilic addition thus changes the stereochemistry (S to R) of the hydroxyl  


























Key: a) DIBAL-H, MeOH quench; b) (-)-IPc2B(CH2CH=CH2), -78 
oC.  
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substitution of the resultant homoallylic alcohol (Scheme 32). During our attempts to 
synthesize 108 (Scheme 31), the NMR and specific rotation of the prepared R,S-
homoallylic alcohol matched with that of the R,R-homoallylic alcohol reported in the 
article.
133
 NOE studies to investigate the stereochemical relationship between C4-H of the 
homoallylic alcohol and the hydrogen  to OH were unsuccessful due to rotation of the 
connecting C-C bond. Assuming the NMR mix-up as an inadvertent mistake of the 
authors, we continued the synthesis, anticipating to resolve the ambiguity at the final step 
(Scheme 31). The rearrangement of oxazoline to pyrrolidine at the penultimate step was 
successful, albeit in low yield. We successfully accomplished the final deprotection step 
using conditions as described (Scheme 31).
133
 Upon completion, we discovered that the 
NMR (of the final molecule made by us and that reported in the article
133
) did not match 
with (R,S)-3-hydroxy-2-hydroxymethylpyrrolidine (108) synthesized by other 
independent strategies.
134,135
 The article from which Scheme 31 was adopted did not 
attempt to verify the final molecule with a crystal structure.
133
 Since all other reactions in 
Scheme 31 were well-established, we suspected that the key rearrangement at the 
penultimate step did not yield the pyrrolidine ring as described. If our suspicion was 
correct, the final molecule in Scheme 31 may not be 108. We did not investigate this 
approach any further, and used a different strategy to make 108. 
Our second attempt to make the hydrochloride salt of 108 exploited the chirality 
of the α-hydroxyl group in L-malic acid (Scheme 33).
136,137
 The advantage of this 
strategy lies in the fact that a number of steps can be carried out without chromatographic 
purification, which makes the approach considerably more efficient than the previous 
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one. In addition, it helped us when scaling up the synthesis. In this scheme, the α-
hydroxyl group of L-malic ester was efficiently protected with a tert-butyl group to  




































Key: a) Ethanol, conc H2SO4, reflux; b) isobutene, H3PO4, P2O5, BF3.Et2O, THF; c) LiAlH4, reflux; d) MsCl, Et3N, DCM; 
e) NH2OH.HCl, Et3N, reflux; f) HgO, DCM; g) Bu3SnCH2OBn, nBuLi, THF; h) Pd(OH)2-C, H2, HCl in MeOH.
92%
HCl salt of 108












generate an O-tert-butyl protected ester.
136
 The stereochemistry of the protected alcohol 
was retained in the C3 hydroxyl of 108. Later in this strategy, the oxidized nitrone was 
subjected to nucleophilic attack by Bu3SnCH2OBn. The trans stereoselectivity (trans/cis 
> 95:5) of the nucleophilic attack with respect to the O-tert-butyl group generated the 
desired S stereochemistry at C4 position. Finally, removal of benzyl and tert-butyl 
protecting groups (by acid treatment and hydrogenolysis, respectively) produced the 
hydrochloride salt of 108 (Scheme 33).
137
 
3.1.2.1.2. Synthesis of cross-linked oligonucleotides 117 containing C4-AP ICL 
analogue 4 
The synthesis of a short (8 bp, 117, Figure 26) oligonucleotide containing C4-AP 
ICL analogue 4 was attempted as a proof of concept. The phosphoramidite 113a was 
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incorporated into the template strand by manual coupling (15 min) with 80% yield, while 
the average stepwise yield was 90.3%. During the synthesis of the template strand, 
commercial 5'-DMT 3'-CE “regular” phosphoramidites (benzoyl-A, isobutyryl-G, and 
benzoyl C) were employed. Following 5'-acetyl capping of the support bound template 
strand containing functionalized C4-AP analogue (114), a portion of the resin (typically 








5'-d(CAT MAT  AT)-3'
d(NA TA)-5'
5'-d(CAT WAT AT)-3'











































Figure 26. Sequences of resin bound oligonucleotide 114, template strand 115, ICL 116 after 5'-extension 





 of the total amount of resin present in a 1 μmol scale column) was subjected 
to photolysis as described before for 1.0, 1.5 and 2.0 h (App. Figure 15). The 5'-arm was 
synthesized with the first phosphoramidite being manually coupled. The rest of the 
phosphoramidites (concentration 0.15 M) were incorporated  into the arm via automated 
synthesis cycle (coupling time 15 min) to produce 116. Following the synthesis of the 
arm, an aliquot from the crude was 
32
P-labeled and analyzed on 20% denaturing PAGE. 
The highest yields were obtained for 1.5 h (78%) and 2.0 h (71.3%) of photolysis (App. 
Figure 15A and 15B). In addition, template strand 115 remained intact on the gel 
implying absence of photodecomposition of benzoyl-dC.  
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Figure 27. Filter aided photolysis and delevulinylation followed by solid phase extensions of support 
bound oligonucleotide 114. Oligonucleotides from each step were subsequently deprotected and cleaved 
from the support by ammonolysis. An aliquot from the crude was 5'-
32
P-labeled, and loaded on 20% 
denaturing PAGE gel. Positions of template strand 115 (from unmodified 114), ICL 116 and 117 are 
annotated. (A) Observation of 5'- and 3'-extension on 20% denaturing PAGE gel. Lane 1, template strand 
115 (from unmodified 114). Lane 2, 114 photolyzed for 2 h in toluene and extended using “regular” 
phosphoramidites. Lane 3, Resin from 5' extension was capped, and subjected to delevulinylation treatment 
(0.25 M hydrazine in 3:2 pyridine/acetic acid, 10 min, room temperature) and solid phase extension using 
5'-CE “reverse” phosphoramidites. (B) MALDI-TOF-MS characterization of 117 and the deletion products.  
(C) Amount of extension product formed with respect to starting material for 5' and 3'-arm synthesis. All 
product bands were taken into account and compared with that from starting material during the 
computation of extension yield. 
Next, we attempted the synthesis of full length ICL 117. After photolysis and 
synthesis of the 5'- arm, 117 was obtained by delevulinylation and synthesis of the 3'-arm 


























































































P-labeling the deprotected crude and analyzed them on 20% denaturing 
PAGE (Figure 27A). The synthesis yielded 2.7 nmol of ICL 117 from 1/5
th
 of the resin 
present in a 1 μmol scale column. Although the 5'- and 3'- extensions proceeded with 
efficient conversion of the starting material into products (70% and 73.5%, respectively, 
Figure 27C), the gel indicated the presence of a mixture of products (Lane 3, Figure 
27A). Upon isolation and characterization using MALDI-TOF MS, the top band on lane 
3 was identified as the desired 117 (calc’d mass 4674.083, found 4675.773, Figure 27B). 
The rest of the bands on the same lane were characterized as deletion products with either 
missing a C or (C + A) or (C + A + G) (Figure 27B). As the deletion products did not 
correlate with the sequence of the 3'-arm, we hypothesized their origin to be elsewhere 
during the ICL synthesis. Since we wanted to synthesize longer C4-AP ICL mimics 
(template strand length  25 nucleotides), the presence of the deletion products convinced 
us to adapt more stringent solid phase synthesis protocols. 
3.1.2.1.3. Applicability of chemical phosphorylating agents during synthesis of 
longer C4-AP ICL mimic (template strand length  25 nucleotides) 
To minimize deletion product generation during the synthesis of ICL 121 (Figure 
28), phosphoramidite 113a was incorporated into the template strand by manual double-
coupling (15 min each). Furthermore, 1000 Å resin was employed to withstand the load 
of longer ( 25 nt) length of template strand synthesis. In addition, automated double-
coupling of the native phosphoramidites were used during solid phase synthesis of the 
template strand (119). Coupling of phosphoramidite 113a occurred in a quantitative 
manner while 98.2% average stepwise yield was obtained. We attempted to 
phosphorylate the 5'-terminus using solid phase chemical phosphorylation with a 
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commercially available masked phosphate amidite (122 or 123, Figure 29). We expected 
the presence of a phosphate to aid us during subsequent T4 DNA ligase mediated ligation 
and selective 5'-
32
P-labeling to synthesize a full-length cross-link product. Since the 
synthesis of the 5' arm would be succeeded by delevulinylation (conversion of 120 to 
3'-d(CCG TGT ATV ATA TGC  GC)-O-PO3
5'-d(GCT GAT CGC GGC ACA TWA TAT ACG CGG ATC TGC ACG)-3'
5'-AcO-[d(GCT GAT CGC GGC ACA T) dR d(A TAT-
- ACG CGG ATC TGC ACG)]-O
3'
5'-d(GCT GAT CGC GGC ACA TPA TAT ACG CGG ATC TGC ACG)
d(N ATA TGC GC)-O-PO3





















































Figure 28. Sequences of support bound oligonucleotide 118, template strand 119, ICL 120 after 5’-
extension and 121 after both 5’- and 3’- extension. 
121, Figure 28), the masking groups on the chemical phosphorylating agents (CONHMe 
and CO2Et) needed to survive the hydrazinolysis.  
 
Figure 29. Commercially purchased chemical phosphorylating reagents. 
To assess the compatibility of 122 and 123 with delevulinylation, we synthesized 
oligonucleotides containing the masked phosphates (124a,b, Scheme 34). After 5'-acyl 
protection, the oligonucleotides were subjected to delevulinylation (0.25 M hydrazine in 
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3:2 pyridine/acetic acid, room temperature) for 10 or 25 min, followed by solid phase 
extension using regular T phosphoramidites. The results were analyzed by deprotecting 
Scheme 34: Determination of compatibility of phosphorylating reagents with delevulinylation 
 
the oligonucleotides from support, 
32
P-labeling the crude and analyzing them on 20% 
denaturing PAGE. If the protecting groups on the phosphorylating agents are stable to 
hydrazinolysis, no extension would be detected on the gel. Both groups were somewhat  
 
Figure 30. Compatibility of phosphorylating agents 122 and 123 with delevulinylation treatment (0.25 M 
hydrazine in 3:2 pyridine/acetic acid, room temperature for specified time). Percentage of extension 
product formed compared to starting material (124a,b) plotted against delevulinylation time. Only bands 
corresponding to starting oligonucleotide (125) and final extension products were taken into account. 
unstable to hydrazinolysis, generating unwanted extension products (branching) (App. 
Figure 16A and B). The slower moving bands were confirmed as the unwanted extension 
products using MALDI-TOF MS (App. Figure 16). To assess the exact nature of the 
effect of hydrazinolysis on the phosphorylating groups, the extension products from 10 
and 25 min of hydrazinolysis were quantified with respect to the starting material. It 
revealed that branching was less for 124a compared to 124b for both durations (Figure 
30).  Furthermore, characterization of bands from the gel by MALDI-TOF MS showed 
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the presence of unphosphorylated 126 along with phosphorylated 125, indicating 
inefficient coupling for 123 (App. Figure 16B and D). Therefore, we chose 122 based on 
the greater efficiency in solid phase coupling and less unwanted extension (branching).  
3.1.2.1.4. Synthesis of longer C4-AP ICL mimic (template strand length  25 
nucleotides) 
3'-d(CCG TGT ATV ATA TGC  GC)-O-PO3



















Next, we strived to optimize the solid phase coupling procedure for minimizing 
the deletion products similar to those detected during the synthesis of 117. As described 
before, stringent strategies were adopted during the synthesis of the template strand, 
including double coupling of native phosphoramidites and double manual coupling of 
C4-AP ICL analogue phosphoramidite (113a).  Anticipating the machine aided 
automated synthesis of the 5'- and 3'- arms as a possible source of inefficient coupling 
(thereby generating deletion products), we resorted to manual coupling. During the 
synthesis of both arms, all phosphoramidites were double-coupled excluding the first, 
which was coupled four times. The coupling yield was computed based on the 
dimethoxytrityl cation content after deblocking (detritylation). The amount of resin used, 
its loading and overall yield during synthesis of the template strand was accounted for 
within the theoretical yield. Quantification of the trityl cation indicated that the first 
coupling of the 5'-arm occurred with 87% yield, while the rest of the arm was synthesized 
with 99.8% average stepwise yield. When the oligonucleotide following 5'-arm synthesis 
was subjected to ammonolysis, cleavage from support, 5'-
32
P-labeling and analysis on a  
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Figure 31. Synthesis of ICL 121 from support bound 118. Oligonucleotides after synthesis of 5'- and 3'- 
arms were deprotected and cleaved from the support by ammonolysis. An aliquot from the crude was 5'-
32
P-labeled, and analyzed on 15% denaturing PAGE gel. Positions of template strand 119 (from unmodified 
118), ICLs 120, 121, and 127 are annotated. Lane 1, Template strand (from unmodified 118). Lane 2, 
photolysis in toluene (2.5 h, room temperature) and synthesis of 5'-arm using “regular” phosphoramidites. 
Lane 3, delevulinylation (0.25 M hydrazine in 3:2 pyridine/acetic acid, room temperature for 25 min) and 
synthesis of 3'-arm using “reverse phosphoramidites. 
15% gel, the efficient synthesis of 5'-arm was evident (Lane 2, Figure 31).  Similarly, 
following removal of the 3'-levulinyl group, the 3'-arm was synthesized using manual 
coupling the same way as the 5'-arm. However, delevulinylation also deprotected some of 
118 that was not cleaved upon photolysis, leading to generation of 127 along with desired 
121 upon solid phase extension (Lane 3, Figure 31). As a result, quantification of the 
dimethoxytrityl cation led to coupling yield > 100%. Apart from that, synthesis of 121 
was achieved without significant generation of deletion products (Lane 3. Figure 31). ICL 





1              2       3
3'-d(CCG TGT ATV ATA TGC GC)-O-PO3
5'-d(GCT GAT CGC GGC ACA TWA TAT ACG CGG ATC TGC ACG)-3'
5'-AcO-[d(GCT GAT CGC GGC ACA T) dR d(A TAT-
- ACG CGG ATC TGC ACG)]-O
3'
5'-d(GCT GAT CGC GGC ACA TPA TAT ACG CGG ATC TGC ACG)
d(N ATA TGC GC)-O-PO3
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Figure 32. Chemically synthesized cross-linked oligonucleotides containing C4-AP ICL mimic (4).  
and purified by denaturing PAGE, producing 5.7 nmole of the desired ICL from half of 
the resin present in a 1 μmol scale column. Using the strategies developed above, ICLs 
128 – 130 were synthesized (Figure 32), which were characterized by ESI-MS (App. 
Figure 114 – 116).  






























































































In summary, we established strategies for the C4-AP ICL mimic (4) synthesis 
using the o-nitroveratryloxycarbonyl (ONV) and levulinyl (Lev) groups. The synthesis 
starts with making of the 5'-O-acetyl capped template (“bottom”) strand, where the 
5'-d(GCA CAT WAT ATG CG)
3'-d(CGT GTA  TVA TAC GC)
5'-d(GCA CAT AWT ATG CG)
3'-d(CGT GTA  TVA TAC GC)
129
130
5'-d(GCT GAT CGC GGC ACA TAW TAT ACG CGG ATC TGC ACG)
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phosphoramidite 113a is incorporated via solid phase synthesis (Scheme 35). Next, we 
determined the viability of removing the ONV group protecting the 5'-hydroxyl of the 
pyrrolidine, followed by the synthesis of the corresponding arm. After capping the 
nascent arm, the levulinyl group was removed by hydrazinolysis. Then we employed 5'-
cyanoethyl “reverse” phosphoramidites to prepare the 3'-arm, following which 
ammonolysis yielded the final cross-link product. Manual coupling was employed during 
synthesis of the arms, while coupling time and counts were optimized to minimize 
deletion products. The strategy enabled successful synthesis of short (template strand 
length 8 – 15 nucleotides) and long (template strand length 36 nucleotides) cross-linked 
oligonucleotides containing 4. 
3.1.2.1.5. Conversion of ICL 121 into 60 bp ICL by T4 DNA ligase mediated ligation 
Scheme 36. Synthesis of 60 bp ICL 5'-
32
P-b-135 by ligation 
 
After synthesizing the C4-AP ICL mimic 121, we explored the possibility of 
converting it to full-length cross-link 135 containing fully complementary strands and 5'-
32
P-labeled bottom strand (cross-linked abasic site containing strand is referred to as 
“top” strand or “t”, while the cross-linked A containing strand is referred to as “bottom” 
















5'-d(GAC ATG GTA CTG)
5'-d(PGCG ATC AGC CAG TAC CAT GTC)
5'-d(GCA TCG GTC GAG CGT GCA GAT C)





3'-d(CTG TAC CAT GAC CGA CTA GCG CCG TGT  ATV ATA TGC GCC TAG ACG TGC GAG CTG GCT ACG)-32P-5'



















3'-d(CCG TGT ATV ATA TGC GC)-O-PO3
5'-d(GCT GAT CGC GGC ACA TWA TAT ACG CGG ATC TGC ACG)-3'
5'
121
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us to synthesize 135. It required phosphorylation of the 5'-end of 121 that was already not 
phosphorylated, and was carried out enzymatically using T4 polynucleotide kinase and  






















































































ATP (see experimentals for further details). In addition, the 5'-terminus of 133 was 
independently 
32
P-labeled with the same enzyme and -32P-ATP. Following hybridization 
of these oligonucleotides, they were ligated (16 C, 12 h) using T4 DNA ligase and ATP. 
Oligonucleotide 5'-
32
P-133 was used as the limiting agent in the hybridization and 
ligation (App. Figure 17B). The ligated full length product was purified by 20% 
denaturing PAGE and isolated from the gel by the crush and soak method. The isolated 
yield varied between 10 – 20% and was determined based on the specific activity of 5'-
32
P-133. Desalting and rehybridization produced pure 5'-
32
P-135, which was sufficiently 
long (60 bp) to be used in nucleotide excision repair experiments. The integrity of 5'-
32
P-
135 was confirmed by using restriction enzymes (App. Figure 17A and C). The ligation 
mediated construction can be employed to selectively label other termini of 135 as well.  
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3.1.2.2. Synthesis of C4-AP ICL mimic from 5'-ALLOC-3'-Lev-C4-AP 
phosphoramidite 
While exploring conditions to synthesize C4-AP ICL mimic using 5'-o-
nitroveratryloxycarbonyl-3'-levulinyl-C4-AP phosphoramidite (113a), we investigated 









































the same. As explained before, we functionalized the 3'-pyrrolidinyl OH using levulinyl 
(Lev) due to its better deprotection efficiency and inefficient 3' to 5' coupling. Similar to 
o-nitroveratryloxycarbonyl (ONV) mediated synthesis of C4-AP, the beginning of the  
HO-d(TTT TTT TTT T)-O
5' 3'













Figure 33. Oligonucleotides used to determine compatibility of O-acyl and exocyclic amine protection 
with Pd(0) catalyzed allyloxycarbonyl (ALLOC) removal. 
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synthesis proceeded by incorporation of the requisite phosphoramidite (113b) into 
template strand by solid phase synthesis. Following removal of the allyloxycarbonyl 
protection from 136, the rest of the synthesis leading to 4 was anticipated to proceed via 
the same strategy as the ONV protected analogue (Scheme 37). 
Previously, the allyloxycarbonyl (ALLOC) group protecting nucleotide exocyclic 
amines was removed using various reagents based on Pd(0) chemistry.
138
 To the best of 
our knowledge, an example of ALLOC deprotection followed by solid phase synthesis on 
oligonucleotide substrates has never been reported. Similar chemistry was reported 
during solid phase peptide synthesis, which we adapted for our cause.
139,140
 The acyl 
capping and exocyclic amine protecting groups needed to withstand the Pd(0) 
deprotection conditions, while the subsequent solid phase extension should be unaffected 
by it. To test their robustness towards Pd(0) based deprotection conditions, we subjected 
136 to ALLOC removal (Pd(PPh3)4 (0.1 μM) and Et2NH•BH3 (7 μM) in DCM) and 
subsequent washing step (using 0.2% trifluoroacetic acid in DCM and 5% DIPEA in 
DCM, see experimental for details). Following Pd(0) treatment and washing, solid phase 
synthesis using 5'-dimethoxytrityl “regular” phosphoramidites was applied to 136. If the 
Pd(0) treatment and washing is compatible with solid phase synthesis, it would lead to 
efficient extension of 136. The efficiency or failure of the extension was probed by 
ammonolysis of the oligonucleotide on the support, 
32
P-labeling, and analysis on 20% 
denaturing PAGE. The analysis revealed inefficient extension compared to that without 
Pd(0) treatment (App. Figure 18). Separate treatment of the resin with the Pd(0) solution 
(as Pd(PPh3)4) or washing conditions identified the former as the cause of the inefficient 
solid phase extension (Lane 3 and 4, App. Figure 18). The Pd(0) treatment contained two 
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components added together, 7 μM Et2NH•BH3 and 0.1 μM Pd(PPh3)4 in 1 mL DCM. To 
pinpoint the possible source of the inefficiency, 136 was independently treated with these 
components as well as with the washing conditions. Furthermore, the washing conditions 
adopted from the solid phase peptide synthesis were followed by subsequent washing 
steps using acetonitrile and methanol (App. Figure 19). This time, however, the solid 
phase extension following these treatment proceeded efficiently, possibly benefitting 
from the modified extensive washing steps.  
 
Figure 34. Solid phase oligonucleotide synthesis following ALLOC removal. (A) Oligonucleotides used to 
determine compatibility of O-acyl and exocyclic amine protection with Pd(0) catalyzed allyloxycarbonyl 
(ALLOC) removal. (B) Synthesis of ICL 143 from support bound 142. Following synthesis, 
oligonucleotides were deprotected and cleaved from the support by ammonolysis. An aliquot from the 
crude was 5'-
32
P-labeled, and loaded on 20% denaturing PAGE gel. Positions of template strand 115 (from 
unmodified 142), and ICL 143 are annotated. Lane 1, Unmodified 136 deprotected. Lane 2, 142 subjected 
to Pd(0) catalyzed ALLOC removal, followed by solid phase extension using “regular” phosphoramidites.  
Having verified the compatibility of Pd(0) deprotection and subsequent washing 
steps with solid phase synthesis, the stability of acetyl capping under the same conditions 
was explored using 137. After Pd(0) treatment, washing, subsequent solid phase 
extension, and ammonolysis of the resin, an aliquot from the crude was probed by 
32
P-
labeling and denaturing PAGE to detect any unwanted extension from the removal of 
1     2
115
143
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acetyl (App. Figure 20). No extension product was detected implying stability of acetyl 
under this condition. Next, we sought to probe the compatibility of exocyclic amine 
protections using 138 – 140. Probing the extension using 
32
P-labeling and subsequent 
denaturing PAGE analysis demonstrated that the amine protections (benzoyl-A, 
isobutyryl-G and benzoyl-C) were stable to the ALLOC deprotection conditions (App. 
Figure 21).  
Having established the compatibility of the ALLOC deprotection conditions with 
acetyl and phosphoramidite amine protections, as well as the solid phase synthesis 
conditions, we attempted to synthesize the 5'-arm using this chemistry. When Pd(0) 
deprotection of 142 and subsequent solid phase synthesis to produce 143 was probed by 
32
P-labeling and denaturing PAGE, 37.5% extension was detected (Figure 34). The 
identity of ICL 143 was confirmed by MALDI-TOF MS (App. Figure 117). Although the 
synthesis revealed significant presence of template strand 115 from unmodified 142, the 
purity of 143 as observed on the gel and by MALDI-TOF MS was satisfactory. We could 
not account for the incomplete extension despite the previously established compatibility 
of solid phase synthesis with Pd(0) based ALLOC removal. In our opinion, the 20 min 
Pd(0) treatment time as described in solid phase peptide synthesis methodology could be 
too short for ALLOC removal from an oligonucleotide. Before experimenting with the 
treatment duration, we decided to establish whether the isolated 143 had the correct 
positioning of the cross-link. We investigated this by subjecting 3'-
32
P-143 to hydroxyl 
radical cleavage treatment (App. Figure 22). While the treatment revealed correct 
connectivity of the cross-link (on the fifth nucleotide from the 3'-terminus), it showed the 
presence of multiple bands for untreated 143, indicating decomposition. Having 
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previously established the purity of 143 by MALDI-TOF MS, the decomposition was 
paradoxical in nature. By this time, our parallel endeavors with 5'-o-
nitroveratryloxycarbonyl protection successfully delivered ICL analogues containing 4. 
Therefore, the inefficient extension observed for 5'-ALLOC, combined with unexplained 




















After we abandoned attempts of making 4 using orthogonal deprotection of 
ALLOC, we came across the synthesis of N3-thymidine-butylene-N3-thymidine ICL 
(55).
33
 The synthesis of 55 was reported prior to our attempts and we were unaware of 
this article, which successfully utilized the orthogonal ALLOC removal.
33
 In contrast to 
our method, the cleavage of 5'-ALLOC employed treating the resin with Pd(PPh3)4 (3 
mM), PPh3 (5.8 mM) in 1.2 M n-butylamine/formic acid buffer in 1 mL THF (35 C, 3 
h).
33
 The removal of the Pd(0) from the resin was carried out by washing it with saturated 
N,N-diethyldithiocarbamate, which acted as a chelating agent for palladium.
33
 Thus, the 
employment of higher concentration of Pd(0), as well as elevated temperature, and longer 
time (3 h versus 20 min) in combination with superior washing method could have led to 
better solid phase synthesis efficiency than ours.  
 




The synthetic strategies discussed enabled successful synthesis of stable 
analogues of DOB and C4-AP ICLs (1 and 2). The native cross-links (1 and 2) contain 
hemiaminal linkages, leading to their instability.
9,31
 The stable analogues (3 and 4) are the 
reduced version of the native ICLs, missing the hemiaminal linkages. While the native 
ICLs contain epimerizable centers, the stereochemistry of the native deoxyribose sugars  
 
are retained in the stabilized cross-link analogues, assuming they would be the least 
distorting. We demonstrated the compatibility of a pair of protecting groups (o-
nitroveratryloxycarbonyl and levulinyl) with solid phase oligonucleotide synthesis, and 
implemented them to synthesize 3 and 4. In combination with enzymatic ligation, this 
strategy enables synthesis of cross-linked oligonucleotides long enough (e.g. 60 bp) for 
nucleotide excision repair studies. In addition, the strategies have general applicability for 










































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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3.2. Nucleotide excision repair studies on DOB and C4-AP ICL 
 
Among UvrA, UvrB and UvrC, the bacterial nucleotide excision repair proteins, 
the first two act as a damage sensor, while UvrC incises an olignucleotide containing the 
lesion. The preliminary damage recognition is done by UvrA, which binds damaged 
DNA as a dimer (Scheme 38). After an initial and not so thorough probing by UvrA2, 
UvrB2 joins the UvrA2-DNA complex in the ongoing damage search and performs a final  












and confirmatory scan. After finalizing that the DNA in question is genuinely damaged, 
UvrA2 departs from the search machinery (Scheme 38). At the same time, UvrB2 forms a 
stable complex with DNA (the preincision complex). The formation of preincision 
complex is regarded as the rate determining step of UvrABC incision.
124
 In the next step, 
UvrC binds the preincision complex and cleaves the DNA. In our study, we probed the 
interaction of UvrABC with DOB and C4-AP ICL analogue (3 and 4). We also 
investigated the efficiency of preincision complex formation for both lesions and 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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3.2.1. Nucleotide excision repair substrate designs and preparations 
 
Figure 35. Oligonucleotides used in nucleotide excision repair studies. 
The lengths (>50 bp) of C4-AP and DOB ICL mimics used for repair studies were 
adequate for UvrABC binding and incision as determined from the footprinting of 
UvrA2B2-DNA complex formation.
111
 The construction of C4-AP ICL substrate 135 was 
independently 
32
P-labeled at all four termini by enzymatic ligation (Scheme 36 and App. 
Figure 17, see experimentals for more details). We prepared cross-linked duplex 144 
containing DOB ICL analogue 3 from precursor 79 by enzymatic ligation (see 
experimental for further details). After conducting incision studies, a standard Tm 
calculator (www.idtdna.com/analyzer/Applications/Oligoanalyzer/) suggested the 



























5'-d(GAC TAC GTA  CTG TTA CGG CTC  CAT  CFC TAC  CGC AAT  CAG GCC AGA TCT  GC)






















3'-d(TAC TTG TAT GAG CAT GAG ACG TAA AGC TY       C   C   G  GGC GGT TGG AGG CGA GGT GCG G)
5'-d(ATG AAC ATA CTC GTA CTC  TGC ATT  TCG XA29   G30G31C  CCG CCA ACC TCC  GCT CCA CGC  C)
GAC ATG GTA CTG GCT GAT CGC     G  GC ACA TWA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)d-3'








5'-d(GAC ATG GTA CTG GCT GAT CGC G22GC ACA     T   W  A TA32T33 A34CG CG   G ATC TGC ACG CTC GAC CGA TGC)
3'-d(CTG TAC CAT GAC CGA CTA GCG C    CG TGT94 A93T92V AT    A   T    GC GC83C TAG ACG TGC GAG CTG GCT  ACG)
*
5'-d(TAC ATA CTC GTA  GTC TGC ATT  ACG  XA26     A27 A28G29C GTT  AGC  G   AT  TAA CAT   CGA  GTC)
3'-d(ATG TAT GAG CAT  CAG ACG TAA TGC T Y         T     T   C   G CAA  TCG  C66TA  ATT  GTA  GCT   CAG)
3'-d(TTC GCA ATC GCT AAT TGT AGC TCA G)
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substrate concentration, 55 C). This was further tested by incubating 2 nM 5'-
32
P-t-144 
(the strand containing abasic site analogue in each substrate is labeled “t” or “top” while 
that containing the cross-linked A is denoted as “b” or “bottom”) with unlabeled 145 (10 











5'-d(ATG AAC ATA CTC GTA CTC TGC ATT TCG XAG GCC - 
-CGC CAA CCT CCG CTC CAC GCC G)
3'-d(G TAA AGC TY)
82
5'-d(TAC ATA CTC GTA GTC TGC ATT ACG YAA AGC GTT - 







in nondenaturing PAGE (20%) revealed up to 28% melting (detected by accumulation of 
5'-
32
P-145) at 60 min, corroborating that 144 was unstable under the UvrABC reaction 
conditions (App. Figure 23). We therefore prepared 146 with greater G-C content in the  





5'-d(GAC ATG GTA CTG GCT GAT CGC G22GC ACA     T   W  A TA32T33 A34CG CG   G ATC TGC ACG CTC GAC CGA TGC)-3'




5'-d(GTA CTG  GCT GAT CGC G22  GC ACA     T   WA TA32 T33 A34CG CG   G ATC TGC  ACG CTC GAC CGA TGC)-3'
3'-d(GAC CGA CTA GCG C    CG TGT94 A93T92V AT    A   T    GC GC83C TAG ACG TGC GAG CTG GCT  ACG)-
32P-5'
GAC ATG GTA CTG GCT GAT CGC     G  GC ACA TWA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)d-3'










5'-d(GTA CTG  GCT GAT CGC G22  GC ACA     T   WA TA32 T33 A34CG CG   G ATC TGC  ACG CTC GAC CGA TGC)-3'
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un-cross-linked duplex region to prevent unwanted denaturation. Similar to 144, 146 was 
prepared and separately labeled at all four termini by enzymatic ligation from its 
precursor 82 (see experimental for further details). The integrity of the full length cross-
linked 146 was confirmed by restriction enzyme digestion (App. Figure 25). An 
estimation using the standard Tm calculator indicated the stability of its un-cross-linked 
region (Tm ~75 C) under UvrABC reaction conditions. Its hybridization persistence was  
 
Figure 36. Histogram describing UvrABC incision of C4-AP ICL analogueue 4 in 135. Data taken from 
four individual experiments in which each terminus of 135 was 
32
P-labeled. 
further verified by incubation of 5'-
32
P-t-146 (2 nM) with unlabeled 147 (10 nM). 
Aliquots were removed over the course of 60 min and analyzed by 20% nondenaturing 
PAGE. There was no accumulation of 5'-
32
P-146 or loss of 5'-
32
P-t-146 at 60 min, 
confirming that 146 was stable at UvrABC reaction conditions (App. Figure 26). The 
incisions of 143, 144, and 146 were compared with that of a duplex containing a C5-
fluoresceinylated thymidine derivative (149), a standard substrate for comparing enzyme 
activity. In addition, substrate 148 containing ICL analogue 4 was prepared with a 
hairpin, and tagged with a 
32
P-label at the 5'-end of the top strand (5'-
32
P-t-148) or 

















5'-d(GAC ATG GTA CTG GCT GAT CGC G22GC ACA     T   W  A TA32T33 A34CG CG   G ATC TGC ACG CTC GAC CGA TGC)
3'-d(CTG TAC CAT GAC CGA CTA GCG C    CG TGT94 A93T92V AT    A   T    GC GC83C TAG ACG TGC GAG CTG GCT  ACG)






P-t-135 were compared on denaturing PAGE to confirm the 
integrity of 148, since both would generate the same radiolabeled product (Schemes 39, 
App. Figures 27 and 28). Furthermore, treatment of internally labeled 148 with restriction 
enzymes Fnu4HI (producing a 44mer product) and HpyCH4V verified its full-length 
structure and hybridization (App. Figure 29). 
3.2.2. UvrABC incision of C4-AP ICL analog (4) 
UvrABC incision sites on C4-AP ICL analogue were determined based on the 




Figure 37. Time dependence of UvrABC incision of C4-AP ICL analogue 4 in 
32
P-labeled 135 compared 
to that in 5′-
32
P-149. The total amount of incision at all nucleotides in the region between the 
32
P label and 
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labeled at each terminus. For the strand containing the abasic site analog (“top” strand), 
only one nucleotide was incised on 5'-side of the lesion (C83), while three nucleotides 
were incised on the 3'-side of it (T92, A93 and T94, Figure 36 and App. Figure 30). It 
should be noted that a 5'-labeled substrate is incised to produce a 3'-OH causing it to 
migrate slower than the equivalent residue in the sequencing lane, which contain a 3'-
phosphate terminus (App. Figure 30).
128
 For the strand containing the cross-linked A 
analogue (“bottom” strand), incisions at lone G22 on the 5'-side, and A32, T33 and A34 on 
the 3'-side of the lesion were observed (Figure 36 and App. Figure 31). The 
quantification of the yield was done on the basis of incision between the cross-link and 
the 
32
P label, although bands from other incisions could be visualized on the gel. For the 
“top” and “bottom” strand, the 5'-incision occurred eight and seven nucleotides from the 
cross-linked sites with cleavage yields of 16% and 13.5% at 8 h, respectively. In contrast, 
the 3'-incision on the “top” and “bottom” strands of 135 occurred  at three positions at 
each strand  and was considerably closer to the respective cross-linked positions. For the 
“top” strand, the incisions on the second and third nucleotides (T92 and A93) starting from 
the cross-linked abasic site analogue accounted for the majority of the 27-28% cleavage 
observed after 8 h (Figure 36). At the same time, the 16-18% cleavage observed after 8 h 
on the 3'-side of the cross-linked A in the “bottom” strand was more evenly distributed 
over A32, T33 and A34, while the incision sites shifted further from the cross-link site. 
Despite the shift, the size of the unhooked oligonucleotide patch was similar for incisions 
on the top and bottom strands of 135, 10 – 12 nucleotides and 11 – 13 nucleotides 
respectively (Figure 36). 
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 The incision yield of a typical substrate by UvrABC is usually compared with that 
of the standard substrate, a duplex containing fluoresceinylated T (149). The comparison 
demonstrated that the incision for 135 was significantly less compared to that for 149 
(Figure 37). While greater than 90% of 5'-
32
P-t-149 was cleaved by 60 min, 27-28% 
incision was observed for 3'-
32
P-t-135 in 8 h, and less so for other regions of 135 (Figure 
37). The cleavages on the 3'-side of the cross-linked nucleotides were greater than that on 
the 5'-side, with the incision on the 3'-side of top strand being almost twice that of 5'-
sides.  
 
UvrABC incisions on an ICL typically occur at the third phosphodiester bond 3' 
to the ICL and ninth phosphodiester bond 5' to the ICL, producing a 14 nucleotide long 
segment.
120
 Although the length of the nucleotide patch resembled that produced by 
incision of the C4-AP ICL, the sites of incision differed slightly. Instead, the 5'-incisions 
were at the eighth and seventh phosphodiester bonds in the top and bottom strands, 
respectively. At the same time, the 3'-incisions were distributed between the first and 
third phosphodiester bonds on the top strand and third and fifth phosphodiester bonds on 
the bottom strand, relative to the cross-linked nucleotide.  The nature of the incisions was 
asymmetric, a fact that was previously encountered during UvrABC incision of the C4-
AP thermodynamic cross-link (13)
22
 and psoralen cross-link (35).
128
 During the UvrABC 











































ICL (13) in DNA
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3' side of the furan adducted strand led to predominant or exclusive incision on that 
side.
128
 Despite the fact that the top strand of 135 had a greater overall incision yield, less 
than 60% G-C content in both its 5' and 3'-side ruled out any possible correlation between 
G-C content and strand preference. 
5'-d(GCA TCG GTC GAG CGT GCA GAT C)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GGC GCA TA)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GTG TTT TCC GAT CAG ATC GAA)
5'-d(GCA TCG GTC GAG CGT GCA GAT)
5'-d(AAG CTA GAC TAG CCT TTT GTG ATC TGC AC CTC GAC CGA TGC)





3'-d(CTG TAC CAT GAC CGA CTA GCG CCG TGT AT)
5'-d(GAC ATG GTA CTG GCT GAT CGC G)
154  
Figure 38. Oligonucleotides used for detection of double strand break during UvrABC incision of C4-AP 
ICL analogue 4. 
3.2.3. Detection of double strand break during UvrABC incision of C4-AP ICL 
analog (4) 
UvrABC incision on A-T and mitomycin C ICLs reportedly produces double 
strand breaks (DSBs) by repetitive cleavage.
20,21
 Since 135 was incised on both strands 
by UvrABC, we determined whether this generates a DSB, or whether reaction occurs on 
opposite strands in separate cross-linked molecules. UvrABC incision of 3'-
32
P-t-135 was 
loaded on a 20% native PAGE, along with the anticipated DSB product 150 labeled at its 
top strand (3'-
32
P-t-150, Scheme 40, Figure 38) in a separate lane. Detection of a band 
that migrated similarly to 3'-
32
P-t-150 indicated 1  3% DSB formation (Figure 39). This 
also implied a single to double strand break ratio of ~10:1, which is slightly greater than 
what was observed during the repair of the C4-AP thermodynamic cross-link (13).
22
 We 
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wondered whether this product is a real product from DSB or an artifact resulting from 
the renaturation of products generated from two independent single-strand incisions. To  
Scheme 40. Repetitive incision on 3'-
32
P-t-135 to produce double strand break  
 
determine the authenticity of the band corresponding to the DSB, we designed substrate 
151 (Figure 38), a potential DSB product from incisions on the 5'-side of the top strand 
and 3'-side of the bottom strand. Duplex 151 was 
32
P-labeled at the 5'-terminus of the top 
strand to produce 5'-
32
P-t-151. To monitor its denaturation and potential renaturation with 
an identical complementary substrate, 5'-
32
P-t-151 was incubated separately with 1 and 5 
equiv of 153 under the UvrABC reaction conditions (55 C, 3 h, Figure 39). 
Oligonucleotide 153 consisted of a complementary region similar to the unlabeled strand 
of 5'-
32



















5'-d(GAC ATG GTA CTG GCT GAT CGC G22GC ACA     T   W  A TA32T33 A34CG CG   G ATC TGC ACG CTC GAC CGA TGC)-3'
3'-32P-d(CTG TAC CAT GAC CGA CTA GCG C    CG TGT94 A93T92V AT    A   T    GC GC83C TAG ACG TGC GAG CTG GCT  ACG)-5'
5'-d( GC ACA     T   WA  T)-3'
3'-d(V AT    A   T    GC G)-5'
3'-32P-t-150
3'-32P-d(CTG TAC CAT GAC CGA CTA GCG CCG TGT AT)
5'-d(GAC ATG GTA CTG GCT GAT CGC G)
UvrC
UvrC
CC TAG ACG TGC GAG CTG GCT  ACG)-5'
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t-151 was based on the observed incision yield detected for UvrABC treatment of 135. 
Upon analysis of the aliquots from the incubation on 16% nondenaturing PAGE, 9.8%  
 
Figure 39. Representative gel showing migration of products from UvrABC incision on 3'-
32
P-t-135 in a 
20% non-detaturing PAGE. Lane 1, independently synthesized 44mer duplex. Lane 2, oligonucleotide 13 
labeled at 5'-side of shorter strand. Lane 3, independently synthesized 60mer duplex. Lane 4, aliquot from 
UvrABC proteins incubated with 3'-32P-t-135 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 C for 8 h. Lane 5, 3'-32P-t-135 without any treatment. 
and 21.9% slower migrating exchange products (5'-
32
P-t-152, Figure 38) were observed 
in the presence of 153 (1 and 5 equivalents, respectively) (App. Figure 32). The exchange 
experiment clearly indicated that visualization of DSB product from 135 could be from 
single strand incision reactions on separate substrate molecules. The hairpin substrate 148 
was therefore employed to resolve this ambiguity (Scheme 41). It was 
32
P-labeled at the 
phosphate between C39 and G40 or at the 5'-terminus of the top strand (5'-
32
P-t-148). 
Incubation of UvrABC with 5'-
32
P-t-148 cleaved the substrate at the same position and 
yield as 5'-
32
P-t-135 (Figure 40A). The identical location and yield of the incision 


























3'-32P-d(CTG TAC CAT GAC CGA CTA GCG CCG TGT AT)
5'-d(GAC ATG GTA CTG GCT GAT CGC G) Double strand 
break
 97  
 
confirmed that the presence of the hairpin did not affect its recognition of 4 by the repair 
proteins. Next, the internally labeled hairpin substrate 148 was treated with UvrABC. We 
anticipated that in the event of concurrent incisions on the top and bottom strands on the 
side of the hairpin loop, internally labeled 148 would produce a single 54-nucleotide 
32
P-  
Scheme 41. Repetitive incision on internally labeled 148 
 
labeled product (Scheme 41). Treatment of internally labeled 148 however did not 
produce any 54-nucleotide long oligonucleotide that migrated like the independently 
synthesized DSB product 5'-
32
P-154 (Scheme 41 and Figure 40B). Instead, both incisions 
on 5'-
32
P-t-148 and internally labeled 148 produced bands that migrated slower than 148 
itself (Figure 40). These bands could be from single incision at regions between 4 and the 
hairpin of 148, since their migration patterns resembled those from an incomplete ligation 
of 148 (App. Figure 33). 
5'-d( GC ACA     T   WA  T)-3'
3'-d(V AT    A   T    GC G)-5'
32P-labeled 153
CTG TAC CAT GAC CGA CTA GCG   CCG TGT AT)d-5'
GAC ATG GTA CTG GCT GAT CGC    G)d-3'
UvrC
UvrC
C  C TAG ACG TGC GAG CTG GCT  ACG)-5'
A TAC   GCG   G ATC TGC ACG CTC GAC CGA TGC)-3'
Detectable  by  denaturing
 PAGE  autoradiogram
GAC ATG GTA CTG GCT GAT CGC     G  GC ACA TWA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)d-3'
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Figure 40. UvrABC incision of hairpin DNA (148) containing C4-AP ICL analogueue 4. (A) Incision of 
5′-
32
P-148: lane 1,  nucleotide size markers; lane 2, unreacted 5′-
32
P-148; lane 3, incised 5′-
32
P-148; lane 4, 
A + G reaction; lane 5, T + C reaction. (B) Incision of internally labeled 
32
P-148:  lane 1, nucleotide size 
markers; lane 2, unreacted 11; lane 3, incised 11; lane 4, 5'-
32
P-153. Position of bands migrating slower 
than 148 are annotated. 
3.2.4. Incision of DOB ICL analogue (3) by UvrABC  
DOB ICL is structurally similar to the C4-AP thermodynamic ICL (13), having a 
strand break adjacent to the cross-link. A misplaced incision (e.g. incision at cross-linked 
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5’-32P-t-148 Internally labeled 148
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the 3'-side of A (“bottom strand”) was detected, which indeed generated double strand 
breaks in 144 (Figure 41, 42 and App. Figure 34 and 35). In addition, minor cleavage at  
 
the 5'-side of the abasic site analogue (“top strand”) of the un-cross-linked region was 
observed (Figure 41, 42 and App. Figure 36).  The sites of incision on the bottom strand 
(A26 – A28) were within one to three nucleotides from the cross-linked site, while on the  
 
top strand it (C66) was 10 nucleotides away (App. Figure 34 and 36). The amount of 
incision on A27 was considerably higher than that on A28. The overall incision yield at the 
bottom strand was ~33% after one hour, while the standard substrate fluoresceinylated T  
 
Figure 41. Histogram describing UvrABC incision of DOB ICL analogue 3 in 144. Data taken from four 












































5'-d(TAC ATA CTC GTA  GTC TGC ATT  ACG  XA26     A27 A28G29C GTT  AGC  G   AT  TAA CAT   CGA  GTC)
3'-d(ATG TAT GAG CAT  CAG ACG TAA TGC T Y         T     T   C   G CAA  TCG  C66TA  ATT  GTA  GCT   CAG)
144
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 was incised with a yield between 81 and 90% by that time (Figure 41A and App. Figure 
35). In contrast, C66 from the “top strand” was incised with a modest ~3% yield in 1 h 
(Figure 41 and App. Figure 36). We speculated that cleavage at C66 was possibly due to 
the immediate vicinity of a strand break (10 nucleotides away from C66), that influenced 
the protein to incise a signature 10 nucleotide long fragment. However, we were unable 
to provide a rationale behind the predominant incisions seen at the 3'-side of the bottom 
strand leading to DSB. 
 
Figure 42. Time dependence of UvrABC incision of DOB ICL analogue 3 in 3′-
32
P-b-144 compared to that 
in 5′-
32
P-t-149 (A) and 5'-
32
P-t-144 (B). 
After we discovered the possibility of un-cross-linked region of 144 becoming 
denatured under UvrABC reaction conditions, we employed oligonucleotide 146 
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containing DOB ICL analogue 3 to study its incision. The incision sites of 146 resembled 
those of 144 and were distributed over 1 – 3 nucleotides on the 3'-side of the cross-linked 
A (“bottom strand”, nucleotides A29, G30 and G31), albeit with a different distribution of 
cleavage (Figure 43 and App. Figure 37). Unlike 144, no other incision was visible on the 
5'-side of the abasic site analogue. The cleavage at dA29 was significantly smaller than 
both G30 and G31 (Figure 43 and App. Figure 37). The incision at G30 was the highest and 
slightly more than that at G31. After 1 h of  
 
Figure 43. Histogram describing UvrABC incision of DOB ICL analogue 3 in 146. (Data taken from 4 





incubation with UvrABC, the overall incision of the three nucleotides was ~16 – 22%, 
while 87% of the standard fluoresceinylated T (5'-
32
P-t-149) was incised by that time 
(Figure 44). We also monitored the incubation of UvrABC with 146 when the 
32
P-
labeling was positioned at the 3'-side of the top strand (3'-
32
P-t-149) or 5'-side of the 
bottom strand (5'-
32






P-b-149 would have produced a product migrating faster than T81 or 
G27 from the sequencing lane, respectively (App. Figure 38 and 39). While no such 
product was observed for either substrate, cleavage products migrating just underneath 
149 and above T81 (for 3'-
32
P-t-149) or G27 (for 5'-
32
P-b-149) were detected (App. Figure 
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the yields for 5'-
32
P-b-146 matched those from 3'-
32
P-b-146 as well (App. Figure 39). In 
addition, treatment of 3'-
32
P-t-146 for 8 h with UvrABC generated more than 60% 
incision products (App. Figure 39). These results were consistent with the incision at A29 
– G31 detected during UvrABC treatment of 3'-
32
P-b-149 (Figure 43 and App. Figure 38). 
We speculated whether the observed regioselectivity of UvrABC incision was due to the 
presence of the nick. During the UvrABC incision on a single strand nick, the cleavage 
occurs at the sixth phosphodiester bond from the strand break on the 5'-direction.
123
 In 
contrast, the UvrABC incision on DOB ICL analogue 3 occurred on the uncleaved strand 
with no strand break. However, an as yet unexplored mechanism of the nick inducing the 
exclusive UvrABC incision on the uncleaved strand of 3 cannot be ruled out.  
 
Figure 44. Time dependence of UvrABC incision of DOB ICL analogue 3 in 3′-
32






3.2.5. Transfer of cross-linked DNA from UvrA to UvrB: preincision complex 
formation 
After doing an initial search for damage in DNA, UvrA2-DNA binds with UvrB2 
to perform a more thorough scan (Scheme 33).
106,110
 Upon confirming the presence of a 
damage site, UvrA2 dissociates and the UvrB2-DNA complex (preincision complex) 
awaits the recruitment of UvrC.
110,114
 Preincision complex formation is regarded as the 
rate-determining step of the incision.
124
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DNA or UvrB2-DNA complex formation of cross-linked oligonucleotides 143 
(containing C4-AP ICL mimic 4), 146 (containing DOB ICL mimic 3), and 149 
(containing fluoresceinylated T) was compared. In addition, the correlation between the 
efficiency of DNA-protein complex formation and incision yield was investigated for the 
three substrates. In order to investigate the UvrA2-DNA complex formation by gel shift 
assay, aliquots from the incubation (55 C, 20 min) of UvrA (0 – 200 nM) with DNA (0.3  
 
Figure 45. Comparison of binding of 0.3 nM DNA (143, 146 and 149) with 80 nM DNA in 1  NER 
buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 °C for 20 
min. 
nM) were analyzed using 4% nondenaturing PAGE at 4 C. The 4% nondenaturing 
PAGE used for the UvrAB gel shift has 80:1 acrylamide to bisacrylamide ratio to 
facilitate effective migration of DNA-protein complexes inside the gel.
125
 Although  
 




P-b-146 (B), and 5'-
32
P-t-
149 (C) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and ATP 1 
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UvrA2 complexation with 5'-
32





146 was significantly higher (Figure 45 and App. Figure 40). Incubation with UvrA (80 







P-t-149 respectively (Figure 46 and Table 1). The dissociation 
constant or Kd is defined as the protein concentration at which half of the DNA is in the 







P-t-149 was calculated by fitting the UvrA2-DNA-vs UvrA binding 
isotherm with the Hill equation
142,143
 for single site binding (Figure 46). The Kd for 143 
and 146 matched the previously reported numbers of UvrA binding of single stranded 
lesions, while the Kd for 5'-
32
P-t-149 is slightly higher.
112,113
 The weak binding noticed 
for UvrA2-DNA complexes is consistent with the catalytic nature of UvrA.  
Table 1. Binding of damaged DNA with UvrA (considering dimer formation) 
Substrate Binding (%) with 80 nM UvrA Dissociation  
Constant (Kd, nM) 
3'-
32
P-t-143 99.87  0.38 5.45  1.10 
3'-
32
P-t-146 65.30  1.98 22.13  5.02 
5'-
32
P-t-149 14.11  6.14 32.98  10.31 
 
Next, we employed gel shift assays to probe the rate determining step of UvrABC 
incision, formation of the UvrB2-DNA preincision complex following transfer from 
UvrA2.
124
 We anticipated that the observed incision yields could be interpreted based on 







t-149. Aliquots from incubation of DNA (0.3 nM), UvrB (500 nM), and UvrA (1, 2, 4, 8 
and 10 nM) were analyzed by gel shift to determine the catalytic UvrA concentrations 
required for effective transfer to UvrB (App. Figure 41 – 43). The high UvrB 
concentration was to drive the equilibrium towards UvrA2 dissociation and UvrB2-DNA 
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from UvrA2 to UvrB2 displayed a trend which was completely  












146 containing DOB ICL 






1 4.62  1.27 5.52 ± 0.05 31.56 ± 3.69 
2 5.67  2.08 6.03 ± 0.78 60.03 ± 4.42 
4 11.89  2.09 11.42 ± 0.28 74.46 ± 1.80 
8 18.94  2.67 21.29 ± 1.88 87.33 ± 0.23 
10 23.89  3.08 24.22 ± 2.09 86.37 ± 2.07 
 
opposite to that of UvrA2 binding. Strong binding with UvrB (> 60%) was detected for 
5'-
32
P-t-149 for UvrA concentrations as small as 2 nM, whereas modest binding (> 10%) 
was possible for 143 and 146 only when the UvrA was present in 4 and 8 nM (Figure 47, 
App. Figure 41  43, and Table 2). As a result, incubation of 143, 146 and 149 (0.3 nM) 
with UvrA (8 nM) and UvrB (500 nM) led to 18.9%, 21.3% and 87.3% preincision 
complex formation (Figure 47 and Table 2). The greater efficiency of preincision 
complex formation for 149 was fully consistent with its higher incision yield. However, 
UvrB binding with 143 and 146 with similar efficiency did not correlate with the 
relatively greater incision observed for 146 (Figure 47 and Table 2). We hypothesize this 
could be due to significantly high UvrB concentration (500 nM) used for the transfer 
assays, that might have diluted the selectivity between 143 and 146. Independent 
incubation of mitomycin C ICL (0.6 – 2 nM) with UvrA alone (15 nM) or with UvrA and 
UvrB (15 nM each) led to almost quantitative protein-DNA complex formation.
20
 
Mitomycin C ICL formed a near-quantitative UvrB2-DNA complex (preincision 
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complex) formation. Despite this, the reported gels indicted that the incision yield for 
mitomycin C was less than 50% (no numbers were provided in the paper).
20
 Although a 
 






P-t-149 (concentration 0.3 nM) with 500 nM UvrB 
following transfer from UvrA (8 nM) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM 
KCl, 5 mM DTT, and ATP 1 mM) at 55 °C for 20 min.  
dissociation constant was not computed for the strong UvrA binding of mitomycin C 
ICL, it resembled the stronger cross-link affinity seen for 143 and 146.
20
 The stronger 
affinity of UvrA towards cross-linked substrates is ambiguous from standpoint of the 










































































AP-dG ICL (11)  
Agents causing interstrand cross-links are widely considered to have the highest 
genotoxicity.
103



















































 by preventing strand separation. Molecules that produce 
cross-links are of the utmost interest in terms of developing therapeutic agents, as well as 
for recognizing potential ICL producing conditions. Recently, even simple abasic sites 
(AP, C4-AP, and DOB) have been implicated in cross-link formation.
6,7,9,31
 While the 
cross-links produced from C4-AP and DOB (1 and 2) have short life spans, they are still 
capable of disrupting cellular processes.  
 
 In this study, we treated stabilized analogues of DOB and C4-AP ICLs (3 and 4) 
with UvrABC, the bacterial nucleotide excision repair proteins, to gain insight into their 
repair. The cross-link analogues are synthesized by solid phase synthesis and enzymatic 
ligation. Treatment of the DOB ICL analogue (3) with UvrABC exclusively produced 
double strand breaks (DSBs), which is the first example of an UvrABC repair gone 
completely wrong. The yield of the DSB is as high as 60% in 8 h. Treatment of C4-AP 
ICL analogue 4 with UvrABC revealed that it is a poor substrate. Since ICL removal is 
necessary to resume blocked activities like replication and transcription in a cell, 
persistence of an ICL against repair proteins can have a very deleterious effect on cellular 
processes. In the gel shift assay binding of cross-links with UvrA and UvrB, two damage 
recognition proteins, was investigated. We experienced a slightly stronger affinity of 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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fluoresceinylated T. The poor efficiency of preincision complex formation explained the 
low incision yield observed for 3 and 4. Consequently, this study based on stabilized 
analogues of 1 and 2 addressed the biochemical effects of their formation.  
3.3. Structural probing of ICL 
3.3.1. Structural probing of DOB ICL mimics 
3.3.1.1. Chemical probing of cross-linked DNA containing DOB ICL analogue 3 
3.3.1.1.1. Chemical probing reactions and substrate design 
Scheme 11. ICL generation by DOB lesion 
 
During the formation of DOB interstrand cross-link (1), the electrophilic lesion 
(25) selectively formed an adduct with N6 of an dA opposite the 3'-adjacent nucleotide 
(Scheme 11).
9
 Compared to 21 – 38% yield for ICL formation with dA opposite 3'-
adjacent nucleotide, only 1 – 3.5% adduct formation was observed with the opposing 
dA.
9
















3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GAX AAG CGT TAG CCA TTA)
84
3
3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GXA AAG CGT TAG CCA TTA)
77
Y
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closer to the C1' aldehyde of DOB than that of an opposing A. The site selectivity thus 
cannot be justified based on the proximity alone. We considered whether the instability of 
the transition state during reversible formation of 1 with an opposing A could be another 
factor.  We hypothesized that the instability originates from structural distortion 
associated with forming 1 with the opposing A. To test the hypothesis, two cross-link 
substrates containing DOB ICL analogue 3 were constructed. Substrate 77, consisting of 
a cross-link with A opposite the 3'-adjacent nucleotide mimicked the “observed” ICL 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)





Figure 48. Oligonucleotides containing 3 and standard substrates used for chemical agent based structural 
probing. 
linking occurs with an opposing A, and mimics the “unobserved” (less observed) ICL. 
The region around the cross-linked A was kept A rich to mimic the flanking sequences of 
the native DOB ICL (1).
9
 The strands containing oligonucleotides 77 and 84 were 
converted to 155 and 156, containing fully complementary strands (Figure 48) and were 
probed using chemical agents. See Experimentals for details regarding the construction of 
155 and 156. Nucleotide specific chemical agents used for structural probing are based on 
the principles of Maxam-Gilbert sequencing experiments.
144
 The reagents used in this 
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study included hydroxyl radical cleaving the sugar backbone, diethyl pyrocarbonate 
(DEPC, final concentration 1.04 M) for A, dimethyl sulfate (DMS, final concentration 25 
mM) for G, hydroxylamine (final concentration 0.8 M) for C, and KMnO4 (final 
concentration 0.3 mM) for T. These reagents preferentially react with solvent exposed 
distorted nucleotides in a strand to create alkali-labile sites (except for hydroxyl radical 
cleavage, which cleaves the backbone without any alkali treatment). As a result, 
nucleotides in bulges, overhangs, loops and distorted regions are more vulnerable to these 
reagents than regular Watson-Crick base pairs. The base-labile sites are then cleaved 
upon piperidine treatment. If the treated strand is 
32
P-labeled at the terminus, the cleavage 
sites can be visualized on denaturing PAGE, pinpointing distortion in a DNA sequence. 
Hydroxyl radical cleavage mediated by Fe(II) based Fenton reaction is widely used to 
quantitatively predict DNA backbone solvent accessibility.
145,146
 KMnO4 and 
hydroxylamine are usually employed to detect point mutations in DNA.
147,148
 DEPC and 









Therefore, when a terminus in 155 or 156 is 
32
P-labeled, treated with chemical 
agents followed by piperidine treatment, sites of distortion between the label and cross-
link are revealed as strand breaks. Each terminus of 155 and 156 was thus independently 
labeled and treated with chemical agents to detect solvent exposed nucleotides between 
the respective terminus and cross-link. Following 
32
P-labeling of 155 and 156, they were 
purified by denaturing PAGE to ensure greater purity. The concentration of 155 and 156 
during exposure to chemical probing reagents ranged between 30 – 60 nM. We pursued 
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single hit kinetics (more than 80% of the DNA would be unaffected by the reaction) to 
ensure the DNA molecule reacted with the chemical agent only once on average.
152,153
 
The single hit kinetics conditions was expected to maximize the sensitivity of solvent 
exposed sites towards chemical agents. From earlier reports on cross-link structures
92
 we 
speculated that increased solvent exposure caused by distortion would be limited to 
within three or four nucleotides from the cross-link site in each strand. Under this pretext, 
the ratio of cleavage band volume of a nucleotide immediately adjacent to the ICL to that 
of a distant nucleotide (preferably the same one and at least five nucleotides away) will 
serve as a measure of distortion. This ratio will act as an internal normalization to 
separate distortion based reactivity (“hyperreactivity”) from any variation in exposure to 
the chemical reagent. We define this ratio as “normalized cleavage” [NC = 
                                                
                                               
], which can detect genuine solvent exposed 
nucleotides or “hyperreactive sites”. However, solvent exposed nucleotides can arise due 
to local sequence effects as well.
154,155
 To avoid misinterpreting any sequence derived 
“hyperreactivity” as a cross-link influenced one, the NC value of a nucleotide was 
compared with a comparable one in the duplex (157) without a cross-link (Figure 48). 
Oligonucleotide 158 (Figure 48) was used as an additional control for investigating 
presence of distortions in nucleotides 5' to T45 in 155 and 156. The two step selection 
process, cleavage normalization (division by the cleavage band volume of an undistorted 
nucleotide) and screening (exclusion of sequence based hyperreactivity using 157 and 
158) would detect the ICL induced hyperreactive sites in 155 and 156. Each experiment 
was replicated at least six times and NC values were subjected to Student’s t test to verify 
their statistical significance (App. Table 2  5). Comparing the hyperreactivity of 
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nucleotides in 155 and 156 would thus help detect their structural distortion, and perhaps 
provide a rationalization for the observed selective formation of the former.  
3.3.1.1.2. Investigation of hyperreactive sites at 5'-side of the bottom strand (cross-
linked A containing strand) 
In the region 5' to the cross-linked A (X14 in 155 and X15 in unobserved ICL 156), 
the reactivity of the nucleotides A11 to A14 were investigated using the normalized 
cleavage or NC value [
                                                
                                               
]. The cross-linked A 
X14 (observed ICL 5'-
32
P-b-155) and X15 (unobserved ICL 5'-
32
P-b-156) were detected 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)

















P-b-157 [the strand containing the abasic site analogue (T46 for 157) was referred 
to “top” strand or “t” in each substrate, while the cross-linked A (A14 and A15 for 157) 
containing strand was named as “bottom” or “b”] with hydroxyl radical, A8 (five 
nucleotides away from cross-linked A) was used as the reference nucleotide. The 
histograms for the three substrates obtained from denaturing PAGE analysis did not 
reveal significant hyperreactivity for cross-linked X14 (for observed 5'-
32
P-b-155) or X15 
(for unobserved 5'-
32
P-b-156) compared to the respective nucleotides in 5'-
32
P-b-157 
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(App. Figure 43). However, comparison of the normalized cleavage (“NC” values) 
indicated that the reactivity at cross-linked position (X14) was higher in 5'-
32
P-b-155 
(observed ICL, NC = 0.94  0.07) compared to that (X15) in 5'-
32
P-b-156 (unobserved 
ICL, NC = 0.75  0.04) (Figure 49A and Table 3).  
 





P-b-156 (unobserved ICL), and 5'-
32
P-b-157 (control duplex) for hydroxyl radical 





P-b-156 and A14, A15 from 5'-
32





P-b-156  and 5'-
32
P-b-157 with respect to A8.  
The diethylpyrocarbonate (DEPC) reaction on 5'-
32
P-b-155 (observed ICL), 5'-
32
P-b-156 (unobserved ICL) and 5'-
32
P-b-157 (control duplex) did not react at the cross-




P-b-156, respectively). The NC values 
[
                                                
                                               
, reference nucleotide A8] indicated that A14 
in 5'-
32
P-b-156 (unobserved ICL, NC = 5.22  0.77) was higher than the respective 
nucleotide in 5'-
32
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Table 3. Chemical probing experiments on DOB ICL analogue 3 on the 5'-side of A containing 
strand (“bottom” strand) 
Nucleotide of interest in 
observed ICL (155), 
unobserved ICL (156) and 
control duplex (157) 
Normalized cleavage (NC) value [ = 
                                                






A14 of 157 
A15 of 157 
0.67  0.04 




cleavage) Cross-linked position of 
155 (X14) 
0.94  0.07 
Cross-linked position of 
156 (X15) 
0.75  0.04 
A14 of 157 0.82  0.07  
A8 (DEPC) X14 of 155 0.09  0.08 
A14 of 156 5.22  0.77 
G13 of 157 0.81  0.08  
G6 (DMS) G13 of 155 1.25  0.07 
G13 of 156 1.41  0.07 
 
49B and Table 3). This indicated loss of H-bonding at A14 in 5'-
32
P-b-156 with the 
opposing T47 caused by ICL induced distortion. The cleavage intensity of A14 was greater 
than that of A8 in unobserved ICL 5'-
32
P-b-156 (App. Figure 45D). In contrast, the 
cleavage intensities of the same nucleotides in 5'-
32
P-b-157 were similar (App. Figure 
45B). This indicates how reactivity (therefore distortion) decreases as one moves further 
from the cross-link. 







P-b-157 was more informative than the DEPC reaction. The reactivity of G13 (one 
nucleotide away from cross-link) was greater than G6 (7 nucleotides away from cross-
link) in 5'-
32
P-b-155 (observed ICL) and 5'-
32
P-b-156 (unobserved ICL) but not in 5'-
32
P-
b-156 (control duplex) (App. Figure 46). This reaffirmed the presence of distortion in 
nucleotides around the DOB ICL. The NC value 
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[
                                                
                                               
, reference nucleotide G6] for G13 was the 
highest for unobserved ICL (5'-
32
P-b-156, NC = 1.41  0.07) among the three substrates 
(Figure 50A and Table 3).  
 





P-b-156 (unobserved ICL), and 5'-
32
P-b-157 (control duplex) for DMS, hydroxylamine 





















P-b-157 with respect to A8. 
We probed C12 for distortion using reaction with hydroxylamine. However, as 
shown here for C12 and other C nucleotides around the ICL, the hydroxylamine reaction 
used to detect distortions at C nucleotide was less effective than other chemical probing 
agents. Since it did not demonstrate a high degree of selectivity between cross-link 
adjacent C12 (2 nucleotide away from ICL) and reference nucleotide C7 (6 nucleotide 
away from ICL), it did not reproducibly indicate hyperreactivity at C12 (App. Figure 47).  
Although the NC for C12 in unobserved ICL 5'-
32






















































































































 116  
 
value than in the observed ICL 5'-
32
P-b-155 (NC = 0.93  0.15) (indicating greater 
distortion), the lack of reproducibility was associated with a high standard deviation 
(Figure 50B and App. Table 1). Finally, NC values for the next nucleotide A11 (3 
nucleotides away from ICL) with reference to A8 were calculated based on the same 
DEPC reaction employed to determine the hyperreactivity at A14 (App. Figure 45). 
Although the NC was higher for 5'-
32
P-b-156 (unobserved ICL), the difference between 
5'-
32
P-b-155 (observed ICL) and 5'-
32
P-b-156 for A11 were statistically insignificant 
(Figure 50A, and App. Table 1). Interpreting this as an indication of dissipating distortion, 
reactivity of any other nucleotides in this region was not pursued any further.  
3.3.1.1.3. Investigation of hyperreactive sites on the 3'-side of the bottom strand 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)










In the region 3' to the cross-linked A (X14 in observed ICL 155 and X15 in 
unobserved ICL 156), the reactivity of the nucleotides A15 to A17 were investigated using 
their normalized cleavage or NC value [
                                                
                                               
]. The 
general trend of greater hyperreactivity in 3'-
32
P-b-156 (unobserved ICL) compared to 3'-
32




P-b-155. Since the 
nucleotides on the 3'-side of the cross-linked A containing strand proximal to the 






P-b-157 were  
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P-b-156 (unobserved ICL), and 3'-
32
P-b-157 (control duplex) for DEPC reaction. (A) 
NC value of DEPC reaction of nucleotides from 3'-
32
P-b-155 (A15 and A16), 3'-
32
P-b-156 (A16), and 3'-
32
P-







P-b-157  with respect to A23.   
treated with DEPC. Although the cross-linked A (X14 for 3'-
32
P-b-155 and X15 for 3'-
32
P-
b-156) again did not react with DEPC, a number of 3'-adjacent As were hyperreactive 
(App. Figure 48). First, we compared the reactivity of cross-link adjacent positions, A15 
in observed ICL (3'-
32
P-b-155) and A16 in unobserved ICL (3'-
32
P-b-156). The NC value 
of A16 (reference nucleotide A23) in unobserved ICL (3'-
32
P-b-155, NC = 3.09  0.85) 
was greater than A15 in observed ICL (3'-
32
P-b-155, NC = 1.93  0.32) (Table 4 and 
Figure 51A), indicating greater distortion. This observation was intriguing since A16 in 3'-
32
P-b-156 was opposite T45 (capable of H-bnding) while A15 in 3'-
32
P-b-155 was opposite 
an abasic site (completely devoid of H-bonding). In addition, the NC value [NC = 
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  reference nucleotide A23] of A16 (one 
nucleotide away from ICL) in 3'-
32
P-b-156 (unobserved ICL, NC = 3.09  0.85) was  
Table 4. Chemical probing experiments on DOB ICL analogue 3 on the 3'-side of A containing strand 
(“bottom” strand) 
Nucleotide of interest in 
observed ICL (155), unobserved 
ICL (156) and control duplex 
(157) 
Normalized cleavage (NC) value [ = 
                                                






A15  of 157 
A16 of 157 
1.120.15 
0.82  0.07 
 
 
A23 (DEPC) Position adjacent to cross-link in 
155 (A15) 
1.93  0.32 
Position adjacent to cross-link in 
156 (A16) 
3.09  0.85 
A16 of 155 1.90  0.36  
A23 (DEPC) 
A16 of 156 3.09   0.85 
A17  of 157 0.520.03  
A23 (DEPC) 
 
A17 of 155 1.17  0.25 
A17 of 156 1.36  0.23 
 
higher than (A16) that in 3'-
32
P-b-155 (observed ICL, NC = 1.90  0.36) (Figure 51A and 
Table 4), signifying greater distortion for 3'-
32
P-b-156. The A17 (two nucleotides away 
from ICL) in 3'-
32
P-b-156 has a higher NC value (reference nucleotide A23) than in 3'-
32
P-
b-155 and in 3'-
32
P-b-157, but it is within statistical error (Figure 51B and Table 4), 
indicating gradually diminished influence of distortion. Nucleotides 3'- to A17 were not 
probed. The general trend of hyperreactivity in 3'-
32
P-b-156 matched that in 5'-
32
P-b-156, 
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3.3.1.1.4. Investigation of hyperreactive sites on the 3'-side of the top strand (abasic 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)






* * = 
32P
 
In the region 3' to the cross-linked abasic site (Y46 in 155 and 156), the reactivity 
of nucleotides Y46 to T50 were investigated using their normalized cleavage or NC value 
[
                                                
                                               
]. Hydroxyl radical cleavage on the 3'-side of  
 





P-t-156 (unobserved ICL), and 3'-
32
P-t-157 (control duplex) for hydroxyl radical 







P-t-157 with reference to G54. (B) NC value for KMnO4 






P-t-157 with respect G54. (C) NC value for 
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the cross-linked abasic site (“top” strand) indicated that the reactivity at cross-linked 




P-t-156 is significantly higher than the corresponding 
un-cross-linked T45 in 3'-
32
P-t-157 (Figure 52A). In fact, the high reactivity of the abasic  
Table 5. Chemical probing experiments on DOB ICL analogue 3 on the 3'-side of abasic side analog 
containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (155), 
unobserved ICL (156) 
and control duplex (157) 
Normalized cleavage (NC) value [ = 
                                                





T46 of 157 0.41  0.39  
G54 (hydroxyl radical 
cleavage) 
Cross-linked position of 
155 (Y46) 
1.87  0.43 
Cross-linked position of 
156 (Y46) 
3.77  0.25 
T47 of 157 0.81  0.11  
G54 (KMnO4) 
 
T47 of 155 18.31  1.23 
T47 of 156 6.22  0.62 
G49 of 157 1.56  0.02  
G54 (DMS) 
 
G49 of 155 1.45  0.22 
G49 of 156 1.90  0.04 
T50 of 157 1.84  0.12  
G54 (KMnO4) 
 
T50 of 155 1.48  0.08 
T50 of 156 2.14  0.27 
 
site analogue in 3'-
32
P-t-156 produced a prominent band in the gel (App. Figure 49). The 
high reactivity of the pyrrolidine ring could be from greater solvent exposure itself or 
inherently higher reactivity of the pyrrolidine ring. The NC value (3.77  0.25, reference 
nucleotide G54) for the cross-linked position in the top strand (Y45) of 3'-
32
P-t-156 
(unobserved ICL) was two times greater than that for 3'-
32
P-t-155 (observed ICL, NC = 
1.87  0.43) (Figure 52A and Table 5).  
KMnO4 reaction for the same substrates however showed an opposite trend. For 
duplex 3'-
32
P-t-157, almost no reaction was observed, indicating low reactivity of the 
based paired Ts towards KMnO4 treatment (App. Figure 50A). The reactivity of T47 3'-
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adjacent to the cross-link in the top strand was higher for 3'-
32
P-t-155 than that in 3'-
32
P-t-
156 (App. Figure 50A). The NC value [
                                                
                                               
, 
reference nucleotide G54] for T47 in 3'-
32
P-t-155 (observed ICL, NC = 18.31  1.23)  
 





P-t-156 (unobserved ICL), and 3'-
32
P-t-157 (control duplex) for DMS and  KMnO4 











P-b-156  and 5'-
32
P-b-
157.with respect to G54. 
was almost three times that of 3'-
32
P-t-156 (unobserved ICL, NC = 6.22  0.62) (Figure 
52B and Table 5). The enigmatic hyperreactivity of T47 in the observed ICL (3'-
32
P-t-155) 
was attributed to the presence of the opposing cross-linked A (X14) and resulting 
disruption of duplex structure. Interestingly, T47 in the top strand of 3'-
32
P-t-156 showed 
significant reactivity, despite being base-paired with A14 (App. Figure 50A and D). This 
effect was consistent with the hyperreactivity detected for A14 in 5'-
32
P-b-156 and was 
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P-t-156 (App. Figure 50A). It co-migrated with the cross-linked position Y45, 
an abasic site. Since no reactivity is expected of an abasic site towards KMnO4, its origin 





(C48) was more ambiguous. 
The peak volume in the histograms revealed that the reactivity of the C48 (two 
nucleotides away from ICL) was generally higher than C55 (nine nucleotides away from 




P-t-156, but very similar for 
duplex 5'-
32
P-t-157, indicating presence of distortion in the ICL substrates (App. Figure 
51). While the average NC value of C48 was higher for 3'-
32
P-t-156 (unobserved ICL, NC 
= 1.15  0.30) than 3'-
32
P-t-155 (observed ICL, NC = 0.89  0.02), the standard deviation 
associated with the former was high, making a definite conclusion impossible (Figure 
52C and App. Table 3). In fact, the higher uncertainties associated with the 
hydroxylamine reaction was a recurring observation in the course of the chemical probing 
reactions. 
In contrast, the DMS reaction proved to be more reliable and reproducible in 
terms of detecting hyperreactivity. Treatment of duplex 5'-
32
P-t-157 with DMS yielded 
higher cleavage at G49 compared to G54 (eight nucleotides away from ICL), revealing an 





P-t-156 was even more reactive than its peer 
in the control duplex (5'-
32
P-t-157) (App. Figure 52A, C and D). The NC value of G49 
[
                                                
                                               
, reference nucleotide G54] in unobserved 




P-t-156, NC = 1.90  0.04) was higher than that from observed ICL (5'-
32
P-t-
155, NC = 1.45  0.22), indicating greater distortion in the former (Figure 53A and Table 
5).  




P-t-156 using the same KMnO4 reaction above (App. Figure 50) 
showed that T50 in 5'-
32
P-t-156 (unobserved ICL) was more reactive than that in 5'-
32
P-t-
155 (observed ICL) (Figure 53B and Table 5). The higher NC value (reference nucleotide 
G54) for 5'-
32
P-t-156 (unobserved ICL, NC = 2.14  0.27) was intriguing since enhanced 
reactivity at opposing A11 was not observed.  This could either be due to different extent 
of solvent exposures for the two strands or from possible low selectivity of the DEPC 
reaction. DEPC reaction carried out on A51 (five nucleotides away from ICL) did not 





implying reduced distortion (not shown). 
3.3.1.1.5. Investigation of hyperreactive sites on the 5'-side of the top strand (abasic 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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This region was not covalently attached to the cross-link but was hydrogen 
bonded to the 3'-side of the bottom strand (cross-linked A containing strand). We  
 





P-t-156 (unobserved ICL), 5'-
32
P-t-157 (control duplex), and 5'-
32
P-t-158 (control to 
assess the effect of strand break) for KMnO4 reaction. (A) Comparison of ratio of KMnO4 cleavage 








P-t-158 with respect to T38. (B) 








P-t-158 with respect to T38. 
expected the 3'-side of the nick to have minimal structural destabilization, but possibly 
some denaturation (and increased reactivity) caused by the adjacent strand break. Since 
this destabilization was anticipated to be confined to the region closest to the nick, which 
consisting primarily of Ts, 155 (observed ICL), 156 (unobserved ICL), and 157 (control 
duplex) 
32






P-t-157) were treated with KMnO4. Substrate 158 
32
P-labeled at the 5'-side of the 
shorter or “top” strand (5'-
32
P-t-158) was used as a control to gauge any effect of the 







P-t-158 (App. Figure 53). Partial denaturation at T45 and T44 caused 
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by the proximity of a single stranded region was believed to be responsible for the 
significant hyperreactivity for 5'-
32
P-t-158. In addition, the NC values 
[
                                                
                                               
 , reference nucleotide T38] for T45 and T44 for  
Table 6. Chemical probing experiments on DOB ICL analogue 3 for 5'-side of abasic side analog 
containing strand (“top” strand) 
Nucleotide of 
interest in 
observed ICL (155), 
unobserved ICL 
(156) and control 
duplex (157) 
Normalized cleavage (NC) value [ = 
                                                





T45  of 157 0.72  0.23  
T38 (KMnO4) 
 
T45  of 158 21.23  0.89 
T45 of 155 6.25  0.44 
T45 of 156 7.20  0.56 
T44  of 157 0.65  0.23  
T38 (KMnO4) 
 
T44  of 158 9.59  0.63 
T44 of 155 2.59  0.17 




P-t-156 (NC = 7.20  0.56 and 5.12  0.22, respectively) and 5'-
32
P-t-155 (NC = 6.25 
 0.44 and 2.59  0.17, respectively) were lower than that for 5'-
32
P-t-158 (NC = 21.23  
0.89 and 9.59 0.63, respectively) but more than the duplex 5'-
32
P-t-156 (NC = 0.72  
0.23 and 0.65  0.23, respectively) (Table 6 and Figure 54). This revealed the effect of 
the strand break in addition to possible hyperreactivity from ICL induced distortion, 
although the extent of the contribution from each is difficult to ascertain (Figure  54A and 
B, and Table 6). Importantly, the NC values for both T45 and T44 were higher for 5'-
32
P-t-
156 (unobserved ICL) than 5'-
32
P-t-155 (observed ICL) (Figure 54 and App. Table 5). 
Nucleotides further from the ICL than the T44 were not probed. 
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3.3.1.1.6. Summary 
Chemical probing revealed that nucleotides in the cross-links 155 and 156 are 
more reactive than the un-cross-linked duplex, indicating the deformity caused by ICL 
formation. Among the chemical probing reagents used in this study, the hydroxylamine 
reaction was not very reproducible, and was associated with a large statistical error. 
While DEPC and DMS reacted with the A and G in canonical base pairs, they were 
significantly more sensitive towards distorted nucleotides adjacent to the DOB ICL 
analogue. In contrast, KMnO4 detected distorted nucleotides more efficiently. Its very 
low reactivity with the canonical Ts of a duplex indicated its effectiveness for detecting 
distortion. Hydroxyl radical cleavage, on the other hand, efficiently detected solvent 
exposure of cross-linked nucleotides. The results of the chemical probing experiments are 
summarized as a histogram (Figure 55) and cartoon (Figure 56). For the 5'-side of the 












(has greater NC value) than 155 (unobserved ICL) (Figure 55 and 56). On the same side 
of ICL 3, the average NC values were higher for unobserved ICL (156) over observed 
ICL (155) for nucleotides A11 and C12. However, the associated errors are large for both 
of them. For the 3'-side of the cross-linked A containing strand, the structural distortion 
was more prominent at A16 and A17 for unobserved ICL (156) than observed ICL (155) 
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(Figure 55 and 56). On the 3'-side of the abasic site analogue containing strand (top 
strand), the hyperreactivity of nucleotides towards chemical agents was detected up to  
 
Figure 55. Histogram describing qualitative comparison of chemical probing on oligonucleotides 155 
(observed ICL) and 156 (unobserved ICL) containing DOB ICL analogue 3. The length of the arrows 
represents the reactivity difference for a particular nucleotide (towards a  specific chemical agent). The 
differences in length for two different nucleotides are not comparable.  
T50. The nucleotides in this region were generally more reactive for 156 (unobserved ICL) 
than 155 (observed ICL), including the position of cross-linking (Y46) itself (Figure 55 
and 56). The only exception was the higher reactivity of T47 in 155 (observed ICL), 
which was probably due to partial or complete loss of H-bonding from the opposing A14. 
The greater distortions for nucleotides in 156 (unobserved ICL) continued through C48 
(albeit with high standard deviation) to G49 until T50, beyond which the distortion could 
not be distinguished from that in 155 (observed ICL). Similarly, T45 and T44 in the un-
cross-linked region 5' to the abasic site analogue were more solvent exposed for 
unobserved ICL 156 (Figure 55 and 56). The statistical significance of the difference in 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)

















5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54T    AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)

















5'-d(AGA CTG6   C   A8T T 11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   G A  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T T 11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   G A  AT38C    GGT AAT)
5'-d(AGA CTG6  C   A8T T 11C     G13 A14A15   6A17G CGT  TA23 24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   45T44C   G A  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T T 11C     G13 A14A15   6A17G  CGT  TA23G24 CCA TTA)
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Figure 56. Cartoon depicting effect of DOB cross-link analogue 3 on 155 (observed ICL) and 156 
(unobserved ICL).  
Hydroxyl radical cleavage showed that the solvent exposure of the cross-linked 
nucleotide X14 (for 155) or X15 (for 156) in the bottom strand was higher in 155 than 156. 
Interestingly, this is opposite to what was found for the top strand, where the reactivity of 
Y46 in 156 was significantly higher than that in 155 (Figure 55 and 56). We theorized that 
the cross-link pushed the X15 in 156 on the bottom strand into the helix backbone, in turn 
protruding out a highly exposed pyrrolidinium ring on top strand (Figure 56). We 
wondered whether unequal solvent exposure detected for the cross-linked A and abasic 
site analogue (characterized by hydroxyl radical cleavage) could originate from their 
different stabilization by helix backbone. The cross-linked A in the bottom strand can be 
stabilized by base stacking or partial H-bonding (Figure 56). In contrast, there is no 
possible way to stabilize the pyrrolidinium ring at the top strand adjacent to a nick, 
resulting in higher solvent exposure.  
A greater number of hyperreactive nucleotides were detected for 155 and 156 in 
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nucleotide from cross-link position, Figure 55) than the cross-linked A containing strand 
(distortion detected until dG13, third nucleotide from cross-link). This is in accordance 
with the unequal degree of distortion found in the strands connected by an asymmetric 
ICL.
88
 Whether the asymmetric distortion seen for 3 is genuine or is a result of unequal 
reproducibility and sensitivity of the chemical probing agents is hard to determine from 
the current set of experiments. If this observation is real, this might be due to the 
translation of the distortion of the cross-linked pyrrolidinium ring into the backbone 
(Figure 55 and 56). It likely produced a relatively longer stretch of distorted nucleotides 
in the top strand. An observation supporting this theory was the presence of nucleotides 
with greater NC value for the top strand of 156 than 155, induced by a more distorted 
pyrrolidine ring. On the other hand, a less distorted A in the bottom strand of 155 and 156 
was unable to influence that many nucleotides, thereby producing only 1 – 2 nucleotides 
with higher NC values for the latter (Figure 55 and 56). 
3.3.1.2. Melting temperature analysis of cross-linked DNA containing DOB ICL 
analogue 3 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
155
156  
Despite chemical probing being a reliable tool for detecting distortion, we wanted 
to validate our findings about instability in cross-linking with opposing nucleotides using 
a more quantitative method, the oligonucleotide melting temperature. We anticipated the 
cross-linked region of the substrates containing DOB ICL analogue 3 would behave like 
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a hairpin, increasing the melting temperature.
149
 Oligonucleotides 85 and 86 containing 3 
were prepared based on a theoretical Tm calculation using hypothetical hairpin substrate 
159 (Figure 57). Oligonucleotides 85 and 86 contained the “observed” (cross-link with A 
opposite 3'-adjacent T) and “unobserved” (cross-linking with opposing A) types of ICL 
and were based on chemical probing substrates 155 and 156, respectively. The stem of  
 
Figure 57. Cross-links containing DOB ICL analogue 3 and their hypothetical hairpin model. (A) Cross-
linked oligonucleotides made using solid phase synthesis. (B) Hypothetical hairpin used to estimate Tm of 
cross-link substrates 86 and 89. 
159 contained of the G6 – A11 sequence in 155 and 156 that did not show any 
hyperreactivity during the chemical probing studies. The A4 loop mimicked the region 
displaying highest reactivity against chemical reagents, 5'-C12G13X14Y46T47C48G49-3' in 
155 and 5'-C12G13A14X15Y46T47C48G49-3' in 156. We anticipated that the vicinity of the A6 
– T11 pair in 159 with the loop would mimic the relatively low-level distortion detected in 
the A11 – T50 pair in 155 and 156. A calculation using an online Tm calculator 
(https://www.idtdna.com/calc/analyzer) predicted ~60 C melting temperature for 159 
(DNA concentration 1 μM, 100 mM Na
+
, 10 mM Mg
2+
). Substrates 85 (“observed” type 
of ICL) and 86 (“unobserved” type of ICL) were converted into 160 and 161 with fully 
complementary arms (Figure 58). The un-cross-linked region in 160 (full length observed 
ICL) and 161 (full length unobserved ICL) was estimated to have a 32.5 C Tm based on 
the online Tm calculator (DNA concentration 1 μM, pH 7.0, 100 mM Na
+














3'-d(CGT26 AAT23 GCT Y19 ) 





3'-d(CGT26 AAT23 GCT   Y19 ) 
5'-d(GCA3   TTA6  CGA9 XAA12 GCG15 TTA18)





















5'-d(GCA3   TTA6   CG X9  A       AA12 GCG15 TTA18)
3
Y
3'-d(CGT34 AAT31 GCT28 Y        TT25  CGC22 AAT19)
5'-d(GCA3   TTA6   CG A9 X       AA12 GCG15 TTA18)
160
3'-d(CGT34 AAT31 GCT28 Y       TT25  CGC22 AAT19)
 
Figure 58. Cross-linked oligonucleotides containing DOB ICL analogue 3 used for melting temperature 
study. 
3.3.1.2.2. Calculation of UV-extinction coefficients of melting temperature 
substrates  
The extinction coefficient of 85 (observed ICL) and 86 (unobserved ICL) at 260 
nm were calculated based on the nearest-neighbor model and a list of corrected extinction 
coefficients available online (http://www.owczarzy.net/extinctionDNA.htm).
156–158
 The 
list and methodologies from the nearest-neighbor model are combined in a standard 
extinction coefficient calculator (http://biophysics.idtdna.com/UVSpectrum.html). To 
simplify the calculation, the hairpin like regions of 85 and 86 were assumed to remain 
base paired even in the absence of salt. Based on this premise, nucleotides G1 – X9 in 85 
were considered as a duplex, with X having the chromophore of A. Since the cross-linked 
abasic site (Y19) lacked a chromophore, it did not contribute towards the extinction 
coefficient. Similarly, we envisioned nucleotides G1 – A9 in 86 to form a duplex. Both 












3'-d(CGT26 AAT23 GCT Y19 ) 





3'-d(CGT26 AAT23 GCT   Y19 ) 
5'-d(GCA3   TTA6  CGA9 XAA12 GCG15 TTA18)
 






 based on the standard extinction coefficient calculator  
(http://biophysics.idtdna.com/UVSpectrum.html). The next nucleotides, A10 – A18 in 85 
and X10 – A18 in 86 were treated as a continuous single stranded chain of residues with 




. According to the nearest neighbor method, the 
extinction coefficients of 85 and 86 would approximately be the sum of the single 




. We estimate an error of less than 5% 
in this calculation due to the direct addition of extinction coefficients of the single 
stranded and duplex regions.  
3.3.1.2.3. Melting temperature study of oligonucleotides containing DOB ICL 
analogue 3  
The melting temperatures of 160 (observed ICL) and 161 (unobserved ICL) show that 
each has two independent melting transitions (Figure 59A). The melting occurring at 
higher temperature was in the range of 60-70C, while the other was around 30C. To 
identify the structural part of the mimics that contributed to different range of Tm values, 
we did melting temperature studies on 85 ( “observed” type of ICL) and 86 
(“unobserved” type of ICL), the cross-links without a duplex un-cross-linked region 
(Figure 59B). Cross-links 85 and 86 had Tm values in the range 60 - 70C (Figure 59B 
and Table 7), further implying that the lower temperature Tm values were from the 
denaturation of un-cross-linked regions of the observed (160) and unobserved (161) ICL. 
The higher Tm values were close to the predicted values of model hairpin substrate 159 
and online Tm calculator, confirming the hairpin like behavior of two complementary 
strands connected through a cross-link. Interestingly, Tm values of 160 and 161 in the un-
cross-linked region were lower than that compared to the predicted Tm (32.8C) under the 
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same salt and oligonucleotide concentrations (Figure 59C and Table 7). This can be an 
indirect corroboration of the deformities encountered in this region during the chemical 
probing studies. 
 
Figure 59. Thermal denaturation analysis of oligonucleotides containing DOB ICL analogue 3. (A) 
Absorbance (260 nm) vs temperature profile of cross-linked substrates 160 (observed ICL) and 161 
(unobserved ICL) [DNA concentration 1 μM, PIPES (pH 7.0) 10 mM, Mg
2+
 10 mM, Na
+
 100 mM]. (B) 
Absorbance (260 nm) vs temperature profile of cross-linked substrates 85 (containing observed type of 
cross-link) and 86 (containing observed type of cross-link) [DNA concentration 1 μM, PIPES (pH 7.0) 10 
mM, Mg
2+
 10 mM, Na
+
 100 mM]. (C) Absorbance (260 nm) vs temperature profile of cross-linked 
substrates 160 and 161 in the temperature range 10 – 50 C [DNA concentration 1 μM, PIPES (pH 7.0) 10 
mM, Mg
2+
 10 mM, Na
+
 100 mM]. (D) Comparison of higher Tm values of 160 (observed ICL) and 161 
(unobserved ICL). (E) Comparison of lower Tm values of 160 and 161.  
Oligonucleotide 160 (observed ICL) had higher Tm values in both regions 
compared to those of 161 (unobserved ICL) (Figure 59, Table 7). The un-cross-linked 
region in the observed ICL (160) melted approximately 2 °C higher than unobserved ICL 
(161) (Figure 59E, Table 7). For the higher Tm region, the melting temperature differed 
slightly for substrates with and without a duplex un-cross-linked region. While substrates 


























































































































































































5'-d(GCA3   TTA6   CG X9  A    AA12 GCG15 TTA18)
3
Y3'-d(CGT34 AAT31 GCT28 Y    TT25  CGC22 AAT19)
5'-d(GCA3   TTA6   CG A9 X    AA12 GCG15 TTA18)
160
3'-d(CGT34 AAT31 GCT28 Y    TT25  CGC22 AAT19)
5'-d(GCA3   TTA6   CGX9AAA12 GCG15 TTA18)
86
85
5'-d(GCA3   TTA6  CGA9 XAA12 GCG15 TTA18)
3'-d(CGT26 AAT23 GCT Y19 )
3'-d(CGT26 AAT23 GCT   Y19 )
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85 (observed ICL) and 86 (unobserved ICL) had Tm values 70.15 ± 0.40 C and 66.28 ± 
0.35 C, the Tm values of full length ICLs 160 and 161 were 69.76 ± 0.83 C and 65.32 ± 
0.03 C in the temperature range, respectively. Since the un-cross-linked region (Tm ~30 
C) is dehybridized at the higher temperature, the difference was considered an artifact. 
Nonetheless, it can be equivocally asserted that cross-link with an A opposite 3'-adjacent 
nucleotide (“observed”, present in 85 and 160) as observed in the native DOB ICL is 
thermodynamically more stable than an ICL with opposing A (“unobserved”, present in 
86 and 161). This observation is in complete accord with the chemical probing studies, 
where nucleotides in 156 (consisting of cross-link with opposing A) generally displayed 
more sensitivity towards chemical probing agents. Together, the melting temperature 
study and chemical probing analysis supported our hypothesis that cross-link with 
opposing A is associated with greater deformity in the helix.  
Table 7. Tm of cross-linked oligonucleotides 85, 86, 160 and 161 [DNA concentration 1 μM, PIPES 
(pH 7.0) 10 mM, Mg
2+
 10 mM, Na
+
 100 mM] 
Substrate Tm (degree C) 
Observed ICL (160) 69.76 ± 0.83 and 30.95 ± 0.26 
Unobserved ICL 161 65.32 ± 0.03 and 28.12 ± 0.55 
85 (ICL with observed type of cross-link) 70.15 ± 0.40 
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3.3.2. Structural probing of C4-AP ICL mimics 
3.3.2.1. Chemical probing of cross-linked DNA containing C4-AP ICL analogue 4 
3.3.2.1.1. Chemical probing reactions and substrate design 
 
C4'-oxidized abasic site (C4-AP) forms the kinetic interstrand cross-link (2) with 
an A opposite 3'-adjacent nucleotide in a site selective manner (Scheme 10). While the 
typical yield of the kinetic cross-link with A opposite 3'-adjacent nucleotide varies from 
16  37%, no cross-linking is detected with an opposing A.
8
 We hypothesized that the 
inherent structural stability of the respective adducts could be a deciding factor behind 
the site selectivity. To probe any possible structural distortions using the chemical 

















analogue of C4-AP ICL (4). Diethylpyrocarbonate (DEPC), KMnO4, hydroxyl radical 
cleavage and dimethyl sulfate (DMS) were the most useful chemical probing techniques 






C4-AP kinetic ICL (2)
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flanking sequence of the chemical probing substrates containing 4 were comprised 
predominantly of As and Ts. Although DMS treatment employed for probing G was 
useful in detecting distortion, the presence of G in the sequence required that we include 
C (to be probed by inefficient hydroxylamine) in the opposing strand. Since the 
hydroxylamine reaction was unreliable in our hands, the flanking sequence of 4 was 
deprived of Gs.   
 
Figure 60. Single stranded and duplex oligonucleotides used to determine the site-selectivity of C4-AP 
cross-link formation.  
To test whether the flanking sequence comprised of As and Ts would lead to the 
previously observed site-selectivity for C4-AP ICL formation, we synthesized 
oligonucleotide 162 containing a 4,5-dimethoxy-2-nitrobenzyl protected C4-AP precursor 
(Figure 60).
8
 After hybridization of 162 with the complementary strand, photoirradiation 
(350 nm) of the resulting duplex (163) produced C4-AP.
8
 Incubation of the irradiated 
duplex labeled at 37 C and analysis of the aliquot thereof by denaturing PAGE indicated 
cross-link formation detected as two slower moving bands (kinetic and thermodynamic 
ICLs). Purification of the slower moving band (high molecular weight or kinetic C4-AP 
ICL) and its treatment with hydroxyl radical indicated ICL formation with A15, the 
nucleotide opposite the 3'-adjacent T (App. Figure 54). Having proven the site-selectivity 
of C4-AP ICL formation in the sequence, we constructed 121 and 164 using synthetic 
3'-d(GGT GTC  GAC GTG TAT XAT ATG  CTC GGC CAG C)
5'-d(CCA3 CAG6 CTG9  CAC12 ATA15 A16TA    TAC  GAG CCG GTC G)
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methodologies developed earlier (Figure 61). While 121 had the “observed” cross-link 
with A opposite the 3'-adjacent T, 164 was comprised of the “unobserved” cross-link 
 
Figure 61. Oligonucleotides used for making the chemical probing substrates on 4 and cartoons showing 
overhang and recessed end. (A) Sequences of oligonucleotides containing the “observed” (121) and 
“unobserved” (164) C4-AP ICL analogue 4. (B) Cartoon showing an example of a 5'-overhang. (C) 
Cartoon showing an example of a 5'-recessed end. 
with the opposing A. Using ligation, substrates 121 and 164 were converted into 165 and 
166 containing full length complementary arms (Figure 62). See Experimentals for 
details regarding the construction of 165 and 166.. The ligation strategy also enabled 
independent 
32
P-labeling of all three termini except the 5'-side of the cross-linking 
Scheme 42. Conversion of 121 or 164 into 5'-
32
P-t-165 or 166 
 
A containing strand (“bottom” strand). Similar to the chemical probing of DOB ICL 
analogue 3, the reactivity of an ICL-adjacent nucleotide of a 
32
P-labeled oligonucleotide 
was represented using the “normalized cleavage” or NC value 
[
                                                
                                               
] with reference to a distant nucleotide. In 
addition, we used duplex 167 as a control substrate to identify hyperreactivity induced by 
3'-d(CCG TGT ATV ATA TGC GC)-O-PO3
5'-d(GCT GAT CGC GGC ACA TWA TAT ACG CGG ATC TGC ACG)-3'
5'
121
3'-d(CCG TGT ATV ATA TGC GC)-O-PO3
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local sequence (Figure 62). The cross-linked A and abasic site analogue in 165 were 
replaced by A and T in 167. The difference in reactivity of nucleotides in observed ICL 
(165) and unobserved ICL (166) were compared using Student’s t test (App. Table 5 – 8).  
 
Figure 62. Oligonucleotides used for chemical probing of C4-AP ICL analogue 4.  
 In order to probe the nucleotides on 5'-side of the bottom strand (cross-linked A 
containing strand, nucleotides G1 – A18 / W18, Figure 62) or on the 5'-side of the top 
strand (the abasic site analogue containing strand, nucleotides V55  G37, Figure 62) of 
165 and 166, the respective ends needed to be independently 
32
P-labeled.  While the 5'-
termini of the top strand can be easily labeled by hybridization with a 
32
P-labeled small 
strand with 121 or 164 followed by enzymatic ligation (Scheme 41, see Experimentals for 
further details), the 5'-
32
P-labeling of the bottom strand was trickier. The 5'-
32
P-labeling 
















3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15   T16 A17W18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T  V  ATA TGC GCC  TAG ACG TGC  GAG CTG GCT ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28W29A TAT ACG CGG ATC TGC  ACG  CTC GAC CGA TGC)
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T   V  ATA TGC GCC  TAG ACG TGC   GAG CTG GCT ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28A29W TAT ACG CGG ATC  TGC  ACG  CTC GAC CGA TGC)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)






3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)-X






3'-d(CTA GAC GTG C)-X
170
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can cause unwanted 5'-
32
P-labeling of the top strand (a recessed end, Figure 61) as well 
(Scheme 42). To avoid this, substrates 121 and 164 were chemically attached with 
Scheme 43. Unwanted 5'-
32
P-labeling of a substrate containing two 5'-terminus 
 
phosphate at the 5'-terminus of abasic site analogue containing strand (“t” or “top” 
strand) during the solid phase synthesis (Figure 61). A phosphate present at the 5'-
recessed end is 15 – 20% less efficiently exchanged than that on an overhang or single 
strand.
159
 In addition, the exchange reaction by T4 PNK becomes 86
th
 times slower at 0 
°C, while the phosphorylation at 5'-OH remains significantly faster.
160
 Therefore, we  
Scheme 44. Fnu4HI treatment of internally labeled 5'-
32
P-b-165 
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48C47C46  T45A   G  ACG TGC)







5'-d(GGC ACA TWA TAT ACG CGG ATC TGC ACG)


























theorized that treatment of 121 and 164 with T4 PNK and -
32
P-ATP at 0 °C would 
significantly slow the exchange of the 5'-phosphate on the top strand with 
32
P-phosphate. 
Under the same conditions, the 
32
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containing strand (“b” or “bottom” strand) would be considerably faster. The theory was 
tested to achieve selective 
32
P-labeling of the bottom strand of 121. After the incubation, 
the T4 PNK was inactivated (heating at 65 °C) and removed from solution (by phenol-
chloroform-isopropanol wash), while 121 was subjected to ligation to make 165. See 
Experimentals for details regarding the construction of 165. The phosphate exchange 
would lead to internal labeling at top strand and was determined by treatment of the 5'-
32
P-b-165 with restriction enzyme Fnu4HI. Absence of internal labeling would 
completely consume 5'-
32
P-b-165 and would only produce a 9 nucleotide long product in 
denaturing PAGE (Scheme 44). If internal labeling occurs, a slower migrating band 
underneath the starting material would be seen in the gel (Scheme 44 and App. Figure 
55). Analysis of the aliquot from Fnu4HI treatment of 5'-
32
P-b-165 revealed the presence 
of up to 32% of internal labeling originating from the phosphate exchange (App. Figure 
56A). In an alternative strategy, 121 was ligated with a 5'-C6-amino modified 
oligonucleotide 168 to produce 169 prior to incubation with T4 PNK and -32P-ATP. The 
presence of the 5'-C6-alkyl amino modification prevents any 5'-
32
P-labeling on the top 
strand, and promotes selective labeling of the bottom strand. Although unlikely, any 
occurrence of 
32
P-labeling on the top strand was probed using treatment with Fnu4HI, 
which would produce a slow moving band (App. Figure 55). Treatment of 5'-
32
P-b-169 
(the bottom strand is referred to as “b”) with Fnu4HI revealed ~11% 
32
P-labeling at top 
strand (App. Figure 56B). We theorized that the undesired labeling at the top strand 
resulted from an impurity lacking the C6-amino modification present in 168, which 
probably fell off during purification. As a result, a small fraction of 169 prepared from 
ligation of 168 was missing the C6-alkyl amino modification and was subsequently 
32
P-
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labeled at the top strand. Since even a small amount of incorrectly located 
32
P-labeling 
could jeopardize the sensitive chemical probing experiments, the selective 5'-labeling 
strategies were bypassed. However, the selective 
32
P-labeling strategy based on C6-alkyl 
amino modification can succeed if 169 is carefully prepared without any impurity.  
To overcome this problem, ICLs 135 and 170 were synthesized specifically for 
probing the nucleotides on the 5'-side of the bottom strand (Figure 62). We intended to 
avoid using 135 and 170 for chemical probing for two fold reasons. We correlated their 
longer length with possibly employment of longer reaction time and higher reagent 
concentration. In addition, we envisioned that four ligations should be needed to 
construct substrates 135 and 170 would yield lower final products in contrast with two 
ligations required for 165 and 166. Both our suspicions were proved wrong with similar 
final isolation yield (4 – 10%) and same chemical agents concentrations used. Ligation 
strategies developed earlier for synthesizing nucleotide excision repair substrates were 
employed to make 135 and 170. It involved phosphorylation of 121 and 164 using cold 
ATP, thereby eliminating any chance of 
32
P-phosphate exchange on the top strand and the 
possibility of internal labeling in full length 170 and 171. The integrity of 5'-
32
P-b-171 
was verified by treatment with restriction enzymes RsaI and Taq

I (App. Figure 55 and 
57). The difference in hyperreactivity between 165 and 167 (alternatively, between 170 
and 171) were analyzed with Student’s t test to verify their statistical significance.  
3.3.1.1.2. Reactivity of nucleotides on the 5'-side of the cross-linked A containing 
strand 
In order to detect hyperreactive nucleotides at the 5'-side of the cross-linked A 
containing strand, treatment of 5'-
32
P-b-167 (control duplex), 5'-
32
P-b-135 (observed  
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3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T  V  ATA TGC GCC  TAG ACG TGC  GAG CTG GCT ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28W29A TAT ACG CGG ATC TGC  ACG  CTC GAC CGA TGC)
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T   V  ATA TGC GCC  TAG ACG TGC   GAG CTG GCT  ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28A29W30 TAT ACG CGG ATC  TGC  ACG  CTC GAC CGA TGC)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)

























P-b-171  (observed ICL) (The A containing strand was referred to as the 
“b” or “bottom” strand, while the abasic site analogue containing strand was denoted as 
“t” or “top”.) required greater concentrations of chemical probing agents than their DOB 
counterparts. Compared to 0.3 mM KMnO4 (final concentration, 10 min, room  
 





P-b-135 (observed ICL), and 5'-
32
P-b-170 (unobserved ICL) for DEPC and KMnO4 







with reference to T18 (T6 for 5'-
32







P-b-170 with reference to A17 (A5 for 5'-
32
P-b-167).  
temperature) and 1.05 M DEPC (final concentration, 12 min, room temperature) 
treatment for DOB substrates, the C4-AP substrates irrespective of the location of 
32
P-
labeling required 0.6 mM KMnO4 (final concentration, 10 min, room temperature) and 
1.75 M DEPC (final concentration, 12 min, room temperature) to achieve similar band 
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intensity on the denaturing PAGE. This could be attributed to less distortion of the C4-
AP substrates than the DOB ones. In addition, the C4-AP substrate concentration ranged 
from 5 – 10 nM, which was smaller than the DOB reaction concentration (30 – 60 nM). 
Assuming single hit kinetics (second order reaction), an equal amount of product 
generation (detected by percentage cleavage) would require a higher concentration of 
reagent for C4-AP, which is indeed the case. 
Table 8. Chemical probing experiments on C4-AP ICL analogue 4 for 5'-side of A containing strand 
(“bottom” strand) 
Nucleotide of interest 
in 
observed ICL (135), 
unobserved ICL (170) 
and control duplex 
(167) 
Normalized cleavage (NC) value [ = 
                                                





T16 of 167 0.84  0.05  
T18 (T6 for 167)
 
(KMnO4) 
T28 of 135 1.42  0.02 
T28 of 170 1.60  0.09 
A15 of 167 0.77  0.17  
A17  (A5 for 167) 
(DEPC) 
A27 of 135 2.43  0.03 
A27 of 170 2.54  0.02 
 





P-b-170 (W29 and W30, respectively) was cleaved upon subjection 
to the A-G sequencing reaction (formic acid, room temperature) (Lanes 6 and 12, App. 
Figure 58). The difference in reactivity could not be rationalized in any way. The reaction 
of 5'-
32
P-b-135 (observed ICL) and 5'-
32
P-b-171 (unobserved ICL) with KMnO4 detected 
hyperreactivity at T28 (nucleotide adjacent to ICL) (App. Figure 58). Unlike the Ts in 
control duplex (157) used for DOB substrates, the Ts present in its C4-AP counterpart 
167 demonstrated significant reactivity, presumably due to the higher KMnO4 
concentration employed. The NC value [
                                                
                                               
, 
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reference nucleotide T18 (T6 for 167)] detected greater hyperreactivity for 5'-
32
P-b-171 
(unobserved ICL, NC = 1.60  0.09) (Figure 63A and Table 8). Due to the presence of 
multiple As in the sequence bordering the cross-link in this region, the treatment of 5'-
32
P-b-135 (observed ICL) and 5'-
32
P-b-170 (unobserved ICL) with DEPC was more 
informative. Hyperreactivity was detected at A29 of 5'-
32
P-b-170 (unobserved ICL) 
indicating partial or complete disruption of H-bonding with opposing T (App. Figure 59). 
Less hyperreactivity was detected for A27 in both substrates from the respective 
denaturing PAGE and histograms (App. Figure 59D and E). The NC value [reference 
nucleotide A17 (A5 for control duplex 167)] indicated the greater distortion for A27 in 5'-
32
P-b-171 (unobserved ICL, NC = 2.54  0.02) (Figure 63B and App. Table 6). 
Examination of the DEPC histograms of observed ICL (5'-
32
P-b-170) and unobserved 
ICL (5'-
32
P-b-171) revealed no hyperreactivity at any As 5' to it, indicating the 
disappearance of ICL induced distortion at A25 and beyond.  
3.3.1.1.2. Reactivity of nucleotides on the 3'-side of the cross-linked A containing 
strand 
  
In the region 3' to the cross-linked A (W17 in observed ICL 165 and W18 in 
unobserved ICL 166), the reactivity of the nucleotides up to T21 were investigated using 
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15   T16 A17W18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
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their normalized cleavage or NC value [
                                                




P-b-165 (observed ICL) and 3'-
32
P-b-166 (unobserved ICL, see 
Experimentals for their preparation) were subjected to hydroxyl radical cleavage reaction 
anticipating it would detect the solvent exposed sugar residues of the backbone, 
especially those of the cross-linked A. However, uniform cleavage intensity was  
 
Figure 64. Comparison of cleavage of nucleotides (as a function of distance from ICL) (control duplex) in 
3'-
32
P-b-167 (control duplex), 3'-
32
P-b-165 (observed ICL), and 3'-
32
P-b-166 (observed ICL) for hydroxyl 
radical cleavage, DEPC and KMnO4 reaction. (A) NC value for hydroxyl radical cleavage reaction of A17 
and A18 from 3'-
32




P-b-166, respectively) with respect to A28. 






P-b-166 with respect to 






P-b-166 with respect 
to A28. (D) NC value for DEPC reaction of A18 from 3'-
32
P-b-165 and A20 from 3'-
32
P-b-166 with reference 
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P-b-166 in this region (App. Figure 60). The cross-
linked A or the nucleotides near it (W17 and W18 for 165 and 166, respectively) did not 
demonstrate any hyperreactivity compared to the distant ones. Instead, the cleavage 
pattern was similar to A17 or A18 in control substrate 3'-
32
P-b-167, revealing little or no 
distortion in the cross-linked As. Corroborating this observation, the NC values 
(reference nucleotide A28) for cross-linked As (W17 and W18 for 165 and 166, 
respectively) were within the error limits of their counterparts in the duplex (A17 and A18 




P-t-166 (App. Figure 61). Interestingly, T19 in the observed ICL (3'-
32
P-
b-165, NC = 14.99  0.84) was ~7 fold more reactive than that in the unobserved ICL (3'-
32
P-b-166, NC = 2.61  0.27) (App. Figure 61, Figure 64B and Table 9). This was 
opposite to the general trend of higher reactivity for nucleotides on 5'-side of the bottom 
strand of the unobserved ICL (166) (Figure 63). The detection of hyperreactivity at A18 
during treatment of 3'-
32
P-b-165 was anticipated due to its position opposite cross-linked 
abasic site analogue (App. Figure 62). Hyperreactivity was detected in A20 as well in 3'-
32
P-b-165 (observed ICL) and 3'-
32
P-b-166 (unobserved ICL), with A20 in 166 being more 
sensitive towards DEPC (NC = 4.80  0.47) (App. Figure 62, Figure 64C and Table 9). 
Interestingly, the reactivity of A20 (one nucleotide away from ICL) in the unobserved ICL 
(3'-
32
P-b-166) was even higher than the ICL-adjacent A18 in observed ICL (3'-
32
P-b-165, 
NC = 4.01  0.19) (Figure 64D and Table 9).  The histograms and NC value detected 
ICL-induced distortion present at the next nucleotides T21 of 3'-
32
P-b-165 (observed ICL, 
NC = 1.85  0.14) and 3'-
32
P-b-166 (unobserved ICL, NC = 1.80  0.11), where its 
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Table 9. Chemical probing experiments on C4-AP ICL analogue 4 for 3'-side of A containing strand 
(“bottom” strand) 
Nucleotide of interest 
in 
observed ICL (165), 
unobserved ICL 
(166) and control 
duplex (167) 
Normalized cleavage (NC) value [ = 
                                                









A18 of 167 1.04 ± 0.23 
W17 of 165 0.67 ± 0.11 
W18 of 166 0.94 ± 0.39 
T19 of 167 1.35 ± 0.17  
T29 (KMnO4) T19 of  165 14.99 ± 0.84 
T19 of 166 2.61 ± 0.27 
A20 of 167 1.47 ± 0.26  
A28 (DEPC) A20 of 165 3.39 ± 0.21 
A20 of 166 4.80 ± 0.47 
A18 of 167 Not calculated  
A28 (DEPC) A20 of 167 1.47  0.26 
A18 of 165 4.01  0.19 
A20 of 166 4.80 ± 0.47 
T21 of 167 0.97 ± 0.24  
T29 (KMnO4) T21 of 165 1.85 ± 0.14 
T21 of 166 1.80 ± 0.11 
 
reactivity was higher than that in the duplex 167 (App. Figure 61C and D, Figure 64E and 




P-b-166 were within the error 
limit of each other (Figure 61E). This was presumably a sign of diminishing distortion at 
T21 and nucleotides 3' to it. Therefore, the nucleotides 3' to T21 were not probed. 
3.3.1.1.3. Reactivity of nucleotides on the 5'-side of the cross-linked abasic site 
containing strand 
In the region 5' to the cross-linked abasic site (V55) containing strand (“t” or 
“top”), the reactivity of the nucleotides up to A52 were investigated using their 
normalized cleavage or NC value [
                                                
                                               
]. 
Sensitivity towards DEPC was detected at A54 and A52 in substrates 5'-
32
P-t-165 
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(observed ICL) and 5'-
32
P-t-166 (unobserved ICL) (see Experimentals for their 
preparation) (App. Figure 63 and 64). During the computation of the NC value, we  
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15   T16 A17W18  T19 A20T21   A  CG  C  GG  A28T29  C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29 C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
























intended A44 to be the reference nucleotide. However, due to its location near the 5'- 
terminus, the band corresponding to A44 was often unclear at the lanes in denaturing 
PAGE. In other instances, merging of the lanes near the 
32
P-labeling terminus due to salt 
complicated the cleavage intensity detection of A44. Therefore, G48 was used as the 
reference nucleotide for computation of NC values for A54 and A52 in control duplex (5'-
32
P-t-167), observed ICL (5'-
32
P-t-165), and unobserved ICL (5'-
32
P-t-166), despite G 
being a poor substrate of DEPC. The As in duplex control (5'-
32
P-t-167) were 





P-t-166) (App. Figure 63A). As a result of poor sensitivity of G towards DEPC and 
low reactivity of the As in the 5'-
32
P-t-167 (control duplex), the NC values of A54 and A52 
for 5'-
32
P-t-165 (observed ICL) and 5'-
32
P-t-166 (unobserved ICL) were significantly 
higher than those for 5'-
32
P-t-167 (control duplex) (Figure 65A and Table 10). The NC 
values helped compare the sensitivity (distortion) of As in observed ICL (5'-
32
P-t-165) 
and unobserved ICL (5'-
32
P-t-166) to one another, high NC values should not be taken 
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P-t-165 (observed ICL), and 5'-
32
P-t-166 (unobserved ICL) for DEPC and KMnO4 






P-t-166 with respect 














respect to G48.  
as a quantitative measure of their distortion.  The NC value of A54 for 5'-
32
P-t-166 
(unobserved ICL, NC = 18.91 ± 6.67) was the highest among the three (Figure 65A and 
Table 10). The ICL-induced distortion was prevalent in the next nucleotide, T53 (one 




P-t-166, which was sensitive towards 
KMnO4 (App Figure 65). Comparison of the peak intensities in the histograms and the 
NC values (reference nucleotide T45) indicated greater sensitivity for T53 in unobserved 
ICL (5'-
32
P-t-166, NC = 3.85  0.87) than the observed ICL (5'-
32
P-t-165, NC = 2.39  
0.27) (App. Figure 65, Figure 65B, and Table 10). 
Higher peak intensity of the next nucleotide A52 (two nucleotides away from ICL) 
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NC value [
                                     
                                        
, reference nucleotide G48] of A52 
indicated highest reactivity for the unobserved ICL (5'-
32
P-t-166, NC = 6.67  1.68) 
Table 10. Chemical probing experiments on the C4-AP ICL analogue 4 for 5'-side of abasic site 
analogue containing strand (“top” strand) 
Nucleotide of interest 
in 
observed ICL (165), 
unobserved ICL 
(166) and control 
duplex (167) 
Normalized cleavage (NC) value [ = 
                                                





A54 of 167 3.01± 0.34  
G48 (DEPC) A54 of 165 5.47 ± 0.35 
A54 of 166 18.91 ± 6.67 
T53 of 167 0.94 ± 0.03  
T45 (KMnO4) T53 of 165 2.39 ± 0.27 
T53 of 166 3.85 ± 0.17 
A52 of 167 1.73 ± 0.37  
G48 (DEPC) A52 of 165 2.44 ± 0.33 
A52 of 166 6.67 ± 1.68 
 
 (Figure 65C and Table 10). Treatment of 5'-
32
P-t-167 (control duplex), 5'-
32
P-t-
165 (observed ICL), and 5'-
32
P-t-166 (unobserved ICL) with KMnO4 did not demonstrate 
any hyperreactivity for T51 in the denaturing PAGE or histograms, indicating 
disappearing influence of ICL induced distortion (App. Figure 65A-D). The nucleotides 
5' to T51 were not probed any further.  
3.3.1.1.4. Reactivity of nucleotides on the 3'-side of the cross-linked abasic site 
containing strand 
In the region 3' to the cross-linked abasic site (V55) containing strand (“t” or 
“top”), the reactivity of the nucleotides up to T58 were investigated using their normalized 
cleavage or NC value [
                                                
                                               
]. Unlike the cross-
linked abasic site in DOB ICL analogue 3, its counterpart in 4 (V55) was not 
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hyperreactive upon hydroxyl radical treatment of 3'-
32
P-t-165 (observed ICL) and 3'-
32
P-
t-166 (unobserved ICL) (See Experimentals for their preparation.) (App. Figure 66A). 
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15   T16 A17W18  T19 A20T21   A  CG  C  GG  A28T29  C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29 C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
























The nucleotide reactivity was uniform throughout the strand for control duplex 
(3'-
32
P-b-167), observed ICL (3'-
32
P-t-165), and unobserved ICL (3'-
32
P-t-166) (App 
Figure 66B – D). We considered three different reasons to explain the absence of 
hyperreactivity at the abasic site. The possibility of multiple hit kinetics was ruled out 





Secondly, the inherent lack of reactivity of abasic site analogue 4 seemed unlikely due to 
its resemblance to the abasic site in 3. Therefore, we considered the third reason, absence 
of any solvent exposed sugar (the hydrogen of which is abstracted by hydroxyl radical) or 
its analogue in the backbone to be a plausible reason behind the lack of detectable 




P-t-166. As a 





P-t-166) could not be differentiated based on the NC value. Since 
the next nucleotide, T56, was opposite a cross-linked A for 3'-
32
P-t-165 (observed ICL), 
we expected high sensitivity towards KMnO4. Unlike its counterpart in the DOB 
“observed” ICL analogue (3'-
32
P-t-155), T56 did not respond to KMnO4 treatment of C4-
AP observed ICL (3'-
32
P-t-165) (App. Figure 67A and C). Instead, T56 in 3'-
32
P-t-165 
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P-t-165 (observed ICL), and 3'-
32
P-t-166 (unobserved ICL) for DEPC and KMnO4 





















with respect to T68.  
 (observed ICL) was more protected than the comparable nucleotide in control duplex (3'-
32
P-t-167) (App. Figure 67A and B). In contrast, T56 in unobserved ICL (3'-
32
P-t-166) 
was sensitive towards KMnO4 (App. Figure 67A and D).  Needless to mention, the NC 
value of T56 (4.45  0.30, reference nucleotide T68) was highest for unobserved ICL (3'-
32
P-t-166) among the three substrates (Figure 66A and Table 11). The lack of reactivity at 
ICL-adjacent T56 in 3'-
32
P-t-165 (observed ICL) was more baffling due to the presence of 





(App. Figure 68A – D). The reactivity of A57 was higher in unobserved ICL (3'-
32
P-t-166, 
NC = 2.72  0.09, reference nucleotide A67) than in observed ICL (3'-
32
P-t-165, NC = 
2.08  0.15) (Figure 66B and Table 11). The reactivity of the next nucleotide, T58 (two 
nucleotide away from ICL), followed the same trend as its neighbor, T56, demonstrating 
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greater reactivity for the 3'-
32
P-t-166 (unobserved ICL, NC = 1.70  0.10, reference 
nucleotide T68) than the the 3'-
32
P-t-165 (observed ICL, NC = 1.07  0.13) (App. Figure 





did not yield any hyperreactivity for nucleotides 3'- to T58, indicating disappeared 
influence of ICL induced distortion (App. Figure 67C and D). Nucleotides 3'- to T58 was 
therefore not investigated.  
Table 11. Chemical probing experiments on C4-AP ICL analogue 4 for 3'-side of abasic site analogue 
containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (165), 
unobserved ICL (166) and 
control duplex (167) 
Normalized cleavage (NC) value [ = 
                                                





A55 of 167 1.00 ± 0.21  
A67 (hydroxyl radical 
cleavage) 
 
V55 of 165 0.84 ± 0.38 
V55 of 166 0.77 ± 0.10 
T56 of 167 2.31 ± 0.22  
T68 (KMnO4) T56 of 165 1.36 ± 0.12 
T56 of 166 4.45 ± 0.30 
A57 of 167 0.95 ± 0.24  
A67 (DEPC) A57 of 165 2.08 ± 0.15 
A57 of 166 2.72 ± 0.09 
T58 of 167 1.28 ± 0.23  
T68 (KMnO4) T58 of 165 1.07 ± 0.13 
T58 of 166 1.70 ± 0.10 
 
3.3.1.1.5. Summary 
To summarize, reaction with DEPC, KMnO4 and hydroxyl radical revealed 
solvent exposed nucleotides on both strands of 165 and 166 (Figure 67). The distortion 
characterized by solvent exposed nucleotides was confined to within 3 – 4 nucleotides on 
each side from the ICL. Like DOB ICL analogue 3, the reactivity of the nucleotides 
varied. At the same time, the distorted (solvent exposed) nucleotides in the top and 
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bottom strands of ICLs containing 4 were more evenly distributed than the DOB ICL 
analogue 3. The varying degree of solvent exposure on the top and bottom 
oligonucleotide strands of containing 4 resembled the uneven nature of distortion 





Figure 67. Histogram describing comparative analysis of chemical probing on oligonucleotides 165 and 
166 containing DOB ICL analogue 3. The length of the arrows represents the reactivity difference for a 
particular nucleotide (towards a  specific chemical agent). The differences in length for two different 
nucleotides are not comparable.  
In general, greater chemical agent concentrations were required for inducing 
cleavage in observed (165) and unobserved ICL (166) compared to ICLs containing 3. In 
the cross-linked A containing strand (“bottom” strand), sensitivity of nucleotides A15, T16, 
and A20 towards the respective chemical agents were higher for 166 (observed ICL) than 
165 (unobserved ICL). In contrast, T19 demonstrated an unexplainable ~7 fold greater 
reactivity in observed ICL (165) than unobserved ICL (166). Hydroxyl radical cleavage 
did not detect any hyperreactivity in the cross-linked A in 165 or 166 (W17 and W18, 
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15   T16 A17W18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T  V  ATA TGC GCC  TAG ACG TGC  GAG CTG GCT ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28W29A TAT ACG CGG ATC TGC  ACG  CTC GAC CGA TGC)
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T   V  ATA TGC GCC  TAG ACG TGC   GAG CTG GCT ACG)
5'-d(GAC ATG GTA CTG GCT15 GA17T18 CGC GGC A25CA27    T28A29W TAT ACG CGG ATC  TGC  ACG  CTC GAC CGA TGC)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48GC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)


























3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29 C  TGC ACG)
 155  
 
respectively). On the cross-linked abasic site analogue-containing strand (“top” strand), a 
greater degree of hyperreactivity was detected for nucleotides A52 to T58 in 166 
(unobserved ICL) compared to 165 (observed ICL). Despite being present opposite a 
cross-linked A with possibly no H-bonding capability, T58 in observed ICL (165) was not 
sensitive towards KMnO4. The lack of reactivity at T58 contradicted the sensitivity of the 
T47 opposite cross-linked A (X14). Among the nucleotides of the top strand of 165 and 
166, no hyperreactivity was detected for the cross-linked abasic site (V55) from the 
hydroxyl radical cleavage. This was in contrast to the hyperreactivity detected for cross-
linked Y48 in 155 and 156 containing DOB ICL analogue 3. Overall, the sensitivity of 
nucleotides in unobserved ICL (166) was generally higher than their counterparts in 
observed ICL (165), indicating the presence of a greater degree of distortion. 
3.3.2.2. Tm analysis of substrates containing C4-AP ICL analogue (4) 
3.3.2.2.1. Optimization of substrate sequence and salt condition for melting 
temperature analysis 
The chemical probing experiments detected greater distortion in C4-AP ICL 
analogue 4 formed with opposing A (the “unobserved” type) than that with A opposite 3'-  
 
adjacent T (“observed”).  In order to validate our findings, the thermal stability of 
oligonucleotides containing the “observed” and “unobserved” type of 4 was investigated. 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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containing 4 than 3. This prompted us to anticipate smaller differences in the Tm’s of the 
“observed” and “unobserved” C4-AP ICL analogue 4 compared to those containing 3. 
The sequence composition in ICL 4, salt, and buffer conditions were optimized to 
maximize the difference between “observed” and “unobserved” ICLs. While we were 
certain about employing PIPES or phosphate buffer along with a monovalent cation for 
Tm experiments, the use of Mg
2+
 in the thermal melting of oligonucleotides was trickier.  
 
Figure 68. Oligonucleotides containing C4-AP ICL analogue 4 used for melting temperature analysis.  
The correlation between thermal stability of duplexes and Mg
2+
 (0 – 600 mM) is not 
continuous.
161
 The Tm initially rises with increasing Mg
2+
 concentration, reaching the 
highest thermal stability around 25 – 350 mM Mg
2+
, then dropping steadily to 600 
mM.
161
 At the same time, the difference in Tm between substrates decreases from 0 to 350 
mM, and then increases again up to 600 mM.
161
 In addition, the difference in Tm behavior 
is dependent on the G-C content of the substrates as well.
161
 Due to the nonlinear nature 
of the correlation, Tm experiments on 4 were initiated using Mg
2+ 
concentration of 10 
mM (this concentration was used for analyzing the thermal stability of 3).  
 In order to compare the thermal stability of the ICL formed with an opposing A 
(the “unobserved” type, 130) and that with A opposite 3'-adjacent T (“observed”, 129), 
















5'-d(GCA3  CAT6   WAT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
129
5'-d(GCA3  CAT6   AWT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
130
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(Figure 68). The core sequence flanking the ICL (4) in 129 and 130 (C4  T11) was 
derived from C14 – T21 region encompassing the ICL in the chemical probing substrates  
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
















3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A44  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29 C  TGC ACG)
165
166  
165 (observed ICL) and 166 (unobserved ICL), respectively. The remaining sequence 
composition and overall length of 129 and 130 were determined using theoretical Tm 
calculations using hypothetical hairpins 171 and 172 (Figure 69). Like DOB ICL 
analogue 3, we anticipated the base paired regions on both sides of the ICL 4 to function 
like hairpins in Tm studies, elevating the Tm. The cross-linked region in 3 resembled a 
single hairpin, making prediction of its melting behavior simpler. In contrast, we 
envisioned ICL analogue 4 to consist of two separate hairpin stem-loop like structures. In 
principle, the A6 – A9 loop of the hairpins 171 and 172 (Figure 69) would represent the 
ICL-adjacent highly distorted solvent exposed region of 4 (e.g. T16W17V55T56A57 and 
T19A18W17V55A54 of 165) detected in chemical probing. We anticipated that the vicinity 
of the A5 – T10 pair in 171 with the loop would mimic the relatively low-level distortion 
detected in the A58 – T58 pair in 165 and 166. Similar kind of correlation was expected of 
the T5 – A10 in 172 and A20 – T53 in the cross-linked substrates (165 and 166). 
Assessment of the length of the stems of 171 and 172 (and corresponding length of arms 
on each side of 4 of the Tm substrates) was trickier. To the best of our knowledge, earlier 
studies on thermal melting of ICLs without a strand break (e.g. those formed from 
mitomycin C or psoralen)
38,79
 did not address whether the melting of the two hairpin-like 
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structures therein comprised of one or two separate transitions. In the absence of such 
theory or experiment, we assumed the thermal melting of the two hairpin like structures 
in ICL 4 would behave as separate transitions. However, we assumed that similar  
 
Figure 69. Hypothetical hairpin oligonucleotides used to estimate the Tm of cross-link substrates containing 
4. 
G-C content on either side of 4 would bring their Tm’s close enough so that both would 
be denatured within a similar temperature range. While the region G11 – A15 of 165 was 
adapted as the stem of the hairpin 171 (G1 – A5), A20 – G24 of 165 was slightly modified 
as the A10 – G14 of 172 to achieve a similar G – C content. The stems of 171 and 172 (G1 
– A5 and A10 – G14, respectively) would resemble the base paired region distant from ICL 
4 (e.g. G11 – A15 and A20 – G24 of 165 and 166) which lacked any influence of distortion 
and sensitivity towards chemical agent. Next, we carried out Tm calculations on 
hypothetical hairpins 171 and 172 (Figure 69). At 100 mM Na
+
 (pH 7.0), 10 mM Mg
2+
 
and oligonucleotide concentration 1 μM, the melting temperatures of 171 and 172 were 
estimated to be ~58 °C and ~62 °C using an online Tm calculator 
(https://www.idtdna.com/calc/analyzer). If our analogy of ICL 4 structure with two 
hairpins is correct, the proximity of estimated Tm values would cause the melting of both 
regions of 4 to occur within a common temperature range. From our experience with 
DOB ICL analogue (3), we anticipated that thermodynamic stability of 129 (observed 
ICL) and 130 (unobserved ICL) can be distinguished based on their Tm in this 
temperature range. If the hypothetical and experimental Tm would be found close enough, 
this method can be applied to estimate the Tm of any cross-link with available structural 
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3.3.2.2.2. Calculation of extinction coefficients of oligonucleotides containing C4-AP 
ICL analogue 4 
 
The extinction coefficient (Ɛ) of oligonucleotides 129 and 130 at 260 nm were 
calculated based on the nearest-neighbor model and a list of corrected extinction 
coefficients of nucleotides (http://www.owczarzy.net/extinctionDNA.htm).
156–158
 The list 
and methodologies from nearest-neighbor model are combined in a standard extinction 
coefficient calculator (http://biophysics.idtdna.com/UVSpectrum.html). To simplify the 
calculation, we assumed the hairpin like regions of 129 and 130 would remain base 
paired even in the absence of salt. Based on this premise, we assumed nucleotides G1 – 
W7 in 129 to be a duplex, with W being A. The cross-linked abasic side analogue on top 
strand was not expected to contribute in the extinction coefficient. Similarly, nucleotides 
G1 – A7 in 130 were assumed to form a duplex as well. Both duplexes are estimated to 




 (based on the online Ɛ calculator). Due to their location 
opposite the cross-linked abasic site analogue, A8 in 129 and W8 in 130 were considered  
5'-d(GCA CAT A)
3'-d(CGT GTA T)





















5'-d(GCA3  CAT6   WAT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
129
5'-d(GCA3  CAT6   AWT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
130
 160  
 
single stranded residues without any base pairing or stacking stabilization. On the other 
hand, nucleotides T9 – G14 were assumed to form a duplex in both the substrates with an 




 (based on the online Ɛ calculator). 
Next, we hypothesized 129 and 130 as two linear oligonucleotides 5'-d(MpApN)-3' (172) 
and 5'-d(MpWpN)-3' (173). M and N, both imaginary nucleotides, represented the duplex 
regions G1 – W(A)7 and T9 – G14 of 129 and 130, respectively (Figure 70). The A and W 
in 172 and 173 were representative of unpaired A8 and W8 in 129 and 130, respectively. 
According to the nearest-neighbor model, the extinction coefficient (Ɛ) of 172 and 173 
(and therefore of 129 and 130) were calculated as follows,  
Ɛ5'-d(MpApN)-3'  = ƐdMpdA + ƐdApdN  ƐpdA 
  = (ƐdM + ƐpdA) + (ƐdA + ƐpdN) – ƐpdA 
   = ƐdM + ƐpdA + ƐdN 
 Based on the above equation, the extinction coefficient of 129 and 130 was 




. We anticipated ~5% error in this value due to the 
direct addition between ƐdM (or ƐdN) and ƐdA during calculation of ƐdMpdA and ƐdApdN.  
3.3.2.2.3. Melting temperature study of oligonucleotides containing C4-AP ICL 
analogue 4 
 
 We carried out a UV-melting study on 129 (observed ICL) and 130 (unobserved 
ICL) [DNA concentration 1 μM, PIPES (pH 7.0) 10 mM, Mg
2+
 10 mM, Na
+
















5'-d(GCA3  CAT6   WAT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
129
5'-d(GCA3  CAT6   AWT9  ATG12 CG)
3'-d(CGT26 GTA23  TVA20 TAC17 GC)
130
 161  
 
Both substrates melted around 60 °C (Figure 71 and Table 12). The melting temperatures 
were in accordance with the estimated Tm of hypothetical oligonucleotides (170 and 171) 
used to design the sequence composition of 129 and 130. For 129 and 130, the Tm values 
for the forward experiments (temperature gradually increased from 20 °C to 85 °C,  
 
Figure 71. Thermal denaturation analysis of oligonucleotides containing C4-AP ICL analogue 4. (A) 
Absorbance (260 nm) vs temperature profile of cross-linked substrate 129 (observed ICL) and 130 
(unobserved ICL) during forward experiment (temperature increased from 20 to 85 °C. DNA concentration 
1 μM, PIPES, pH 7.0, 10 mM, Mg
2+
 10 mM, Na
+
 100 mM. (B) Absorbance (260 nm) vs temperature 
profile of cross-linked substrate 129 and 130 during reverse experiment (temperature decreased from 85 to 
20 °C. DNA concentration 1 μM, PIPES (pH 7.0) 10 mM, Mg
2+
 10 mM, Na
+
 100 mM.  
Figure 71A) were slightly lower than the respective reverse experiment (temperature 
gradually decreased from 85°C to 20 °C, Figure 71B and Table 12). We  considered this 
difference to be an artifact since the values were within error limits of each other. An 
important difference detected in the Tm profiles of 3 and 4 was the broadness of the 
melting transitions.  Compared to ~18 – 20 °C melting transition range observed for DOB 
ICL analogues (3), the change in UV absorption for 4 occurred over a broader region 
(~23 – 27 °C). We rationalized the increase in melting temperature range by the slightly 
different G-C distribution in the two duplex arms (G1  T6 and T9 – G14) of 129 and 130. 
As a result, the two hairpin-like regions with the different G-C content would have 
slightly different Tm, leading to overlapping and broader melting transitions. Broad UV 
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 Most importantly, we detected consistently greater Tm values for 
observed ICL (129) over unobserved ICL (130) for both forward and reverse experiments 
(Table 12). This validated the greater thermodynamic stability for “observed” cross-
linking with A opposite a 3'-adjacent T (as in 129) over “unobserved” ICL formationwith 
an opposing A (as in 130). The observations also corroborated  with the chemical probing 
results, in which oligonucleotides containing ICL 4 with an opposing A were more 
distorted (characterized by solvent exposure). In addition, the difference in Tm between 
“observed” ICL 129 and “unobserved” 130 was much less compared to that between the 
observed and unobserved DOB ICL analogue 3 (160 and 161, Tm ~ 4 °C for the hairpin 
like cross-linked region, Table 7). This was despite the fact that the length of the duplex 
region was shorter in the C4-AP ICL analogue 4 than for 3. The smaller difference in C4-
AP ICL Tm’s is consistent with the lower distortion detected for oligonucleotides 
containing 4 during chemical probing. 
Table 12. Melting temperature of oligonucleotides containing C4-AP ICL analogue 4 (averaging is 
based on at least three replicates) 
Substrate Tm in forward experiment (°C) Tm in reverse Experiment (°C) 
129 59.07  0.23 60.09  0.66 
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3.3.1.1.5. Correlation between nucleotide solvent exposure, strand break and 
UvrABC incision of 3 and 4 
 
Earlier, we hypothesized that the lower sensitivity of oligonucleotides containing 
C4-AP ICL analogue (4) towards chemical probing agents compared to those containing 
the DOB ICL analogue (3) substrates were due to less distortion in the former. In 
addition, ICL 4 had smaller differences in Tm’s between the “observed” (adduct 
formation with A opposite 3'-adjacent T) and “unobserved” (ICL with opposing A) cross-
links than the analogous substrates containing 3. 
 
While both observations support the notion of less distortion in 4, we attempted to 
validate it with a direct comparison between 3 and 4. Previously, nucleotide reactivity 
towards chemical agents were compared between a mitomycin C ICL and the 
corresponding un-cross-linked duplex.
40













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)













































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)





3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  T55  A54T53A52   T51GC  G48CC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC  ACA15  T16 A17 A18  T19 A20T21   A  CG  C   GG  A28T29C  TGC ACG)
165
167
5'-d(AGA CTG6   C   A8   T A11C     G13 X14A15    A16A17G  CGT  TA23G24 CCA  TA)
3'-d(TCT  GAC55 G54T A   AT50G49  C48T47Y46         T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT   TA23G24 CCA TTA)
3'-d( CT GAC55 G54T    AT50G49   C48T47  T46   45 44       38      )
155
157
 164  
 
solvent exposed nucleotides and correlated well with the NMR derived structure of 
mitomycin C ICL.
88
 Intrigued, I compared the solvent exposure of nucleotides 
(characterized by sensitivity towards chemical agents) in cross-linked substrates 155 and 
165 with a reference consisting of the respective un-cross-linked duplexes (157 and 167). 
Oligonucleotides 155 and 165 were chosen because their cross-link connectivity (the 
“observed” type) matched those used earlier in UvrABC nucleotide excision repair 
experiments.  The ratio of the NC value of a particular nucleotide from ICL to that of the 
same nucleotide in the corresponding un-cross-linked duplex was estimated as a measure 
of solvent exposure. Only those nucleotides that showed signs of hyperreactivity in the 
chemical probing experiments were chosen for this analysis. The ratios of NC values 
between the duplex and ICL were plotted against the same scale for nucleotides in top 
(having the abasic site analogue) and bottom strand (containing the cross-liked A) (Figure 
72). The comparison of the ratio of NC values between 155 and 165 clearly indicated a 
high degree of distortion around the ICL 3 in 155, especially in the top strand (Figure 
72A). Among the nucleotides demonstrating very high degree of distortion were cross-
linked abasic analogue Y46, T47, T45 and T44. In addition, A15, A16 and A17 were among 
hyperreactive sites on the other strand. On the other hand, the sensitivity of distorted 
nucleotides of 165 (containing C4-AP ICL analogue 4) towards chemical agents were 
more evenly distributed with the exception of T19, which was detected with a surprisingly 
high reactivity. With the exception of T19, none matched the extreme solvent exposure 
demonstrated by nucleotides encompassing DOB ICL analogue 3 in 155. 




Figure 72. The reactivity of nucleotides in cross-linked substrates 155 (observed ICL containing DOB ICL 
analogue 3) and 165 (observed ICL containing C4-AP ICL analogue 4). (A) Comparative reactivity of 
nucleotides in 155 with reference to 157. The reactivity of C12 was not included due to lack of 
hydroxylamine probing on the C12 of 157. (B) Comparative reactivity of nucleotides in 165 with reference 
to 167.  
One possible reason behind the greater distortion in substrates containing DOB 
ICL analogue 3 could be the presence of the strand break adjacent to the ICL, which 
provides additional flexibility. The presence of a continuous helical backbone in 4 may 
help contain distortion. Despite the ICL induced distortion, the continuous backbone 
holds the adjacent  
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(T45T44C   GCA  AT38C    GGT AAT)
158  
nucleotides together, preventing disruption of stabilizing forces like base stacking and H-
bonding. In contrast, a strand break itself introduces a number of solvent exposed 
nucleotides in the terminus adjacent to the nick (e.g. detection of hyperreactivity at T45 
and T44 of 158, App Figure 53). In combination with ICL induced distortion, an adjacent 
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5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  A 38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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strand break as in 3 could thus produce greater disruption in base stacking and greater 
solvent exposure in the region flanking the cross-link. According to the current model of 
UvrABC damage detection, the bulged backbone of a damaged DNA backbone causes 
steric clash with the protein wall of a narrow tunnel in UvrA2B2 complex. This steric 
clash distinguishes a damaged DNA from an undamaged one without any bulged 
backbone, which fits well within the tunnel.110 Greater distortion in a substrate containing 
DOB ICL analogue 3 would result into greater steric clash in the protein tunnel of 
UvrA2B2, inducing more efficient preincision complex formation
124
 and higher incision 
yield.  
While the greater distortion in DOB ICL analogue 3 was consistent with a higher 
incision yield by UvrABC endonuclease, the distribution of solvent exposed nucleotides 
therein could not explain the regioselective nature of the observed incision. Earlier 
studies have correlated helical instability with greater incision yield,
102
 possibly due to 
the ease of local unwinding for a thermodynamically less stable region. Although the 
hairpin-like cross-linked region in 3 had a number of solvent exposed nucleotides 
including the abasic site analogue, the high Tm values indicated significant 
thermodynamic stability. In contrast, low Tm of the un-cross-linked region revealed a 
considerably less thermodynamically stable structure. Since UvrABC incision occurred 
on the strand not carrying the nick on the un-cross-linked region of 3 (Figure 43),
123
 the 
distorted ICL was presumably the alluring reason for UvrA binding and preincision 
complex formation. The combination of local distortion in the un-cross-linked region 
(visualized in the form of solvent exposed nucleotides) with the low structural stability is 
possibly causing regioselective UvrC incision.  




Figure 73. Energy dynamics of site selective DOB (A) and C4-AP ICL (B) formation.  
In conclusion, the “observed” (ICL with A opposite 3'-adjacent nucleotide) and 
“unobserved” (ICL with opposing A) type of cross-link formation in DOB (3) and C4-AP 
ICL (4) analogues were successfully probed using chemical agents. Quantification of 
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its percent cleavage intensity in gel compared to that of the unreacted starting 
material.
147,148
 However, we identified that such computation would be susceptible to 
human errors such as variation in reaction time, and concentration of reagents. Therefore, 
we employed an internal normalization of cleavage band volume of the nucleotide of 
interest (closer to ICL) by taking its ratio with that of a potentially unperturbed one (far 
from ICL). We anticipated that such “normalized cleavage” or NC value 
[
                                                
                                               
] would be relatively insulated from the 
above-mentioned human errors, at least to some degree. Computation of NC values for 3 
and 4 determined that the distortions were contained within 3 – 4 nucleotides from the 
ICL in both directions. However, an uneven distribution of deformity in the cross-linked 
strands was detected for DOB ICL analogue (3) and C4-AP ICL analogue (4). The range 




Comparison of the NC values obtained from the “observed” and “unobserved” 
types of ICLs for 3 and 4 revealed that the nucleotides in the “unobserved” substrates 
were consistently associated with a greater degree of solvent exposure. This implied that 
the “unobserved” (cross-linking with opposing A) type of ICLs were more distorted than 
their “observed” (cross-linking with A opposite 3'-adjacent T) counterparts. This 
observation was corroborated by UV thermal melting studies, where the Tm of the 
“unobserved” type of cross-links were lower than their “observed” counterparts for 3 and 
4. 
In contrast to NMR, chemical probing cannot be used to detect specific reasons 
behind solvent exposure, such as changes in nucleobase orientation (syn or anti), non-
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native deoxyribose conformation, or change in base pair geometries. The advantage of 
chemical probing lies in the use of significantly smaller oligonucleotide quantities, and 
relatively straightforward qualitative detection of distorted nucleotides. The observation 
of greater distortion in the “unobserved” type of ICL is consistent with NMR and Tm 
studies on trimethylene ICL (22), the reduced version of acrolein ICL, where the 

















The observation of higher solvent exposure in nucleotides of “unobserved” 3 and 
4 is consistent with the hypothesis of greater degree of distortion present during cross-
linking with opposing A. Adduct formation with an opposing A thus could be associated 
with an energetically less stable intermediate (associated with an unfavorable transition 
state) than that with an A opposite a 3'-adjacent T (Figure 73A and B). Since the 
generation of 1 and 2 from their respective lesions are reversible processes, ICL 
formation with opposing A should have a lower Keq, instead favoring the more stable 
“observed” adduct formation.  
4. Conclusion 
C4'-abasic site (C4-AP) and dioxobutane (DOB) lesions are generated by 
oxidative assaults on DNA. These lesions form interstrand cross-links (ICLs) with the N6 
amine of A. The DOB, a lesion generated concomitantly with a 5'-strand break, forms a 
short-lived ICL (1, half life 10 h).
9
 The C4-AP initially forms an unstable kinetic ICL (2, 
 170  
 
half life 3.1 h), which reverts to C4-AP, ultimately undergoes a strand scission and forms 
a stable thermodynamic ICL (13).
31
 Although both ICLs (1 and 2) are unstable, they are  
 
capable of disrupting essential cellular processes in their short lifetime. Comprehension 
of their biochemical effect thus remains necessary. In this report, we described synthetic 
strategies for making stabilized analogues (3, 4) of DOB and C4-AP kinetic interstrand 
cross-links (1 and 2).
9,31
 Orthogonal chemistry compatible with solid phase DNA 
synthesis was developed for synthesis of the analogues (3 and 4).
162
 In combination with 
enzymatic ligation, we synthesized long oligonucleotides (60 bp) suitable for bacterial 
nucleotide excision repair studies. In principle, the analogues can be used to make even 
longer substrates suitable for mammalian repair studies
163
 as well. The synthetic 
strategies have broad applicability and are not restricted by sequence constraints. They 





































































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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Long oligonucleotides containing the stabilized ICL analogues (3 and 4) were 
subjected to UvrABC, bacterial nucleotide excision repair protein responsible for cross-
link removal.
141
 The C4-AP cross-link analogue 4 was incised on both the cross-linked A 
and abasic site analogue containing strand. The cleavage yield was low (maximum 30% 
in 8 h), indicating C4-AP to be a persistent block in essential cellular processes, such as 
transcription and replication. In contrast to previous findings involving A-T and 
mitomycin C ICLs,
20,21
 no double strand break (DSB) was detected from repetitive 
incisions on both strands. Treatment of the DOB ICL analogue (3) with UvrABC 
produced exclusive incision on the strand containing cross-linked A, producing a DSB. 
Previously, treatment of C4-AP thermodynamic ICL (also contained a strand break) with 
UvrABC has resulted formation of DSB with 15% of the total incision yield.
22
 To the 
best of our knowledge, DOB ICL analogue 3 is the only substrate that exclusively yields 
a DSB upon UvrABC treatment. 
 
The DOB and C4-AP kinetic ICLs form in a site selective and reversible manner, 
with the N6 amine of an A opposite the 3'-adjacent nucleotide, while almost no ICL 
formation was observed with A opposite the lesions themselves. The measurement of 






C4-AP kinetic ICL (2)DOB ICL (1)
NX
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lesions using a Spartan® model did not justify the high selectivity. In addition to 
distance, we hypothesized that the site selectivity could be driven by the relative 
stabilities of the two type of ICLs, with the favored one being less distorted. Based upon 
this hypothesis, any potential ICL with an opposing A (“unobserved”) should be more 
distorted and will have a more solvent exposed helical backbone than the ICL formed 
with an A opposite the 3'-adjacent T (“observed”). Utilizing the strategies developed for 
making C4-AP and DOB ICL analogues (3 and 4), cross-links with both connectivities 
(“observed” and “unobserved”) were synthesized. All four sets of cross-links (the 
“observed” 3 and 4, and the “unobserved” 3 and 4) were subjected to nucleotide specific 
chemical reagents that predominantly react with solvent exposed nucleobases.
146–151
  For 
both 3 and 4, the nucleotides in cross-links with “unobserved” connectivity were more 
reactive than those with “observed” ICLs, indicating greater solvent exposure in the 
former. This observation was further corroborated by melting temperature analysis of 
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5. Experimentals 
General Methods. Solvents used in reactions were purified and dried (using 
CaH2 or Na/benzophenone) by distillation before use. Reagents were purchased from 
commercial sources and were used without further purification. Reactions were carried 
out under a positive pressure of argon atmosphere and monitored by TLC on silica gel G-
25 UV254 (0.25 mm). Spots were detected using UV light and/or by charring with a 
solution of either ammonium molybdate, ceric ammonium sulfate in water and H2SO4, or 
p-anisaldehyde in ethanol and H2SO4. Flash chromatography was performed on silica gel 
60 (40-60 μm). The ratio between silica gel and crude product ranged from 100:1 to 20:1 
(w/w). 
Oligonucleotides were synthesized via automated DNA synthesis on an Applied 
Biosystems model 394 instrument. Commercially available DNA synthesis reagents 
including phosphorylation reagent was purchased from Glen Research. Phosphoramidites 
66a, 66b, 113a, and 113b were dried for 12 h in a lyophilizer prior to the experiment. 
Oligonucleotides containing cross-link analogues were deprotected using concentrated 
NH4OH at 55 °C for 12 h. Oligonucleotides containing native nucleotides only were 
deprotected using 1:1 mixture of aqueous methylamine (40%)-concentrated concentrated 
NH4OH at 55 °C for 1 h. Oligonucleotides were purified by 20% denaturing 
polyacrylamide gel electrophoresis (PAGE), isolated by the crush and soak method, and 
desalted using C-18-Sep-Pak cartridges (Waters). Oligonucleotides containing modified 
nucleotides were characterized by MALDI-TOF MS or ESI-MS. Oligonucleotides were 
5'-
32
P-labeled by T4 polynucleotide kinase (New England Biolabs) and γ-
32
P-ATP 
(Perkin-Elmer). Radiolabeling of the 3'-termini was done using -
32
P-cordycepin 
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triphosphate (Perkin-Elmer) and terminal deoxynucleotidyl transferase (NEB). 
Radioisotopic “fill in” experiments at 3'-termini were carried out with Klenow (exo-) 
(NEB) and -
32
P-dCTP (Perkin-Elmer). Experiments involving radiolabeled 
oligonucleotides were analyzed following PAGE using a Storm 840 phosphorimager and 
Imagequant TL software. The band intensities of the target and reference nucleotides in 
chemical probing experiments was analyzed using the 1D gel analysis feature of 
ImageQuant TL, along with the “Rolling Ball” automated background correction. RSaI, 
Taq

I, CviQI, Fnu4HI, BsrBI, Taq

I, HpyCH4V, NEB 2.0, NEB 3.1, and CutSmart 
buffers were from NEB. 
Synthesis of 62. The hydrochloride salt of 62 (667 mg, 5.5 mmol) 
was added to a stirred solution of 61 (1.6 g, 2.7 mmol) in THF (50 
mL), followed by addition of Cs2CO3 (4.2 g, 13.5 mmol). The 
reaction was allowed to stir for 3.5 h at room temperature at which 
time the solvent was evaporated in vacuo. The crude material was dissolved in DCM 
(100 mL) and washed with saturated sodium bicarbonate (70 mL). The organic layer was 
collected and dried over sodium sulfate and concentrated. Flash chromatography (70% 
EtOAc in DCM to 100% EtOAc) yielded 11.2 g of 63 (82%). Rf (5% MeOH in DCM) = 
0.3. 
1
H NMR (CDCl3): δ 8.3 (s, 1H), 8.0 (s, 1H), 6.41 (t, 1H, J = 6.4 Hz), 4.60 (m, 1H), 
4.56 (m, 1H), 3.84-4.54 (m, 5H), 3.81 (dd, 1H, J = 3.9, 11 Hz), 3.72 (dd, 1H, J = 3.7, 11 
Hz), 3.05 (bd s, 1H), 2.59 (dt, 1H, J = 5.6, 12.2 Hz), 2.38 (m, 1H), 2.13 (m, 2H), 1.89 (bd 
s, 1H), 0.88 (s, 18H), 0.074 (s, 6H), 0.070 (s, 6H). 
13
C NMR (CDCl3): δ 153.2, 152.7, 
149.8, 137.2, 120.8, 87.8, 84.2, 72.3, 63.1, 45.8, 41.1, 26.1, 25.9, 18.6, 18.2, 8.7, -4.5, -
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HRMS (ESI/APCI) m/z [M + H]
+
 calculated for C26H48N5O4Si2 550.3239, found 
550.3250. 
Synthesis of 63a. Levulinic acid (604 mg, 529 µL, 5.1 mmol), DMAP (731 mg, 5.9 
mmol), and EDCI (989 mmol, 5.2 mmol) were added to a stirred solution of 62 (405 mg, 
0.7 mmol) in DMF (9 mL). The reaction mixture was stirred for 4 
h at room temperature under inert atmosphere. The resulting light 
orange mixture was diluted with EtOAc (80 mL) and then washed 
with water (50 ml), saturated sodium bicarbonate (50 mL), and 
brine solution (50 mL). The organic layer was dried over sodium 
sulfate, concentrated in vacuo and subjected to flash chromatography using 30% EtOAc 
in DCM to obtain the desired product (445 mg, 93%). Rf (30% EtOAc in DCM) = 0.31.
 
1
H NMR (CDCl3): δ 8.32 (s, 1H), 7.97 (s, 1H), 6.42 (t, 1H, J = 6 Hz), 5.45 (m, 1H), 4.56 
(s, 1H), 3.97-4.54 (m, 5H), 3.76 (dd, 1H, J = 4.6, 10.8 Hz), 3.72 (dd, 1H, J = 2.5, 10.8 
Hz), 2.69 (m, 2H), 2.59 (m, 1H), 2.52 (m, 2H), 2.37 (m, 1H), 2.19 (m, 2H), 2.12 (s, 3H), 
0.88 (s, 18H), 0.07 (s, 6H), 0.04 (s, 6H). 
13
C NMR (CDCl3): δ 206.4, 172.3, 153.1, 152.8, 
150.1, 137.5, 120.8, 87.8, 84.1, 72.2, 62.9, 41.1, 37.9, 29.9, 28.2, 26.1, 25.8, 18.5, 18.1, -
4.6, -4.7, -5.3, -5.4. IR (neat): 2852, 2926, 2856, 1720, 1591, 1471, 1156, 1093, 834, 777 
cm
-1
. HRMS (ESI/APCI) m/z calculated for [M + H]
+
 C31H54N5O6Si2 648.3607, found 
648.3616. 
Synthesis of 63b. A mixture of 62 (304 mg, 0.55 mmol), o-nitroveratryloxycarbonyl 
chloride
164
 (615 g, 2.22 mmol) and dimethylaminopyridine (549 mg, 4.43 mmol) were 
stirred in DCM (6 mL) at room temperature for 2 h, at which time the solution was 
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bicarbonate (2 × 50 mL) followed by washing with brine (50 mL). The combined 
aqueous layers were washed with DCM (50 mL) and the combined organic layers were 
dried over sodium sulfate. After evaporating the solvent in vacuo, the product mixture 
was dissolved in DCM. It was purified by flash chromatography 
(10% EtOAc in DCM to 60% EtOAc in DCM) to yield the desired 
product as a white solid (401 mg, 92%). Rf (50% EtOAc in DCM): 
0.6. 
1
H NMR (CDCl3): δ 8.35 (s, 1H), 7.99 (s, 1H), 7.72 (s, 1H), 
7.02 (s, 1H), 6.45 (t, 1H, J = 8 Hz), 5.59 (s, 2H), 5.45 (m, 1H), 
4.60 (m, 1H), 4.01- 4.38 (m, 5H), 3.94 (s, 3H), 3.93 (s, 3H), 3.83 (dd, 1H, J = 11.2, 4.8 
Hz), 3.75 (dd, 1H, J = 3.2, 10.8 Hz), 2.63 (td, 1H, J = 6, 12.8 Hz), 2.41 (m, 1H), 2.33 (m, 
2H), 0.914 (s, 9H), 0.911 (s, 9H), 0.11, (s, 6H), 0.08 (s, 6H). 
13
C NMR (CDCl3): δ 154.3, 
153.8, 153.0, 152.8, 150.1, 148.4, 139.7, 137.6, 126.7, 120.8, 87.9, 84.1, 72.3, 66.6, 63.0, 
56.7, 56.6, 41,2, 30.7, 26.1, 25.9, 18.6, 18.2, -4.5, -4.6, -5.2, -5.3. IR (neat): 2953, 2928, 
2856, 1749, 1591, 1523, 1470, 1253, 1219, 1064, 834, 776 cm
-1
. HRMS (ESI/APCI) m/z 
[M + H]
+
 calculated for C36H57N6O10Si2 789.3669, found 789.3661.  
Synthesis of 64a. Triethylamine trihydrofluoride (0.220 mg, 221 µL, 
1.37 mmol) was added to a solution of levulinyl protected 63a (310 
mg, 0.47 mmol) in THF (3.0 mL). After stirring at room temperature 
for 17 h, TLC (5% MeOH in DCM) showed that a small amount of 
starting material was still present. An additional equivalent of 
desilylating reagent was added and the reaction stirred for 6 additional h at which time no 
starting material remained. The reaction was evaporated to dryness in vacuo, and 140 mg 
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chromatography (2% MeOH in DCM to 5% MeOH in DCM). Rf (5% MeOH in DCM ) = 
0.3.  
1
H NMR (MeOH-d4): δ 8.23 (s, 1H), 8.18 (s, 1H), 6.42 (t, 1H, J = 6.8 Hz), 5.44 (m, 
1H), 4.88 (m, 4H), 4.56 (d, 1H, J = 3.6 Hz), 4.10-4.50 (1H), 4.05 (d, 1H, J = 2.4 Hz), 
3.87-4.02 (1H), 3.84 (dd, 1H, J = 11.2, 2.6 Hz), 3.73 (dd, 1H, J = 12.4, 2.9 Hz), 2.70-2.86 
(3H), 2.52 (t, 2H, J = 6.4 Hz), 2.37 (m, 1H), 2.24 (m, 2H), 2.06 (s, 3H). 
13
C NMR 
(MeOD-d4): δ 209.4, 174.0, 154.2, 153.2, 150.4, 140.6, 121.8, 89.8, 87.2, 73.1, 63.6, 
42.6, 38.6, 32.9, 31.1, 29.5, 29.0. IR (neat): 3263, 2929, 1713, 1593, 1472, 1204, 1158. 
1095 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 calculated for C19H26N5O6 410.1878, found 
420.1887. 
Synthesis of 64b. Triethylamine trihydrofluoride (208 mg, 209 µL, 
1.28 mmol) was added to a solution of NVOC protected 63b (202 
mg, 0.26 mmol) in THF (2.7 mL) and the mixture was stirred 
overnight at room temperature. After evaporating the solvent in vacuo 
the residue was dissolved in DCM and purified by flash chromatography (18  2.2 cm) 
(2% methanol in DCM to 4% methanol in DCM) to yield the desired product as a white 
foam (131 mg, 89%). Rf (4% methanol in DCM) = 0.15. 
1
H NMR (CDCl3): δ 8.29 (s, 
1H), 7.77 (s, 1H), 7.72 (s, 1H), 7.01 (s, 1H), 6.86 (d, 1H, J = 8 Hz), 6.31 (dd, 1H, J = 5.6, 
8 Hz), 5.59 (s, 2H), 5.45 (d, 1H, J = 16 Hz), 4.8 (d, 1H, J = 4 Hz), 4.57 (m, 1H), 3.96-
4.34 (m, 4H), 3.95 (s, 3H), 3.94 (s, 3H), 3.79 (t, 1H, J = 8 Hz), 3.14 (m, 1H), 2.63 (s, 
1H), 2.28 (d, 1H, J = 5.2 Hz), 2.25 (d, 1H, J = 5.5 Hz). 
13
C NMR (CDCl3): δ 154.3, 
153.8, 153.4, 152.1, 149, 148.5, 139.8, 139.1, 126.5, 122.2, 110.2, 108.3, 89.9, 87.9, 77.4, 
73.8, 66.6, 63.7, 56.6, 56.5, 54.7, 53.2, 46.5, 45.4, 40.6, 32.3, 30.2, 29.7,  8.9. IR (neat): 













. HRMS (ESI/APCI) m/z [M + H]
+
 calculated for C24H29N6O10 561.1940, found 
561.1944. 
Synthesis of 65a. A pyridine (2 mL) solution of DMT-Cl (73 mg, 
0.19 mmol) and azeotropically dried 64a (75 mg, 0.19 mmol) was 
stirred overnight, at which time the reaction was quenched with 
MeOH, and evaporated to dryness in vacuo. The dry mass was 
dissolved in EtOAc (20 mL), and washed with saturated sodium bicarbonate (15 mL) and 
dried over sodium sulfate. A flash silica column was prepared using 1% Et3N in hexanes 
that was washed with 5 column volumes of 1% MeOH in EtOAc prior to loading the 
mixture. A solvent combination of 1% MeOH in EtOAc that was increased to 3% MeOH 
in EtOAc was used to obtain 93 mg of product (68%). Rf (5% MeOH in DCM) = 0.4. 
1
H 
NMR (CDCl3): δ 8.29 (s, 1H), 7.86 (s, 1H), 7.38 (d, 2H, J = 8.6 Hz), 7.14-7.34 (m, 7H), 
6.78 (d, 4H, J = 8.6 Hz), 6.45 (t, 1H, J = 6.0 Hz), 5.48 (s, 1H), 4.64 (m, 1H), 4.15-4.55 
(m, 2H), 4.12 (m, 1H), 3.72-4.09 (m, 2H), 3.78 (s, 3H), 3.75 (s, 3H), 3.36 (m, 2H), 3.05 
(bd s, 1H), 2.68-2.85 (m, 3H), 2.44-2.59 (m, 3H), 2.21 (m, 2H), 2.15 (s, 3H). 
13
C NMR 
(CDCl3): δ 206.4, 172.3, 158.5, 153.0, 152.6, 149.8, 144.5, 137.2, 135.7, 130.0, 128.0, 
127.9, 126.9, 120.7, 113.1, 86.5, 85.8, 83.9, 72.6, 63.8, 55.2, 54.0, 53.1, 47.0, 45.8, 40.3, 
37.8, 30.7, 24.2, 29.8, 28.0. IR (neat): 3300 (bd), 2932, 2836, 1720, 1592, 1508, 1443 cm
-
1
. HRMS (ESI/APCI) m/z [M + H]
+
 calculated for C40H44N5O8 722.3184, found 
722.3188. 
Synthesis of 65b. A pyridine (3 mL) solution of DMT-Cl (108 mg, 0.26 mmol) and 
azeotropically dried (pyridine) 64b (131 mg, 0.23 mmol) was stirred overnight, at which 
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saturated ammonium chloride (2  50 mL), followed by washing with brine (50 mL). The 
aqueous layers were washed with EtOAc (50 mL) and the combined organic layers were 
dried over sodium sulfate. After evaporating the solvent in vacuo, the 
product mixture was dissolved in DCM containing a few drops of 
Et3N. A silica column packed with 1% Et3N in DCM was used for 
separation.  The crude product was purified by flash chromatography 
(60% EtOAc in DCM with a few drops of Et3N to 3% methanol with 
90% EtOAc in DCM with a few drops of Et3N) to yield the desired product as a faint 
yellow foam (125 g, 64%).  Rf (3% methanol and 90% EtOAc in DCM) = 0.3.
 1
H NMR 
(CDCl3): δ 8.30 (s, 1H), 7.88 (s, 1H), 7.72 (s, 1H), 7.41 (d, 2H, J = 5.2 Hz), 7.20-7.38 (m, 
7H), 7.01 (s, 1H), 6.81 (d, 4H, J = 12 Hz), 6.45 (t, 1H, J = 6.4 Hz), 5.58 (s, 2H), 5.45 (m, 
1H), 4.64 (m, 1H), 4.03-4.58 (m, 5H), 3.94 (s, 3H), 3.91 (s, 3H), 3.77 (s, 6H), 3.38 (m, 
2H), 2.76 (m, 1H), 2.51 (m, 1H), 2.31 (bd s, 3H). 
13
C NMR (CDCl3):  158.6, 154.3, 
153.9, 153.1, 152.8, 150.0, 148.5, 144.7, 139.8, 137.5, 135.8, 131.1, 130.1, 128.9, 128.2, 
128.0, 127.0, 126.6, 120.9, 113.3, 109.9, 108.3, 86.7, 85.9, 84.1, 72.8, 66.6, 63.9, 56.7, 
56.5, 55.3, 46.2, 40.4, 38.6, 32.1, 30.5, 29.8, 26.1, 23.9, 23.1, 14.3, 11.1, 8.9. IR (neat): 
3314 (bd), 2926, 2853, 1749, 1593, 1508, 1250, 1219, 1064, 909, 729 cm
-1
. HRMS 
(ESI/APCI) m/z [M + H]
+
 calculated for C45H47N6O12 863.3246, found 863.3236. 
Synthesis of 66a. DIPEA (85 mg, 0.66 mmol) was added to 65a (79.2 mg, 0.11 mmol) 
that was azeotropically dried with pyridine followed by 0.2 mL of freshly distilled DCM. 
The solution was cooled in an ice bath and 2-cyanoethyl N,N-
diisopropylchlorophosphoramidite (23 mg, 0.11 mmol) was added. After stirring the 
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with saturated sodium bicarbonate (15 mL), and then dried over sodium sulfate. After the 
organic layer was concentrated in vacuo, the compound was purified by flash 
chromatography (15  1.5 cm, packed using 0.5% Et3N in hexanes and then washed with 
5 column volumes of EtOAc) using EtOAc as eluent to isolate 66a (79.6 mg, 78%). Rf 
(100% EtOAc) = 0.5. 
1
H NMR (CDCl3): δ 8.31 (s, 1H), 7.90 (d , 1H, J = 7.7 Hz), 7.35-
7.46 (m, 2H), 7.13-7.32 (m, 7H), 6.72 (m, 4H), 6.44 (t, 1H, J = 
5.1 Hz), 5.47 (s, 1H), 4.70 (m, 1H), 4.28 (m, 1H), 3.84-4.57 (m, 
3H), 3.76 (s, 6H), 3.64 (m, 1H), 3.57 (m, 2H), 3.37 (m, 2H), 
3.29 (m, 2H), 2.79 (m, 1H), 2.73 (d, 1H, J = 6.4 Hz), 2.69 (d, 
1H, J = 6.4 Hz), 2.63 (m, 1H), 2.55 (m, 2H), 2.12 (m, 2H), 2.14 
(s, 3H), 1.07-1.19 (m, 12H). 
31
P NMR (CDCl3): 149.06, 148.95. IR (neat): 2960, 1720, 
1593, 1509, 1469, 1250, 1178, 1077 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 calculated 
for C49H60N7O9P 922.4263, found 922.4265.  
Synthesis of 66b. DIPEA (94 mg, 0.73 mmol) was added 
to 65b (118 mg, 0.13 mmol) that was azeotropically dried 
with pyridine, followed by 1.5 mL of freshly distilled 
DCM. The solution was cooled in an ice bath and 2-
cyanoethyl N,N-diisopropylchlorophosphoramidite (42.6 
mg, 0.11 mmol) was added. After stirring the reaction mixture for 1 h, the reaction 
mixture was diluted with EtOAc (30 mL), washed with saturated sodium bicarbonate (20 
mL), and then dried over sodium sulfate. After evaporating the solvent in vacuo, the 
product mixture was dissolved in 60% ethyl in hexanes. A silica column was packed with 
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hexanes. The above solution was loaded onto the column and separated (60% EtOAc in 
hexanes to 90% EtOAc in hexanes) to yield the desired product (108 mg, 75%). Rf (90% 
EtOAc in hexanes) = 0.6. 
1
H NMR (CDCl3): δ 8.31 (s, 1H), 7.92 (d, 1H, J = 6.2 Hz), 7.74 
(s, 1H), 7.39 (m, 2H, J = 11.2 Hz), 7.15-7.33 (m, 7H), 7.01 (s, 1H), 6.72-6.84 (m, 4H), 
6.45 (t, 1H, J = 8 Hz), 5.59 (s, 2H), 5.45 (bd s, 1H), 4.72 (m, 1H), 4.00-4.60 (m, 5H), 
3.95 (s, 3H), 3.92 (s, 3H), 3.77 (s, 6H), 3.26-3.71 (m, 5H), 2.82 (m, 1H), 2.75 (t, 1H, J = 
4 Hz), 2.52-2.67 (m, 2H), 2.44 (t, 1H, J = 4 Hz), 2.34 (bd s, 2H), 1.08-1.57 (m, 12H). 
31
P 
NMR (CDCl3): δ 148.9, 148.7. IR (neat): 2925, 2852, 1749, 1592, 1509, 1467, 1249, 
1065, 1033, 977, 793 cm
-1
. HRMS (ESI) m/z [M + H]
+
 calculated for C54H63N8O13P 
1063.0976, found 1085.3 (M+Na
+
).  
Synthesis of 109. A DMF (130 mL) solution of (2R,3S)-2-(hydroxymethyl)-3-
hydroxypyrrolidine hydrochloride
137
 (108, 2.02 g, 13.1 mmol) and Cs2CO3 (17.1 g, 52.6 
mmol) were stirred at room temperatures for 30 min, at which time 9 (9.4 g, 15.7 mmol) 
was added. The reaction was stirred overnight at room 
temperature followed by dilution with 400 mL EtOAc. The 
diluted contents were washed with saturated sodium bicarbonate 
(300 ml), followed by washing with brine (2  200 mL). The 
combined aqueous layers were washed with EtOAc (200 mL) 
and the combined organic layers were dried over sodium sulfate. After evaporating the 
solvent in vacuo, the product mixture was dissolved in DCM. It was purified by flash 
chromatography (30-80% EtOAc in DCM to 3% methanol and 7% DCM in EtOAc) to 
yield the desired product as a white solid (3.54 g, 46%). Rf (90% EtOAc in DCM) = 0.2. 
1
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4.02-4.43 (m, 3H), 3.99 (dd, 1H, J = 4, 7.1 Hz), 3.85 (dd, 1H, J = 4.8, 11.9 Hz), 3.61-3.80 
(m, 3H), 2.51-2.74 (m, 2H), 2.41 (m, 1H), 2.01-2.26 (m, 2H), 1.87 (bd s, 1H), 0.89 (s, 
18H), 0.08 (s, 6H), 0.06 (s, 6H). 
13
C NMR (CDCl3): δ 154.0, 152.5, 150.1, 137.8, 120.6, 
88.0, 84.4, 84.4, 73.9, 72.1, 70.5, 65.5, 62.9, 41.3, 26.8, 26.2, 25.99, 25.97, 18.6, 18.2, -
4.4, -4.5, -5.1, -5.2. IR (neat): 3331 (bd), 2950, 2929, 2857, 1591, 1471, 1254, 1099, 
1071, 836, 778 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 C27H50N5O5Si2 calculated for 
580.3345, found 580.3335.  
Synthesis of DMT-protected 109. After azeotropically drying 
with pyridine, 109 (1.01 g, 1.7 mmol) was dissolved in a 
mixture of DMT-Cl (859.6 mg, 2.09 mmol) and, 
dimethylaminopyridine (43 mg, 0.348) mmol) in pyridine (20 
mL) at 0C. The reaction mixture was allowed to slowly warm 
to room temperatures and then stirred overnight, at which time it was diluted with 150 
mL of EtOAc. The diluted contents were washed with saturated ammonium chloride (2  
200 mL) and then with brine (100 mL). The combined aqueous layers were washed once 
with EtOAc (100 mL) and the combined organic layers were dried with sodium sulfate. 
After evaporating the solvent in vacuo, the product mixture was dissolved in DCM 
containing a few drops of Et3N. A flash chromatography on a column packed with 1% 
Et3N in DCM (30% EtOAc in DCM to 70% EtOAc in DCM, along with a few drops of 
Et3N) yielded the desired product as a faint yellow foam (1.19 g, 72%). Rf (30% EtOAc 
in DCM) = 0.2. 
1
H NMR (CDCl3): δ 8.29 (s, 1H), 7.93 (s, 1H), 7.38 (d, 2H, J = 8.2 Hz), 
7.10-7.29 (m, 7H), 6.70 (m, 4H), 6.43 (t, 1H, J = 6.8 Hz), 4.59 (m, 2H), 4.05-4.21 (m, 
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(dd, 1H, J = 3.6, 9.2 Hz), 3.27 (dd, 1H, J = 9.2, 6.8 Hz), 2.59 (td, 1H, J = 7.2, 12.4 Hz), 
2.39 (m, 1H), 2.33 (m, 1H), 2.00 (bd s, 1H), 1.75 (bd s, 1H), 0.92 (s, 9H), 0.90 (s, 9H), 
0.11 (s, 6H), 0.08 (s, 3H), 0.07 (s, 3H). 
13
C NMR (CDCl3): δ 158.35, 158.33, 153.2, 
152.4, 144.8, 137.1, 136.7, 136.2, 136.0, 130.0, 129.9, 128.2, 127.6, 126.6, 120.6, 112.96, 
112.92, 87.7, 86.4, 84.1, 77.2, 74.5, 72.1, 67.0, 62.9, 60.3, 55.1, 46.9, 41.0, 32.3, 25.9, 
25.7, 18.4, 18.0, -4.67, -4.79, -5.3, -5.4. IR (neat): 3301 (bd), 3034, 2952, 2856, 1737, 
1589, 1508, 1469, 1250, 1093, 1033, 834, 779 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 
calculated for C48H68N5O7Si2 882.4652, found 882.4635. 
Synthesis of 110. 1-Ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (1.15 g, 6 mmol) and DMAP 
(655 mg, 5.26 mmol) in  DMF (10 mL) were added to DMT 
protected 109 (715 mg, 0.75 mmol). After stirring for 10 min 
at room temperature, levulinic acid (608 mg, 533 µL, 5.25 
mmol) was added to the reaction mixture. The reaction mixture was stirred for 2 h 
followed by dilution with 70 mL EtOAc. The solution was washed with saturated sodium 
bicarbonate (1 × 70 mL) and then with brine (2  50 mL). The combined aqueous layers 
were washed once with EtOAc (50 mL) and the combined organic layers were dried with 
sodium sulfate. After evaporating the solvent in vacuo, the product mixture was dissolved 
in DCM containing a few drops of Et3N. It was purified by flash chromatography (10% 
EtOAc in DCM with few drops of Et3N to 35% EtOAc in DCM with a few of drops of 
Et3N) to yield the desired product as a white foam (714 mg, 89%).  Rf (30% EtOAc in 
DCM) = 0.4. 
1
H NMR (CDCl3) at 39C: δ 8.27 (bd s, 1H), 7.91 (bd s, 1H), 7.15-7.26 (m, 
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1H), 4.13 (m, 1H), 4.02 (m, 2H), 3.82 (m, 1H), 3.79 (m, 1H), 3.75 (s, 3H), 3.74 (s, 3H), 
3.57 (m, 2H), 2.60-2.78 (m, 3H), 2.47-2.59 (m, 3H), 2.43 (m, 1H), 2.13 (m, 4H), 0.94 (s, 
9H), 0.91 (s, 9H), 0.11 (s, 6H), 0.08 (s, 6H). 
13
C NMR (CDCl3) at 39C: δ 206.3, 172.3, 
158.67, 158.64, 153.4, 152.7, 150.7, 145.1, 137.4, 136.4, 136.2, 130.29, 130.20, 128.4, 
127.8, 126.8, 121.2, 113.2, 113.2, 88.0, 86.9, 84.3, 77.2, 72.5, 64.6, 63.2, 55.3, 41.2, 38.1, 
29.9, 28.5, 26.3, 26.0, 18.6, 18.2, -4.4, -4.5, -5.1, -5.2. IR (neat): 2961, 2929, 2856, 1725, 
1720, 1588, 1509, 1468, 1251, 1177, 1088, 1033, 835 cm
-1
. HRMS (ESI/APCI) m/z [M + 
H]
+
 calculated for C53H74N5O9Si2 980.5020, found 980.5028. 
Synthesis of DMT deprotected 110. Acetic acid, water and 
tetrahydrofuran (3:1:1, 50 mL) were added to 110 (715 mg, 0.67 
mmol). After stirring for 22 min at room temperature, methanol 
(2 mL) was added and the solution was stirred for an additional 
8 min, at which time 300 mL of EtOAc was added. The solution 
was washed with water (3  100 mL). The combined aqueous layers were washed with 
fresh EtOAc (200 mL). The combined organic layers were carefully washed with 
saturated sodium bicarbonate (400 mL) and then dried over sodium sulfate. After 
evaporating the solvent in vacuo, the product mixture was dissolved in 30% EtOAc in 
hexanes and purified by flash chromatography (50% EtOAc in hexanes to 80% EtOAc in 
hexanes) to yield the desired product as a white foam (403 mg, 89%). Rf (70% EtOAc in 
hexanes) = 0.3. 
1
H NMR (CDCl3): δ 8.32 (s, 1H), 8.06 (s, 1H), 6.44 (t, 1H, J = 6.8 Hz), 
5.22 (bd s, 1H), 4.75 (bd s, 1H), 4.60 (td, 1H, J = 5.2, 3.2 Hz), 4.23 (m, 2H), 3.99 (dt, 1H, 
J = 3.2, 7.1 Hz), 3.93 (m, 1H), 3.84 (dd, 1H, J = 4.3, 10.6 Hz), 3.75 (dd, 1H, J = 3.1, 10.6 
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(m, 2H), 2.42 (m, 1H), 2.14-2.39 (m, 3H), 2.12 (s, 3H), 0.92 (s, 18H), 0.10 (s, 6H), 0.08 
(s, 6H). 
13
C NMR (CDCl3): δ 206.7, 206.2, 172.1, 153.7, 152.3, 150.1, 137.8, 87.8, 84.7, 
77.2, 71.9, 67.0, 65.3, 62.7, 41.1, 37.7, 30.85, 30.81, 29.79, 29.73, 29.6, 28.0, 25.9, 25.7, 
18.3, 17.9, -4.6, -4.8, -5.4, -5.5. IR (neat): 3363 (bd), 2953, 2928, 2856, 1719, 1589, 
1470, 1253, 1157, 1110, 1071, 1029, 836, 778 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 
calculated for C32H56N5O7Si2 678.3726, found 678.3729. 
Synthesis of 111a. Nitroveratryloxycarbonyl chloroformate
164
 (326 mg, 1.18 mmol), 
DMAP (277 mg, 2.23 mmol), and DCM (6 mL) were added to azeotropically dried 
(pyridine) DMT deprotected 110 (310 mg, 0.447 mmol). After stirring at room 
temperature for 2 h, the reaction mixture was diluted with 100 mL DCM. The diluted 
solution was washed with sodium bicarbonate (50 mL) and brine (50 mL). The aqueous 
layers were washed with DCM (50 mL). The combined organic layers were dried over 
sodium sulfate. After evaporating the solvent in vacuo, the crude was dissolved in 30% 
EtOAc in hexanes and purified by flash chromatography (30-
70% EtOAc in hexanes) to yield the desired product as a 
yellowish foam (349 mg, 83%).  Rf (50% EtOAc in hexanes) = 
0.3. 
1
H NMR (CDCl3): δ 8.35 (s, 1H), 8.01 (s, 1H), 7.71 (s, 
1H), 7.02 (s, 1H), 6.43 (t, 1H, J = 8 Hz), 5.55 (s, 2H), 5.42 (bd 
s, 1H), 4.59 (m, 1H), 4.55 (m, 2H), 4.17 (m, 1H), 3.98 (m, 2H), 3.89-3.97 (m, 7H), 3.81 
(dd, 1H, J = 4.4, 11.2 Hz), 3.74 (dd, 1H, J = 4.3, 11.2 Hz), 2.70 (m, 2H), 2.63 (m, 1H), 
2.53 (m, 2H), 2.41 (m, 2H), 2.18 (m, 1H), 2.12 (s, 3H), 0.90 (s, 9H), 0.89 (s, 9H), 0.09 (s, 
6H), 0.07 (s, 3H), 0.06 (s, 3H). 
13
C NMR (CDCl3): δ 206.2, 172.0, 154.4, 153.7, 153.0, 
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62.8, 56.4, 56.3, 47.3, 40.9, 37.7, 29.9, 29.6, 29.6, 28.0, 25.9, 25.7, 18.3, 17.9, 18.3, 17.9, 
15.3,  -4.7, -4.8, -5.4, -5.5. IR (neat): 2953, 2928, 2856, 1738, 1587, 1524, 1466, 1278, 
1253, 1221, 1065, 837, 780 cm-
1
. HRMS (ESI/APCI) m/z [M + H]
+
 calculated for 
C43H68N6O13Si2 917.4143, found 917.4128. 
Synthesis of 111b. Allyl chloroformate (107 μL, 1 mmol), DMAP (372 mg, 3 mmol), 
and DCM (8 mL) were added to azeotropically dried (pyridine) DMT deprotected 110 
(403mg, 0.59 mmol). After stirring at room 
temperature for 2 h, the reaction mixture was 
diluted with 100 mL DCM. The diluted 
solution was washed with sodium bicarbonate 
(40 mL) and brine (40 mL). The aqueous 
layers were washed with DCM (30 mL). The 
combined organic layers were dried over sodium sulfate. After evaporating the solvent in 
vacuo, the crude was dissolved in DCM and purified by flash chromatography (20% 
EtOAc in DCM) to yield the desired product (354 mg, 77%).  Rf (50% EtOAc in DCM) = 
0.3. 
1
H NMR (CDCl3) δ 8.36 (s, 1H), 8.02 (s, 1H), 6.45 (t, J = 6.5 Hz, 1H), 5.90 (ddt, J = 
16.4, 11.0, 5.8 Hz, 1H), 5.46 – 5.15 (m, 3H), 4.55 (dd, J = 21.9, 4.5 Hz, 5H), 4.00 (q, J = 
3.7 Hz, 2H), 3.79 (ddd, J = 23.5, 11.1, 3.9 Hz, 3H), 2.84 – 2.29 (m, 8H), 2.26 – 2.07 (m, 
4H), 0.96 – 0.80 (m, 18H), 0.21 (m, 12H). ESI (TOF) m/z [M+H
+
] calculated for 
C36H59N5O9Si2 762.0, found 762.1. 
Synthesis of 112a. A solution of triethylamine trihydrofluoride (291 mg, 293 L, 1.8 
mmol) and 111a (339 mg, 0.36 mmol) in THF (4 mL) were stirred overnight at room 
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dichloromethane and purified by flash chromatography (2-4% methanol in DCM) to yield 
the desired product as a white foam (271 mg, 93%). Rf (4% methanol in DCM) = 0.15. 
1
H 
NMR (CDCl3): δ 8.31 (s, 1H), 7.78 (s, 1H), 7.70 (s, 1H), 7.01 
(s, 1H), 6.62 (d, 1H, J = 12 Hz), 6.30 (dd, 1H, J = 6, 8.8 Hz), 
5.54 (s, 2H), 5.42 (m, 1H), 4.65-4.86 (m, 2H), 4.55 (m, 2H), 
4.19 (s, 1H), 3.86-4.01 (m, 9H), 3.76 (m, 1H), 3.10 (m, 1H), 
2.72 (m, 2H), 2.37-2.59 (m, 3H), 2.17-2.33 (m, 3H), 2.13 (s, 
3H).
  13
C NMR (CDCl3): δ 206.3, 172.1, 154.4, 153.6, 153.4, 151.8, 149.3, 148.3, 139.6, 
139.4, 129.4, 126.4, 110.0, 108.2, 89.6, 87.7, 77.6, 73.5, 66.5, 63.5, 63.2, 56.4, 56.3, 53.3, 
40.4, 37.7, 29.7, 29.6, 27.9. IR (neat): 3341 (bd), 2927, 1717, 1588, 1523, 1468, 1330, 
1277, 1220, 1158, 1096, 1065 cm
-1
. HRMS (ESI/APCI) m/z [M + H]
+
 calculated for 
C31H40N6O13 689.2413, found 689.2445. 
Synthesis of 112b. A solution of triethylamine 
trihydrofluoride (367 μL, 2.26 mmol) and 111b (354 mg, 
0.46 mmol) in THF (4 mL) were stirred overnight at room 
temperature. After evaporating the solvent in vacuo the 
residue was dissolved in dichloromethane and purified by 
flash chromatography (90% ethyl acetate in DCM to remove 112b, then 5% methanol 
and 4% DCM in ethyl acetate to elute 112b) to yield the desired product (215 mg, 87%). 
Rf (5% methanol and 4% DCM in ethyl acetate) = 0.2. 
1
H NMR (CDCl3): δ 8.29 (d, J = 
6.2 Hz, 1H), 7.79 (s, 1H), 6.70 (d, J = 11.0 Hz, 1H), 6.30 (dd, J = 9.5, 5.5 Hz, 1H), 5.88 
(ddt, J = 16.4, 10.4, 5.9 Hz, 1H), 5.39 (broad s, 1H), 5.35 – 5.20 (m, 2H), 4.77 (d, J = 5.0 
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1H), 4.19 (s, 1H), 4.00 – 3.83 (m, 2H), 3.77 (t, J = 11.4 Hz, 1H), 3.10 (ddd, J = 14.1, 9.5, 
5.0 Hz, 1H), 2.80 – 2.38 (m, 6H), 2.27 (dd, J = 13.4, 5.4 Hz, 1H), 2.17 (broad s, 1H), 
2.13 (s, 3H), 1.83 (s, 1H). 
13
C NMR (CDCl3) δ 206.5, 172.3, 154.8, 153.6, 151.9, 139.5, 
131.5, 119.3, 89.8, 87.8, 73.6, 68.8, 63.7, 63.5, 60.5, 40.7, 37.9, 29.8, 28.2, 21.1, 14.3. IR 
(neat): 3367 (broad), 2925, 1737, 1776, 1587, 1469, 1236, 1157, 1095, 941, 728, 646. 
ESI (TOF) m/z [M+H
+
] calculated for C24H31N5O9 533.5, found 534.1. 
.Synthesis of DMT protected 112a. DMT-Cl (130 mg, 
0.32 mmol), dimethylaminopyridine (1 mg, 0.01 mmol) 
and pyridine (4 mL) were added to azeotropically dried 
(pyridine) 112a (186 mg, 0.26 mmol) at 0 °C. The reaction 
mixture was allowed to slowly warm to room temperature and stir overnight, at which 
time it was diluted with 50 mL of ethyl acetate. The solution was washed with saturated 
ammonium chloride (2  50 mL), followed by washing with brine (50 mL). The 
combined aqueous layers were washed with ethyl acetate (50 mL) and the combined 
organic layers were dried with sodium sulfate. After evaporating the solvent in vacuo, the 
crude mixture was dissolved in dichloromethane containing a few drops of Et3N. The 
product was purified by flash chromatography (20-60% ethyl acetate in dichloromethane 
to 3% methanol in ethyl acetate, with a few drops of Et3N) using a column packed with 
1% Et3N in DCM. The desired product was isolated as a faint yellow foam (182 mg, 
64%). Rf (5% methanol in DCM) = 0.4.
 1
H NMR (CDCl3): δ 8.30 (s, 1H), 7.88 (s, 1H), 
7.71 (s, 1H), 7.39 (d, 2H, J = 7.8 Hz), 7.19-7.33 (m, 7H), 7.03 (s, 1H), 6.79 (d, 4H, J = 9 
Hz), 6.44 (t, 1H, J = 5.2 Hz), 5.55 (s, 2H), 5.43 (bd s, 1H), 4.63 (bd s, 1H), 4.25-4.82 (m, 
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10.8 Hz), 3.38 (dd, 1H, J = 5.4, 10.8 Hz), 2.67-2.80 (m, 3H), 2.36-2.53 (m, 3H), 2.23 (m, 
1H), 2.12 (s, 3H). 
13
C NMR (CDCl3): δ 206.2, 172.1, 158.5, 154.4, 153.7, 153.1, 152.5, 
150.2, 148.3, 144.5, 139.6, 137.7, 135.7, 130.0, 128.0, 127.8, 126.9, 126.5, 120.8, 113.2, 
109.9, 108.2, 86.6, 85.7, 83.9, 80.2, 77.7, 72.7, 66.4, 63.8, 63.1, 60.5, 56.5, 56.4, 55.2, 
47.5, 40.1, 37.7, 30.6, 29.7, 28.0, 26.1. IR (neat): 2982-2939 (bd), 1734, 1587, 1509, 
1372, 1236, 1176, 1157, 1043, 1064 cm
-1





) 991.3720, found 991.3726. 
Synthesis of DMT protected 112b. DMT-Cl (206 mg, 0.49 mmol), 
dimethylaminopyridine (DMAP, 2 mg) and pyridine 
(4.5 mL) were added to azeotropically dried (pyridine) 
112a (212 mg, 0.40 mmol) at 0 °C. The reaction mixture 
was allowed to slowly warm to room temperature and 
stir overnight. The solvent was removed in vacuo and 
the residue was redissolved in DCM containing a few drops of Et3N. The product was 
purified by flash chromatography (70% ethyl acetate in dichloromethane to 2% methanol 
and 8% DCM in ethyl acetate, with a few drops of Et3N) using a column packed with 1% 
Et3N in DCM. The desired product was isolated as a faint yellow foam (236 mg, 71%). Rf 
(2% methanol and 8% DCM in ethyl acetate) = 0.5.
 1
H NMR (CDCl3) δ δ 8.30 (s, 1H), 
7.87 (d, J = 3.3 Hz, 1H), 7.44 – 7.36 (m, 2H), 7.36 – 7.13 (m, 9H), 6.88 – 6.73 (m, 4H), 
6.43 (t, J = 6.5 Hz, 1H), 5.89 (ddt, J = 16.4, 10.3, 5.8 Hz, 1H), 5.41 (s, 1H), 5.37 – 5.19 
(m, 2H), 4.70 – 4.61 (m, 1H), 4.61 – 4.43 (m, 4H), 4.11 – 3.98 (m, 1H), 3.78 (s, 7H), 3.40 
(qd, J = 10.1, 5.1 Hz, 2H), 2.81 – 2.60 (m, 3H), 2.60 – 2.37 (m, 4H), 2.19 (d, J = 23.2 Hz, 
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1177, 1033, 953, 829, 728, 703, 648, 583 cm
-1
.ESI (TOF) m/z [M+H
+
] calculated for 
C45H49N5O11 835.87, found 858.3 [M+Na
+
]. 
Synthesis of 113a. DMT protected 112a (110 mg, 0.11 mmol) was azeotropically dried 
with pyridine. 2-Cyanoethyl-N,N-diisopropylchlorophosphoramidite (42.2 mg, 44 L, 
0.19 mmol), diisopropylethylamine (120 mg, 161 L, 0.9 
mmol) and dichloromethane (3 mL) were added and the 
reaction mixture was stirred for 45 min at room 
temperature, at which time it was diluted with 60 mL of 
ethyl acetate. The solution was washed with saturated 
sodium bicarbonate (25 mL), followed by brine (25 mL), 
and then dried with sodium sulfate. After evaporating the solvent in vacuo, the mixture 
was dissolved in 60% ethyl acetate in hexanes and purified (60-90% ethyl acetate in 
hexanes) on a silica column packed with 1% Et3N in hexanes, and washed with 3 column 
volumes of 60% ethyl acetate in hexanes. The yield of the desired product was 101.1 mg 
(78%). Rf (90% EtOAc in hexanes) = 0.6. 
1
H NMR (CDCl3): δ 8.31 (s, 1H), 7.91 (d, 1H, 
J = 7.1 Hz), 7.72 (s, 1H), 7.40 (m, 2H), 7.15-7.34 (m, 7H), 7.04 (s, 1H), 6.79 (m, 4H), 
6.44 (t, 1H, J = 6.4 Hz), 5.55 (s, 2H), 5.42 (bd s, 1H), 4.57-4.71 (m, 4H), 4.29 (m, 1H), 
3.94 (m, 7H), 3.77 (s, 6H), 3.58 (m, 2H), 3.38 (m, 3H), 3.29 (m, 3H), 2.63-2.84 (m, 4H), 
2.36-2.63 (m, 4H), 2.21 (bd s, 1H), 2.11 (s, 3H), 1.05-1.20 (m, 12H). 
31
P NMR (CDCl3): 
δ 148.7, 148.5. IR (neat): 2965, 2932, 1736, 1586, 1623, 1508, 1465, 1364, 1329, 1278, 
1246, 1221, 1178, 1156, 1065, 1032, 975, 823, 793, 727 cm
-1
. HRMS (ESI) m/z [M + H]
+
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Synthesis of 113b. DMT protected 112b (235 mg, 0.28 
mmol) was azeotropically dried with pyridine. 2-
Cyanoethyl-N,N-diisopropylchlorophosphoramidite 
(42.2 mg, 0.19 mmol), diisopropylethylamine (261 L, 
1.8 mmol) and dichloromethane (3 mL) were added and 
the reaction mixture was stirred for 45 min at room 
temperature, at which time it was diluted with 60 mL of ethyl acetate. The solution was 
washed with saturated sodium bicarbonate (40 mL), followed by brine (40 mL), and then 
dried with sodium sulfate. After evaporating the solvent in vacuo, the mixture was 
dissolved in 60% ethyl acetate in hexanes and purified (60-90% ethyl acetate in hexanes) 
on a silica column packed with 1% Et3N in hexanes, and washed with 3 column volumes 
of 60% ethyl acetate in hexanes. The yield of the desired product was 203.1 mg (70%). Rf 
(90% EtOAc in hexanes) = 0.8. 
1
H NMR δ 8.31 (s, 1H), 7.92 (d, J = 10.2 Hz, 1H), 7.40 
(dd, J = 7.6, 3.3 Hz, 2H), 7.23 – 7.25 (m, 9H), 6.79 (dd, J = 8.6, 5.4 Hz, 4H), 6.45 (d, J = 
4.9 Hz, 1H), 5.89 (m, 1H), 5.39 (s, 1H), 5.29 (m, 2H), 4.83 – 4.64 (m, 2H), 4.64 – 4.40 
(m, 5H), 4.27 (dd, J = 6.1, 3.3 Hz, 1H), 3.72 – 3.78 (m, 9H), 3.66 – 3.41 (m, 4H), 3.44 – 
3.27 (m, 2H), 2.87 – 2.44 (m, 10H), 2.17 (s, 2H), 2.13 (s, 3H), 1.42 – 1.16 (m, 12H). 
31
P 
NMR (CDCl3) δ 148.7, 148.6. IR (neat) 2965, 2929, 1743, 1719, 1623, 1587, 1508, 1466, 
1248, 1177, 908, 726, 647 cm
-1
. ESI (TOF) m/z [M+H
+
] calculated for C54H66N7O12P 
1036.1, found 1058.5 [M+Na
+
]. 
General Procedure for Synthesis of Template Strand Containing 67, 103, and 
136. Native nucleotides were coupled using standard synthesis cycles (25 s coupling, 5 s 
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detritylation with 3% TCA in DCM) for all oligonucleotides except for the 127 and 128, 
where double coupling was utilized. Oligonucleotides 77, 79, 82, 83, 84, 127 and 128 
were prepared on 1000 Å resin. All other oligonucleotides were synthesized using 500 Å 
resin. Modified phosphoramidites 66a, and b were coupled using automated double 
coupling cycles (15 min coupling time) while 113a and b were coupled manually, as 
described below. The synthesizer was programmed to pause when it reached the point 
where the manual coupling was utilized.  
General Procedure for Manual Coupling. Phosphoramidite 113a (13 mg, 11 
mol) or 113b (15 mg, 15 mol) was dissolved in 300 L activator solution (5-ethylthio-
1H-tetrazole in acetonitrile, 0.25 M). The solution was repeatedly passed through a 
column for 10 min containing the partially synthesized oligonucleotide on CPG resin that 
was fitted with two 1 mL plastic syringes. The resin was washed with dry acetonitrile (5 
mL) and dried under vacuum for 10 min. For manual double coupling, this procedure was 
repeated using a fresh solution of phosphoramidite and activator prior to carrying out the 
remaining solid phase synthesis steps on the automated synthesizer.  
General Procedure for Trityl Quantification. The trityl output collected from 
the DNA synthesis was diluted in a volumetric flask using 0.1 M pTsOH in acetonitrile. 
The synthetic yield of the corresponding step was calculated based on the absorbance of 
trityl cation measured at 495 nm (ε495 = 70000).  
General Procedure for Photolysis of Resin Containing 67 (ONV protected) 
and 103. Photolysis of the resin was carried out in 6-8 mg portions in toluene for 2 h in a 
Pyrex tube using a Schoeffel 1000 W short-arc lamp (model LH151N/2, intensity 9 




 at 350 nm) fitted with an optical filter (Newport # CGA-375). The resin was 
stirred using a pipe cleaner (to prevent crushing the resin) during the photolysis. After the 
photolysis, the resin was washed sequentially with hexanes (3  3mL), DCM (3  3 mL), 
and methanol (10  3 mL) within the Pyrex tube. After drying on a rotovap, the resin was 
transferred to a DNA synthesis column and dried under vacuum before any further 
synthetic modification. Methanol wash and drying in the previous step was repeated until 
complete recovery of resin was achieved.  
General Procedure for Delevulinylation of Levulinyl Protected 67 and 105. A 
solution of 0.25 M hydrazine in pyridine/acetic acid (3:2) was passed back and forth 
through the resin in a DNA synthesis column as described above for the manual coupling 
procedure, for 10 min (for ≤ 25 nucleotide long) or 25 min (for longer substrates). For 
longer treatment times, fresh hydrazine solution was used every 6 min. At the end of the 
treatment, the resin was washed sequentially with methanol (5  10 mL) and acetonitrile 
(5  10 mL) and then dried under vacuum before continuing the oligonucleotide 
synthesis.   
General Procedure for ALLOC Removal from 136. ALLOC removal of the 
resin was carried out in 6-8 mg portions of resin in a Pyrex vial fitted with a pipe cleaner. 
After adding Et2NH•BH3 (14 μM) in DCM (0.5 mL) and stirring for 5 min (room 
temperature), Pd(PPh3)4 (0.2 μM) in DCM (0.5 mL) was added. After stirring for 10 min 
(room temperature), the resin as allowed to settle and the supernatant was removed. The 
resin was resuspended and washed with DCM (4  1 mL). After the DCM was removed 
as a supernatant, the resin was treated with Et2NH•BH3 and Pd(PPh3)4 as described 
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above. Following the removal of Et2NH.BH3 and Pd(PPh3)4 and DCM wash (4  1 mL), 
the resin was dried on a rotavap and transferred to a DNA synthesis column. The resin 
was then fitted with a glass luer lock syringe and successively washed with 0.2% 
trifluoroacetic acid in DCM (15  1 mL), DCM (15  1 mL), 5% DIPEA in DCM (15  1 
mL), DCM (15  1 mL). In the modified washing procedure, this was followed by 
acetonitrile (10  1 mL) and methanol (10  1 mL) wash using a luer lock syringe. The 
resin in the DNA synthesis column was then dried under vacuum before any continuing 
solid phase synthesis.  
Table 13. Solvent conditions for HPLC chromatogram for purification of 79 containing DOB ICL 
mimic 3 
Time Flow %A (50 mM TEAA) %B (ACN) 
0.00 4.00 95.0 5.0 
5.00 4.00 92.0 8.0 
50.00 4.00 87.0 13.0 
55.00 4.00 80.0 20.0 
60.00 4.00 60.0 40.0 
65.00 4.00 20.0 80.0 
70.00 4.00 95.0 5.0 
81.00 4.00 95.0 5.0 
81.10 4.00 95.0 5.0 
82.10 4.00 95.0 5.0 
 
HPLC Purification of 79. Upon completion of solid phase synthesis (under 
“trityl on” mode for the final coupling), the oligonucleotide was deprotection and cleaved 
from the resin by ammonolysis (65 °C, overnight). After removal of ammonia and water, 
the crude oligonucleotide mixture was resuspended in 50 mM TEAA (100 μL), filtered 
(Whatman nylon membrane syringe filter, 0.22 μm)  and subjected to HPLC analysis on a 
RP-C18 HPLC column with monitoring carried out at 260 nm. The peaks were analyzed 
using the following gradient conditions (Table 13). The relevant peak of interest was 
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collected from the LC, lyophilized to dryness, detritylated, and analyzed by MALDI-TOF 
MS. 
LC/MS Characterization of Synthesized Cross-links. Cross-links (25 μM) 
were dissolved in H2O and filtered (Whatman nylon membrane syringe filter, 0.22 μm) 
prior to analysis. The injection volume was 5 – 10 μL. An orthogonal ESI-Q-TOF mass 
spectrometer (Xevo-G2, Waters) was connected in-line with an ACQUITY H-class 
UPLC. Mass spectra were acquired in negative ion mode using an ESI-MS capillary 
voltage of 2.5 kV, a sample cone voltage of 35 V and an extraction cone voltage of 4 V 
The cone gas flow was set up to 0 L/h and desolvation gas flow was 400 L/h. Desolvation 
temperature and source temperature were set to 350 and 120 °C, respectively. The 
acquisition range as m/z 500 – 3500. The LC/MS system was operated by Mass Lynx 
software. Raw summed spectra were deconvoluted using the MaxEnt1 algorithm.  
Table 14. Solvent conditions for LC/MS characterization of synthesized cross-links. 
Time (min) % A (15 mM TEA, 200 mM HFIP) %B (50% MeOH, 50% mobile 
phase A) 
0.0 90 10 
2.0 90 10 
30.0 55 45 
31.0 10 90 
33.0 10 90 
33.1 90 10 
 
LC was performed using a linear gradient containing mobile phase A (15 mM 
TEA, 200 mM HFIP) to mobile phase B (50% MeOH, 50% mobile phase A) on a 
ACQUITY UPLC®BEH C18 column (17 μM, 21  50 mm) using the following linear 
gradient (Table 14). The built in column heater of the UPLC system was set to 60 °C and 
mobile phase flow rate was 0.2 mL/min. 
 196  
 
3'-d(CCG TGT ATV ATA TGC GCP)

















5'-d(GCT GAT CGC GGC ACA TAW TAT ACG CGG ATC TGC ACG)
3'-d(CCG TGT ATV ATA TGC GCP)
164
5'-d(GAC ATG GTA CTG)
5'-d(PGCG ATC AGC CAG TAC CAT GTC)
5'-d(GCA TCG GTC GAG CGT GCA GAT C)









Figure 74. Oligonucleotides used for preparing 135, 148, and 170. 
General Procedure for Preparing 135. Scheme 45 describes the the general procedure 
for preparing 135 from 121 (Figure 74). Oligonucleotide 131 (80 pmol, Figure 74) was 
5'-
32
P-labeled in reaction (80 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 
7.6, 10 mM MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 50 μCi -
32
P-ATP, and 
30 U of T4 PNK at 37 °C for 1 h. Excess -32P-ATP was removed by passing the reaction 
through a 1 mL Sephadex G25 column. The specific activity was determined by counting 
the radioactivity (using a liquid scintillation counter) and measuring the concentration of 




). Separately, 121 (40 pmol, Figure 74) was 5'-
phosphorylated on the template strand in a 25 μL reaction containing 1  T4 PNK buffer, 
ATP (80 pmol), and 30 U of T4 PNK at 37 °C for 1 h. Both phosphorylation reactions 
were stopped by heating at 65 C for 30 min. The phosphorylated products were 
hybridized with 160 pmol each of 132, 133, and 134 (Figure 74) 
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in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly 
cooling from 90 C to 16 C. The reaction was incubated overnight at 16 C in presence 
of T4 DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
10 mM DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% formamide, 10 mM 
EDTA, pH 8.0) was added, followed by heating at 90 C for 5 min and cooling on ice 
prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was run 
under limiting power (55 W) for 18 h. The product band was excised from the gel, 
crushed, and the DNA was eluted overnight in 5 mL of elution buffer (0.2 M NaCl and 1 
mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to 
provide 5'-
32
P-b-135. The yield (10-20%) of 5'-
32
P-b-135 was determined based on the 
specific activity of 5'-
32
P-131.  
General Procedure for Preparing 5'-
32
P-b-170. Scheme 45 describes the 
general procedure for preparing 5'-
32
P-b-170 from 164. Oligonucleotide 131 (80 pmol, 
Figure 74) was 5'-
32
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TRIS-HCl pH 7.6, 10 mM MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 50 μCi -
32
P-ATP, and 30 U of T4 PNK at 37 °C for 1 h. Excess -32P-ATP was removed by 
passing the reaction through a 1 mL Sephadex G25 column. The specific activity was 
determined by counting the radioactivity (using a liquid scintillation counter) and 




). Separately, 164 (40 
pmol, Figure 74) was 5'-phosphorylated on the template strand in a 25 μL reaction 
containing 1  T4 PNK buffer, ATP (80 pmol), and 30 U of T4 PNK at 37 °C for 1 h. 
Both phosphorylation reactions were stopped by heating at 65 C for 30 min. The 
phosphorylated products were hybridized with 160 pmol each of 132, 133, and 134 
(Figure 74) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution 
by slowly cooling from 90 C to 16 C. The reaction was incubated overnight at 16 C in 
presence of T4 DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 
mM MgCl2, 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 C for 5 min 
and cooling on ice prior to purification by 20% denaturing PAGE (37  32  0.04 cm). 
The gel was run under limiting power (55 W) for 18 h. The product band was excised 
from the gel, crushed, and the DNA was eluted overnight in 5 mL of elution buffer (0.2 
M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak 
cartridge to provide 5'-
32
P-b-170. The yield (10-20%) of 5'-
32
P-b-170 was determined 
based on the specific activity of 5'-
32
P-131.  
General Procedure for Synthesis of 5'-
32
P-t-148. The preparation of 5'-
32
P-t-148 
is described in Scheme 46. Oligonucleotide 133 (80 pmol, Figure 74) was 5'-
32
P-labeled 
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in reaction (80 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 mM 
MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 50 μCi -
32
P-ATP, and 30 U of T4 
PNK at 37 C for 2 h. Excess -
32
P-ATP was removed by passing the reaction through a 1 
mL Sephadex G25 column. The specific activity was determined by counting the 
radioactivity (using a liquid scintillation counter) and measuring the concentration of 133 




). Separately, 121 (40 pmol, Figure 74) was 5'-
phosphorylated on the template (bottom) strand in a 25 μL  




reaction containing 1  T4 PNK buffer, ATP (80 pmol), and 30 U of T4 PNK at 37 C for 
1 h. Both phosphorylation reactions were stopped by heating at 65 C for 30 min. The 
phosphorylated products were hybridized with 160 pmol each of 134 and 175 (Figure 74) 
in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly 
cooling from 90 C to 16 C. The reaction was incubated overnight at 16 C in presence 
of T4 DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
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EDTA, pH 8.0) was added, followed by heating at 90 C for 5 min and cooling on ice 
prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was run 
under limiting power (55 W) for 18 h. The product band was excised from the gel, 
crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 
mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to 
provide 5'-
32
P-t-148. The yield (10-20%) of 5'-
32
P-t-148 was determined based on the 
specific activity of 5'-
32
P-133.  
Scheme 47. General Procedure for preparing internally labeled 148 
 
General Procedure for Synthesis of Internally 
32
P-labeled 148. The 
preparation of internally radiolabeled 148 is described in Scheme 47. Oligonucleotide 
175 (80 pmol, Figure 74) was 5'-
32
P-labeled in reaction (80 μL) containing 1  T4 PNK 
exchange buffer buffer (50 mM imidazole-HCl pH 6.4, 18 mM MgCl2, 5 mM DTT, 0.1 
mM spermidine, and 0.1 mM ADP), 6% PEG 8000 solution (w/v), 12 μM ATP, 50 μCi -
32
P-ATP, and 30 U of T4 PNK at 37 C for 2 h. Excess -
32
P-ATP was removed by 
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determined by counting the radioactivity (using a liquid scintillation counter) and 




). Separately, 121 (40 











5'-d(ATG AAC ATA CTC GTA CTC TGC ATT TCG XAG GCC - 
-CGC CAA CCT CCG CTC CAC GCC G)
3'-d(G TAA AGC TY)
82
5'-d(TAC ATA CTC GTA GTC TGC ATT ACG YAA AGC GTT - 






3'-d(ATG TAT GAG CAT CAG ACGP)
5'-d(PCAG AGT ACG AGT ATG TTC AT)
3'-d(TTC GCA ATC GCT AAT TGT AGC TCA G)
145




5'-d(GGA CTC GAT GTT AAT AGA CGC)
178




Figure 75. Oligonucleotides used to make 144 and 146. 
containing 1  T4 PNK buffer, ATP (80 pmol), and 30 U of T4 PNK at 37 C for 1 h. 
Both phosphorylation reactions were stopped by heating at 65 C for 30 min. The 
phosphorylated products were hybridized with 160 pmol each of 133 and 134 (Figure 74) 
in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly 
cooling from 90 C to 16 C. The reaction was incubated overnight at 16 C in presence 
of T4 DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
10 mM DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% formamide, 10 mM 
EDTA, pH 8.0) was added, followed by heating at 90 C for 5 min and cooling on ice 
prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was run 
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under limiting power (55 W) for 18 h. The product band was excised from the gel, 
crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 
mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to 
provide internally radiolabeled 148. The yield (10-20%) of internally 
32
P-labeled  148 
was determined based on the specific activity of 5'-
32
P-175.  
General Procedure for Synthesis of 3'-
32
P-b-144. The preparation of 3'-
32
P-b-
144 is described in Scheme 48. Oligonucleotide 176 (160 pmol, Figure 75) was 
hybridized with 79 (50 pmol) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium 
chloride solution (20 L) by slowly cooling from 90 C to 16 C. The reaction was 
incubated overnight at 16 C in presence of T4 DNA ligase (50 U) and 1  ligase buffer 
(50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). The ligation was 
stopped by heating at 65 C for 30 min. After addition of 178 (160 pmol, Figure 75) to 
the solution, it was hybridized with the cross-link by slowly cooling down from 90 C to 
16 C.  The cross-linked substrate was then 3'-
32
P-labeled in its bottom strand using a 
“fill in” reaction (150 μL) containing 1  NEB 2.0 buffer (50 mM NaCl, 10 mM TRIS-
hCl, 10 mM MgCl2, 1 mM DTT, pH 7.9), 30 μCi -
32
P-dCTP, and 30 U of klenow exo(-
) at 37 C for 3 h. The “fill in” reaction was stopped by heating at 75 C for 30 min. 
Excess -
32
P-dCTP was removed by passing the reaction through a 1 mL Sephadex G25 
column. The specific activity was determined by counting the radioactivity (using a 
liquid scintillation counter) and assuming hundred percent recovery of the radiolabeled 
cross-linked substrate. Formamide loading buffer (50 L, 90% formamide, 10 mM 
EDTA, pH 8.0) was added to the recovered substrate, followed by heating at 90 C for 5 
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min and cooling on ice prior to purification by 20% denaturing PAGE (37  32  0.04 
cm). The gel was run under limiting power (55 W) for 18 h. The product band was 
excised from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution 
buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-
18-Sep-Pak cartridge, concentrated and then hybridized with 145 (Figure 75) by slow 
cooling from 90 °C to 25 °C in 1  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 
mM NaCl)  to provide 3'-
32
P-b-144. The yield (10-20%) of 3'-
32
P-b-144 was determined 
based on the specific activity of 3'-
32
P-radiolabeled cross-link, assuming 100% recovery 
from Sephadex column.  




General Procedure for Synthesis of 5'-
32
P-t-144. The preparation of 5'-
32
P-t-
144 is described in Scheme 49. Oligonucleotide 79 (1.5 nmol, Figure 75) was hybridized 



































































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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chloride solution (50 L) by slowly cooling from 90 C to 16 C. The reaction was 
incubated overnight at 16 C in presence of T4 DNA ligase (50 U) and 1  ligase buffer 
(50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). Formamide loading 
buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) was added, followed by heating 
at 90 C for 5 min and cooling on ice prior to purification by 20% denaturing PAGE (37 
 32  0.1 cm). The gel was run under limiting power (45 W) for 14 h. The product band 
was detected using UV, excised from the gel, crushed, and the DNA was eluted overnight 
in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was 
concentrated by repeatedly mixing with 1-butane and then desalted by precipitation. The 
yield of ligation (22%) was determined from the concentration of isolated product (A260, 




 ). In a separate reaction 145 (20 pmol, Figure 75) was 5'-
32
P-
labeled in reaction (80 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 
mM MgCl2, 5 mM DTT), 50 μCi -
32
P-ATP, and 30 U of T4 PNK at 37 C for 2 h.  The 
5'-
32
P-145 was then hybridized with the ligated cross-link by slow cooling from 90 °C to 
25 °C in 1  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 mM NaCl) to obtain 5'-
32
P-t-144.  




General Procedure for Synthesis of 3'-
32
P-b-146. The preparation of 3'-
32
P-b-











































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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hybridized with 82 (50 pmol, Figure 75) in 10 mM sodium phosphate (pH 7.2) and 100 
mM sodium chloride solution (20 L) by slowly cooling from 90 C to 16 C. The 
reaction was incubated overnight at 16 C in presence of T4 DNA ligase (50 U) and 1  
ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). The  




ligation was stopped by heating at 65 C for 30 min. After addition of 179 (160 pmol, 
Figure 75) to the solution, it was hybridized with the cross-link by slowly cooling down 
from 90 C to 16 C.  The cross-linked substrate was then 3'-
32
P-labeled in its bottom 
strand using a “fill in” reaction (150 μL) containing 1  NEB 2.0 buffer (50 mM NaCl, 10 
mM TRIS-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9), 30 μCi -
32
P-dCTP, and 30 U of 
Klenow exo(-) at 37 C for 3 h. The “fill in” reaction was stopped by heating at 75 C for 
30 min. Excess -
32
P-dCTP was removed by passing the reaction through a 1 mL 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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radioactivity (using a liquid scintillation counter) and assuming hundred percent recovery 
of the radiolabeled cross-linked substrate. Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added to the recovered substrate, followed by 
heating at 90 C for 5 min and cooling on ice prior to purification by 20% denaturing 
PAGE (37  32  0.04 cm). The gel was run under limiting power (55 W) for 18 h. The 
product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 
mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using 
a 100 mg C-18-Sep-Pak cartridge, concentrated and then hybridized with 147 (Figure 75) 
by slow cooling from 90 °C to 25 °C in 1  PBS buffer (10 mM sodium phosphate, pH 
7.2, 100 mM NaCl) to provide 3'-
32
P-b-146. The yield (10-20%) of 3'-
32
P-b-146 was 
determined based on the specific activity of 3'-
32
P-radiolabeled cross-link, assuming 
100% recovery from the Sephadex column. 




General Procedure for Synthesis of 5'-
32
P-b-146. The preparation of 5'-
32
P-b-9 
is described in Scheme 51. Oligonucleotide 82 (50 pmol, Figure 75) was 5'-
32
P-labeled in 
reaction (80 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 mM 
MgCl2, 5 mM DTT), 50 μCi -
32
















































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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phosphorylation reaction was stopped by heating at 65 C for 30 min. Excess -
32
P-ATP 
was removed by passing the reaction through a 1 mL Sephadex G25 column. The specific 
activity was determined by counting the radioactivity (using a liquid scintillation counter) 







radiolabeled 82 were hybridized with 176 (160 pmol, Figure 75) in 10 mM sodium 
phosphate (pH 7.2) and 100 mM sodium chloride solution by slowly cooling from 90 C 
to 16 C. The reaction was incubated overnight at 16 C in presence of T4 DNA ligase 
(50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 
mM ATP). Formamide loading buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) 
was added, followed by heating at 90 C for 5 min and cooling on ice prior to purification 
by 20% denaturing PAGE (37  32  0.04 cm). The gel was run under limiting power (55 
W) for 18 h. The product band was excised from the gel, crushed, and the DNA was 
eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The 
supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, concentrated and then 
hybridized with 145 (Figure 75) by slow cooling from 90 °C to 25 °C in 1  PBS buffer 
(10 mM sodium phosphate, pH 7.2, 100 mM NaCl) to provide 5´-
32
P-b-146. The yield 
(10-20%) of 5´-
32
P-b-146 was determined based on the specific activity of 5´-
32
P-82.  










































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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General Procedure for Synthesis of 3'-
32
P-t-146. The preparation of 3'-
32
P-t-146 
is described in Scheme 52. Oligonucleotide 177 (80 pmol, Figure 75) was 3'-
32
P-labeled 
in reaction (80 μL) containing 1  TdT buffer buffer (50 mM KOAc, 20 mM TRIS-OAc, 
10 mM MgCl2, pH 7.9), 40 μCi -
32
P-cordycepin triphosphate, and 30 U of terminal 
deoxynucleotidyl transferase at 37 C for 2 h. The reaction was stopped by heating at 75 
C for 30 min. Excess -
32
P-cordycepin triphosphate was removed by passing the 
reaction through a 1 mL Sephadex G25 column. The specific activity was determined by 
counting the radioactivity (using a liquid scintillation counter) and measuring the 
concentration of 177 (A260). The 3'-
32
P-labeled 177 was hybridized with 82 (50 pmole, 
Figure 75) in 10 mM sodium phosphate (pH 7.2) and 100 mM sodium chloride solution 
(100 L) by slowly cooling from 90 C to 16 C. The reaction was incubated overnight at 
16 C in presence of T4 DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 
7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added, followed by heating at 90 C for 5 min 
and cooling on ice prior to purification by 20% denaturing PAGE (37  32  0.04 cm). 
The gel was run under limiting power (55 W) for 18 h. The product band was excised 
from the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 
M NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak 
cartridge, concentrated and then hybridized with 147 (Figure 75) by slow cooling from 90 
°C to 25 °C in 1  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 mM NaCl) to 
provide 3'-
32
P-t-146. The yield (10-20%) of 3'-
32
P-t-146 was determined based on the 
specific activity of 3'-
32
P-177.  













3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GAX AAG CGT TAG CCA TTA)
84
3
3'-d(  CT GAC GTA ATG CTY ) 
5'-d(AGA CTG CAT TAC GXA AAG CGT TAG CCA TTA)
77
Y
3'-d(TTC GCA ATC GGT AAT)
3'-d(GCA TAC ATC GGT AAT G)
3'-d(CGT26 AAT23 GCT Y19 ) 
5'-d(GCA3   TTA6   CGX9AAA12 GCG15 TTA18)
86
85
3'-d(CGT26 AAT23 GCT   Y19 ) 





Figure 76. Oligonucleotides used to make 155, 156, 160 and 161. 










P-b-156. Scheme 53 




P-b-156 from 77 and 84, respectively. 
Oligonucleotide 77 or 84 (50 pmol, Figure 76) was 5'-
32
P-labeled in reaction (80 μL) 
containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 mM MgCl2, 5 mM DTT), 
50 μCi -
32
P-ATP, and 30 U of T4 PNK at 37 C for 2 h.  The phosphorylation reaction 
was stopped by heating at 65 C for 30 min. Excess -
32
P-ATP was removed by passing 











































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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Sephadex G25 column. The specific activity was determined by counting the 
radioactivity (using a liquid scintillation counter) and assuming hundred percent recovery 
of the radiolabeled cross-linked substrate. Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added to the recovered substrate, followed by 
heating at 90 C for 5 min and cooling on ice prior to purification by 20% denaturing 
PAGE (37  32  0.04 cm). The gel was run under limiting power (55 W) for 8 h. The 
product band was excised from the gel, crushed, and the DNA was eluted overnight in 1 
mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using 
a 100 mg C-18-Sep-Pak cartridge, concentrated and then hybridized with 180  (Figure 
76) by slow cooling from 90 °C to 25 °C in 1  PBS buffer (10 mM sodium phosphate, 




P-b-156. The yield (30-50%) of 
3'-
32
P-b-146 was determined based on the specific activity of 5'-
32
P-labeled 77 and 84. 




P-b-156. Scheme 54 




P-b-156 from 77 and 84, respectively. 
Oligonucleotide 77 or 84 (50 pmol, Figure 76) was subjected to a “fill in” reaction (30 













5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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mM DTT, pH 7.9), dTTP (1 mM), and 30 U of Klenow exo(-) at 37 C for 3 h.  The “fill 
in” reaction was stopped by heating at 75 C for 30 min. The reaction was then added and 
hybridized with 181 (100 pmol, Figure 76) in 10 mM sodium phosphate (pH 7.2) and 100 
mM sodium chloride solution (100 L) by slowly cooling from 90 C to 16 C. The 
annealed substrate was then 3'-
32
P-labeled in its bottom strand using a “fill in” reaction 
(150 μL) containing 1  NEB 2.0 buffer (50 mM NaCl, 10 mM TRIS-HCl, 10 mM 
MgCl2, 1 mM DTT, pH 7.9), 30 μCi -
32
P-dCTP, and 30 U of Klenow exo(-) at 37 C for 
3 h. The “fill in” reaction was stopped by heating at 75 C for 30 min. Excess -
32
P-
dCTP was removed by passing the reaction through a 1 mL Sephadex G25 column. The 
specific activity was determined by counting the radioactivity (using a liquid scintillation 
counter) and assuming hundred percent recovery of the radiolabeled cross-linked 
substrate. Formamide loading buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) 
was added to the recovered substrate, followed by heating at 90 C for 5 min and cooling 
on ice prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was 
run under limiting power (55 W) for 8 h. The product band was excised from the gel, 
crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 
mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, 
concentrated and then hybridized with 180  (Figure 76) by slow cooling from 90 °C to 25 




P-b-156. The yield (30-50%) of 3'-
32
P-b-146 was determined based on 
the specific activity of 3'-
32
P-labeled 77 and 84. 
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P-t-156. Scheme 55 




P-t-156 from 77 and 84, respectively. 
Oligonucleotide 77 or 84 (50 pmol, Figure 76) was subjected to a “fill in” reaction (50 
μL) containing 1  NEB 2.0 buffer (50 mM NaCl, 10 mM TRIS-HCl, 10 mM MgCl2, 1 
mM DTT, pH 7.9), 30 μCi -
32
P-dTTP, and 30 U of Klenow exo(-) at 37 C for 3 h.  The 
“fill in” reaction was stopped by heating at 75 C for 30 min. The specific activity was 
determined by counting the radioactivity (using a liquid scintillation counter) and 
assuming hundred percent recovery of the radiolabeled cross-linked substrate. 
Formamide loading buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) was added to 
the recovered substrate, followed by heating at 90 C for 5 min and cooling on ice prior 
to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was run under 
limiting power (55 W) for 8 h. The product band was excised from the gel, crushed, and 
the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). 
The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge, concentrated and 
then hybridized with 180  (Figure 76) by slow cooling from 90 °C to 25 °C in 1  PBS 




P-t-156. The yield (30-50%) of 3'-
32
P-b-146 was determined based on the specific 
activity of 3'-
32












































5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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P-t-156. Scheme 56 




P-t-156 from 77 and 84 (Figure 76), 
respectively. Oligonucleotide 180 (30 pmol, Figure 76) was 5'-
32
P-labeled in reaction (50 
μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 mM MgCl2, 5 mM 
DTT), 50 μCi -
32
P-ATP, and 30 U of T4 PNK at 37 C for 2 h.  The phosphorylation 
reaction was stopped by heating at 65 C for 30 min. Excess -
32
P-ATP was removed by 
passing the reaction through a 1 mL Sephadex G25 column. The specific activity was 
determined by counting the radioactivity (using a liquid scintillation counter) and 




P-180 was hybridized 
with with 77 or 84 (60 pmol, Figure 76) by slow cooling from 90 °C to 25 °C in 1  PBS 





General Procedure for Preparing 160 and 161 for Tm Experiments. 
Oligonucleotides 85 and 86 (500 pmol, Figure 76) were independently mixed with 182 
(500 pmol, Figure 76) in a solution (500 μL) containing 10 mM PIPES (pH 7.0), NaCl 
(100 mM) and MgCl2 (10 mM). The oligonucleotide solutions were hybridized by slow 





























5'-d(AGA CTG6   C   A8T TA11C     G13 X14A15       A16A17G  CGT  TA23G24 CCA TTA)
Y3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14X15       A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47Y46       T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
3'-d(TCT GAC55 G54TA   AT50G49  C48T47T46   T45T44C   GCA  AT38C    GGT AAT)
5'-d(AGA CTG6   C   A8T TA11C     G13 A14A15   A16A17G  CGT  TA23G24 CCA TTA)
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3'-d(CCG TGT ATV ATA TGC  GCP)

















5'-d(GCT GAT CGC GGC ACA TAW TAT ACG CGG ATC TGC ACG)







3'-d(CTA GAC GTG C)-X
5'-d(PGCG ATC AGC)
5'-d(GCG TGC AGA TC)




Figure 77. Oligonucleotides used to make 165, 166 and 169. 
General Procedure for Preparing 5'-
32
P-b-165. Scheme 57 describes the 
general procedure for preparing 5'-
32
P-b-165 from 121 (Figure 77). Oligonucleotide 121 
(80 pmol, Figure 77) was 5'-
32
P-labeled in reaction (50 μL) containing 1  T4 PNK buffer 
(70 mM TRIS-HCl pH 7.6, 10 mM MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 
50 μCi -
32
P-ATP, and 30 U of T4 PNK at 0 C for 2 h. Excess -
32
P-ATP was removed 
by passing the reaction through a 1 mL Sephadex G25 column. The phosphorylation 
reaction was stopped by heating at 65 C for 30 min and the T4 PNK was removed by 
phenol-chloroform-isopropanol extraction. The 5'-
32
P-b-121 was hybridized with 183 and 
183 (160 pmol each, Figure 77) in 10 mM sodium phosphate (pH 7.2) and 100 mM 
sodium chloride solution (120 μL) by slowly cooling from 90 C to 16 C. The reaction 
was incubated overnight at 16 C in presence of T4 DNA ligase (50 U) and 1  ligase 
buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). Formamide 
loading buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) was added to the 
reaction, followed by heating at 90 C for 5 min and cooling on ice prior to purification 
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by 20% denaturing PAGE (37  32  0.04 cm). The gel was run under limiting power (55 
W) for 11 h. 




The product band was excised from the gel, crushed, and the DNA was eluted overnight 
in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted 
using a 100 mg C-18-Sep-Pak cartridge to provide 5'-
32
P-b-165. The isolated final 
products were suspended in  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 mM 
NaCl) and hybridized by slow cooling from 90 °C to 25 °C. 




P-b-166. Scheme 58 




P-b-166 from 121 and 
164 (Figure 77), respectively. Oligonucleotide 121 or 164 (50 pmol) was annealed with 
183 and 184 (100 pmol, Figure 77) in 10 mM sodium phosphate (pH 7.2) and 100 mM 
sodium chloride solution (50 L) by slowly cooling from 90 C to 16 C. The reaction 
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buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). The ligated 
substrates were subjected to a “fill in” reaction (100 μL) containing 1  NEB 2.0 buffer 
(50 mM NaCl, 10 mM TRIS-HCl, 10 mM MgCl2, 1 mM DTT, pH 7.9), dTTP (1 mM), 
and 30 U of Klenow exo(-) at 37 C for 3 h.  The “fill in” reaction  






was stopped by heating at 75 C for 30 min. Excess -32P-ATP was removed by passing 
the reaction through a 1 mL Sephadex G25 column. The specific activity was determined 
by counting the radioactivity (using a liquid scintillation counter) and assuming hundred 
percent recovery from Sephadex column. Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added the 
32
P-labeled substrates, followed by 
heating at 90 C for 5 min and cooling on ice prior to purification by 20% denaturing 
PAGE (37  32  0.04 cm). The gel was run under limiting power (55 W) for 11 h. The 
product band was excised from the gel, crushed, and the DNA was eluted overnight in 5 
mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using 
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final products were suspended in  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 





P-b-166 was determined based on the specific activity of 
crude substrates. 




P-t-166. Scheme 59 




P-t-166 from 121 and 
164 (Figure 77), respectively. Oligonucleotide 185 (80 pmol, Figure 77) was 5'-
32
P-
labeled in reaction (50 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 7.6, 10 
mM MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 50 μCi -
32
P-ATP, and 30 U of 
T4 PNK at 37 C for 2 h. Excess -
32
P-ATP was removed by passing the reaction through 
a 1 mL Sephadex G25 column. The specific activity was determined by counting the 
radioactivity (using a liquid scintillation counter) and measuring the concentration of 185 




). The phosphorylation reaction was stopped by heating at 
65 C for 30 min. The 5'-
32
P-185 was hybridized with 50 pmol of 121 or 164 (Figure 77) 
and 160 pmol of 183 (Figure 77) in 10 mM sodium phosphate (pH 7.2) and 100 mM 
sodium chloride solution (120 μL) by slowly cooling from 90 C to 16 C. The reaction 
was incubated overnight at 16 C in presence of T4 DNA ligase (50 U) and 1  ligase 
buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP). Formamide 
loading buffer (50 L, 90% formamide, 10 mM EDTA, pH 8.0) was added to the 
reaction, followed by heating at 90 C for 5 min and cooling on ice prior to purification 
by 20% denaturing PAGE (37  32  0.04 cm). The gel was run under limiting power (55 
W) for 11 h. The product band was excised from the gel, crushed, and the DNA was 
eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The 
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P-t-166. The isolated final products were suspended in  PBS buffer (10 mM 
sodium phosphate, pH 7.2, 100 mM NaCl) and hybridized by slow cooling from 90 °C to 




P-t-166 was determined based on the 
specific activity of 5'-
32
P-185.  










P-t-166. Scheme 60 




P-t-166 from 121 and 
164 (Figure 77), respectively. Oligonucleotide 183 (80 pmol, Figure 77) was 3'-
32
P-
labeled in reaction (50 μL) containing containing 1  TdT buffer buffer (50 mM KOAc, 
20 mM TRIS-OAc, 10 mM MgCl2, pH 7.9), 40 μCi -
32
P-cordycepin triphosphate, and 
30 U of terminal deoxynucleotidyl transferase at 37 C for 2 h. Excess -
32
P-cordycepin 
triphosphate was removed by passing the reaction through a 1 mL Sephadex G25 column. 
The specific activity was determined by counting the radioactivity (using a liquid 







P-labeled 22 was hybridized with 121 or 164 (50 pmole) in 10 mM sodium 
phosphate (pH 7.2) and 100 mM sodium chloride solution (100 L) by slowly cooling 
from 90 C to 16 C. The reaction was incubated overnight at 16 C in presence of T4 
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mM DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% formamide, 10 mM 
EDTA, pH 8.0) was added to the reaction, followed by heating at 90 C for 5 min and 
cooling on ice prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The 
gel was run under limiting power (55 W) for 11 h. The product band was excised from 
the gel, crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M 
NaCl and 1 mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak 




P-t-166. The isolated final products were 
suspended in  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 mM NaCl) and 





P-t-166 was determined based on the specific activity of 3'-
32
P-183.  






General Procedure for Synthesis of 5'-
32
P-b-169. Scheme 61 describes the 
general procedure for preparing 3'-
32
P-b-169 from 121 (Figure 77). Oligonucleotide 121 
(50 pmol) was annealed with 168 and 183 (100 pmol, Figure 77) in 10 mM sodium 
phosphate (pH 7.2) and 100 mM sodium chloride solution (50 L) by slowly cooling 
from 90 C to 16 C. The reaction was incubated overnight at 16 C in presence of T4 
DNA ligase (50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 
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phosphorylation reaction (50 μL) containing 1  T4 PNK buffer (70 mM TRIS-HCl pH 
7.6, 10 mM MgCl2, 5 mM DTT), 6% PEG 8000 solution (w/v), 50 μCi -
32
P-ATP, and 
30 U of T4 PNK at 37 C for 2 h. Excess -
32
P-ATP was removed by passing the reaction 
through a 1 mL Sephadex G25 column. The phosphorylation reaction was 




stopped by heating at 65 C for 30 min. Formamide loading buffer (50 L, 90% 
formamide, 10 mM EDTA, pH 8.0) was added the 
32
P-labeled substrate, followed by 
heating at 90 C for 5 min and cooling on ice prior to purification by 20% denaturing 
PAGE (37  32  0.04 cm). The gel was run under limiting power (55 W) for 11 h. The 
product band was excised from the gel, crushed, and the DNA was eluted overnight in 5 
mL of elution buffer (0.2 M NaCl and 1 mM EDTA). The supernatant was desalted using 
a 100 mg C-18-Sep-Pak cartridge and concentrated to provide 5'-
32
P-b-169. The isolated 
final product was suspended in  PBS buffer (10 mM sodium phosphate, pH 7.2, 100 
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General Procedure for Preparing 129 and 130 for Tm Experiments. 
Oligonucleotides 129 and 130 (500 pmol, Figure 77) were independently suspended in 
solutions (500 μL) containing 10 mM PIPES (pH 7.0), NaCl (100 mM) and MgCl2 (10 
mM). The oligonucleotide solutions were hybridized by slow cooling from 90 °C to 25 
°C and then dispensed into three UV quartz cuvettes (160 μL each). 
3'-d(CCG TGT ATV ATA TGC GCP)

















5'-d(GCA TCG GTC GAG CGT GCA GAT C)
5'-d(PCTC GAC CGA TGC)
133
134
5'-d(PGCG ATC AGC CAG TAC CAT GTC GAA AGA CAT GGT ACT G)
175
P = phosphate
5'-d(AAG CTA GAC TAG CCT TTT GTG ATC TGC AC CTC GAC CGA TGC)
153
187
5'-d(GCA TCG GTC GAG CGT GCA GAT)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GGC GCA TA)
188
 







General Procedure for Synthesis of 3'-
32
P-b-189. Scheme 62 describes the 
general procedure for preparing 3'-
32
P-b-189 from 121 (Figure 78). Oligonucleotide 134 
(80 pmol, Figure 78) was 3'-
32
P-labeled in reaction (80 μL) containing containing 1  
TdT buffer buffer (50 mM KOAc, 20 mM TRIS-OAc, 10 mM MgCl2, pH 7.9), 40 μCi -
32
P-cordycepin triphosphate, and 30 U of terminal deoxynucleotidyl transferase at 37 C 
for 2 h. Excess -
32
P-cordycepin triphosphate was removed by passing the reaction 
through a 1 mL Sephadex G25 column. The specific activity was determined by counting 
the radioactivity (using a liquid scintillation counter) and measuring the concentration of 
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P-labeled 134 was hybridized with 121 (50 
pmole), 133 (160 pmol), and 153 (160 pmol) in 10 mM sodium phosphate (pH 7.2) and 
100 mM sodium chloride solution (100 L) by slowly cooling from 90 C to 16 C  
(Figure 78). The reaction was incubated overnight at 16 C in presence of T4 DNA ligase 
(50 U) and 1  ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM  




DTT, 1 mM ATP). Formamide loading buffer (50 L, 90% formamide, 10 mM EDTA, 
pH 8.0) was added to the reaction, followed by heating at 90 C for 5 min and cooling on 
ice prior to purification by 20% denaturing PAGE (37  32  0.04 cm). The gel was run 
under limiting power (55 W) for 11 h. The product band was excised from the gel, 
crushed, and the DNA was eluted overnight in 1 mL of elution buffer (0.2 M NaCl and 1 
mM EDTA). The supernatant was desalted using a 100 mg C-18-Sep-Pak cartridge to 
provide 3'-
32
P-b-189. The yield (410%) of 3'-
32
P-b-189 was determined based on the 
specific activity of 3'-
32
P-134. 
General Procedure for Restriction Enzyme Treatment of 135. The restriction 
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enzyme (10 U) and 5´-
32
P-b-135 were incubated in a 10 L reaction containing of 1 X 
CutSmart buffer (50 mM potassium acetate, 20 mM TRIS acetate, 10 mM magnesium 
acetate, 100 g/mL BSA, pH 7.9) at 37C (RsaI) or 65C (Taq

I) for 1 h, at which time 
formamide loading buffer (2 μL, 90% formamide, 10 mM EDTA, pH 8.0) was added 
followed by heating at 90C and cooling on ice. The reactions were analyzed by 20% 
denaturing PAGE.  
GAC ATG GTA CTG)d-OH        HO-d(GCT GAT CGC   G  GC ACA TWA TAT ACG CGG ATC TGC ACGCTC GAC CGA TGC)d-32P-3'






5'-32P-d(GCA TCG GTC GAG CGT GCA GAT C)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GGC GCA TA)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GTG TTT TCC GAT CAG ATC GAA)


























General Procedure for Restriction Enzyme Treatment of 170. The restriction 
enzyme sites on 170 are described on App. Figure 55. The appropriate restriction enzyme 
(10 U) and 5'-
32
P-b-170 were incubated in a 10 L reaction containing of 1 X CutSmart 
buffer (50 mM potassium acetate, 20 mM TRIS acetate, 10 mM magnesium acetate, 100 
g/mL BSA, pH 7.9) at 37C (RsaI) or 65C (Taq

I) for 1 h, at which time formamide 
loading buffer (2 μL, 90% formamide, 10 mM EDTA, pH 8.0) was added followed by 
heating at 90C and cooling on ice. The reactions were analyzed by 15% denaturing 
PAGE.  
General Procedure of Restriction Enzyme Treatment for Characterization of 
146. The appropriate restriction enzyme (10 U) and 
32
P-labeled 146 were incubated in a 8 
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L reaction containing of 1  CutSmart buffer (50 mM potassium acetate, 20 mM TRIS 
acetate, 10 mM magnesium acetate, 100 g/mL BSA, pH 7.9) at 37C (Fnu4HI and 
BsrBI) for 1 h, at which time formamide loading buffer (2 μL, 90% formamide, 10 mM 
EDTA, pH 8.0) was added followed by heating at 90C and cooling on ice. The reactions 
were analyzed by 15% denaturing PAGE.  
General Procedure of Restriction Enzyme Treatment for Characterization of 
5'-
32
P-t-148. The restriction enzyme Taq

I (10 U) and 5´-
32
P-t-148 were incubated in a 8 
L reaction containing of 1  CutSmart buffer (50 mM potassium acetate, 20 mM TRIS 
acetate, 10 mM magnesium acetate, 100 g/mL BSA, pH 7.9) at 65C (Taq

I) for 1 h. In 




P-t-11 in 8 L 
reactions containing of 1  NEB 3.1 buffer (50 mM potassium acetate, 20 mM TRIS 
acetate, 10 mM magnesium acetate, 100 g/mL BSA, pH 7.9) at room temperature for 1 
h. After 1 h, formamide loading buffer (2 μL, 90% formamide, 10 mM EDTA, pH 8.0) 
was added to these reactions followed by heating at 90C and cooling on ice. The 
reactions were analyzed by 15% denaturing PAGE. 
General Procedure of Restriction Enzyme Treatment for Characterization of 
Internally Radiolabeled 148. The appropriate restriction enzyme (10 U) and internally 
radiolabeled 148 were incubated in a 8 L reaction containing of 1  CutSmart buffer (50 
mM potassium acetate, 20 mM TRIS acetate, 10 mM magnesium acetate, 100 g/mL 
BSA, pH 7.9) at 37C (Fnu4HI and HpyCH4V) for 1 h, at which time formamide loading 
buffer (2 μL, 90% formamide, 10 mM EDTA, pH 8.0) was added followed by heating at 
90C and cooling on ice. The reactions were analyzed by 15% denaturing PAGE.  
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General Procedure of Determination of Thermal Stability of 5'-
32
P-t-144 
Under Nucleotide Excision Repair Conditions. Oligonucleotide 5'-
32
P-t-144 (2 nM) 
was incubated with 145 (10 nM) for 1 h in 60 L reaction containing 1  NER buffer (50 
mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 C 
for 3 h. Aliquots (9 L) were taken out at 0, 5, 10, 15, 30 and 60 min and mixed with 
glycerol loading buffer (2 L, 80% glycerol in water, v/v). The exchange was analyzed 
by 20% non-denaturing PAGE. 
General Procedure of Determination of Thermal Stability of 5'-
32
P-t-146 
Under Nucleotide Excision Repair Conditions.  Oligonucleotide 5'-
32
P-t-146 (2 nM) 
was incubated with 147 (10 nM) for 1 h in 60 L reaction containing 1  NER buffer (50 
mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 55 C 
for 3 h . Aliquots (9 L) were taken out at 0, 5, 10, 15, 30 and 60 min and mixed with 
glycerol loading buffer (2 L, 80% glycerol in water, v/v). The exchange was analyzed 
by 20% non-denaturing PAGE. 
General procedure of determination of thermal stability of 151 under 
nucleotide excision repair condition. Oligonucleotide 5'-
32
P-t-151 (0.26 nM) was 
incubated with 153 (0.26 nM or 2.6 nM) in a 50 L reaction containing 1  NER buffer 
(50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and ATP 1 mM) at 
55 C for 3 h. The experiment was cooled down to 4 C and added with glycerol loading 
buffer (5.5 L, 80% glycerol in water, v/v). The exchange was analyzed by 15% non-
denaturing PAGE. 
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UvrABC Incision Reaction. The purified cross-linked DNA was resuspended in 
100 mM NaCl and 10 mM potassium phosphate buffer (pH 7.2, 25 L), and rehybridized 
by heating to 65 C (2 min), cooled to room temperature over the course of 2 h, and 
allowed to equilibrate at 4 C overnight. The UvrA, UvrB, and UvrC were freshly 
prepared from stock solutions and heated individually at 65 C for 10 min before use. 
They were added sequentially to the reactions. The reaction buffer contains 50 mM Tris-
HCl (pH 7.5), MgCl2 (10 mM), KCl (50 mM), DTT (5 mM), and ATP (1.0 mM). The 
cross-linked DNA (2.0 nM) was incubated with UvrA (20 nM), UvrB (100 nM), and 
UvrC (50 nM) in a total volume of 20 L at 55 C. The concentration of cross-linked 
DNA was based upon the specific activity of the initially labeled oligonucleotide, which 
was determined by counting the radioactivity (using a liquid scintillation counter) and 
measuring the concentration (A260). After 60 min the reaction was quenched by 
precipitation with 5 M NH4OAc (5 L), 1 g/L calf thymus DNA (5 L), and cold 
ethanol (75 L). The incision products were separated by 20% denaturing PAGE and 
visualized using the Phosphorimager. For the time course reaction (60 L total volume) 
aliquots (7 L) were removed at the prescribed times and immediately quenched by 
addition of 90% formamide loading buffer (3 L) and heating at 90C for 2 min.  
Gel Shift Assays. Gel shift assays were performed to determine the Kd values of 
UvrA for ICL-containing DNA.
125
 Reaction contained 0.3 nM DNA duplex (144, 146 
and 149) 
32
P-labeled at the end in 1  NER buffer [50 mM Tris-HCl (pH 7.5), MgCl2 (10 
mM), KCl (50 mM), DTT (5 mM), and ATP (1.0 mM)], and UvrA concentration ranging 
from 0.5 nM to 200 nM. Samples of protein/DNA mixture was incubated at 55 °C for 20 
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min followed by the addition of 2 μL of 80% glycerol. Bound versus unbound DNA was 
visualized using electrophoresis on a 4% nondenaturing PAGE (80:1 
acrylamide:bisacrylamide ratio) at 4 °C in TBE running buffer (89 mM Tris, 89 mM 
boric acid, 2 mM ETDA) containing 10 mM MgCl2 and 1 mM ATP at 150 V for 2 – 3 h. 
Gels were dried and exposed to a storage phosphor screen overnight. Kd values were 
determined by fitting the data (percent bound substrate vs. log[UvrA]) in one site binding 
Hill equation (  
    
       
 
   where   is fraction of DNA bound to protein, [L] is free 
protein concentration, n is the number of binding sites, Kd is dissociation constant)  in 
Origin 8.0. The Kd values were determined from data generated from at least three 
separate experiments using separately diluted UvrA in each experiment.  
 The loading of UvrB by UvrA was examined by incubating 
32
P-labeled 0.3 nM 
DNA duplex (144, 146 and 149) with UvrA (0.5, ) in the presence of 500 nM UvrB in 1  
NER buffer [50 mM Tris-HCl (pH 7.5), MgCl2 (10 mM), KCl (50 mM), DTT (5 mM), 
and ATP (1.0 mM)] at 55 °C for 20 min. After addition of 80% glycerol, samples were 
electrophoresed as described above.
125
 The percent UvrB:DNA complex was determined 
from quantitation of the storage phosphor autoradiogram. At least three separate 
experiments were performed and the values averaged to provide the % UvrB loaded onto 
the damaged DNA. 
UV Melting Temperature Experiments. UV melting temperature experiments 
were carried out in quartz cells with a path length of 1 cm. The samples were prepared by 
mixing oligonucleotides (1 μM), PIPES, pH 7.0 (10 mM), NaCl (100 mM), and MgCl2 
(10 mM). For substrates During the forward melting experiments on 85, 86, 160 and 161, 
















the temperature was held at 13 °C to 2 min, then ramped linearly to 85 °C at a rate 1.0 °C 
/ min while monitoring the change in UV absorbance at 260 nm. During the reverse 
experiment, the temperature was held at 85 °C to 5 min, then ramped linearly to 13 °C at 
a rate 1.0 °C / min while monitoring the change in UV absorbance at 260 nm. In addition, 
the cuvette rack was constantly flushed with N2 flow to avoid moisture condensation at 
low (< 17 °C). For substrates 129 and 130, the low and high temperature during forward 
and reverse experiments were kept at 20 °C and 85 °C, respectively. For each experiment, 
the change in absorbance (260 nm) with temperature for a solution containing the same 
buffer but without the oligonucleotides was monitored and subsequently subtracted from 
the absorbance (260 nm) of the oligonucleotides. The data was processed using Origin 
6.1 by plotting the absorbance (260 nm) versus temperature and fitting the curve to the 
Boltzmann equation [y = A2 + (A1-A2)/(1 + exp((x-x0)/dx)), where y is the absorbance, 
A1 is the intial value (left horizontal asymptote), A2 is the final value (right horizontal 
asymptote), x0 is center (point of inflection or Tm), dx is the change in X corresponding 
to the most significant change in Y value].  
 Synthesis of 162 Containing C4-AP Precursor. Synthesis, ICL formation and 
determination of ICL location was done following procedures published earlier.
8
 
Standard synthesis cycles (25 s coupling, 5 s capping with acetic anhydride, 15 s 
oxidation with 1 M t-butylhydroperoxide in THF, 95 s 
detritylation with 3% TCA in methylene chloride) were 
employed prior to the incorporation of the photochemical 
precursor of the lesion. After the C4-AP phosphoramidite 
was inserted, the cycles were modified to include a shorter detritylation period (45 s) to 
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ensure stability of the lesion. The C4-AP phosphoramidite was itself incorporated with 5 
min coupling, 25 s capping, 40 s oxidation, and the shorter 45 s detritylation  using the 
same synthesis reagents. After overnight aqueous ammonia deprotection (55C), 162 
were purified by 20% PAGE. 
General Procedure for ICL formation in C4-AP Containing Duplexes. 
Duplex DNA (163, 200 nM) 3'-
32
P-labelled at the complementary strand in PBS buffer 
(100 mM NaCl and 10 mM sodium phosphate, pH 7.2) was photolyzed in a clear 
eppendorf for 45 min at room temperature. The DNA was then diluted to 100 nM. These 
reactions were typically incubated at 37 °C for 10 h or overnight. At the end of 
incubation period, the reaction solution was mixed with equal volume of formamide 
loading buffer and the DNA was resolved using 20% denaturing polyacrylamide gel 
electrophoresis (PAGE). 
Determination of ICL Location using the Hydroxyl-Radical Cleavage 
Reaction. Duplex DNA (163, concentration 100 nM) constructed of a C4-AP containing 
strand and a 3′-
32
P-labeled complement was incubated at 37°C overnight in PBS. The 
reaction was evaporated and purified by 20% analytical (0.4 mm thickness) PAGE. The 
bands corresponding to the high molecular weight ICL product was carefully cut from the 
gel, crushed, and eluted in 500 µL of water for 1 h at room temperature with mild 
vortexing. The solution was then filtered using a 10 mL Polyprep Column (Biorad) and 
desalted using a C18 column (100 mg Sep-Pak, Waters). After concentration, a portion of 
the desalted DNA (30,000- 60,000 cpm) was resuspended in 8 µL of water and mixed 
with 10 µL of the 2  oxidation buffer (20  mM NaCl, 20 mM sodium phosphate, pH 7.2, 
2 mM sodium ascorbate, and 0.25 mM hydrogen peroxide). To the reaction 2 µL of the 
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Fe•EDTA solution (1 mM EDTA and 0.5 mM Fe(NH4)2(SO4)2•6H2O) was added as the 
catalyst as well as the initiator and the reaction was allowed to proceed for 3-5  min. The 
reaction was quenched with 10 µL of 100 mM thiourea and concentrated. The DNA was 
then suspended in formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 
8.0, 0.1% xylene cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 
°C, 5 min), and analyzed by 20% denaturing PAGE.  
General Procedure of Hydroxyl Radical Cleavage Reaction for Probing DNA 
Backbone. The 
32
P-labeled oligonucleotide (5,000 – 15,000 CPM) was suspended in 8 
μL of water and mixed with 10 µL of the 2  oxidation buffer (20  mM NaCl, 20 mM 
sodium phosphate, pH 7.2, 2 mM sodium ascorbate, and 0.5 mM hydrogen peroxide). To 
the reaction 2 µL of the Fe•EDTA solution (1 mM EDTA and 0.5 mM 
Fe(NH4)2(SO4)26H2O) was added as the catalyst, as well as the initiator, and the reaction 
was allowed to proceed for 3-5  min. The reaction was quenched by addition of 10 µL of 
100 mM thiourea and subjected precipitated with 3 M NaOAc (4 L), 1 g/L calf 
thymus DNA (5 L), and cold ethanol (115 L). After concentration, the DNA was 
suspended in formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 8.0, 
0.1% xylene cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 °C, 5 
min), and were analyzed following PAGE (20% denaturing) using a Storm 840 
phosphorimager and Imagequant TL software. 
General Procedure for Diethylpyrocarbonate (DEPC) Treatment of 
Oligonucleotides 155 – 157. The 
32
P-labeled oligonucleotides (5,000 – 15,000 CPM) 
were suspended in 25.4 μL of 1.18  PBS buffer (11.8 mM sodium phosphate, pH 7.2, 
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118 mM NaCl). The oligonucleotides were then incubated with 1.04 M DEPC (final 
concentration, diluted from neat 6.8 M DEPC) for 10 min at room temperature. The final 
reaction volume and buffer concentration were 30 μL and 1  PBS (10 mM sodium 
phosphate, pH 7.2, 100 mM NaCl), respectively. The reaction tubes were vortexed at an 
interval of every 2 min during the incubation. Following incubation with DEPC, the 
samples were precipitated with 5 M NH4OAc (5.2 L), 1 g/L calf thymus DNA (5 
L), water (10 μL), and cold ethanol (155 L). After precipitation and concentration, the 
samples were treated with 1 M piperidine (50 μL) for 20 min at 90 °C, and dried in 
vacuo. The samples were suspended in water (50 μL) and again dried in vacuo. The DNA 
was suspended in formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 
8.0, 0.1% xylene cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 
°C, 5 min), and were analyzed following PAGE (20% denaturing) using a Storm 840 
phosphorimager and Imagequant TL software. 
General Procedure for DEPC Treatment of Oligonucleotides 165 – 167, 135 
and 170. The 
32
P-labeled oligonucleotides (5,000 – 15,000 CPM) were suspended in 25.5 
μL of 1.4  PBS buffer (14 mM sodium phosphate, pH 7.2, 140 mM NaCl). The 
oligonucleotides were then incubated with 1.75 M DEPC (final concentration, diluted 
from neat 6.8 M DEPC) for 10 min at room temperature. The final reaction volume and 
buffer concentration were 35.5 μL and 1  PBS (10 mM sodium phosphate, pH 7.2, 100 
mM NaCl), respectively. The reaction tubes were vortexed at an interval of every 2 min 
during the incubation. Following incubation with DEPC, the samples were precipitated 
with 5 M NH4OAc (5.2 L), 1 g/L calf thymus DNA (5 L), water (7 μL), and cold 
ethanol (155 L). After precipitation and concentration, the samples were treated with 1 
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M piperidine (50 μL) for 20 min at 90 °C, and dried in vacuo. The samples were 
suspended in water (50 μL) and again dried in vacuo. The DNA was suspended in 
formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 8.0, 0.1% xylene 
cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 °C, 5 min), and 
were analyzed following PAGE (20% denaturing) using a Storm 840 phosphorimager 
and Imagequant TL software. 
General Procedure for KMnO4 Treatment of Oligonucleotides. The 
32
P-
labeled oligonucleotides (5,000 – 15,000 CPM) were suspended in 18 μL of 1.11  PBS 
buffer (11.1 mM sodium phosphate, pH 7.2, 111 mM NaCl). For 155 – 158, the 
oligonucleotides were then incubated with 0.3 mM KMnO4 (diluted from an aqueous 
stock solution of 3 mM) for 10 min at room temperature. For 165 – 167, 135 and 170, the 
oligonucleotides were incubated with 0.6 mM KMnO4 (diluted from an aqueous stock 
solution of 6 mM) for 10 min at room temperature. The final reaction volume and buffer 
concentration in both instances were 20 μL and 1  PBS (10 mM sodium phosphate, pH 
7.2, 100 mM NaCl), respectively. The reaction tubes were vortexed at an interval of 
every 2 min during the incubation. Following incubation with KMnO4, the reactions were 
quenched by addition of neat allyl alcohol (1 μL) and vortexing the reaction tube. The 
samples were precipitated with 5 M NH4OAc (5.2 L), 1 g/L calf thymus DNA (5 
L), water (20.5 μL), and cold ethanol (155 L). After precipitation and concentration, 
the samples were treated with 1 M piperidine (50 μL) for 20 min at 90 °C, and dried in 
vacuo. The samples were suspended in water (50 μL) and again dried in vacuo. The 
oligonucleotides were suspended in formamide loading buffer (10 L, 50% formamide, 5 
mM EDTA, pH 8.0, 0.1% xylene cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 
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min), cooled (0 °C, 5 min), and analyzed following PAGE (20% denaturing) using a 
Storm 840 phosphorimager and Imagequant TL software. 
General Procedure for Dimethyl Sulfate (DMS) Treatment of 
Oligonucleotides. The 
32
P-labeled oligonucleotides (5,000 – 15,000 CPM) were 
suspended in 18 μL of 1.11  PBS buffer (11.1 mM sodium phosphate, pH 7.2, 111 mM 
NaCl). The oligonucleotides were then incubated with 25 mM DMS (diluted from a 250 
nM DMS solution in ethanol) and incubated for 12 min at room temperature. The final 
reaction volume and buffer concentration were 20 μL and 1  PBS (10 mM sodium 
phosphate, pH 7.2, 100 mM NaCl), respectively. The reaction tube was vortexed at an 
interval of every 2 min during the incubation. Following incubation, the samples were 
precipitated with 5 M NH4OAc (5.2 L), 1 g/L calf thymus DNA (5 L), water (20.5 
μL), and cold ethanol (155 L). After precipitation and concentration, the samples were 
treated with 1 M piperidine (50 μL) for 20 min at 90 °C, and dried in vacuo. The samples 
were suspended in water (50 μL) and again dried in vacuo. The oligonucleotides were 
suspended in formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 8.0, 
0.1% xylene cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 °C, 5 
min), and analyzed following PAGE (20% denaturing) using a Storm 840 
phosphorimager and Imagequant TL software. 
General Procedure for Preparation of 1.04 M and 2 M Solution of 
Hydroxylamine (pH 6.0). To make a 10 mL 2 M stock solution of hydroxylamine (pH 
6.), 1.34 g hydroxylamine hydrochloride salt was dissolved in 5 mL autoclaved water. 
Diethylamine (approximately 1.2 mL) was added to adjust the pH to 6.0. Autoclaved 
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water was added to this solution to achieve a final volume of 10 mL. The stock solution 
was diluted with autoclaved water to make 1.04 M hydroxylamine solution. The 2 M 
stock solution can be stored in a -20C freezer and can be used for one week.  
General Procedure for Hydroxylamine Treatment of Oligonucleotides. The 
32
P-labeled oligonucleotides (5,000 – 15,000 CPM) were suspended in 6 μL of 4.3  PBS 
buffer (43.3 mM sodium phosphate, pH 7.2, 433 mM NaCl). The oligonucleotides were 
then incubated with 0.80 M hydroxylamine, pH 6.0 (diluted from a 1.04 M stock 
solution) and incubated for 10 min at room temperature. The final reaction volume and 
buffer concentration were 26 μL and 1  PBS (10 mM sodium phosphate, pH 7.2, 100 
mM NaCl), respectively. The reaction tube was vortexed at an interval of every 2 min 
during the incubation. Following incubation, the samples were precipitated with 5 M 
NH4OAc (5.2 L), 1 g/L calf thymus DNA (5 L), water (20.5 μL), and cold ethanol 
(155 L). After precipitation and concentration, the samples were treated with 1 M 
piperidine (50 μL) for 20 min at 90 °C, and dried in vacuo. The samples were suspended 
in water (50 μL) and again dried in vacuo. The oligonucleotides were suspended in 
formamide loading buffer (10 L, 50% formamide, 5 mM EDTA, pH 8.0, 0.1% xylene 
cyanol, and 0.1% bromophenol blue), heated (90 °C, 2 min), cooled (0 °C, 5 min), and 
analyzed following PAGE (20% denaturing) using a Storm 840 phosphorimager and 








App. Figure 1. Assessment of stability of 5'-O-acetyl and 5'-O-pivaloyl protection on resin bound 
oligonucleotide under delevulinylation treatment (0.25 M hydrazine in 3:2 pyridine/acetic acid for 10 min, 
room temperature) after introduction of modified 5'-capping strategy. Delevulinylation and any potential 
extension of 190 was probed by deprotection, 
32
P-labeling and analysis of crude radiolabeled materials on 
20% denaturing PAGE.  (A) Stability of acetyl capping under delevulinylation analyzed on 20% denaturing 
PAGE Lane 1, 190 deprotected and 
32
P-labeled.  Lane 2, acetyl capped 190 subjected to solid phase 
extension for 6 dT nucleotides, deprotected and 
32
P-labeled. Lane 3, acetyl capped 190 subjected to 
delevulinylation treatment followed by 6 dT extension, deprotected and 
32
P-labeled. (B) Stability of 
pivaloyl capping under delevulinylation analyzed on 20% denaturing PAGE. Lane 1, 191 deprotected and 
32
P-labeled.  Lane 2, pivaloyl capped 191 subjected to delevulinylation treatment followed by 6 dT 
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App. Figure 2. Delevulinylation and solid phase extension of 70. Following solid phase synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and analyzed on 
20% denaturing PAGE gel. Position of 71 (from unmodified 70) and 72 are annotated. Lane 1, 70 
deprotected and radiolabeled.  Lane 2, acetyl capped 70 subjected to solid phase extension using 6 dT 
nucleotides. Lane 3, acetyl capped 70 subjected to delevulinylation treatment followed by 6 dT extension. 
 
App. Figure 3. Compatibility of commercial nucleobase amine protections under delevulinylation 
treatment (0.25 M hydrazine in 3:2 pyridine/acetic acid, room temperature) analyzed on a preparative 20% 
PAGE gel. Benzoyl protection was used for exocyclic amines of A and C while isobutyryl was used for G. 
The bands are detected under UV lamp with the aid of fluorescent TLC plate. Position of 74 and 75 are 
annotated. Lane 1, 74 from deprotection of unmodified 73. Lane 2, 73 after five nucleotide extension using 
5'-CE “reverse” T phosphoramidites and ammonolytic deprotection. Lane 3, 4, and 5, 73 subjected to 
delevulinylation treatment for 1, 5, and 10 min followed by five nucleotide extension using 5'-CE “reverse” 




























































5'-d(TAC GAZ AAC TCA)
3'-d(TTT TTY ) 
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App. Figure 4. Purification of DOB ICL mimic 77. Following ammonolytic deprotection and cleavage 
from support, crude oligonucleotide mixture from synthesis of 77 loaded on a preparative 20% denaturing 
PAGE. The bands are visualized under UV lamp with the aid of a fluorescent TLC plate. 
 
App. Figure 5. HPLC purification of ICL 79. (A) Template strand 78 and ICL 79. (B) HPLC 
chromatogram of purification of 79 in a reverse phase C-18 column. Various isolated fractions (1 – 5) are 
annotated. (C) Radiolabeling of fractions from the chromatogram of purification of 79 loaded on a 15% 
denaturing PAGE. Lane 1, 10 bp ladder. Lane 2, fraction 2. Lane 3, fraction 3. Lane 4, fraction 4. Lane 5, 
32

























5'-d(AGA CTG CAT TAC GZA -
-AAG CGT TAG CCA TTA)
76
3'-d(  CT GAC GTA ATG CTY ) 

























5'-d(TAC ATA CTC GTA GTC TGC ATT ACG YAA AGC GTT - 
-AGC GAT TAA CATCGA GTC)-3'
3'-d(TAA TGC TX)
5'-d(TAC ATA CTC GTA GTC TGC ATT ACG ZAA AGC GTT - 
-AGC GAT TAA CATCGA GTC)-3'
78
79
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App. Figure 6. Absorbtion of N6-benzoyl-dA and N4-benzoyl dC phosphoramidites (54 μM in 
acetonitrile). 
 
App. Figure 7. Assessment of compatibility of isobutyryl with delevulinylation and subsequent extension 
for resin bound and 5'-O-acetyl capped oligonucleotide 90, 93, 96, and 99. Following solid phase synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and analyzed on 
20% denaturing PAGE gel. Positions of template strands and corresponding branching or cross-link 
product on the gel are annotated.  (A) Extension of 90. Lane 1, 90 deprotected without any modification. 
Lane 2, 90 subjected to solid phase extension using regular T phosphoramidites. Lane 3 and 4, 90 subjected 
to delevulinylation and subsequent solid phase extension using regular T phosphoramidites. (B) Extension 
of 93. Lane 1, 93 deprotected without any modification. Lane 2, 93 subjected to solid phase extension using 
regular T phosphoramidites. Lane 3 and 4, 93 subjected to delevulinylation and subsequent solid phase 
extension using regular T phosphoramidites. (C) Extension of 96 and 99. Lanes 1 and 4, 96 and 99 
deprotected without any modification, respectively. Lanes 2 and 5, 96 and 99 subjected to solid phase 
extension using regular T phosphoramidites, respectively. Lane 3 and 6, 96 and 99 subjected to 
delevulinylation followed by solid phase extension using regular T phosphoramidites, respectively.  
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App. Figure 8. Light transmission profile of Newport 375 nm long pass filter (CGA-375). 
 
App. Figure 9. Assessment of filter-aided-photolysis (375 nm long pass) and subsequent extension 
capability for resin bound and 5'-O-acetyl capped oligonucleotide 87. Following solid phase synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and analyzed on 
20% denaturing PAGE gel. Positions of template strand 88 (from unmodified 87) and corresponding cross-
link product 89 on the gel are annotated. Lane 1, 87 deprotected. Lane 2, 87 photolyzed in toluene for 2 h, 
extended using regular T phosphoramidites.  
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App. Figure 10. Determination of photolysis yield as a function of irradiation time. (A) Photolysis (using 
350 nm light source fitted with 375 nm long pass filter) and extension of 87 in toluene. Following solid 
phase synthesis, oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled 
and analyzed on 20% denaturing PAGE gel. Positions of 88 (generated from deprotection of unmodified 
87) and 89 are annotated. Lane 1, unmodified 87. Lane 2, 87 subjected to extension using regular T 
phosphoramidites. Lane 3  9, 87 subjected to 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0 h of photolysis followed by 
extension using regular T phosphoramidites. (B) Plot of percentage of extension product obtained with 
respect to photolysis time. Extension yields were calculated based on the band intensity of template strand 
and final product. 
1        2             3        4          5         6          7          8          9

















Time of photolysis (h)





1        2             3        4          5         6          7          8          9

















Time of photolysis (h)
A                                                                             
B
17














   5'-d(TTT TTY)
89
5'-d(CAT ZAT AT)
























 241  
 
 
App. Figure 11. Assessment of the effect of 4:1 pyridine/acetic acid washing on photolysis yield. (A) 
Effect of 4:1 pyridine acetic acid wash on photolysis (using 350 nm light source fitted with 375 nm long 
pass filter) and subsequent solid phase extension. Following solid phase synthesis, oligonucleotides were 
deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and analyzed on 20% denaturing PAGE 
gel. Positions of 88 (generated from deprotection of unmodified 87) and 89 are annotated. Lane 1, 
deprotected 87. Lane 2, 87 subjected to 2.0 h of photolysis in acetonitrile-water (9:1) followed by extension 
using regular T phosphoramidites. Lane 3, 87 subjected to 2.0 h of photolysis in acetonitrile followed by 
3:2 pyridine/acetic acid wash, extension using regular T phosphoramidites. Lane 4, 87 subjected to 2.0 h of 
photolysis in acetonitrile followed by 3:2 pyridine/acetic acid wash and extension using regular T 
phosphoramidites. (B) Efficiency of photolysis determined by percentage of 88 converted to 89. Extension 
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App. Figure 12. Assessment of the effect of 4:1 pyridine/acetic acid wash on photolysis. Photolysis (using 
350 nm light source fitted with 375 nm long pass filter) and extension of 87. Following solid phase 
synthesis, oligonucleotides were deprotected, cleaved from the support (ammonolysis), 
32
P-labeled and 
analyzed on 20% denaturing PAGE gel. Position of 88 (generated from unmodified 87) is annotated. Lane 
1, 87 without any modification. Lane 2, photolysis of 87 in 4:1 pyridine/acetic acid for 1 h. Lane 3, resin-
bound 87 submerged in 4:1 pyridine/acetic acid for 1 h followed by extension. Lane 4, photolysis of 87 in 
toluene for 1 h, then washed with 4:1 pyridine/acetic acid. Lane 5, photolysis of 87 in 9:1 acetonitrile/water 
for 1 h, then washed with 4:1 pyridine/acetic acid.  
 
App. Figure 13. Effect of photolysis followed by extension on the solid phase extension of support bound 
oligonucleotide 102. Following solid phase synthesis, oligonucleotides were deprotected, cleaved from the 
support (ammonolysis), 
32
P-labeled and analyzed on 20% denaturing PAGE. Positions of template strand 
88 (from unmodified 87) and ICL 89 are annotated. Delevulinylation treatment was carried out by treating 
the resin with 0.25 M hydrazine in 3:2 pyridine/acetic acid for 10 min at room temperature. Photolysis was 
carried out by irradiating (350 nm light source fitted with 375 nm long pass filter) the resin for 2 h in 
toluene at room temperature. 
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App. Figure 14. Effect of delevulinylation treatment followed by photolysis (using 350 nm light source 
fitted with 375 nm long pass filter, 2 h, toluene, room temperature) on the solid phase extension of support 
bound oligonucleotide 87. Following solid phase synthesis, oligonucleotides were deprotected, cleaved 
from the support (ammonolysis), 
32
P-labeled and analyzed on 20% denaturing PAGE gel. Positions of 
template strand 88 (from unmodified 87) and uncharacterized band (presumably from decomposition of 88) 
are annotated. Delevulinylation treatment was carried out by treating the resin with 0.25 M hydrazine in 3:2 
pyridine/acetic acid for 10 min at room temperature.  
 
App. Figure 15. Effect of photolysis (using 350 nm light source fitted with 375 nm long pass filter) 
followed by solid phase extension of support bound oligonucleotide 114. Following synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 32P-labeled and analyzed on 
20% denaturing PAGE gel. Positions of template strand 115 (from unmodified 114) and ICL 116 are 
annotated. (A) Photolysis and 5'-arm extension of 114. Lane 1, unmodified 114 deprotected. Lane 2, 114 
subjected to 1.0 h photolysis in toluene (room temperature) and solid phase extension. Lane 3, 114 
subjected to 1.5 h photolysis in toluene (room temperature) and solid phase extension. Lane 4, 114 
subjected to 2.0 h photolysis in toluene (room temperature) and solid phase extension. (B) Extension yields 
plotted against photolysis time. Yields were calculated based on the band intensity of template strand and 
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App. Figure 16. Compatibility of phosphorylating agents 122 and 123 with delevulinylation (0.25 M 
hydrazine in 3:2 pyridine/acetic acid, room temperature for specified time). Following synthesis, 
oligonucleotides were deprotected, cleaved from the support (ammonolysis), 32P-labeled and analyzed on 
20% denaturing PAGE gel. Positions of unphosphorylated template strand 126, phosphorylated template 
strand 125 (from unmodified 124a,b) and extension products are annotated. (A) Compatibility of 
phosphorylating agents 122 with delevulinylation treatment tested using oligonucleotide 124a. Lane 1, 
124a deprotected. Lane 2, 124a subjected to solid phase extension using four regular T phosphoramidites. 
Lane 3, 124a subjected to delevulinylation treatment for 10 min followed by solid phase extension using 
regular T phosphoramidites. Lane 4, 124a subjected to delevulinylation treatment for 25 min followed by 
solid phase extension using regular T phosphoramidites. (B) Compatibility of phosphorylating agents 123 
with delevulinylation treatment tested using oligonucleotide 124b. Lane 1, 124b deprotected. Lane 2, 124b 
subjected to solid phase extension using four regular T phosphoramidites. Lane 3, 124b subjected to 
delevulinylation treatment for 10 min followed by solid phase extension using regular T phosphoramidites. 
Lane 4, 124b subjected to delevulinylation treatment for 25 min followed by solid phase extension using 
regular T phosphoramidites. (C) MALDI-TOF-MS of extension product. (D) MALDI-TOF-MS of 126. 
Calc’d mass 2487.689, observed mass 2483.213 [M + Na]
+
 2457.689. (E) MALDI-TOF-MS of 125. Calc’d 
mass 2436.218, observed mass 2524.022. 
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App. Figure 17. Ligation for constructing 5´-
32
P-135 and restriction enzyme treatment of purified 5´-
32
P-
40. (A) RsaI and Taq
α
I restriction enzyme sites on 135. (B) Representative 12% denaturing PAGE gel 
showing the ligation to construct 5´-
32
P-135. Lane 1, 10 base pair DNA ladder. Lane 2, 5’-
32
P-133. Lane 3, 
crude reaction to produce 5´-
32
P-135. (C) Representative 15% denaturing PAGE gel analysis of restriction 
enzyme treatment of purified 5´-
32
P-135. Lane 1, 10 base pair DNA ladder. Lane 2, 5´-
32
P-135 without any 
treatment. Lane 3, 5´-
32
P-135 treated with RsaI. Lane 4, 5´-
32








5'-d(GAC ATG GTA CTG GCT GAT CGC GGC ACA TWA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)-3'
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App. Figure 18. Compatibility of solid phase extension with Pd(0) catalyzed deprotection. Support bound 
136 was subjected to extension with or without Pd(0) deprotection and washing, followed by six nucleotide 
extension. Pd(0) deprotection and washing was done as described in “Pd(0) removal of ALLOC: procedure 
1”(Experimental Procedure). Following synthesis, oligonucleotides were deprotected, cleaved from the 
support (ammonolysis), 
32
P-labeled and analyzed on 20% denaturing PAGE gel. 
 
App. Figure 19. Compatibility of solid phase extension with Pd(0) catalyzed deprotection. Support bound 
136 was subjected to extension with or without treating the resin with Pd(PPh3)4, Et2NH.BH3 and washing, 
followed by six nucleotide extension. Pd(0) deprotection and washing was done as described in “Pd(0) 
removal of ALLOC: procedure 2”(Experimental Procedure). Following synthesis, oligonucleotides were 
deprotected, cleaved from the support (ammonolysis), 
32




App. Figure 20. Compatibility of 5'-O-acyl protection with Pd(0) catalyzed deprotection. Support bound 
137 was subjected to extension with or without Pd(0) deprotection and washing, followed by six nucleotide 
extension. Pd(0) deprotection and washing was done as described in “Pd(0) removal of ALLOC: procedure 
2”(Experimental Procedure). Following synthesis, oligonucleotides were deprotected, cleaved from the 
support (ammonolysis), 
32





























































5'-AcO-d(TTT TTT TTT T)-O
3'
137
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App. Figure 21. Compatibility of exocyclic amine protections on native phosphoramidites [benzoyl-dA 
(A), isobutyryl-dG (B), and benzoyl-dC (C)] with Pd(0) catalyzed deprotection and washing. Treatment of 
Support bound and 5'-capped 135 (A), 139 (B), and 140 (C) with or without Pd(0) deprotection and 
washing, followed by six nucleotide extension. Pd(0) deprotection and washing was done as described in 
“Pd(0) removal of ALLOC: procedure 2”(Experimental Procedure). Following synthesis, oligonucleotides 
were deprotected, cleaved from the support by ammonolysis, 
32




App. Figure 22. Hydroxyl radical cleavage of 3'-
32
P-137. Lane 1, 3'-
32
P-137 without any modification. 
Lane 2, 3 and 4, 3'-
32
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App. Figure 23. Thermal stability of 5'-
32
P-t-144 analyzed using non-denaturing (20%) PAGE. (Panel A) 
Melting of 144 at NER condition [1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 
mM dTT, and ATP 1 mM), 55 C]. Lanes 1 and 2, aliquots at 0 and 60 min from single stranded 5'-
32
P-144, 
respectively. Lane 3, hybridized 5'-
32
P-t-144 without any treatment. Lanes 4 to 9, aliquots taken at 0, 5, 10, 
15, 30 and 60 min from 5'-
32
P-t-144 (2 nM) incubated with non-radiolabeled 144 (10 nM) in 1  NER 
buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C. (Panel 
B) Percentage melting plotted against time (min). 
 
 
App. Figure 24. Restriction enzyme sites present on 146. 


































3'-d(TAC TTG TAT GAG CAT GAG ACG TAA AGC TY    CCG  GGC GGT TGG AGG CGA GGT GCG G)
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(A) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 3'-
32
P-b-146. 
Lane 1, 10 base pair DNA ladder. Lane 2, 3'-
32
P-b-146 without any treatment. Lane 3, 3'-
32
P-b-146 treated 
with CviQI. Lane 4, 3'-
32
P-b-146 treated with BsrBI. (B) Representative 15% denaturing PAGE gel 
analysis of restriction enzyme treatment of 3'-
32
P-t-146. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-
32
P-t-
146 without any treatment. Lane 3, 3'-
32
P-t-146 treated with CviQI. Lane 4, 3'-
32
P-t-146 treated with BsrBI. 
(C) Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of 5'-
32
P-b-146. 
Lane 1, 10 base pair DNA ladder. Lane 2, 5'-
32
P-b-146 without any treatment. Lane 3, 5'-
32
P-b-146 treated 
with CviQI. Lane 4, 5'-
32
P-b-146 treated with BsrBI. (D) Representative 15% denaturing PAGE gel 
analysis of restriction enzyme treatment of 5'-
32
P-t-146. Lane 1, 10 base pair DNA ladder. Lane 2, 5'-
32
P-t-
146 without any treatment. Lane 3, 5'-
32
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App. Figure 26. Thermal stability of 5'-
32
P-t-146 analyzed using non-denaturing (20%) PAGE. Lane 1 and 
2, aliquots at 0 and 60 min from single stranded 5'-
32
P-146, respectively. Lane 3, hybridized 5'-
32
P-t-146 
without any treatment. Lanes 4 to 9, aliquots taken at 0, 5, 10, 15, 30 and 60 min from 5'-
32
P-t-146 (2 nM) 
incubated with non-radiolabeled 146 (10 nM) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C. 
 
App. Figure 27. Restriction enzyme sites present on 135 and 148. 
















GAC ATG GTA CTG GCT GAT CGC GGC ACA TVA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)d-3'















5'-d(GAC ATG GTA CTG GCT GAT CGC GGC ACA TVA TAT ACG CGG ATC TGC ACG CTC GAC CGA TGC)
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P-t-148.  (A) Representative 15% 
denaturing PAGE gel analysis of restriction enzyme treatment of 5'-
32
P-t-148. Lane 1, 10 base pair DNA 
ladder. Lane 2, 5'-
32
P-t-148 without any treatment. Lane 3, 5'-
32
P-t-148 treated with with Taq

I. (B) 




P-t-135. Lane 1, 5'-
32
P-t-135 without any treatment. Lane 2, 5'-
32
P-t-135 treated with CviQI. Lane 3, 5'-
32
P-t-148 without any treatment. Lane 2, 5'-
32
P-t-148 treated with CviQI. 
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App. Figure 29. Representative 12% denaturing PAGE gel analysis of restriction enzyme treatment on 148 
internally labeled at 3'-side of the abasic site analog (V). Lane 1, 10 base pair DNA ladder. Lane 2, 
internally labeled 148 without any treatment. Lane 3, internally labeled 148 treated with Fnu4HI. Lane 3, 
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App. Figure 30. Denaturing (20%) PAGE showing UvrABC incision on the top strand (t) of 135. (Panel 
A) Strand containing abasic site analog (V) labeled at its 3'-terminus. (Panel B) Strand containing abasic 
site analog (V) labeled at its 5'-terminus. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-
32
P-t-135 (Panel A) 
or 5-
32
P-t-135 (Panel B). Lane 3, 3'-
32
P-t-135 (Panel A) or 5'-
32
P-t-135 (Panel B) treated with UvrABC for 
8 h. Lane 4, A+G sequencing of 3'-
32
P-t-135 (Panel A) or 5'-
32
P-t-135 (Panel B). Lane 5, T+C sequencing 
of 3'-
32
P-t-135 (Panel A) or 5'-
32
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App. Figure 31. Denaturing (20%) PAGE showing UvrABC incision on bottom strand (b) of 135. (Panel 
A) Strand containing deoxyadenosine analog (W) labeled at its 5'-terminus. (Panel B) Strand containing 
deoxyadenosine analog (W) labeled at its 3'-terminus. Lane 1, 10 base pair DNA ladder. Lane 2, 5'-
32
P-b-
135 (Panel A) or 3'-
32
P-b-135 (Panel B). Lane 3, 5'-
32
P-b-135 (Panel A) or 3'-
32
P-b-135 (Panel B) treated 
with UvrABC for 8 h. Lane 4, A+G sequencing of 5'-
32
P-b-135 (Panel A) or 3'-
32
P-b-135 (Panel B). Lane 5, 
T+C sequencing of 5'-
32
P-b-135 (Panel A) or 3'-
32
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App. Figure 32.Non-denaturing (16%) PAGE analysis of thermal stability of putative UvrABC double 
strand cleavage product of 135.  Lane 1, 5'-
32
P-t-151. Lane 2, 5'-
32
P-t-151. Lane 3, 5'-
32
P-t-151 (0.26 nM) 
incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 
mM) at room temperature for 3 h. Lane 4, 5'-
32
P-t-151 (0.26 nM) incubated in 1  NER buffer (50 mM 
Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C for 3 h. Lane 5, 5'-
32
P-
t-151 (0.26 nM) incubated with 153 (0.26 nM) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C for 3 h. Lane 6, 5'-
32
P-t-151 (0.26 nM) incubated with 
153 (1.3 nM) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and 
ATP 1 mM) at 55 C for 3 h. 
 
App. Figure 33. Representative 12% gel showing migration of bands from ligation of 3'-
32
P-b-189. Lane 1, 
3'-
32
P-b-148. Lane 2, 10 base pair DNA ladder. Lane 3, 3'-
32








5'-32P-d(GCA TCG GTC GAG CGT GCA GAT C)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GGC GCA TA)
3'-d(CGT AGC CAG CTC  GCA CGT CTA GTG TTT TCC GAT CAG ATC GAA)
5'-32P-d(GCA TCG GTC GAG CGT GCA GAT)
5'-32P-t-151
5'-32P-t-152
5'-32P-d(GCA TCG GTC GAG CGT GCA GAT)
5'-32P-187
3'-d(CGT AGC CAG CTC  GCA CGT CTA GTG TTT TCC GAT CAG ATC GAA)
153
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App. Figure 34. Denaturing PAGE gel (20%) analysis of UvrABC incision on 3'-
32
P-b-144. Lane 1, 3'-
32
P-
b-144 without any treatment. Lane 2, 3'-
32
P-b-144  incubated with UvrABC proteins in 1  NER buffer (50 
mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C for 1 h. Lane 3, 
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App. Figure 35. Representative denaturing (20%) PAGE showing 1 h time course study of UvrABC 
incision on 3'-
32
P-b-144. Lane 1, 3'-
32
P-b-144 incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 
mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 C for 0 min. Lane 2 to 
7, aliquots (in triplicate) taken at 0, 5, 10, 15, 30, and 60 min from incubation of 3'-
32
P-b-144 incubated 
with UvrABC in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and 
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App. Figure 36. Representative denaturing (20%) PAGE showing 1 h time course study of UvrABC 
incision on 5'-
32
P-t-144. Lane 1, 5'-
32
P-t-144 incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM 
MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 C for 0 min. Lane 2 to 7, 
aliquots (in triplicate) taken at 0, 5, 10, 15, 30, and 60 min from incubation of 5'-
32
P-t-144 incubated with 
UvrABC in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 
mM) at 55 C. Lane 8, A+G sequencing reaction on 5'-
32
P-t-144.  
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App. Figure 37. Denaturing PAGE gel (20%) analysis of UvrABC incision on 3'-
32
P-b-146. Lane 1, 3'-
32
P-
b-146 without any treatment. Lane 2, 3'-
32
P-b-146  incubated with UvrABC proteins in 1  NER buffer (50 
mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C for 1 h. Lane 3, 
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App. Figure 38. Representative denaturing PAGE gel (20%) showing 8 h time course study of UvrABC 
incision on 3'-
32
P-t-146. Lane 1, 10 base pair DNA ladder. Lane 2, 3'-
32
P-t-146 incubated in 1  NER buffer 
(50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment 
at 55 C for 0 h. Lane 3, 3'-
32
P-t-146 incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 
50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 C for 8 h. Lane 4 to 10, aliquots (in 
triplicate) taken at 0, 1, 2, 3, 4, 6, and 8 h from incubation of 3'-
32
P-t-146 incubated with UvrABC in 1  
NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C. 
Lane 11, A+G sequencing reaction on 3'-
32
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App. Figure 39. Representative denaturing (20%) PAGE showing 1 h time course study of UvrABC 
incision on 5'-
32
P-b-146. Lane 1, 5'-
32
P-b-146 incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 
mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) without any treatment at 55 C for 0 min. Lane 2, 5'-
32
P-b-146 incubated in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, 
and ATP 1 mM) without any treatment at 55 C for 60 min. Lane 3 to 9, aliquots (in triplicate) taken at 0, 5, 
10, 15, 30, and 60 min from incubation of 5'-
32
P-b-146 incubated with UvrABC in 1  NER buffer (50 mM 
Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and ATP 1 mM) at 55 C. Lane 11, A+G 
sequencing reaction on 5'-
32
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P-t-149 (containing fluoresceinylated 
dT or Fl-dT. Aliquots from DNA-protein incubations are analyzed by gel shift assay (4% nondenaturing 
PAGE). Positions of UvrA2-DNA complex and free DNA are annotated. Lanes 1 – 9, incubation of UvrA 
(0.5, 5, 10, 20, 40, 60, 80, 120, and 200 nM, respectively) with 0.3 nM 3'-
32





P-t-149 (C) in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, 
and ATP 1 mM) at 55 °C for 20 min.  
 
1     2   3    4    5   6   7   8  9  
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App. Figure 41. UvrA binding and subsequent transfer of 5'-
32
P-t-143 to UvrB. Aliquots from the reaction 
are analyzed by gel shift assay (4% nondenaturing PAGE). Positions of free DNA, UvrA2-DNA, UvrB2-
DNA complexes are annotated. Lanes 1 – 5, incubation of UvrA (1, 2, 4, 8 and 10 nM, respectively) and 
UvrB (500 nM) with 0.3 nM 3'-
32
P-t-143 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 
mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C for 20 min. Lane 6, incubation of 200 nM UvrA with 0.3 
nM 3'-
32
P-t-143 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and 
ATP 1 mM) at 55 °C for 20 min. 
 
App. Figure 42. UvrA binding and subsequent transfer of 5'-
32
P-t-146 to UvrB. Aliquots from the reaction 
are analyzed by gel shift assay (4% nondenaturing PAGE). Positions of free DNA, UvrA2-DNA, UvrB2-
DNA complexes are annotated. Lanes 1 – 5, incubation of UvrA (1, 2, 4, 8 and 10 nM, respectively) and 
UvrB (500 nM) with 0.3 nM5'-
32
P-t-146 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 
mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C for 20 min. Lane 6, incubation of 200 nM UvrA with 0.3 
nM 5'-
32
P-t-146 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and 




















1       2        3         4            5         6
5-32P-b-143
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App. Figure 43. UvrA binding and subsequent transfer of 5'-
32
P-t-149 to UvrB. Aliquots from the reaction 
are analyzed by gel shift assay (4% nondenaturing PAGE). Positions of free DNA, UvrA2-DNA, UvrB2-
DNA complexes are annotated. Lanes 1 – 5, incubation of UvrA (1, 2, 4, 8 and 10 nM, respectively) and 
UvrB (500 nM) with 0.3 nM 5'-
32
P-t-149 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 
mM KCl, 5 mM dTT, and ATP 1 mM) at 55 °C for 20 min. Lane 6, incubation of 200 nM UvrA with 0.3 
nM 5'-
32
P-t-149 in 1  NER buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 5 mM dTT, and 







1   2   3    4   5     6
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App. Figure 44. Hydroxyl radical cleavage reaction on 5'-
32
P-b-155 (observed ICL), 5'-
32
P-b-156 
(unobserved ICL), and 5'-
32







P-b-157 analyzed on 20% denaturing PAGE. Nucleotides of interest are 
indicated with arrows. Lane 1, 5'-
32
P-b-157 without any treatment. Lanes 2 – 5, 5'-
32
P-b-157 subjected to 





P-b-155 without any treatment. Lanes 8 – 11, 5'-
32
P-b-155 subjected to hydroxyl radical 
cleavage reaction for 5 min, room temperature. Lane 12, A-G sequencing of 5'-
32
P-b-155. Lane 13, 5'-
32
P-
b-156 without any treatment. Lanes 14 – 17, 5'-
32
P-b-156 subjected to hydroxyl radical cleavage reaction 
for 5 min, room temperature. Lane 18, A-G sequencing of 5'-
32
P-b-156.    (B) Representative lane profile 
from hydroxyl radical cleavage of 5'-
32
P-b-157. (C) Representative lane profile from hydroxyl radical 
cleavage of 5'-
32
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App. Figure 45. Diethylpyrocarbonate (DEPC) reaction on 5'-
32
P-b-155 (observed ICL), 5'-
32
P-b-156 
(unobserved ICL), and 5'-
32







P-b-157 analyzed on 20% denaturing PAGE. Nucleotides of interest are 
indicated with arrows. Lane 1, 1 M piperidine treatment of 5'-
32
P-b-157. Lanes 2 – 4, 5'-
32
P-b-157 treated 
with 1.04 M DEPC for 12 min, room temperature. Lane 5, A-G sequencing of 5'-
32
P-b-157. Lane 6, 1 M 
piperidine treatment of 5'-
32
P-b-155. Lanes 7 – 9, 5'-
32
P-b-155 treated with 1.04 M DEPC for 12 min, room 
temperature. Lane 10, A-G sequencing of 5'-
32
P-b-155.  Lane 11, 1 M piperidine treatment of 5'-
32
P-b-156. 
Lanes 12 – 14, 5'-
32
P-b-156 treated with 1.04 M DEPC for 12 min, room temperature. Lane 15, A-G 
sequencing of 5'-
32
P-b-156.  (B) Representative lane profile from DEPC treatment of 5'-
32
P-b-157. (C) 
Representative lane profile from DEPC treatment of 5'-
32
P-b-155. (D) Representative lane profile from 
DEPC treatment of 5'-
32
P-b-156. 
1 2 3 4 5 6 7 8 9 10
5’-32P-b-157 5’-32P-b-155 5’-32P-b-156
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App. Figure 46. Dimethylsulfate (DMS) reaction on 5'-
32
P-b-155 (observed ICL), 5'-
32
P-b-156 
(unobserved ICL), and 5'-
32







P-b-157 analyzed on 20% denaturing PAGE. Nucleotides of interest are indicated with arrows. Lane 1, 
1 M piperidine treatment of 5'-
32
P-b-157. Lanes 2 – 4, 5'-
32
P-b-157 treated with 25 mM DMS for 12 min, 
room temperature. Lane 5, A-G sequencing of 5'-
32
P-b-157. Lane 6, 1 M piperidine treatment of 5'-
32
P-b-
155. Lanes 7 – 9, 5'-
32
P-b-155 treated with 25 mM DMS for 12 min, room temperature. Lane 10, A-G 
sequencing of 5'-
32
P-b-155.  Lane 11, 1 M piperidine treatment of 5'-
32
P-b-156. Lanes 12 – 14, 5'-
32
P-b-156 
treated with 25 mM DMS for 12 min, room temperature. Lane 15, A-G sequencing of 5'-
32
P-b-156.  (B) 
Representative lane profile from DMS treatment of 5'-
32
P-b-157. (C) Representative lane profile from DMS 
treatment of 5'-
32
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App. Figure 47. Hydroxylamine reaction on 5'-
32
P-b-155 (observed ICL), and 5'-
32
P-b-156 (unobserved 




P-b-156 analyzed on 20% denaturing PAGE. 
Nucleotides of interest are indicated with arrows. Lane 1, 1 M piperidine treatment of 5'-
32
P-b-155. Lanes 2 
– 5, 5'-
32
P-b-155 treated with 0.80 M hydroxylamine for 10 min, room temperature. Lane 6, A-G 
sequencing of 5'-
32
P-b-155. Lane 7, 1 M piperidine treatment of 5'-
32
P-b-156. Lanes 8 – 11, 5'-
32
P-b-156 
treated with 0.80 M hydroxylamine for 10 min, room temperature. Lane 12, A-G sequencing of 5'-
32
P-b-
156.  (B) Representative lane profile from hydroxylamine treatment of 5'-
32
P-b-155. (C) Representative 
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App. Figure 48. Diethylpyrocarbonate (DEPC) reaction on 3'-
32





P-b-157 (control duplex), and 3'-
32
P-b-158 (control). (A) Diethylpyrocarbonate 








P-b-158. analyzed on 20% denaturing 
PAGE. Nucleotides of interest are indicated with arrows. Lane 1, 1 M piperidine treatment of 3'-
32
P-b-157. 
Lanes 2 – 5, 3'-
32
P-b-157 treated with 1.04 M DEPC for 12 min, room temperature. Lane 6, A-G 
sequencing of 3'-
32
P-b-157. Lane 7, 1 M piperidine treatment of 3'-
32
P-b-158. Lanes 8 – 11, 3'-
32
P-b-158 
treated with 1.04 M DEPC for 12 min, room temperature. Lane 12, A-G sequencing of 5'-
32
P-b-158.  Lane 
13, 1 M piperidine treatment of 3'-
32
P-b-155. Lanes 14 – 17, 3'-
32
P-b-155 treated with 1.04 M DEPC for 12 
min, room temperature. Lane 18, A-G sequencing of 5'-
32
P-b-155. Lane 19, 1 M piperidine treatment of 3'-
32
P-b-156. Lanes 20 – 23, 3'-
32
P-b-156 treated with 1.04 M DEPC for 12 min, room temperature. Lane 24, 
A-G sequencing of 3'-
32
P-b-156.   (B) Representative lane profile from DEPC treatment of 3'-
32
P-b-157. (C) 
Representative lane profile from DEPC treatment of 3'-
32
P-b-158. (D) Representative lane profile from 
DEPC treatment of 3'-
32
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App. Figure 49. Hydroxyl radical cleavage reaction on 3'-
32
P-t-155 (observed ICL), 3'-
32
P-t-156 
(unobserved ICL), and 3'-
32







P-t-157 analyzed on 20% denaturing PAGE. Nucleotides of interest are indicated 
with arrows. Lane 1, 3'-
32
P-t-157 without any treatment. Lanes 2 – 5, 3'-
32
P-t-157 subjected to hydroxyl 
radical cleavage reaction for 5 min, room temperature. Lane 6, A-G sequencing of 3'-
32
P-t-157. Lane 7, 3'-
32
P-t-155 without any treatment. Lanes 8 – 11, 3'-
32
P-t-155 subjected to hydroxyl radical cleavage reaction 
for 5 min, room temperature. Lane 12, A-G sequencing of 3'-
32
P-t-155. Lane 13, 3'-
32
P-t-156 without any 
treatment. Lanes 14 – 17, 3'-
32
P-t-156 subjected to hydroxyl radical cleavage reaction for 5 min, room 
temperature. Lane 18, A-G sequencing of 3'-
32
P-t-156.    (B) Representative lane profile from hydroxyl 
radical cleavage of 3'-
32
P-t-157. (C) Representative lane profile from hydroxyl radical cleavage of 3'-
32
P-t-
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App. Figure 50. KMnO4 cleavage reaction on 3'-
32
P-t-155 (observed ICL), 3'-
32
P-t-156 (unobserved ICL), 
and 3'-
32







analyzed on 20% denaturing PAGE. Nucleotides of interest are indicated with arrows. Lane 1, 1 M 
piperidine treatment of 3'-
32
P-t-157. Lanes 2 – 5, 3'-
32
P-t-157 subjected to 0.3 mM KMnO4 for 10 min, 
room temperature. Lane 6, A-G sequencing of 3'-
32
P-t-157. Lane 7, 1 M piperidine treatment of 3'-
32
P-t-
155. Lanes 8 – 11, 3'-
32
P-t-155 subjected to 0.3 mM KMnO4 for 10 min, room temperature. Lane 12, A-G 
sequencing of 3'-
32
P-t-155. Lane 13, 1 M piperidine treatment of 3'-
32
P-t-156. Lanes 14 – 17, 3'-
32
P-t-156 
subjected to 0.3 mM KMnO4 for 10 min, room temperature. Lane 18, A-G sequencing of 3'-
32
P-t-156.    (B) 
Representative lane profile from KMnO4 reaction of 3'-
32
P-t-157. (C) Representative lane profile from 
KMnO4 reaction of 3'-
32
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App. Figure 51. Hydroxylamine cleavage reaction on 3'-
32
P-t-155 (observed ICL), 3'-
32
P-t-156 
(unobserved ICL), and 3'-
32







P-t-157 analyzed on 20% denaturing PAGE. Nucleotide of interest are indicated with arrows. 
Lane 1, 1 M piperidine treatment of 3'-
32
P-t-157. Lanes 2 – 5, 3'-
32
P-t-157 subjected to 0.80 M 
hydroxylamine for 10 min, room temperature. Lane 6, A-G sequencing of 3'-
32
P-t-157. Lane 7, 1 M 
piperidine treatment of 3'-
32
P-t-155. Lanes 8 – 11, 3'-
32
P-t-155 subjected to 0.80 M hydroxylamine for 10 
min, room temperature. Lane 12, A-G sequencing of 3'-
32
P-t-155. Lane 13, 1 M piperidine treatment of 3'-
32
P-t-156. Lanes 14 – 17, 3'-
32
P-t-156 subjected to 0.80 M hydroxylamine for 10 min, room temperature. 
Lane 18, A-G sequencing of 3'-
32
P-t-156. (B) Representative lane profile from hydroxylamine reaction of 
3'-
32
P-t-157. (C) Representative lane profile from hydroxylamine reaction of 3'-
32
P-t-155. (D) 
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App. Figure 52. DMS cleavage reaction on 3'-
32
P-t-155 (observed ICL), 3'-
32
P-t-156 (unobserved ICL), 
and 3'-
32







on 20% denaturing PAGE. Nucleotides of interest are indicated with arrows. Lane 1, 1 M piperidine 
treatment of 3'-
32
P-t-157. Lanes 2 – 5, 3'-
32
P-t-157 subjected to 25 mM DMS for 12 min, room temperature. 
Lane 6, A-G sequencing of 3'-
32
P-t-157. Lane 7, 1 M piperidine treatment of 3'-
32
P-t-155. Lanes 8 – 11, 3'-
32
P-t-155 subjected to 25 mM DMS for 12 min, room temperature. Lane 12, A-G sequencing of 3'-
32
P-t-
155. Lane 13, 1 M piperidine treatment of 3'-
32
P-t-156. Lanes 14 – 17, 3'-
32
P-t-156 subjected to 25 mM 
DMS for 12 min, room temperature. Lane 18, A-G sequencing of 3'-
32
P-t-156. (B) Representative lane 
profile from DMS reaction of 3'-
32
P-t-157. (C) Representative lane profile from DMS reaction of 3'-
32
P-t-
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App. Figure 53. KMnO4 cleavage reaction on 5'-
32
P-t-155 (observed ICL), 5'-
32
P-t-156 (unobserved ICL), 
5'-
32
P-t-157 (control duplex) and 5'-
32









P-t-158 analyzed on 20% denaturing PAGE. Lane 1, 1 M piperidine treatment of 5'-
32
P-t-157. Lanes 2 – 5, 5'-
32
P-t-157 subjected to 0.3 mM KMnO4 for 10 min, room temperature. Lane 6, A-
G sequencing of 5'-
32
P-t-157. Lane 7, 1 M piperidine treatment of 5'-
32
P-t-158. Lanes 8 – 11, 5'-
32
P-t-158 
subjected to 0.3 mM KMnO4 for 10 min, room temperature. Lane 12, A-G sequencing of 5'-
32
P-t-158. Lane 
13, 1 M piperidine treatment of 5'-
32
P-t-155. Lanes 14 – 17, 5'-
32
P-t-155 subjected to 0.3 mM KMnO4 for 
10 min, room temperature. Lane 18, A-G sequencing of 5'-
32
P-t-155. Lane 19, 1 M piperidine treatment of 
5'-
32
P-t-156. Lanes 20 – 23, 5'-
32
P-t-156 subjected to 0.3 mM KMnO4 for 10 min, room temperature. Lane 
24, A-G sequencing of 5'-
32
P-t-156.   (B) Representative lane profile from KMnO4 reaction of 3'-
32
P-t-157. 
(C) Representative lane profile from KMnO4 reaction of 3'-
32
P-t-158. (D) Representative lane profile from 
KMnO4 reaction of 3'-
32
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App. Figure 54. Photoirradiation (350 nm) of 3'-
32
P-b-163 and hydroxyl radical cleavage reaction on C4-
AP kinetic ICL. (A) Photoirradiation (350 nm) of 3'-
32
P-b-163. Positions of kinetic (high molecular weight) 
and thermodynamic (low molecular weight) C4-AP ICLs are annotated. Lane 1, 10 bp ladder. Lane 2, 3'-
32
P-b-163 without any treatment. Lane 3, 3'-
32
P-b-163 subjected to 45 min irradiation (350 nm) followed by 
overnight incubation (37 °C). (B) Hydroxyl radical cleavage of C4-AP kinetic ICL. Lane 1, 3'-
32
P-b-163 
without any treatment. Lane 2, 3'-
32
P-b-163 without any treatment. Lanes 2 – 4, 3'-
32
P-b-163 subjected to 
hydroxyl radical cleavage, 5 min, room temperature. Lane 5, A-G sequencing of 3'-
32
P-b-163. Lane 6, the 
slowest moving band isolated from irradiation of 3'-
32
P-b-163 without any treatment. Lanes 7 – 9, hydroxyl 
radical cleavage treatment of slowest moving band from irradiation of 3'-
32
P-b-163, 8 min, room 
temperature. Lanes 10 – 12, hydroxyl radical cleavage treatment of slowest moving band from irradiation 
of 3'-
32












3'-d(GGT GTC  GAC GTG TAT XAT ATG  CTC GGC CAG C)
5'-d(CCA3 CAG6 CTG9  CAC12 ATA15 A16TA    TAC  GAG CCG GTC G)















 276  
 
 





3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48GC  T45A  G  ACG TGC)
5'-d(GCT3   G A5T6   CGC  GGC   ACA15  T16 W17A18  T19 A20T21   A  CG  C  GG  A28T29C  TGC ACG)
165
3'-d(CTG TAC CAT GAC CGA   CT   A   GCG CCG T   GT       A   T   V  ATA TGC GCC  TAG ACG TGC   GAG CTG GCT ACG)






3'-d(CGA    CT68A67 GCG  CCG   TGT58  A57T56  V55  A54T53A52   T51GC  G48GC  T45A  G  ACG TGC)-X
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P-b-169. (A) Representative 15% 
denaturing PAGE gel analysis of restriction enzyme treatment of purified 5'-
32
P-b-165. Lane 1, 10 base pair 
DNA ladder. Lane 2, 5'-
32
P-b-165 without any treatment. Lane 3, 5'-
32
P-b-165 treated with Fnu4HI. (B)  
Representative 20% denaturing PAGE gel analysis of restriction enzyme treatment of purified 5'-
32
P-b-169 
Lane 1, 10 base pair DNA ladder. Lane 2, 5'-
32
P-b-169 without any treatment. Lane 3, 5'-
32
P-b-169 treated 
with Fnu4HI. Lane 4, 5'-
32
P-b-169 treated with BstYI.  
 
 
App. Figure 57. Ligation for constructing 5'-
32
P-b-170 and restriction enzyme treatment of purified 5'-
32
P-
b-170. (A) Representative 15% denaturing PAGE gel showing the ligation to construct 5'-
32
P-b-170. Lane 
1, 10 base pair ladder. Lane 2, 5'-
32
P-b-131. Lane 3, crude reaction to produce 5'-
32
P-b-170. (B) 
Representative 15% denaturing PAGE gel analysis of restriction enzyme treatment of purified 5'-
32
P-b-170. 
Lane 1, 10 base pair DNA ladder. Lane 2, 5'-
32
P-b-170 without any treatment. Lane 3, 5'-
32
P-b-170 treated 
with RsaI. Lane 4, , 5'-
32
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App. Figure 58. KMnO4 reaction on 5'-
32
P-b-167 (control duplex), 5'-
32
P-b-135 (observed ICL), and 5'-
32
P-
b-170 (unobserved ICL). Nucleotides of interest are indicated with arrows. (A) KMnO4 reaction on 3'-
32
P-
b-167 analyzed on 20% denaturing PAGE. Lane 1, 1 M piperidine treatment of 5'-
32
P-b-167. Lanes 2 – 5, 
5'-
32
P-b-167 treated with 0.6 mM KMnO4 for 10 min, room temperature. Lanes 6 and 7, A-G and T-C 
sequencing of 5'-
32














P-b-170 treated with 0.6 mM KMnO4 for 10 min 





respectively. (C) Representative lane profile from KMnO4 treatment of 5'-
32
P-b-167. (D) Representative 
lane profile from KMnO4 treatment of 5'-
32
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App. Figure 59. Diethylpyrocarbonate (DEPC) reaction on 5'-
32
P-b-167 (control duplex), 5'-
32
P-b-135 
(observed ICL), and 5'-
32
P-b-170 (unobserved ICL). Nucleotides of interest are indicated with arrows. (A) 
DEPC reaction on 3'-
32
P-b-167 analyzed on 20% denaturing PAGE. Lane 1, 1 M piperidine treatment of 5'-
32
P-b-167. Lanes 2 – 7, 5'-
32
P-b-167 treated with 1.75 M DEPC for 12 min, room temperature. Lanes 8 and 
9, A-G and T-C sequencing of 5'-
32



















P-b-170, respectively. (C) Representative lane profile from DEPC treatment of 5'-
32
P-b-167. 
(D) Representative lane profile from DEPC treatment of 5'-
32
P-b-135. (E) Representative lane profile from 
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App. Figure 60. Hydroxyl radical cleavage reaction on 3'-
32
P-b-167 (control duplex), 3'-
32
P-b-165 
(observed ICL), and 3'-
32
P-b-166 (unobserved ICL). Nucleotides of interest are indicated with arrows. (A) 






P-b-167 analyzed on 20% 






P-b-166 without any treatment. 






P-b-166 subjected to hydroxyl radical 
cleavage reaction for 5 min, room temperature. Lanes 8 and 9, A-G and T-C sequencing of 3'-
32
P-b-167, 




P-b-166, respectively. (B) 
Representative lane profile from hydroxyl radical cleavage reaction of 3'-
32
P-b-167. (C) Representative lane 
profile from hydroxyl radical cleavage reaction of 3'-
32
P-b-165. (D) Representative lane profile from 
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App. Figure 61. KMnO4 reaction on 3'-
32
P-b-167 (control duplex), 3'-
32
P-b-165 (observed ICL), and 3'-
32
P-







P-b-167 analyzed on 20% denaturing PAGE. Lanes 1, 8, and 14, 1 M 













P-b-166 treated with 0.6 mM KMnO4 for 10 min, room temperature. Lanes 6 
and 7, A-G and T-C sequencing of 3'-
32





P-b-166, respectively. (B) Representative lane profile from KMnO4 reaction of 3'-
32
P-b-167. 
(C) Representative lane profile from KMnO4 reaction of 3'-
32
P-b-165. (D) Representative lane profile from 
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App. Figure 62. DEPC reaction on 3'-
32
P-b-167 (control duplex), 3'-
32
P-b-165 (observed ICL), and 3'-
32
P-







P-b-167 analyzed on 20% denaturing PAGE. Lanes 1, 8, and 14, 1 M 













P-b-166 treated with 1.75 M DEPC for 12 min, room temperature. Lanes 6 and 
7, A-G and T-C sequencing of 3'-
32





P-b-166, respectively. (C) Representative lane profile from DEPC reaction of 3'-
32
P-b-167. 
(D) Representative lane profile from DEPC reaction of 3'-
32
P-b-165. (E) Representative lane profile from 
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App. Figure 63. DEPC reaction on 5'-
32
P-t-167 (control duplex), 5'-
32
P-t-165 (observed ICL), and 5'-
32
P-t-
166 (unobserved ICL). Nucleotides of interest are indicated with arrows. (A) DEPC reaction on 5'-
32
P-t-167 
analyzed on 20% denaturing PAGE. Lanes 1, 1 M piperidine treatment of 5'-
32
P-t-167. Lanes 2 – 9, 3'-
32
P-t-
167 treated with 1.75 M DEPC for 12 min, room temperature. Lane 10, A-G sequencing of 3'-
32
P-t-167. (B) 




P-t-166 analyzed on 20% denaturing PAGE. Lanes 1 and 11, 1 M 






































1 2 3 4 5 6 7 8 9 10 11 12 13 14 1516 17 18 19 201 2 3 4 5 6 7 8 9 10A B
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App. Figure 64. Representative Histograms of DEPC reaction on 5'-
32
P-t-167 (control duplex), 5'-
32
P-t-165 
(observed ICL), and 5'-
32
P-t-166 (unobserved ICL). Nucleotides of interest are indicated. (A) 
Representative lane profile from DEPC reaction of 5'-
32
P-t-167. (B) Representative lane profile from DEPC 
reaction of 5'-
32
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App. Figure 65. KMnO4 reaction on 5'-
32
P-t-167 (control duplex), 5'-
32
P-t-165 (observed ICL), and 5'-
32
P-





















P-t-166 treated with 0.6 mM KMnO4 for 10 min, room temperature. Lanes 6, 12, and 18, A-






P-t-166, respectively. (B) Representative lane profile 
from KMnO4 reaction of 5'-
32
P-t-167. (C) Representative lane profile from KMnO4 reaction of 5'-
32
P-t-165. 




























T45T53 T515’-32P-t-167 5’-32P-t-165 5’-32P-t-166
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App. Figure 66. Hydroxyl radical cleavage reaction on 3'-
32





P-t-166 (unobserved ICL). Nucleotides of interest are indicated with arrows. (A) Hydroxyl 






P-t-166 analyzed on 20% denaturing PAGE. 






P-t-166 without any treatment. Lanes 2 – 7, 11 – 16 






P-t-166 subjected to hydroxyl radical cleavage reaction for 5 
min, room temperature. Lanes 8 and 9, A-G and T-C sequencing of 3'-
32
P-t-167, respectively. Lanes 17 and 




P-t-166, respectively. (B) Representative lane profile from 
hydroxyl radical cleavage reaction of 3'-
32
P-t-167. (C) Representative lane profile from hydroxyl radical 
cleavage reaction of 3'-
32
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App. Figure 67. KMnO4 reaction on 3'-
32
P-t-167 (control duplex), 3'-
32
P-t-165 (observed ICL), and 3'-
32
P-





















P-t-166 treated with 0.6 mM KMnO4 for 10 min, room temperature. Lanes 6 and 7, A-G and 
T-C sequencing of 3'-
32





166, respectively. (B) Representative lane profile from KMnO4 reaction of 3'-
32
P-t-167. (C) Representative 
lane profile from KMnO4 reaction of 3'-
32
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App. Figure 68. DEPC reaction on 3'-
32
P-t-167 (control duplex), 3'-
32
P-t-165 (observed ICL), and 3'-
32
P-t-





















P-t-166 treated with 1.75 M DEPC for 12 min, room temperature. Lanes 6 and 7, A-G and 
T-C sequencing of 3'-
32





166, respectively. (C) Representative lane profile from DEPC reaction of 3'-
32
P-t-167. (D) Representative 
lane profile from DEPC reaction of 3'-
32




























































C NMR spectra of 62. 
 








C NMR spectra of 63a. 








C NMR spectra of 63b. 








C NMR spectra of 64a. 








C NMR spectra of 64b. 








C NMR spectra of 65a. 








C NMR spectra of 65b. 








C NMR spectra of 66a. 








C NMR spectra of 66b. 








C NMR spectra of 109. 








C NMR spectra of DMT protected 109. 








C NMR spectra of 110. 








C NMR spectra of DMT deprotected 110. 








C NMR spectra of 111a. 
 




App. Figure 83. 
1
H NMR and ESI-MS spectra of 111b. 








C NMR spectra of 112a. 








C NMR spectra of 112b. 








C NMR spectra of DMT protected 112a. 




App. Figure 87. 
1
H NMR and ESI-MS spectra of DMT protected 112b. 








P NMR spectra 113a. 
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App. Figure 90. LC/MS of oligonucleotide 77. Extracted  ion chromatogram of 77 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
 
App. Figure 91. LC/MS of oligonucleotide 83. Extracted  ion chromatogram of 83 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
 
 
App. Figure 92. LC/MS of oligonucleotide 84. Extracted  ion chromatogram of 84 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
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App. Figure 93. LC/MS of oligonucleotide 121. Extracted  ion chromatogram of 121 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
 
App. Figure 94. LC/MS of oligonucleotide 129. Extracted  ion chromatogram of 129 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
 312  
 
 
App. Figure 95. LC/MS of oligonucleotide 130. Extracted  ion chromatogram of 130 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
 
App. Figure 96. LC/MS of oligonucleotide 164. Extracted  ion chromatogram of 164 with the 
oligonucleotide sequence and chemical structure of cross-link are shown.  
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App. Figure 97. MALDI-TOF-MS of 71. Calc’d mass 2450.622, observed mass 2447.696. 
 
App. Figure 98. MALDI-TOF-MS of 72. Calc’d mass 4275.806, observed mass 4278.632. 
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App. Figure 99. MALDI-TOF-MS of 73. Calc’d mass 6107.621, observed mass 5483.628 [72 + 5dT], 
6190.154 [72 + 6dT]. 
 
App. Figure 100. MALDI-TOF-MS of 74. Calc’d mass 3692.454, observed mass 3694.659. 
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App. Figure 101. MALDI-TOF-MS of 75. Calc’d mass 5213.422, observed mass 5214.517. 
 
App. Figure 102. MALDI-TOF-MS of 76. Calc’d mass 9293.094, observed mass 9304.480. 
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App. Figure 103. ESI-MS of 77. Calc’d mass 13304.603, observed mass 13305.800, 13344.200 [M + K]
+
, 
13365.001 [M + K + Na]
+
, 13381.800 [M + 2K]
+
, 13403.600 [M + 2K + Na]
+





App. Figure 104. MALDI-TOF-MS of 79. Calc’d mass 17908.693, observed mass 8948.023 (z = -2), 
17915.067. 
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App. Figure 105. ESI-MS of 82. Calc’d mass 19262.492, observed mass 19263.699, 19302.500 [M + K]
+
, 
19223.400 [M + K + Na]
+
, 19341.400 [M + 2K]
+
, 19361.699 [M + 2K + Na]
+
, 19380.599 [M + 3K]
+
.  
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App. Figure 106. ESI-MS of 83. Calc’d mass 12718.312, observed mass 12718.700, 12756.400 [M + K]
+
, 
12793.800 [M + 2K]
+
. 
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App. Figure 107. ESI-MS of 84. Calc’d mass 13304.603, observed mass 13305.900, 13344.900 [M + K]
+
, 
13365.601 [M + K + Na]
+
, 13382.200 [M + 2K]
+
, 13403.700 [M + 2K + Na]
+




App. Figure 108. MALDI-TOF-MS of 85. Calc’d mass 8377.514, observed mass 2763.987 (z = -3), 
4188.692 (z = -2), 8376.265. 
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App. Figure 109. MALDI-TOF-MS of 86. Calc’d mass 8377.514, observed mass 2796.987 (z = -3), 
4194.692 (z = -2), 8385.662. 
 
App. Figure 110. MALDI-TOF-MS of 89. Calc’d mass 3983.611, observed mass 3982.567, 4004.878 [M 
+ Na]
+
, 4021.506 [M + K]
+
. 
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App. Figure 111. MALDI-TOF-MS of 115. Calc’d mass 2492.651, observed mass 2488.390. 
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App. Figure 113. ESI-MS of 121. Calc’d mass 16182.485, observed mass 16184.500, 16223.799 [M + 
K]
+
, 16261.500 [M + 2K]
+
, 16282.200 [M + 2K + Na]
+
, 16299.700 [M + 3K]
+
, 16320.700 [M + 3K + Na]
+
, 
16357.700 [M + 4K + Na]
+
, 16374.700 [M + 5K]
+
. 
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App. Figure 114. ESI-MS of 128. Calc’d mass 16511.658, observed mass 16513.699, 16551.599 [M + 
K]
+
, 16589.500 [M + 2K]
+
, 16628.400 [M + 3K]
+
.  
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App. Figure 115. ESI-MS of 129. Calc’d mass 8383.464, observed mass 4191.800 (z = -2), 8383.200, 
8404.900 [M + Na]
+
, 8421.200 [M + K]
+
, 8442.800 [M + Na + K]
+
, 8458.000 8421.200 [M + 2K]
+
, 
8463.900 [M + 2Na + K]
+
.  
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App. Figure 116. ESI-MS of 130. Calc’d mass 8383.464, observed mass 4192.000 (z = -2), 8383.500, 
8405.300 [M + Na]
+
, 8421.300 [M + K]
+




App. Figure 117. MALDI-TOF-MS of 143. Calc’d mass 4287.809, observed mass 4287.397. 
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App. Figure 118. ESI-MS of 162. Calc’d mass 9855.495, observed mass 9857.100, 9894.700 [M + K]
+
.  
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App. Figure 119. ESI-MS of 164. Calc’d mass 16182.485, observed mass 16185.800, 16207.900 [M + 
Na]
+
, 16245.501 [M + Na + K]
+
, 16283.801 [M + Na + 2K]
+
, 16307.300 [M + 2Na + 2K]
+
, 16323.201 [M 
+ Na + 3K]
+
, 16333.900 [M + 3Na + 2K]
+














3'-d(CCG TGT ATV ATA TGC CG)-O-PO3
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App. Table 1. Chemical probing experiments on DOB ICL analogue 3 for 5'-side of dA containing 






(156) and control 
duplex (157) 
Normalized cleavage (NC) value [ = 
                                                







based on  
student’s t test (between 
155 and 156) 
A14 of 157 
A15 of 157 
0.67  0.04 





The difference is 
significant to P value 
0.003 
Cross-linked 
position of 155 
(X14) 
0.94  0.07 
Cross-linked 
position of 156 
(X15) 
0.75  0.04 




The difference is 
significant to P value 
0.0983 
G13 of 155 1.25  0.07 
G13 of 156 1.41  0.07 





The difference is 
significant to P value 
0.4839 
C12 of 155 0.87  0.03 
C12 of 156 0.93  0.15 




The difference is 
significant to P value 
0.2 
A11 of 155 1.03  0.11 
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App. Table 2. Chemical probing experiments on DOB ICL analogue 3 for 3'-side of dA containing 
strand (“bottom” strand) 
Nucleotide of interest in 
observed ICL (155), 
unobserved ICL (156) and 
control duplex (157) 
Normalized cleavage (NC) value [ = 
                                                









on student’s t test 
(between 155  
and 156) 
A15  of 157 
A16 of 157 
1.120.15 










The difference is 
significant to P 
value  
0.0440 
A15  of 158 
A16 of 158 
4.56  0.48 
4.18  0.62 
Position adjacent to cross-
link in 155 (A15) 
1.93  0.32 
Position adjacent to cross-
link in 156 (A16) 
3.09  0.85 
A16 of 155 1.90  0.36 A23 
(DEPC) 
The difference is 
significant to P 
value 0.0425 A16 of 156 3.09   0.85 





The difference is 
significant to P 
value  
0.3169 
A17  of 158 1.83  0.12 
A17 of 155 1.17  0.25 
A17 of 156 1.36  0.23 
 
App. Table 3. Chemical probing experiments on DOB ICL analogue 3 for 3'-side of abasic side 
analog containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (155), 
unobserved ICL (156) 
and control duplex 
(157) 
Normalized cleavage (NC) value [ = 
                                                






significance based on 
student’s t test 
(between 155 and 
156) 
T46 of 157 0.41  0.39 G54 
(hydroxyl 
radical) 
The difference is 
significant to P value  
0.000 
Y46 of 155  1.87  0.43 
Y46 of 156  3.77  0.25 





The difference is 
significant to P value  
0.000 
T47 of 155 18.31  1.23 
T47 of 156 6.22  0.62 
C48 of 157 0.76  0.22  C55 
(hydroxyl 
amine) 
The difference is 
significant to P value  
0.136 
C48 of 155 0.89  0.02 
C48 of 156 1.15  0.30 




The difference is 
significant to P value  
0.008 
G49 of 155 1.45  0.22 
G49 of 156 1.90  0.04 





The difference is 
significant to P value  
0.002 
T50 of 155 1.48  0.08 
T50 of 156 2.14  0.27 
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App. Table 4. Chemical probing experiments on DOB ICL analogue 3 for 5'-side of abasic side 
analog containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (155), 
unobserved ICL (156) 
and control duplex (157) 
Normalized cleavage (NC) value [ = 
                                                







on student’s t test 
(between 155 and 
156) 





The difference is 
significant to P 
value 0.0842 
T45  of 158 21.23  0.89 
T45 of 155 6.25  0.44 
T45 of 156 7.20  0.56 





The difference is 
significant to P 
value 0.001 
T44  of 158 9.59  0.63 
T44 of 155 2.59  0.17 
T44 of 156 5.12  0.22 
 
App. Table 5. Chemical probing experiments on C4-AP ICL analogue 4 for 5'-side of dA containing 
strand (“bottom” strand) 
Nucleotide of interest in 
observed ICL (135), 
unobserved ICL (170) 
and control duplex (167) 
Normalized cleavage (NC) value [ = 
                                                







on student’s t test 
(between 135 and 
170) 
T16 of 167 0.84  0.05 T18 (T6 for 
167) 
(KMnO4) 
The difference is 
significant to P 
value 0.008 
T28  of 135 1.42  0.02 
T28 of 170 1.60  0.09 
A15 of 167 0.77  0.17 A17 (A5 for 
167) 
(DEPC) 
The difference is 
significant to P 
value 0.001 
A27 of 135 2.43  0.03 
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App. Table 6. Chemical probing experiments on C4-AP ICL analogue 4 for 3'-side of dA containing 
strand (“bottom” strand) 
Nucleotide of interest in 
observed ICL (165), 
unobserved ICL (166) 
and control duplex (167) 
Normalized cleavage (NC) value [ = 
                                                







on student’s t test 
(between 165 and 
166) 




The difference is 
significant to P 
value 0.13 
A18 of 167 1.04 ± 0.23 
W17 of 165 0.67 ± 0.11 
W18 of 166 0.94 ± 0.39 
T19 of 167 1.35 ± 0.17 T29 
(KMnO4) 
 
The difference is 
significant to P 
value 0.000 
T19 of  165 14.99 ± 0.84 
T19 of 166 2.61 ± 0.27 
A20 of 167 1.47 ± 0.26 A28 
(DEPC) 
 
The difference is 
significant to P 
value 0.002 
A20 of 165 3.39 ± 0.21 
A20 of 166 4.80 ± 0.47 
A18 of 167 Not calculated A28 
(DEPC) 
 
The difference is 
significant to P 
value 0.02 
A20 of 167 1.47  0.26 
A18 of 165 4.01  0.19 
A20 of 166 4.80 ± 0.47 
T21 of 167 0.97 ± 0.24 T29 
(KMnO4) 
 
The difference is 
significant to P 
value 0.59 
T21 of 165 1.85 ± 0.14 
T21of 166 1.80 ± 0.11 
 
App. Table 7. Chemical probing experiments on C4-AP ICL analogue 4 for 5'-side of abasic site 
analogue containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (165), 
unobserved ICL (166) 
and control duplex (167) 
Normalized cleavage (NC) value [ = 
                                                







on student’s t test 
(between 165 and 
166) 
A54 of 167 3.01± 0.34 G48 (DEPC) The difference is 
significant to P 
value 0.000 
A54 of 165 5.47 ± 0.35 
A54 of 166 18.91 ± 6.67 
T53 of 167 0.94 ± 0.03 T45 
(KMnO4) 
The difference is 
significant to P 
value 0.000 
T53 of 165 2.39 ± 0.27 
T53 of 166 3.85 ± 0.17 
A52 of 167 1.73 ± 0.37 G48 
(DEPC) 
The difference is 
significant to P 
value 0.000 
A52 of 165 2.44 ± 0.33 
A52 of 166 6.67 ± 1.68 
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App. Table 8. Chemical probing experiments on C4-AP ICL analogue 4 for 3'-side of abasic site 
analogue containing strand (“top” strand) 
Nucleotide of interest in 
observed ICL (165), 
unobserved ICL (166) 
and control duplex (167) 
Normalized cleavage (NC) value [ = 
                                                






on student’s t test 
(between 165 and 
166) 




The difference is 
significant to P 
value 0.67 
V55 of 165 0.84 ± 0.38 
V55 of 166 0.77 ± 0.10 
T56 of 167 2.31 ± 0.22 T68 
(KMnO4) 
The difference is 
significant to P 
value < 0.00001 
T56 of 165 1.36 ± 0.12 
T56 of 166 4.45 ± 0.30 
A57 of 167 0.95 ± 0.24  
A67 
(DEPC) 
The difference is 
significant to P 
value 0.0004 
A57 of 165 2.08 ± 0.15 
A57 of 166 2.72 ± 0.09 
T58 of 167 1.28 ± 0.23  
T68 
(KMnO4) 
The difference is 
significant to P 
value 0.0002 
T58 of 165 1.07 ± 0.13 
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